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FSP Section 20,000
Checklists and Illustrative Financial
Statements for Life and Health Insurance
Entities
Letter to Customers
Dear Valued Customer,
The following checklists and illustrative materials have been developed by the AICPA Accounting and Auditing Publications Staff to serve as nonauthoritative practice aids for use by preparers of financial statements and by practitioners who audit, review, or compile financial statements. The auditor’s and accountant’s report checklists address those requirements most likely to be encountered when reporting on financial
statements of a commercial corporation prepared in conformity with U.S. generally accepted accounting
principles.
Relevant financial statement reporting and disclosure guidance issued through September 30, 2009, has been
considered in the development of this edition of the checklist. The accounting guidance in this checklist has
been conformed to reflect reference to FASB Accounting Standards Codificatione as it existed on September
30, 2009.
Any guidance issued subsequent to September 30, 2009, has not been included in this checklist; therefore, if
your entity has a fiscal year-end after September 30, 2009, you need to consider the applicability of such
guidance. In determining the applicability of newly issued guidance, its effective date also should be considered.
Recognizing that many entities have December 31 year-ends and in an effort to assist those users, this checklist includes guidance issued through September 30, 2009, which may become effective by December 31,
2009. This guidance is discussed in each section of the checklist when applicable. Additional questions appear and are indicated with an “A” or “B” reference. As determined by the effective date or early implementation decision
●

entities for which this guidance has not been implemented should consider all questions with an
“A” reference (for example, question 1A, question 2A, and so on) and should place an
“N/A” mark by questions with a “B” reference.

●

entities for which this guidance has been implemented should consider all questions with a “B”
reference (for example, question 1B, question 2B, and so on) and should place an “N/A” mark by
questions with an “A” reference.

Therefore, based upon the year-end of the entities and the decision to early implement (if allowed), the
appropriate additional questions should be answered when provided.
We hope you find this checklist helpful as you perform your audit and compilation and review engagements. We would greatly appreciate your feedback on this checklist. You may e-mail these comments to
A&APublications@aicpa.org or write to
A&A Publications
AICPA
220 Leigh Farm Road
Durham, NC 27707-8110

FSP §20,000
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Life and Health Insurance Entities

Introduction
.01 The function of insurance is to pool the risks of many persons who are exposed to similar risks. For
a payment known as a premium, insurance companies undertake to relieve the policyholder of all or part of
a risk and to spread the total cost of similar risks among large groups of policyholders. One of the primary
purposes of life insurance is to provide financial assistance to named beneficiaries at the time of the death
of the insured. The long-term nature of the coverage involving the risk of death—a risk that increases with
age—is the distinguishing characteristic that sets life insurance apart from other forms of insurance. Traditionally, life insurance entities provided life and health products to protect against the loss of financial stability resulting from premature death or illness and provided annuity products to protect against the risk of
outliving one’s financial resources. The primary emphasis was on meeting the customer’s insurance needs.
The provisions of AICPA Audit and Accounting Guide Life and Health Insurance Entities (2009) (product no.
012639kk) apply to all life and health insurance entities including stock, mutual, fraternal, and assessment
entities.
.02 The National Association of Insurance Commissioners (NAIC) codified statutory accounting practices for certain insurance enterprises, resulting in a revised Accounting Practices and Procedures Manual. The
insurance laws and regulations of the states require insurance companies domiciled in the states to comply
with the guidance provided in the NAIC Accounting Practices and Procedures Manual except as prescribed or
permitted by state law.
.03 Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 944-505-50-3
requires insurance entities to disclose, at the date each balance sheet is presented, a description of the prescribed or permitted statutory accounting practice and the related monetary effect on statutory surplus of
using an accounting practice that differs from either state prescribed statutory accounting practices or NAIC
statutory accounting practices.
.04 As discussed in FASB ASC 944-505-50-2, those disclosures should be made if (a) state prescribed
statutory accounting practices differ from NAIC statutory accounting practices or (b) permitted state statutory accounting practices differ from either state prescribed statutory accounting practices or NAIC statutory
accounting practices, and the use of prescribed or permitted statutory accounting practices (individually or
in the aggregate) results in reported statutory surplus or risk-based capital that is significantly different from
the statutory surplus or risk-based capital that would have been reported had NAIC statutory accounting
practices been followed.
.05 According to paragraphs 4–6 of FASB ASC 944-505-50, those disclosures should be applied by a U.S.
insurance entity, a U.S. entity with a U.S. insurance subsidiary, or a foreign entity with a U.S. insurance
subsidiary if the entity prepares U.S. generally accepted accounting principles (GAAP) financial statements.
If a foreign insurance entity that does not have a U.S. insurance subsidiary prepares U.S. GAAP financial
statements or is included in its parent’s consolidated U.S. GAAP financial statements, the notes to the financial statements should disclose permitted regulatory accounting practices that significantly differ from the
prescribed regulatory accounting practices of its respective regulatory authority and their monetary effects.
If an insurance entity’s risk-based capital would have triggered a regulatory event had it not used a permitted practice, that fact should be disclosed in the financial statements.

General
.06 This publication includes the following information:
●

Financial Statements and Notes Checklist (FSP section 20,100)—For use by preparers of financial
statements and by auditors as they evaluate the adequacy of disclosures

●

Auditors’ Reports Checklist (FSP section 20,200)—For use by auditors in reporting on audited
financial statements

FSP §20,000.01
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●

Supplemental Information for Life Insurance Entities That are Securities and Exchange Commission Registrants (FSP section 20,300)

●

Illustrative Financial Statements (FSP section 20,400)

.07 This checklist is intended to be used in connection with engagements of nonpublic entities and is
not intended to be used in connection with audits of public entities that are required to be audited under
standards established by the Public Accounting Oversight Board (PCAOB).
.08 These checklists and illustrative materials have been developed by the AICPA Accounting and Auditing Publications Staff to serve as nonauthoritative practice aids for use by preparers of financial statements and by practitioners who audit them. The auditor’s report checklist addresses those requirements
most likely to be encountered when reporting on financial statements of a life and health insurance entity
prepared in conformity with U.S. GAAP. They do not include reporting requirements relating to other matters such as internal control or agreed-upon procedures. The financial statement and notes checklist includes
disclosure considerations applicable to life and health insurance entities in preparing financial statements in
conformity with U.S. GAAP. It does not include disclosures prescribed by guidance whose applicability to
life and health insurance entities is considered to be remote.
.09 Users of the financial statements and notes checklist should remember that it is a disclosure checklist
only and not a comprehensive U.S. GAAP application or measurement checklist. Accordingly, application
and measurement issues related to preparing financial statements in conformity with U.S. GAAP are not
included in the checklist.
.10 The checklists and illustrative financial statements should be used by, or under the supervision of,
persons having adequate technical training and proficiency in the application of U.S. GAAP, generally accepted auditing standards, and other relevant technical guidance.
.11 In some cases, this checklist uses the term Common Practice or provides additional practice tips to
describe a disclosure item. In such cases, although there is no authoritative guidance to support such a
disclosure for nonpublic entities, it has become a common practice (sometimes due to Securities and
Exchange Commission [SEC] requirements) that such disclosures are made. Entities should evaluate
whether such items warrant disclosure in their financial statements.
.12 Relevant financial statement reporting and disclosure guidance issued through September 30, 2009,
has been considered in the development of this edition of the checklist. This includes relevant guidance
issued up to and including the following:
●

FASB Accounting Standards Updates issued through September 30, 2009

●

Statement on Auditing Standards No. 116, Interim Financial Information (AICPA,Professional Standards, vol. 1, AU sec. 722)

●

Interpretation No. 19, "Financial Statements Prepared in Conformity With International Financial Reporting Standards as Issued by the International Accounting Standards Board," of AU
section 508, Reports on Audited Financial Statements (AICPA, Professional Standards, vol. 1, AU sec.
9508 par. .93–.97)

●

Statement of Position (SOP) 09-1, Performing Agreed-Upon Procedures Engagements That Address
the Completeness, Accuracy, or Consistency of XBRL-Tagged Data (AICPA, Technical Practice Aids,
AUD sec. 14,440)

●

Statements on Standards for Attestation Engagements No. 15, An Examination of an Entity’s Internal Control Over Financial Reporting That Is Integrated With an Audit of Its Financial Statements
(AICPA, Professional Standards, vol. 1, AT sec. 501)

●

Interpretation No. 7, "Reporting on the Design of Internal Control," of AT section 101, Attest
Engagements (AICPA, Professional Standards, vol. 1, AT sec. 9101 par. .59–.69)

●

PCAOB Auditing Standard No. 6, Evaluating Consistency of Financial Statements (AICPA, PCAOB
Standards and Related Rules, Auditing Standards)

FSP §20,000.12

4

Life and Health Insurance Entities

.13 Any guidance issued subsequent to September 30, 2009, has not been included in this checklist;
therefore, if your entity has a fiscal year-end after September 30, 2009, you need to consider the applicability
of such guidance. In determining the applicability of newly issued guidance, its effective date should also
be considered.
.14 Recognizing that many entities have December 31 year-ends and in an effort to assist those users,
questions are also included in this checklist if the guidance was issued on or before September 30, 2009, and
will become effective for entities with fiscal year-ends on or before December 31, 2009.
.15 Because such questions may not be applicable for September 30, 2009, year-ends, they are separately
identified with an "A" or "B" designation in the checklist (for example, question 1A and question 1B).
Throughout the checklist information is presented to assist entities in making decisions, based on a consideration of the effective date of the guidance or early implementation decision made by the entity, as to which
questions are applicable, ensuring that the appropriate additional questions are answered when provided.
.16 Users with September 30, 2009, fiscal year-ends should consider questions designated "A" and place
an "N/A" mark in questions designated "B." Users with fiscal years-end after September 30, 2009, must
consider the effective date of the pronouncement. If applicable, users should answer questions designated
"B" and should place an "N/A" mark in questions designated "A." If not applicable, questions designated
"A" should be answered and an "N/A" mark should be used for questions designated "B."
.17 These checklists contain numerous references to accounting and auditing guidance. Abbreviations
and acronyms used in such references include the following:
FASB ASC5

Reference to a topic, subtopic, section, or paragraph in Financial Accounting
Standards Board Accounting Standards Codificatione

AAG-LHI5

Reference to AICPA Audit and Accounting Guide Life and Health Insurance
Entities (2009)

AU5

Reference to a section number in AICPA Professional Standards for U.S.
Auditing Standards that are applicable to nonissuers

AUD5

Reference to a section number in AICPA Technical Practice Aids, Statements of
Position—Auditing and Attestation

PCAOB AU5

Reference to a section number in AICPA PCAOB Standards and Related Rules
for interim auditing standards, as amended, of the PCAOB that are
applicable to issuers

SOP5

AICPA Statement of Position

.18 The accounting guidance in this checklist has been conformed to reflect reference to FASB ASC as it
existed on September 30, 2009.
.19 On June 30, 2009, FASB issued FASB Statement No. 168, The FASB Accounting Standards Codificatione and the Hierarchy of Generally Accepted Accounting Principles—a replacement of FASB Statement No. 162,
which is codified at FASB ASC 105, Generally Accepted Accounting Principles. On the effective date of this
statement, FASB ASC is the authoritative source of U.S. accounting and reporting standards for nongovernmental entities, in addition to guidance issued by the SEC. At that time, FASB ASC supersedes all thenexisting, non-SEC accounting and reporting standards for nongovernmental entities. Once effective, all other
nongrandfathered, non-SEC accounting literature not included in FASB ASC is nonauthoritative. This statement is effective for financial statements issued for interim and annual periods ending after September 15,
2009. See the FASB Web site at www.fasb.org for further information.

Instructions
.20 Within these checklists are a number of questions or statements that are accompanied by references
to applicable authoritative guidance. The financial statements and notes checklist is organized into seven
discrete sections. Disclosures listed in the "General," "Balance Sheet," "Income Statement," "Statement of Cash
Flows," "Interim Financial Statements," and "Summary of Significant Accounting Policies" sections are com-

FSP §20,000.13
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mon to most life and health insurance entities. Those listed in the "Other Financial Statement Disclosures"
section are required when circumstances dictate.
.21 The checklists provide spaces for checking off or initialing each question or point to indicate that it
has been considered. Carefully review the topics listed and consider whether they represent potential disclosure items for the reporting entity for which you are preparing or auditing financial statements. Users
should check or initial
●

Yes—If the disclosure is required and has been made appropriately.

●

No—If the disclosure is required but has not been made.

●

N/A (Not Applicable)—If the disclosure is not applicable to the organization.

.22 It is important that the effect of any "No" response be considered on the auditor’s or accountant’s
report. For audited financial statements, a "No" response that is material to the financial statements may
warrant a departure from an unqualified opinion as discussed in paragraphs .20–.64 of AU section 508. If a
"No" response is indicated, the authors recommend that a notation be made in the margin to explain why
the disclosure was not made (for example, because the item was not considered to be material to the financial statements).
.23 Users may find it helpful to use the right margin for certain other remarks and comments as appropriate, including the following:
a.

For each disclosure for which a "Yes" is indicated, a notation as to where the disclosure is located
in the financial statements and a cross-reference to applicable working papers where the support
to a disclosure may be found

b.

For items marked as "N/A," the reasons for which they do not apply in the circumstances of the
particular report

c.

For each disclosure for which a "No" response is indicated, a notation as to why the disclosure
was not made (for example, because the item was not considered to be material to the financial
statements)

.24 Recognizing that many entities have December 31 year-ends and in an effort to assist those users,
this checklist includes guidance issued through September 30, 2009, which may become effective by December 31, 2009. This guidance is discussed in each section of the checklist where applicable. Additional questions appear and are indicated with an "A" or "B" reference. As determined by the effective date or early
implementation decision, entities for which this guidance has not been implemented should consider all
questions indicated with an "A" reference (for example, question 1A and question 2A) and should place an
"N/A" mark in question indicated with a "B" reference. Entities for which the guidance has been implemented should consider all questions indicated by a "B" reference (for example, question 1B and question
2B) and place an "N/A" mark by questions indicated with an "A" reference. Therefore, based upon your
entities year-end and decision to early implement or not (if allowed), the appropriate additional questions
should be answered when provided.
.25 These checklists and illustrative materials have been prepared by the AICPA staff. They have not
been reviewed, approved, disapproved, or otherwise acted on by any senior technical committee of the
AICPA and do not represent official positions or pronouncements of the AICPA.
.26 The use of these or any other checklists requires the exercise of individual professional judgment.
These checklists are not substitutes for the original authoritative guidance. Users of these checklists and
illustrative materials should refer directly to applicable authoritative guidance when appropriate. The
checklists and illustrative materials may not include all disclosures and presentation items promulgated, nor
do they represent minimum standards or requirements. Additionally, users of the checklists and illustrative
materials should tailor them as required to meet specific circumstances. As an additional resource, users
may call the AICPA Technical Hotline at (877) 242-7212.

FSP §20,000.26
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Recognition
.27 The AICPA gratefully appreciates the invaluable assistance Michele Adams provided in updating
and maintaining the guidance in this checklist.
.28 We hope you find this checklist helpful as you perform your audit engagement. We would greatly
appreciate your feedback on this checklist. You may e-mail these comments to killuzzi@aicpa.org or write
to
Kristy L. Illuzzi, CPA
AICPA
220 Leigh Farm Road
Durham, NC 27707-8110

FSP §20,000.27
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FSP Section 20,100
Financial Statements and Notes Checklist
.01 Checklist Questionnaire. This financial statement disclosure checklist is organized into sections. Carefully review the topics listed and consider whether they represent potential disclosure items for the entity
for which you are preparing or auditing financial statements. Place a check mark by the topics or sections
that are applicable and complete those sections of the checklist. Other sections may be marked “N/A” or
left blank. For example, if the entity had a change in accounting principle, place a check mark by the section
“Accounting Changes” and complete that section of the checklist. On the other hand, if the entity did not
have a change in accounting principle, do not place a check mark by “Accounting Changes” and skip that
section when completing the checklist.
Place U by
Sections Applicable
I.

II.

III.

IV.
V.

VI.

General
A.
Titles and References
B.
Comparative Financial Statements
C.
Consolidated Financial Statements
D.
Risks and Uncertainties
Balance Sheet
A.
General
B.
Cash
C.
Investments in Debt and Equity Securities
D.
Receivables
E.
Reinsurance Receivables
F.
Deposit Accounting
G.
Investments Accounted for by the Equity Method
H.
Property and Equipment
I.
Deferred Income Tax Assets and Liabilities
J.
Other Assets and Deferred Charges
K.
Intangible Assets and Goodwill
L.
Separate Account Assets
M.
Deferred Acquisition Costs
N.
Policy Liabilities
O.
Current Liabilities
P.
Notes Payable and Other Debt
Q.
Shareholders’ Equity
R.
Changes in Shareholders’ Equity
Income Statement
A.
Revenue and Expenses
B.
Income Taxes
C.
Extraordinary Items
D.
Earnings Per Share
E.
Comprehensive Income
Statement of Cash Flows
Summary of Significant Accounting Policies
A.
Accounting Policies
B.
Certain Significant Estimates
Interim Reporting

FSP §20,100.01
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Place U by
Sections Applicable
VII.

Other Financial Statement Disclosures
A.
Business Combinations
A1.
Business Combinations (Subject to FASB Statement No. 141(R))
B.
Accounting Changes and Error Corrections
C.
Commitments and Contingencies (See also part I, "Guarantees")
D.
Current Vulnerability Due to Certain Concentrations
E.
Employee Stock Ownership Plans
F.
Employers’ Disclosures for Defined Benefit Pension and Other
Postretirement Plans
G.
Environmental Remediation Liabilities
H.
Financial Instruments
I.
Guarantees
J.
Foreign Currency Matters
K.
Long-Lived Assets and Disposal Groups to Be Disposed Of
L.
Impaired Loans
M.
Impairment of Long-Lived Assets to Be Held and Used
N.
Leases—Lessors
O.
Leases—Lessees
P.
Nonmonetary Transactions
Q.
Postemployment Benefits
R.
Related-Party Transactions and Economic Dependency
S.
Demutualizations and Formations of Mutual Insurance Holding
Companies
T.
Exit or Disposal Activities
U.
Segment Reporting
V.
Stock Compensation Plans
W.
Subsequent Events
X.
Accounting for Servicing of Financial Assets
Y.
Troubled Debt Restructurings—Creditors
Z.
Troubled Debt Restructurings—Debtors
AA.
Asset Retirement Obligations
BB.
Fair Value Measurements

I. General
Yes
A.

Titles and References
1.

FSP §20,100.01

For a full presentation in conformity with accounting principles generally accepted in the United States (U.S. GAAP), are
the following financial statements presented:
a.

Balance sheet?

b.

Statement of income (operations)?

c.

Statement of retained earnings or changes in shareholders’ equity?

d.

Statement of cash flows?

e.

Description of accounting policies?

f.

Notes to the financial statements?
[Common Practice]

No

N/A

9

Financial Statements and Notes Checklist

Yes

B.

C.

2.

Is each financial statement suitably titled?
[Common Practice]

3.

Does each statement include a reference to the notes, which
are an integral part of the financial statements?
[Common Practice]

No

N/A

Comparative Financial Statements
1.

If changes have occurred in the manner of or basis for presenting corresponding items for two or more periods, has information been disclosed that will explain the change (for example, any change in practice that affects comparability of
financial statements must be disclosed)?
[FASB ASC 205-10-50-1]

2.

Has the entity disclosed appropriate explanations of changes
related to any differences in the manner of or basis for presenting corresponding items for two or more periods?
[FASB ASC 205-10-45-3]

3.

If comparative statements are presented, are the notes and
other disclosures included in the financial statements of the
preceding year(s) repeated, or at least referred to, to the extent that they continue to be of significance?
[FASB ASC 205-10-45-4 ]

Consolidated Financial Statements

Notes: In March 2008, the Financial Accounting Standards Board (FASB)
issued Statement No. 160, Noncontrolling Interests in Consolidated Financial
Statements—an amendment of ARB No. 51, to establish accounting and reporting standards for the noncontrolling interests in a subsidiary and for
the deconsolidation of a subsidiary, areas for which limited guidance previously existed. FASB Statement No. 160 clarifies that a noncontrolling interest in a subsidiary is an ownership interest in the consolidated entity
that should be reported as equity in the consolidated financial statements.
This statement amended authoritative accounting literature to change the
term minority interest to noncontrolling interest. FASB Statement No. 160
does not change the requirements in FASB Interpretation No. 46 (revised
December 2003), Consolidation of Variable Interest Entities.
FASB Statement No. 160 changes the way the consolidated income statement is presented. It requires consolidated net income to be reported at
amounts that include the amounts attributable to both the parent and the
noncontrolling (minority) interest. It also requires disclosure, on the face of
the consolidated statement of income, of the amounts of consolidated net
income attributable to the parent and to the noncontrolling interest.
FASB Statement No. 160 establishes a single method of accounting for
changes in a parent’s ownership interest in a subsidiary that do not result
in deconsolidation and clarifies that all of those transactions are equity
transactions if the parent retains its controlling financial interest in the subsidiary.
FASB Statement No. 160 requires expanded disclosures in the consolidated
financial statements that clearly identify and distinguish between the interests of the parent’s owners and the interests of the noncontrolling owners
(continued)

FSP §20,100.01
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Yes

No

N/A

of a subsidiary. Those expanded disclosures include a reconciliation of the
beginning and ending balances of the equity attributable to the parent and
the noncontrolling owners and a schedule showing the effects of changes
in a parent’s ownership interest in a subsidiary on the equity attributable
to the parent. These provisions are effective for fiscal years, and interim
periods within those fiscal years, beginning on or after December 15, 2008
(that is, January 1, 2009, for entities with calendar year-ends). FASB Statement No. 160 should be applied prospectively as of the beginning of the
fiscal year in which the statement is initially adopted. Presentation and disclosure requirements should be applied retrospectively for all periods presented.
This checklist has been updated to include the presentation and disclosure
requirements of FASB Statement No. 160.
As determined by the effective date or early implementation decision, entities for which this guidance has not been implemented should consider
all questions indicated with an “A” reference (for example, question 1A
and question 2A) and should place an “N/A” mark in questions indicated
with a “B” reference. Entities for which the guidance has been implemented should consider all questions indicated by a “B” reference (for example, question 1B and question 2B) and place an “N/A” mark by questions indicated with an “A” reference. Therefore, based upon your entity’s
year-end and decision to early implement or not (if allowed), the following
additional questions will be answered when provided in this section (check
one that applies for your entity):
pppA pppB
Readers can refer to the full text of the statement on the FASB Web site at
www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and
open effective date information discussed in FASB Accounting Standards
Codification (ASC) 810-10-65-1.

Practice Tip
The purpose of consolidated statements is to present, primarily for the benefit of the shareholders and creditors of the parent entity, the results of operations and the financial position of a parent entity and subsidiaries essentially as if the group were a single entity with one or more branches or divisions. There is a
presumption that consolidated statements are more meaningful than separate statements and that they are
usually necessary for a fair presentation when one of the entities in the group directly or indirectly has a
controlling financial interest in the other entities.
In some cases parent entity statements may be needed, in addition to consolidated statements, to indicate
adequately the position of bondholders and other creditors or preferred stockholders of the parent. Consolidating statements, in which one column is used for the parent entity and other columns for particular
subsidiaries or groups of subsidiaries, often are an effective means of presenting the pertinent information.
[FASB ASC 810-10-10-1; FASB ASC 810-10-45-11]
1.

FSP §20,100.01

Has the entity disclosed the consolidation policy, if consolidated statements are presented?
[FASB ASC 810-10-50-1; FASB ASC 235-10-50-4]
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Yes

No

N/A

Practice Tip
(FASB Statement No. 160) With regard to question 2B, if a parent deconsolidates a subsidiary through a
nonreciprocal transfer to owners, such as a spinoff, the accounting guidance in FASB ASC 845-10 applies.
[“Pending Content” in FASB ASC 810-10-40-5]
2B.

3B.

(FASB Statement No. 160) Has the entity disclosed the following, as a parent, if a subsidiary has been deconsolidated:
a.

The amount of any gain or loss recognized in accordance with FASB ASC 810-10-40-5?

b.

The portion of any gain or loss related to the remeasurement of any retained investment in the former subsidiary to its fair value?

c.

The caption in the income statement in which the gain
or loss is recognized unless separately presented on the
face of the income statement?
[“Pending Content” in FASB ASC 810-10-50-1B]

(FASB Statement No. 160) Has the entity disclosed the following, if the entity is a parent with one or more less-thanwholly owned subsidiaries:
a.

b.

Separately, on the face of the consolidated financial
statements, both of the following:
i.

The amounts of consolidated net income and
consolidated comprehensive income?

ii.

The related amounts on each attributable to the
parent and the noncontrolling interest?

Either in the notes or on the face of the consolidated
income statement, amounts attributable to the parent
for any of the following, if reported in the consolidated
financial statements:
i.

Income from continuing operations?

ii.

Discontinued operations?

iii.

Extraordinary items?

c.

Either in the consolidated statement of changes in equity, if presented, or in the notes to consolidated financial statements, a reconciliation at the beginning and
the end of the period of the carrying amount of total
equity (net assets), equity (net assets) attributable to the
parent, and equity (net assets) attributable to the noncontrolling interest? (See FASB ASC 810-10-50-1A and
FASB ASC 810-10-55-4(G) for example disclosures.)

d.

In notes to the consolidated financial statements, a separate schedule that shows the effects of any changes in
a parent’s ownership interest in a subsidiary on the equity attributable to the parent?
[“Pending Content” in FASB ASC 810-10-50-1A]
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Yes
4.

Has the entity eliminated for presentation material intra-entity transactions and accounts, including any intra-entity
profit or loss on assets that remain within the consolidated
group?
[FASB ASC 810-10-45 par. 1 and 6]

5.

If the financial reporting periods of any subsidiaries are different from that of the parent, are intervening events that materially affect financial position or results of operations disclosed?
[FASB ASC 810-10-45-12]
If a parent company reports a change to (or the elimination
of) a previously existing difference between the parent’s reporting period and the reporting period of a consolidated entity in the parent’s consolidated financial statements as described in FASB ASC 810-10-45-13, has the change been
reported as a change in accounting principle in accordance
with the provisions of FASB ASC 250, Accounting Changes and
Error Corrections, excluding retrospective application if it is
impracticable to do so?
[FASB ASC 810-10-45-13]

6.

Consolidation of Variable Interest Entities
Notes: In June 2009, FASB issued Statement No. 167, Amendments to
FASB Interpretation No. 46(R). Among other things, FASB Statement No.
167 amends FASB Interpretation No. 46(R), Consolidation of Variable Interest Entities (revised December 2003)—an interpretation of ARB No. 51, to
require an entity to perform an analysis to determine whether the entity’s variable interest or interests give it a controlling financial interest
in a variable interest entity (VIE) and to provide enhanced disclosures
that will provide more transparent information about an entity’s involvement in a VIE.
FASB Statement No. 167 is effective as of the beginning of each reporting entity’s first annual reporting period that begins after November 15,
2009 (that is, January 1, 2010, for entities with calendar year-ends), for
interim periods within that first annual reporting period, and for interim and annual reporting periods thereafter. Earlier application is
prohibited.
This checklist has not been updated to include the presentation and disclosure requirements of FASB Statement No. 167.
Readers can refer to the full text of this statement on the FASB Web site
at www.fasb.org.
******
In December 2007, FASB issued Statement No. 141 (revised 2007), Business Combinations, to improve the relevance, representational faithfulness, and comparability of the information that a reporting entity provides in its financial reports about a business combination and its
effects. FASB Statement No. 141(R) supersedes FASB Statement No.
141, Business Combinations, but retains the fundamental requirements in
(continued)
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Yes

No

N/A

FASB Statement No. 141 that the acquisition method of accounting (formerly called the purchase method in FASB Statement No. 141) be used
for all business combinations and that an acquirer be identified for each
business combination.
Among many other significant amendments to existing pronouncements precipitated by FASB Statement No. 141(R), this statement redefines goodwill in FASB Statement No. 142, Goodwill and Other Intangible
Assets, to mean an asset representing the future economic benefits arising from other assets acquired in a business combination that are not
individually identified and separately recognized.
FASB Statement No. 141(R) applies to all transactions or other events
in which an entity (the acquirer) obtains control of one or more businesses (the acquiree), including those sometimes referred to as true
mergers or mergers of equals and combinations achieved without the
transfer of consideration, for example, by contract alone or through the
lapse of minority veto rights. This statement applies to all business entities, including mutual entities that previously used the pooling-of-interests method of accounting for some business combinations. It does
not apply to the following:
a.

The formation of a joint venture

b.

The acquisition of an asset or a group of assets that does not
constitute a business

c.

A combination between entities or businesses under common
control

d.

A combination between not-for-profit entities or the acquisition
of a for-profit business by a not-for-profit entity

This statement applies prospectively to business combinations for
which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008 (that is,
January 1, 2009, for entities with calendar year-ends). An entity may not
apply it before that date.
This checklist has been updated to include the presentation and disclosure requirements of FASB Statement No. 141(R).
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should consider all questions indicated with an “A” reference (for example, question 1A and question 2A) and should place an “N/A” mark in questions indicated with a “B” reference. Entities for which the guidance has
been implemented should consider all questions indicated by a “B” reference (for example, question 1B and question 2B) and place an “N/A”
mark by questions indicated with an “A” reference. Therefore, based
upon your entity’s year-end and decision to early implement or not (if
allowed), the following additional questions will be answered when
provided in this section (check one that applies for your entity):
pppA pppB
Readers can refer to the full text of the statement on the FASB Web site
at www.fasb.org.
(continued)
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Yes

No

N/A

This guidance is labeled as "Pending Content" due to the transition and
open effective date information discussed in FASB ASC 805-10-65-1.
Practice Tip
A VIE may issue voting equity interests, and the entity that holds a majority voting interest also may be the
primary beneficiary of the VIE. If so, the disclosures in question 7A are not required.
[FASB ASC 810-10-50-3]
7A.

If the entity is a primary beneficiary of a VIE, has the entity
disclosed all of the following (unless the primary beneficiary
also holds a majority voting interest):
a.

The nature, purpose, size, and activities of the VIE?

b.

The carrying amount and classification of consolidated
assets that are collateral for the VIE’s obligations?

c.

Lack of recourse if creditors (or beneficial interest holders) of a consolidated VIE have no recourse to the general credit of the primary beneficiary?
[FASB ASC 810-10-50-3]
Practice Tips

(FASB Statement No. 141(R)) The primary beneficiary of a VIE that is a business should disclose items
required by FASB ASC 805, Business Combinations. The primary beneficiary of a VIE that is not a business
should disclose the amount of gain or loss recognized on the initial consolidation of the VIE.
[“Pending Content” in FASB ASC 810-10-50-3]
******
(FASB Statement No. 141(R)) A VIE may issue voting equity interests, and the entity that holds a majority
voting interest also may be the primary beneficiary of the VIE. If so, the disclosures in question 7B are not
required.
[“Pending Content” in FASB ASC 810-10-50-3]
7B.

8.

(FASB Statement No. 141(R)) If the entity is a primary beneficiary of a VIE, has the entity disclosed all of the following
(unless the primary beneficiary also holds a majority voting
interest):
a.

The nature, purpose, size, and activities of the VIE?

b.

The carrying amount and classification of consolidated
assets that are collateral for the VIE’s obligations?

c.

Lack of recourse if creditors (or beneficial interest holders) of a consolidated VIE have no recourse to the general credit of the primary beneficiary?
[“Pending Content” in FASB ASC 810-10-50-3]

Have the following disclosures been made if the entity holds
a significant variable interest in a VIE but is not the primary
beneficiary:
a.
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The nature of its involvement with the VIE and when
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Yes
b.

The nature, purpose, size, and activities of the VIE?

c.

The enterprise’s maximum exposure to loss as a result
of its involvement with the VIE?
[FASB ASC 810-10-50-4]

No

N/A

Practice Tip
The disclosures required by FASB ASC 860, Transfers and Servicing, about a VIE should be included in the
same note to the financial statements as the information required by the “Variable Interest Entities” subsections of FASB ASC 810, Consolidation. Further, information about VIEs may be reported in the aggregate for
similar entities if separate reporting would not add material information.
[FASB ASC 810-10-50-5]
9.

If the entity does not apply the guidance in the “Variable Interest Entities” subsections of FASB ASC 810 to one or more
VIEs or potential VIEs because of the condition described in
FASB ASC 810-10-15-17(c), is the following information disclosed:
a.

The number of entities to which this guidance is not
being applied and the reason why the information required to apply this guidance is not available?

b.

The nature, purpose, size (if available), and activities of
the entity(ies) and the nature of the enterprise’s involvement with the entity(ies)?

c.

The reporting enterprise’s maximum exposure to loss
because of its involvement with the entity(ies)?

d.

The amount of income, expense, purchases, sales, or
other measure of activity between the reporting enterprise and the entity(ies) for all periods presented?
[FASB ASC 810-10-50-6]

Notes: In December 2008, FASB issued FASB Staff Position (FSP) FAS
140-4 and FIN 46(R)-8, Disclosures by Public Entities (Enterprises) about
Transfers of Financial Assets and Interests in Variable Interest Entities. The
objective of this FSP is to require public entities to provide additional
disclosures about transfers of financial assets. It also amend FASB Interpretation No. 46(R) to require public enterprises, including sponsors
that have a variable interest in a VIE, to provide additional disclosures
about their involvement with VIEs. Further, it amends FASB Interpretation No. 46(R) to required disclosure by (a) a nontransferor sponsor
of a qualifying special purpose entity (QSPE) that holds a variable interest in the QSPE and (b) a nontransferor servicer of a QSPE that holds
a significant variable interest in the QSPE. Note that this FSP does not
change the existing disclosure requirements for nonpublic entities.
This FSP applies to public entities that are subject to the disclosure requirements of FASB Statement No. 140, Accounting for Transfers and
Servicing of Financial Assets and Extinguishment of Liabilities—a replacement of FASB Statement No. 125, and public enterprises that are subject
to the disclosure requirements of FASB Interpretation No. 46(R) as
amended by this FSP.
(continued)
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Yes
This FSP is effective for the first reporting period (interim or annual)
ending after December 15, 2008 (that is, December 31, 2008, for entities
with calendar year-ends), and for interim and annual reporting periods
thereafter. Earlier application is encouraged.
Readers can refer to the full text of both the FSP and the statement on
the FASB Web site at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and
open effective date information discussed in FASB ASC 860-10-65-2.
Readers should be aware that this FSP was superseded by FASB Statement No. 167 and by FASB Statement No. 166, Accounting for Transfers
of Financial Assets—an amendment of FASB Statement No. 140. Both FASB
Statement No. 167 and FASB Statement No. 166 are effective as of the
beginning of each reporting entity’s first annual reporting period that
begins after November 15, 2009 (that is, January 1, 2010, for entities
with calendar year-ends), for interim periods within that first annual
reporting period, and for interim and annual reporting periods thereafter. Earlier application is prohibited.
This checklist has not been updated to include the presentation and disclosure requirements of FASB Statement No. 166 or FASB Statement
No. 167.
Readers can refer to the full texts of these statements on the FASB Web
site at www.fasb.org.
******
In December 2007, FASB issued Statement No. 141(R) to improve the
relevance, representational faithfulness, and comparability of the information that a reporting entity provides in its financial reports about a
business combination and its effects. FASB Statement No. 141(R) supersedes FASB Statement No. 141 but retains the fundamental requirements in FASB Statement No. 141 that the acquisition method of accounting (formerly called the purchase method in FASB Statement No.
141) be used for all business combinations and that an acquirer be identified for each business combination.
Among many other significant amendments to existing pronouncements precipitated by FASB Statement No. 141(R), this statement redefines goodwill in FASB Statement No. 142 to mean an asset representing
the future economic benefits arising from other assets acquired in a
business combination that are not individually identified and separately recognized.
FASB Statement No. 141(R) applies to all transactions or other events
in which an entity (the acquirer) obtains control of one or more businesses (acquiree), including those sometimes referred to as true mergers or mergers of equals and combinations achieved without the transfer of consideration, for example, by contract alone or through the lapse
of minority veto rights. This statement applies to all business entities,
including mutual entities that previously used the pooling-of-interests
method of accounting for some business combinations. It does not apply to the following:
a.

The formation of a joint venture
(continued)
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Yes
b.

The acquisition of an asset or a group of assets that does not
constitute a business

c.

A combination between entities or businesses under common
control

d.

A combination between not-for-profit entities or the acquisition
of a for-profit business by a not-for-profit entity

No

N/A

This statement applies prospectively to business combinations for
which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008 (that is,
January 1, 2009, for entities with calendar year-ends). An entity may not
apply it before that date.
This checklist has been updated to include the presentation and disclosure requirements of FASB Statement No. 141(R).
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should consider all questions indicated with an “A” reference (for example, question 1A and question 2A) and should place an “N/A” mark in questions indicated with a “B” reference. Entities for which the guidance has
been implemented should consider all questions indicated by a “B” reference (for example, question 1B and question 2B) and place an “N/A”
mark by questions indicated with an “A” reference. Therefore, based
upon your entity’s year-end and decision to early implement or not (if
allowed), the following additional questions will be answered when
provided in this section (check one that applies for your entity):
pppA pppB
Readers can refer to the full text of the statement on the FASB Web site
at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and
open effective date information discussed in FASB ASC 805-10-65-1.

Practice Tips
(Issuers Only) The entity should determine, in light of the facts and circumstances, how much detail it
should provide to satisfy the disclosure requirements of FASB ASC 810-10-50, how much emphasis it places
on different aspects of the requirements, and how it aggregates information to display its overall involvements with VIEs with different risk characteristics. The entity must strike a balance between obscuring important information as a result of too much aggregation and overburdening financial statements with excessive detail that may not assist financial statement users to understand the reporting entity’s financial
position.
The public entity disclosures required in the “Variable Interest Entities” subsection of FASB ASC 810-10-50
may be provided in more than one note to financial statements, as long as the objectives in FASB ASC 81010-50-8 are met. If the disclosures are provided in more than one note to financial statements, the reporting
entity should provide a cross reference to the other notes to financial statements that provide the disclosures
prescribed in the “Variable Interest Entities” subsection of FASB ASC 810-10-50 for similar VIEs.
[“Pending Content” in FASB ASC 810-10-50 par. 10–11]
******
(continued)
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Yes

No

N/A

(Issuers Only) The entity should consider the overall objectives in question 10 in providing disclosures. To
achieve those objectives, the entity may need to supplement the disclosures required in FASB ASC 810-1050, depending on the facts and circumstances surrounding the VIE and the reporting entity’s interest in that
VIE.
[“Pending Content” in FASB ASC 810-10-50-8]
10.

(Issuers Only) Has the entity made disclosures that provide
financial statement users with information regarding all of
the following:
a.

11.

The significant judgments and assumptions made by a
reporting entity in determining whether it must do any
of the following:
i.

Consolidate a VIE?

ii.

Disclose information about its involvement with
a VIE?

b.

The nature of restrictions on a consolidated VIE’s assets
reported by a reporting entity in its statement of financial position, including the carrying amounts of such
assets?

c.

The nature of, and changes in, the risks associated with
a reporting entity’s involvement with the VIE?

d.

How a reporting entity’s involvement with the VIE affects the entity’s financial position, financial performance, and cash flows?
[“Pending Content” in FASB ASC 810-10-50-8]

(Issuers Only) If reporting disclosures in aggregate, which
may be more useful, has the entity disclosed how similar entities are aggregated and distinguish between
a.

VIEs that are not consolidated because the reporting
entity is not the primary beneficiary but has a significant variable interest or is the sponsor that holds a variable interest?

b.

VIEs that are consolidated?
[“Pending Content” in FASB ASC 810-10-50-9]
Practice Tip

(Issuers Only) A VIE may issue voting equity interests, and the reporting entity that holds a majority voting
interest also may be the primary beneficiary of the VIE. If so, the disclosures in questions 12 and 13A are
required if the activities of the VIE are primarily related to securitizations or other forms of asset-backed
financings or single-lessee leasing arrangements.
[“Pending Content” in FASB ASC 810-10-50-13]
12.
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an entity that holds a significant variable interest in a VIE but
is not the primary beneficiary, or an entity that is a sponsor
that holds a variable interest in a VIE have the following disclosures been made:

19

Financial Statements and Notes Checklist

Yes
a.

Its methodology for determining whether the entity is
(or is not) the primary beneficiary of a VIE, including,
but not limited to, significant judgments and assumptions made?

b.

If the conclusion to consolidate a VIE has changed in
the most recent financial statements the primary factors
that caused the change and the effect on the entity’s financial statements?

c.

Whether the entity has provided financial or other support during the periods presented to the VIE that it was
not previously contractually required to provide, including both of the following:

d.

i.

The type and amount of support?

ii.

The primary reasons for providing the support?

No

N/A

Qualitative and quantitative information about the reporting entity’s involvement with the VIE, including
but not limited to the nature, purpose, size, and activities of the VIE, including how the VIE is financed?
[“Pending Content” in FASB ASC 810-10-50-12]

13A. (Issuers Only) If the entity is the primary beneficiary of a VIE,
have the following disclosures been made:
a.

The carrying amount and classification of the VIE’s assets and liabilities in the statement of financial position
that are consolidated in accordance with the guidance
in the “Variable Interest Entities” subsections of FASB
ASC 810-10, including qualitative information about
the relationship(s) between those assets and associated
liabilities?

b.

Lack of recourse if creditors (or beneficial interest holders) of a consolidated VIE have no recourse to the general credit of the primary beneficiary?

c.

Terms of arrangements, giving consideration to both
explicit arrangements and implicit variable interests,
that could require the reporting entity to provide financial support to the VIE, including events or circumstances that could expose the reporting entity to a loss?
[“Pending Content” in FASB ASC 810-10-50-14]
Practice Tip

(FASB Statement No. 141(R)) (Issuers Only) With respect to question 13B, the primary beneficiary of a VIE
that is a business should disclose items required by FASB ASC 805. The primary beneficiary of a VIE that is
not a business should disclose the amount of gain or loss recognized on the initial consolidation of the VIE.
[“Pending Content” in FASB ASC 805-10-50-14]
13B. (FASB Statement No. 141(R)) (Issuers Only) If the entity is
the primary beneficiary of a VIE, have the following disclosures been made:
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Yes
a.

The carrying amount and classification of the VIE’s assets and liabilities in the statement of financial position
that are consolidated in accordance with the guidance
in the “Variable Interest Entities” subsections of FASB
ASC 810-10, including qualitative information about
the relationship(s) between those assets and associated
liabilities?

b.

Lack of recourse if creditors (or beneficial interest holders) of a consolidated VIE have no recourse to the general credit of the primary beneficiary?

c.

Terms of arrangements, giving consideration to both
explicit arrangements and implicit variable interests,
that could require the reporting entity to provide financial support to the VIE, including events or circumstances that could expose the reporting entity to a loss?
[“Pending Content” in FASB ASC 810-10-50-14]

No

N/A

Practice Tip
(Issuers Only) With regard to question 14(c), the entity should provide qualitative and quantitative information to allow financial statement users to understand the differences between the two amounts (liability
and maximum exposure to loss).
[“Pending Content” in FASB ASC 810-10-50-15]
14.

(Issuers Only) Has the entity made the following disclosures
if it holds a significant variable interest or is a sponsor that
holds a variable interest in a VIE, but is not the VIE’s primary
beneficiary:
a.

The carrying amount and classification of the assets
and liabilities in the reporting entity’s statement of financial position that relate to the reporting entity’s variable interest in the VIE.

b.

The reporting entity’s maximum exposure to loss as a
result of its involvement with the VIE, including the
following:

c.

FSP §20,100.01

i.

How the maximum exposure is determined.

ii.

The significant sources of the reporting entity’s
exposure to the VIE.

iii.

If a maximum exposure cannot be identified, that
fact should be disclosed.

A tabular comparison of the carrying amount of the liability (as required by item (a)) and the reporting entity’s maximum exposure to loss (as required by item
(b)).
[“Pending Content” in FASB ASC 810-10-50-15]
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Yes
15.

16.

No

N/A

(Issuers Only) If the entity has not applied the guidance in
the “Variable Interest Entities” subsections of FASB ASC 81010-50 to one or more VIEs or potential VIEs because of the
condition described in FASB ASC 810-10-15-17(c) (see preceding practice tip), has all of the following information been disclosed:
a.

The number of legal entities to which that guidance is
not being applied?

b.

The reason why the information required to apply that
guidance is not available?

c.

The nature, purpose, size (if available), and activities of
the legal entities?

d.

The nature of the reporting entity’s involvement with
the legal entities?

e.

The reporting entity’s maximum exposure to loss because of its involvement with the legal entities?

f.

The amount of income, expense, purchases, sales, or
other measure of activity between the reporting entity
and the legal entities for all periods presented?
[“Pending Content” in FASB ASC 810-10-50-16]

(Issuers Only) If the entity is either a nontransferor sponsor
or a nontransferor servicer, (as defined in FASB ASC 810-1050-17), have they disclosed information that provides financial statement users with an understanding of its involvement
with the QSPE?
[“Pending Content” in FASB ASC 810-10-50-17]
Practice Tip

(Issuers Only) Disclosures may be reported in the aggregate for similar entities if separate reporting would
not provide more useful information to financial statement users. The reporting entity should disclose how
similar entities are aggregated. In determining whether to aggregate QSPEs, the reporting entity should
consider quantitative and qualitative information about the different risk and reward characteristics of each
QSPE and the importance of each QSPE to the reporting entity.
[“Pending Content” in FASB ASC 810-10-50-18]
17.

(Issuers Only) If the entity is either a nontransferor sponsor
(see FASB ASC 810-10-50-8(a)) or a nontransferor servicer
(see FASB ASC 810-10-50-8(b)) of a QSPE, have the following
been disclosed:
a.

The nature, purpose, size, and activities of the QSPE,
including how the entity is financed?

b.

The carrying amount and classification of the assets
and liabilities recognized in the statement of financial
position related to the entity’s involvement with the
QSPE?
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Yes

D.

c.

Terms of arrangements that could require the reporting
entity to provide financial support to the QSPE, including events or circumstances that could expose the entity
to loss? (All available evidence should be considered.
See FASB ASC 810-10-50-19(c) for specific examples of
evidence to consider).

d.

The entity’s maximum exposure to loss as a result of its
involvement with the QSPE, including how the maximum exposure is determined and the significant
sources of the reporting entity’s exposure to the QSPE?
(If the entity’s maximum exposure to loss as a result of
its involvement with the QSPE cannot be quantified,
that fact should be disclosed.)

e.

Whether the entity has provided financial or other support during the periods presented to the QSPE that it
was not previously contractually required to provide,
including both of the following:
i.

The type and amount of support?

ii.

The primary reasons for providing the support?
[“Pending Content” in FASB ASC 810-10-5019]

Risks and Uncertainties
Note: In April 2008, FASB issued FSP FAS 142-3, Determination of the
Useful Life of Intangible Assets, to improve the consistency between the
useful life of a recognized intangible asset under FASB Statement No.
142 and the period of expected cash flows used to measure the fair
value of the asset under FASB Statement No. 141(R) and other U.S.
GAAP. This FSP applies to recognized intangible assets that are accounted for pursuant to FASB Statement No. 142 and applies regardless of the nature of the transaction that resulted in the recognition of
the intangible asset, that is, whether acquired in a business combination or otherwise.
Among other significant provisions, FSP FAS 142-3 will add criterion
as to whether disclosure related to the estimated useful life of an intangible asset should be required under FASB ASC 275-10-50-8.
FSP FAS 142-3 is effective for financial statements issued for fiscal
years beginning after December 15, 2008 (that is, January 1, 2009, for
entities with calendar year-ends), and interim periods within those
fiscal years. Early adoption is prohibited.
This checklist has been updated to include the presentation and disclosure requirements of FSP FAS 142-3.
Readers can refer to the full text of the FSP on the FASB Web site at
www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 350-1065-1.
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Yes

No

N/A

Practice Tips
The 4 areas of disclosure prescribed by FASB ASC 275-10-50-1, in question 1, are not mutually exclusive.
The information required by some may overlap. Accordingly, the disclosures required by FASB ASC 27510-50 may be combined in various ways, grouped together, or placed in diverse parts of the financial statements, or included as part of the disclosures made pursuant to other U.S. GAAP requirements.
[FASB ASC 275-10-50-1]
******
Whether an estimate meets the criteria for disclosure under FASB ASC 275, Risks and Uncertainties, does not
depend on the amount that has been reported in the financial statements but rather on the materiality of the
effect that using a different estimate would have had on the financial statements. Simply because an estimate
resulted in the recognition of a small financial statement amount, or no amount, does not mean that disclosure is not required under FASB ASC 275-10.
[FASB ASC 275-10-50-14]
1.

Has the entity made disclosures about the risks and uncertainties existing as of the date of the financial statements in
the following areas:
a.

Nature of operations?

b.

Use of estimates in the preparation of financial statements?

c.

Certain significant estimates?

d.

Current vulnerability due to certain concentrations?
[FASB ASC 275-10-50-1]

2.

Has the entity disclosed a description of the major products
or services the entity sells or provides and it principal markets, including the locations of those markets?
[FASB ASC 275-10-50-2]

3.

If the entity operates in more than one business, have the disclosures made indicated the relative importance of its operations in each business and the basis for this determination (assets, revenues, and earnings)?
[FASB ASC 275-10-50-2]

4.

Do the financial statements include an explanation that the
preparation of financial statements in conformity with U.S.
GAAP requires the use of managements’ estimates?
[FASB ASC 275-10-50-4]

5.

If, based on known information available to the entity before
the issuance of the financial statements, it is reasonably possibly that estimates in the financial statements will change in
the near term (as defined by the FASB ASC glossary as a period of time not to exceed one year from the date of the financial statements) and the effects will be material, is there discussion (including an estimate of the effect of the change in
condition, situation, or set of circumstances that existed at the
date of the financial statements) in the financial statements of
these facts and circumstances?
[FASB ASC 275-10-50-6]
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Yes

No

N/A

Practice Tip
(FSP FAS 142-3) In determining whether disclosure about an estimate of the useful life of an intangible asset
is required under FASB ASC 275-10-50-8, the criterion in item (b) of that paragraph should be considered
met if the effect of either of the following would be material to the financial statements, either individually
or in aggregate by major intangible asset class:
●

A change in the useful life of an intangible

● A change in the expected likelihood of renewal or extension of an intangible asset
[“Pending Content” in FASB ASC 275-10-50-15A]

II. Balance Sheet
A.

B.

C.

General
1.

For classified balance sheets, are assets and liabilities segregated into current and noncurrent classifications with totals
presented for current assets and current liabilities?
[FASB ASC 210-10-05–5; FASB 210-10-45-5; FASB ASC 470-1045-2; FASB ASC 70-10-45-15]

2.

Are assets not expected to be realized during the current operating cycle classified as noncurrent?
[FASB ASC 210-10-45 par. 3–4]

Cash
1.

Has the entity made disclosures related to any restrictions on
cash?
[Common Practice]

2.

Is any cash restricted as to withdrawal or use for other than
current operations excluded from current assets?
[FASB ASC 210-10-45-4]

3.

Are bank overdrafts reclassified to and presented separately
in current liabilities?
[Common Practice]

4.

Are held checks (those written before but not released until
after the balance sheet date) reclassified to accounts payable?
[Common Practice]

Investments in Debt and Equity Securities
Practice Tip

FASB ASC 320, Investments—Debt and Equity Securities, as discussed in following questions, does not apply
to investments in equity securities that, absent the election of the fair value option in FASB ASC 825-10-251, would be required to be accounted for under the equity method, nor to investments in consolidated
subsidiaries.
[FASB ASC 320-10-15-7]
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Yes

No

N/A

Notes: In April 2009, FASB issued FSP FAS 115-2 and FAS 124-2,
Recognition and Presentation of Other-Than-Temporary Impairments. This
FSP amends the other-than-temporary impairment guidance in U.S.
GAAP for debt securities to make the guidance more operational
and to improve the presentation and disclosure of other-than-temporary impairments on debt and equity securities in the financial
statements. This FSP does not amend existing recognition and measurement guidance related to other-than-temporary impairments of
equity securities. This FSP incorporates other-than-temporary impairment guidance for debt securities from Securities and Exchange
Commission (SEC) Staff Accounting Bulletin Topic 5M and other authoritative literature, modifies and expands it to address the unique
features of debt securities, and clarifies the interaction of the factors
that should be considered when determining whether a debt security
is other than temporarily impaired.
The FSP is effective for interim and annual reporting periods ending
after June 15, 2009 (that is, December 31, 2009, for entities with calendar year-ends), with early adoption permitted for periods ending
after March 15, 2009. This FSP does not require disclosures for earlier
periods presented for comparative purposes at initial adoption. In
periods after initial adoption, this FSP requires comparative disclosures only for periods ending after initial adoption.
This checklist has not been updated to include the presentation and
disclosure requirements of FSP FAS 115-2 and FAS 124-2.
Readers can refer to the full text of the FSP on the FASB Web site at
www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 320-1065-1.

Practice Tip
The disclosures in this FASB ASC 320-10-50 are required for all interim and annual periods. Major security
types should be based on the nature and risks of the security. In determining whether disclosure for a
particular security type is necessary and whether it is necessary to further separate a particular security type
into greater detail, an entity should consider all of the following:
●

Shared activity or business sector

●

Vintage

●

Geographic concentration

●

Credit quality

● Economic characteristic
[“Pending Content” in FASB ASC 320-10-50 par. 1A–1B]
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Yes
1.

2.

No

N/A

Has the entity disclosed all of the following, for securities
classified as available for sale, by major security type, as of
each date for which a statement of financial position is presented:
a.

Amortized cost basis?

b.

Aggregate fair value?

c.

Total other-than-temporary impairment recognized in
accumulated other comprehensive income (OCI)?

d.

Total gains for securities with net gains in accumulated
OCI?

e.

Total losses for securities with net losses in accumulated OCI?

f.

Information about the contractual maturities of those
securities as of the date of the most recent statement of
financial position reported?
[“Pending Content” in FASB ASC 320-10-50-2]

Has the entity disclosed any investments in available-for-sale
securities and trading securities separately from similar assets
that are subsequently measured using another measurement
attribute on the face of the statement of financial position
and, in doing so, does the entity
a.

present the aggregate of those fair value and non-fairvalue amounts in the same line item and parenthetically disclose the amount of fair value included in the
aggregate amount?

b.

present two separate line items to display the fair value
and non-fair-value carrying amounts?
[FASB ASC 320-10-45-1]
Practice Tip

Maturity information may be combined in appropriate groupings. Securities not due at a single maturity
date, such as mortgage-backed securities, may be disclosed separately rather than allocated over several
maturity groupings; if allocated, the basis for allocation also should be disclosed.
Investments in mutual funds that invest only in U.S. government debt securities may be shown separately
rather than grouped with other equity securities in the disclosures by major security type required by FASB
ASC 942-320-50-2 related to depository and lending entities and the required investment disclosures.
[FASB ASC 320-10-50 par. 3–4]
3.
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Has the entity made the following disclosures for securities
classified as held-to-maturity, by major security type as of
each date for which a statement of financial position is presented:
a.

Amortized cost basis?

b.

Aggregate fair value?

c.

Gross unrecognized holding gains?

d.

Gross unrecognized holding losses?
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Yes
e.

Net carrying amount?

f.

Total other-than-temporary impairment recognized in
accumulated OCI?

g.

Gross gains and losses in accumulated OCI for any derivatives that hedged the forecasted acquisition of the
held-to-maturity securities?

h.

Information about the contractual maturities of those
securities as of the date of the most recent statement of
financial position presented?
[“Pending Content” in FASB ASC 320-10-50-5]

4.

If the entity presents a classified statement of financial position, are all individual held-to-maturity securities, individual
available-for-sale securities, and individual trading securities
reported as either current or noncurrent, as appropriate, under the current asset and current liability provisions of FASB
ASC 210-10?
[FASB ASC 320-10-45-2]

5.

For all investments in an unrealized loss position, including
those that fall within the scope of FASB ASC 325-40, for
which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in OCI), does an investor disclose the following in its
interim and annual financial statements:
a.

No

N/A

As of each date for which a statement of financial position is presented, quantitative information, aggregated by category of investment—each major security
type that the entity discloses in accordance with FASB
ASC 320-10 and cost-method investments—in tabular
form
i.

the aggregate related fair value of investments
with unrealized losses?
Practice Tip

The reference point for determining how long an investment has been in a continuous unrealized loss position is the balance sheet date of the reporting period in which the impairment is identified. The continuous
unrealized loss position ceases upon either of the following:
●

The recognition of the total amount by which amortized cost basis exceeds fair value as an otherthan-temporary impairment in earnings

The investor becoming aware of a recovery of fair value up to (or beyond) the cost of the investment
during the period.
[“Pending Content” in FASB ASC 320-10-50-8]
●

ii.

the aggregate amount of unrealized losses (that
is, the amount by which cost exceeds fair value)?
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Yes
b.

As of the date of the most recent statement of financial
position, additional information (in narrative form) that
provides sufficient information to allow financial statement users to understand the quantitative disclosures
and the information that the entity considered (both
positive and negative) in reaching the conclusion that
the impairment or impairments are not other than temporary? (See “Pending Content” in FASB ASC 320-1050-6 for example disclosures.)
[“Pending Content” in FASB ASC 320-10-50-6]

6.

Has the entity disclosed, for interim and annual periods in
which an other-than-temporary impairment of a debt security
is recognized and only the amount related to a credit loss was
recognized in earnings, by major security type, the methodology and significant inputs used to measure the amount related to credit loss? (Examples include default rates, delinquency rates, percentage of nonperforming assets,
loan-to-collateral-value ratios, third-party guarantees, current
levels of subordination, vintage, geographic concentration
and credit ratings.)
[“Pending Content” in FASB ASC 320-10-50-8A]

7.

Has the entity disclosed, in tabular format, a rollforward of
the amount related to credit losses recognized in earnings in
accordance with FASB ASC 320-10-35-34D, for interim and
annual periods, including, at a minimum,
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a.

the beginning balance of the amount related to credit
losses on debt securities held by the entity at the beginning of the period for which a portion of an other-thantemporary impairment was recognized in OCI?

b.

additions for the amount related to the credit loss for
which an other-than-temporary impairment was not
previously recognized?

c.

reductions for securities sold during the period (realized)?

d.

reductions for securities for which the amount previously recognized in OCI was recognized in earnings
because the entity intends to sell the security or more
likely than not will be required to sell the security before recovery of its amortized cost basis?

e.

if the entity does not intend to sell the security and it is
not more likely than not that the entity will be required
to sell the security before recovery of its amortized cost
basis, additional increases to the amount related to the
credit loss for which an other-than-temporary impairment was previously recognized?

f.

reductions for increases in cash flows expected to be
collected that are recognized over the remaining life of
the security?

No

N/A
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Yes
g.

8.

9.

No

N/A

the ending balance of the amount related to credit
losses on debt securities held by the entity at the end of
the period for which a portion of an other-than-temporary impairment was recognized in OCI?
[“Pending Content” in FASB ASC 320-10-50-8B]

Has the entity disclosed the following for each period for
which an income statement is presented:
a.

The proceeds from sales of available-for-sale securities
and gross realized gains and losses that have been included in earnings as a result of those sales?

b.

The basis on which the cost of a security sold or the
amount reclassified out of accumulated OCI into earnings was determined (that is, specified identification,
average cost, or other method used)?

c.

The gross gains and losses included in earnings from
transfers of securities from the available-for-sale category to the trading category?

d.

The amount of the net unrealized holding gain or loss
on available-for-sale securities for the period that has
been included in accumulated OCI and the amount of
gains and losses reclassified out of accumulated OCI
into earnings for the period?

e.

The portion of trading gains and losses for the period
that relates to trading securities still held at the reporting date?
[FASB ASC 320-10-50-9]

Has the entity disclosed the following for any sales of or
transfers from securities classified as held-to-maturity for
each period for which an earnings statement is presented:
a.

Net carrying amount of the sold or transferred security?

b.

The net gain or loss in accumulated OCI for any derivative that hedged the forecasted acquisition of the heldto-maturity security?

c.

Related realized or unrealized gain or loss?

d.

The circumstances leading to the decision to sell or
transfer the security?
[FASB ASC 320-10-50-10]

10.

Are cash flows from purchases, sales, and maturities of available-for-sale securities and held-to-maturity securities classified as cash flows from investing activities and reported gross
for each security classification in the statement of cash flows?
[FASB ASC 320-10-45-11]

11.

Are cash flows from purchases, sales, and maturities of trading securities classified as cash flows based on the nature and
purpose for which the securities were acquired (generally,
operating activities) in the statement of cash flows?
[FASB ASC 320-10-45-11]
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Yes
12.

For cost-method investments, does the entity disclose the following additional information, if applicable, as of each date
for which a statement of financial position is presented in its
annual financial statements:
a.

The aggregate carrying amount of all cost-method investments?

b.

The aggregate carrying amount of cost-method investments that the entity did not evaluate for impairment
(see FASB ASC 325-20-35)?

c.

The fact that the fair value of a cost-method investment
is not estimated if there are no identified events or
changes in circumstances that may have a significant
adverse effect on the fair value of the investment, and
i.

the entity determined, in accordance with paragraphs 16–19 of FASB ASC 825-10-50, that it is
not practicable to estimate the fair value of the
investment?

ii.

the entity is exempt from estimating fair value
under FASB ASC 825?

iii.

the entity is exempt from estimating interim fair
values because it does not meet the FASB ASC
definition of a publicly traded company?
[“Pending Content” in FASB ASC 325-20-50-1]

13.

If an insurance entity is a not-for-profit entity (NFP), has the
change in fair value of equity securities that are not within
the scope of FASB ASC 958-320 because they do not have a
readily determinable fair value recognized?
[FASB ASC 944-325-45-2]

14.

Has the entity considered separate captions for each of the
following investment categories:

15.

FSP §20,100.01

a.

Fixed-maturity securities?

b.

Mortgage loans on real estate?

c.

Investment real estate?

d.

Policy loans?

e.

Other long-term investments?
[AAG-LHI app. B]

Are unrealized gains and losses under FASB ASC 944-325-351 reported, net of applicable income taxes, in other comprehensive income?
[FASB ASC 944-325-45-1]

No

N/A
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Yes
D.

No

N/A

Receivables
Notes: In December 2008, FASB issued FSP FAS 140-4 and FIN 46(R)8 to amend FASB Statement No. 140 to require public entities (enterprises) to provide additional disclosures about transfers of financial
assets. It also amends FASB Interpretation No. 46(R) to require public enterprises, including sponsors that have a variable interest in a
VIE, to provide additional disclosures about their involvement with
VIEs. Additionally, this FSP requires certain disclosures to be provided by a public enterprise that is (a) a sponsor of a QSPE that holds
a variable interest in the QSPE but was not the transferor (nontransferor) of financial assets to the QSPE and (b) a servicer of a QSPE
that holds a significant variable interest in the QSPE but was not the
transferor (nontransferor) of financial assets to the QSPE. The disclosures required by this FSP are intended to provide greater transparency to financial statement users about a transferor’s continuing involvement with transferred financial assets and an enterprise’s
involvement with VIEs and QSPEs.
This FSP applies to public entities that are subject to the disclosure
requirements of FASB Statement No. 140 and public enterprises that
are subject to the disclosure requirements of FASB Interpretation No.
46(R) as amended by this FSP.
This FSP is effective for the first reporting period (interim or annual)
ending after December 15, 2008 (that is, December 31, 2008, for entities with calendar year-ends), with earlier application encouraged.
This FSP applies to each annual and interim reporting period thereafter. An entity (enterprise) is encouraged, but not required, to disclose comparative information in periods earlier than the effective
date for disclosures that were not previously required for public entities (enterprises) by FASB Statement No. 140 and FASB Interpretation No. 46(R). In periods after initial adoption, comparative disclosures for those disclosures that were not previously required for
public entities (enterprises) by FASB Statement No. 140 and FASB
Interpretation No. 46(R) are required only for periods subsequent to
the effective date.
This checklist has been updated to include the presentation and disclosure requirements of FSP FAS 140-4 and FIN 46(R)-8.
Readers can refer to the full text of the FSP on the FASB Web site at
www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 860-1065-2.
Readers should be aware that this FSP was superseded by FASB
Statement No. 166 and FASB Statement No. 167. Both FASB Statement No. 167 and FASB Statement No. 166 are effective as of the
beginning of each reporting entity’s first annual reporting period
that begins after November 15, 2009 (that is, January 1, 2010, for entities with calendar year-ends), for interim periods within that first
(continued)
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Yes
annual reporting period, and for interim and annual reporting periods thereafter. Earlier application is prohibited.
This checklist has not been updated to include the presentation and
disclosure requirements of FASB Statement No. 166 or FASB Statement No. 167.
Readers can refer to the full texts of these statements on the FASB
Web site at www.fasb.org.
1.

Are accounts and notes receivable from officers, employees,
and affiliated entities shown separately with appropriate disclosures, and not included under a general heading such as
notes receivable or accounts receivable?
[FASB ASC 310-10-45-13; FASB ASC 850-10-50-2]

2.

Are unbilled receivables shown separately from billed receivables?
[Common Practice]

3.

Are unbilled costs and fees under cost-plus-fixed fee contracts
shown as receivables rather than advances or inventory?
[FASB ASC 912-310-25-1]

4.

Are allowances for uncollectible receivables shown as deductions from the related receivables?
[FASB ASC 310-10-45-4; FASB ASC 310-10-50-14]

5.

For each period for which results of operations are presented,
has the entity disclosed the activity in the total allowance for
credit losses related to loans, including
a.

the balance in the allowance at the beginning and end
of each period?

b.

additions charged to operations?

c.

direct write-downs charged against the allowance?

d.

recoveries of amounts previously charged off?
[FASB ASC 310-10-50-12]

6.

Are unearned discounts (other than cash or quantity discounts and the like), finance charges, and interest included in
the face amounts of receivables shown as a deduction from
the related receivables?
[FASB ASC 310-10-45-8]

7.

If a note is noninterest bearing or has an inappropriate stated
interest rate,
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a.

is the discount or premium presented as a deduction
from or addition to the face amount of the note?

b.

does the disclosure include the effective interest rate
and face amount of the note?

c.

is amortization of discount or premium reported as interest in the income statement?

No

N/A
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d.

No

N/A

are issue costs reported on the balance sheet as deferred
charges?
[FASB ASC 835-30-45 par. 1A and 2–3]
Practice Tip

Questions 8–18 that follow apply to entities that lend to or finance the activities of others (including trade
receivables). Refer to FASB ASC 942-10-15-2 to determine whether your entity falls within the scope of this
guidance. This checklist includes only the disclosure requirements for the more common activities within
the scope of FASB ASC 942-10-15-2. If the entity is a financial institution, or purchases or sells loans or
servicing rights, forecloses on a loan, or engages in other more complex lending activities, the additional
disclosure requirements of FASB ASC 860 not included herein, also should be considered. See additional
disclosure requirements contained in the AICPA’s Depository and Lending Institutions: Checklists and Illustrative Financial Statements (product no. 0089109 [paperback] or WDP-CL [online]).
8.

Does the accounting policy note disclosure include the following:
a.

The basis of accounting for loans, trade receivables, and
lease financings, including those classified as held for
sale?

b.

The method used in determining the lower of cost or
fair value of nonmortgage loans held for sale (that is
aggregate or individual asset basis)?

c.

The method for recognizing interest income on loan
and trade receivables, including a statement about the
entity’s policy for treatment of related fees and costs,
including the method of amortizing net deferred fees or
costs?

d.

The classification and method of accounting for interest-only strips, loans, other receivables, or retained interests in securitizations that can be contractually prepaid or otherwise settled in a way that the holder
would not recover substantially all of its recorded investment?

e.

In addition to the loss contingencies disclosures required by FASB ASC 450-20, a description of the accounting policies and methodology the entity used to
estimate its allowance for loan losses, allowance for
doubtful accounts, and any liability for off-balance
sheet credit losses, and related charges for loan, trade
receivable or other credit losses, including a description
of the factors that influenced management’s judgment?

f.

The policy for placing loans (and trade receivables if
applicable) on nonaccrual status (or discontinuing accrual of interest) and recording payments received on
nonaccrual loans (and trade receivables if applicable),
and the policy for resuming accrual of interest?

g.

The policy for charging off uncollectible loans and
trade receivables?
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Yes
h.

The policy for determining past due or delinquency
status (that is, whether past due status is based on how
recently payments have been received or contractual
terms)?
[FASB ASC 310-10-50 par. 2, 6, and 9]

9.

Has the entity disclosed the aggregate amount of gains or
losses on sales of loans or trade receivables (including adjustments to record loans held for sale at the lower of cost or fair
value) separately in the financial statements or in the notes to
the financial statements?
[FASB ASC 860-20-50-5]

10.

Loans or trade receivables may be presented on the balance
sheet as aggregated amounts. However, are the following exceptions disclosed:
a.

Are loans or trade receivables held for sale presented
on the balance sheet in a separate category?

b.

Are major categories of loans or trade receivables presented separately either in the balance sheet or in the
notes to the financial statements?

c.

Are the allowance for credit losses, the allowance for
doubtful accounts, and, as applicable, any unearned income, any unamortized premiums and discounts, and
any net unamortized deferred fees and costs, disclosed
in the financial statements?
[FASB ASC 310-10-45 par. 2–4]

11.

Are foreclosed and repossessed assets classified as a separate
balance-sheet amount or included in other assets on the balance sheet with separate disclosures in the notes to the financial statements?
[FASB ASC 310-10-45-3; FASB ASC 310-10-50-11]

12.

Are certain returned or repossessed assets, such as inventory,
subsequently to be utilized by the entity in operations, not
classified separately?
[FASB ASC 310-10-45-3]

13.

Is the valuation allowance for loans prior to foreclosure not
carried over as a separate element of the cost basis in the foreclosed asset for purposes of accounting for the long-lived asset under FASB ASC 360, Property, Plant, and Equipment, after
foreclosure?
[FASB ASC 310-40-40-10]

14.

Is the recorded investment in loans (and trade receivables if
applicable) on nonaccrual status as of each balance sheet date
disclosed in the notes to the financial statements?
[FASB ASC 310-10-50-7]

15.

Is the recorded investment in loans (and trade receivables if
applicable) past due 90 days or more and still accruing disclosed?
[FASB ASC 310-10-50-7]
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16.

Insurance subsidiaries may be required to deposit securities
with state regulatory authorities. If so, is the carrying amount
of securities deposited disclosed?
[FASB ASC 944-320-50-1]

17.

Is the carrying amount of loans, trade receivables, securities
and financial instruments that serve as collateral for borrowings disclosed pursuant to ASC 860-30-50-1(b) for public entities and pursuant to FASB ASC 860-30-50-4(b) for nonpublic
entities?
[“Pending Content” in FASB ASC 310-10-50-5]

18.

Do the notes to financial statements describe how prepayments are considered in the determination of contractual cash
flows and cash flows expected to be collected?
[FASB ASC 310-30-50-1]

19.

For each balance sheet presented, has the entity disclosed the
following information about loans within the scope of FASB
ASC 310-30:
a.

b.

No

N/A

Separately for both those loans that are accounted for
as debt securities and those loans that are not accounted for as debt securities,
i.

the outstanding balance and related carrying
amount at the beginning and end of the period?

ii.

the amount of accretable yield at the beginning
and end of the period, reconciled for additions,
accretion, disposals of loans, and reclassifications
to or from nonaccretable difference during the
period?

iii.

for loans acquired during the period, the contractually required payments receivable, cash flows
expected to be collected, and fair value at the acquisition date?

iv.

for those loans within the scope of FASB ASC
310-30 for which the income recognition model is
not applied in accordance with FASB ASC 31030-35-3, the carrying amount at the acquisition
date for loans acquired during the period and the
carrying amount of all loans at the end of the period?

Further, for those loans that are not accounted for as
debt securities, has the entity disclosed
i.

the amount of (a) any expense recognized pursuant to FASB ASC 310-30-35-10(a) and (b) any reductions of the allowance recognized pursuant to
FASB ASC 310-30-35-10(b)(1) for each period for
which an income statement is presented?

ii.

the amount of the allowance for uncollectible accounts at the beginning and end of the period?
[FASB ASC 310-30-50-2]
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E.

20.

Has the entity considered reporting premiums due as assets?
[AAG-LHI table 3-1]

21.

Has the entity considered offsetting deferred premiums
against liabilities for future policy benefits?
[AAG-LHI table 3-1]

No

N/A

Reinsurance Receivables
1.

Are the following disclosed in relation to ceded insurance
transactions:
a.

Nature of the transaction(s)?

b.

Purpose of the transaction(s)?

c.

Effect of the transaction(s) on the entity’s operations?

d.

The fact that the insurer is not relieved of its primary
obligation to the policyholder in a reinsurance transaction?
[FASB ASC 944-20-50 par. 3–4]
Practice Tip

Although amounts recoverable on unasserted claims should be reported as reinsurance receivables, separate
presentation or disclosure of various types of receivables is not precluded. In addition, separate presentation
or disclosure of servicing carrier activity is not precluded.
[FASB ASC 944-20-50 par. 5–6]
2.

3.

Are the following disclosed for short-duration reinsurance
contracts on both a written and an earned basis:
a.

Premiums from direct business?

b.

Reinsurance assumed?

c.

Reinsurance ceded?
[FASB ASC 944-605-50-1]

Are the following disclosed for long-duration reinsurance
contracts:
a.

Premiums and amounts assessed against policyholders
from direct business?

b.

Reinsurance assumed?

c.

Reinsurance ceded?

d.

Premiums and amounts earned?
[FASB ASC 944-605-50-1]

4.

Has the entity disclosed the amounts of premiums, claims
and expenses in the underwriting account for each balance
sheet presented?
[FASB ASC 944-605-50-1]

5.

For foreign reinsurance accounted for by the open year
method, has the entity disclosed all of the following for each
period for which an income statement is presented:
a.
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b.

The additions to underwriting balances for the year for
reported premiums, claims and expenses?
[FASB ASC 944-605-50-1]

F.

6.

Are the methods used for income recognition on reinsurance
contracts disclosed?
[FASB ASC 944-605-50-1]

7.

Has an entity participating in ceding transactions reported an
estimated reinsurance receivable arising from those contracts
described in FASB ASC 944-310-25-2 separately as an asset?
[FASB ASC 944-310-45-5]

8.

Are amounts receivable and payable between the ceding entity and an individual reinsurer offset only when a right of
offset exists as defined in subtopic 210-20?
[FASB ASC 944-310-45-7]

9.

Are the amounts of earned premiums ceded and recoveries
recognized under reinsurance contracts reported in the statements of earnings as separate line items or disclosed in the
notes?
[FASB ASC 944-605-50-1]

Deposit Accounting
1.

G.

Has the following information regarding the changes in the
recorded amount of the deposit arising from an insurance or
reinsurance contract that transfers only significant underwriting risk been disclosed:
a.

The present values of initial expected recoveries that
will be reimbursed under the insurance or reinsurance
contracts that have been recorded as an adjustment to
incurred losses?

b.

Any adjustment of amounts initially recognized for expected recoveries? (The individual components of the
adjustment [meaning interest accrual, the present value
of additional expected recoveries, and the present value
of reductions in expected recoveries] should be disclosed separately.)

c.

The amortization expense attributable to the expiration
of coverage provided under the contract?
[FASB ASC 340-30-50-2]

Investments Accounted for by the Equity Method
1.

Has the entity made the following disclosures for investments
in common stock accounted for by the equity method:
a.

The name of each investee and their percentage of ownership of common stock?

b.

The accounting policies of the investor with respect to
investments in common stock?
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2.

3.

c.

The difference between the amount at which an investment is carried and the amount of underlying equity in
net assets, and the accounting treatment of this difference?

d.

For investments in common stock for which a quoted
market price is available, the aggregate value of each
identified investment based on the quoted market
price? (This is not required for investments in common
stock of subsidiaries.)

e.

For investments in common stock, corporate joint ventures, or other investments which are in the aggregate
material in relation to the financial position or results
of operations of an investor, summarized information
as to assets, liabilities, and results of operation of the
investees as appropriate?

f.

Material effects of conversions of outstanding convertible securities, exercises or contingent issuances?
[FASB ASC 323-10-50-3]

If the entity holds 20 percent or more of the voting stock of a
significant investee corporation but does not account for the
investment using the equity method, are the following disclosed:
a.

The name of such investee?

b.

The reasons why the equity method is not considered
appropriate?
[FASB ASC 323-10-50-3(a)(2)]

If the entity holds less than 20 percent of the voting stock of
a significant investee corporation and accounts for the investment using the equity method, are the following disclosed:
a.

The name of such investee?

b.

The reasons why the equity method is considered appropriate?
[FASB ASC 323-10-50-3(a)(2)]

4.

Upon loss of significant influence, has the investor recorded
the proportionate share of an investee’s equity adjustments
for OCI as offset against the carrying value of the investment
at the time significant influence is lost?
[FASB ASC 323-10-35-39]

5.

To the extent that the offset results in a carrying value of the
investment that is less than zero, has the investor (a) reduced
the carrying value of the investment to zero and (b) recorded
the remaining balance in income?
[FASB ASC 323-10-35-39]

FSP §20,100.01

No

N/A

39

Financial Statements and Notes Checklist

Yes

No

N/A

Practice Tip
FASB ASC 323-10-35-39 does not provide guidance for entities that have historically not recorded their proportionate share of an investee’s equity adjustments for OCI. These entities should refer to the correction-oferror guidance in FASB ASC 250-10-45-2.
[FASB ASC 323-10-35-39]

H.

6.

When previous losses have reduced the common stock investment account to zero (as discussed in paragraphs 27–28
of FASB ASC 323-10-35), is the selected policy disclosed for
determining the amount of equity losses?
[Common Practice]

7.

Has the life insurance entity considered disclosing any contingent obligations or commitments for additional funding or
guarantees of obligations of the investee?
[AAG-LHI 11.112]

Property and Equipment
1.

2.

I.

For depreciable assets, do the financial statements include
disclosure of
a.

depreciation expense for each period?

b.

balances of major classes of depreciable assets by nature or function?

c.

accumulated depreciation, either by major classes of assets or in total?

d.

the method or methods used in computing depreciation for each major class of depreciable assets?
[FASB ASC 360-10-50-1]

Is real estate that is acquired in settling claims separately reported in the balance sheet and not classified as an investment?
[FASB ASC 944-360-45-1]

Deferred Income Tax Assets and Liabilities
1.

2.

Are the components of the net deferred tax liability or asset
recognized in the balance sheet disclosed as follows:
a.

The total of all deferred tax liabilities (measured as described in FASB ASC 740-10-30-5(b))?

b.

The total of all deferred tax assets (measured as described in (c) and (d) of FASB ASC 740-10-30-5)?

c.

The total valuation allowance recognized for deferred
tax assets (measured as described in FASB ASC 740-1030-5(e))?
[FASB ASC 740-10-50-2]

Is the net change during the year in the valuation allowance
disclosed?
[FASB ASC 740-10-50-2]
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3.

Are deferred tax assets and liabilities classified as current or
noncurrent based on the classification of the related asset or
liability?
[FASB ASC 740-10-45-4]

4.

Are deferred tax assets not related to an asset or liability for
financial reporting (see paragraphs 25–26 of FASB ASC 74010-25), including those related to carryforwards, classified according to the expected reversal date of the temporary difference?
[FASB ASC 740-10-45-9]

5.

For each particular tax-paying component of the reporting
entity and within each particular tax jurisdiction:
a.

Are all current deferred tax liabilities and assets offset
and presented as a single amount?

b.

Are all noncurrent deferred tax liabilities and assets offset and presented as a single amount?
[FASB ASC 740-10-45-6]

6.

Is the valuation allowance for each particular tax jurisdiction
allocated between current and noncurrent deferred tax assets
for that jurisdiction on a pro rata basis?
[FASB ASC 740-10-45-5]

7.

(Issuers Only) Has the entity disclosed the types of temporary differences and carryforwards that give rise to a significant portion of deferred tax liabilities and deferred tax assets
(before valuation allowances) and if the entity is not subject
to income taxes because its income is taxed directly to its
owners, is that fact and the net difference between the tax
bases and reported amounts of the enterprises’ assets and liabilities disclosed?
[FASB ASC 740-10-50 par. 6–7 and 16]

8.

(Nonissuers Only) Has the entity disclosed the types of temporary differences and carryforwards that give rise to a significant portion of deferred tax liabilities and deferred tax assets (before valuation allowances)?
[FASB ASC 740-10-50-8]

9.

Is the following information disclosed if a deferred tax liability is not recognized because of the exceptions to comprehensive recognition of deferred taxes for any of the areas addressed by FASB ASC 740-10-25:
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a.

A description of the types of temporary differences for
which a deferred tax liability has not been recognized
and the types of events that would cause those temporary differences to become taxable?

b.

The cumulative amount of each type of temporary difference?
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c.

J.

No

N/A

The amount of the deferred tax liability for temporary
differences other than the policyholders’ surplus of a
life insurance entity that is not recognized in accordance with the provisions of FASB ASC 740-10-25-3?
[FASB ASC 944-740-50-1]

Other Assets and Deferred Charges
1.

Has the entity made the following disclosures for computer
software to be sold, leased, or otherwise marketed:
a.

The amount of unamortized computer software costs
included in each balance sheet presented?
[FASB ASC 985-20-50-1(a)]

b.

The amount charged to expense for amortization of
these costs and for amounts written down to net realizable value disclosed in each income statement presented?
[FASB ASC 985-20-50-1(b)]

c.

The amount of research and development expense incurred for computer software to be sold, leased, or otherwise marketed charged to expense in each period for
which an income statement is presented?
[FASB ASC 985-20-50-2; FASB ASC 730-10-50-1]

2.

Is any payment by an S Corporation to the IRS to retain its
fiscal year for tax purposes classified as an asset (deposit)?
[FASB ASC 740-10-55-71]

3.

Have investments in life insurance been reported at amounts
that can be realized as of the statement-of-financial-position
date and calculated in accordance with FASB ASC 325-30?
[FASB ASC 325-30-35-1]

4.

Are investments in life insurance reported using one of the
following measurements:

5.

a.

Transaction price plus all initial direct external costs,
which is then tested for impairment?
[FASB ASC 325-30-30-1C; FASB ASC 325-30-35-10]

b.

Fair value?
[FASB ASC 325-30-30-2; FASB ASC 325-30-35-12]

If the entity chooses to report using measurement (a) or (b) in
question 4, do the financial statements include all of the following disclosures required by FASB ASC 325-30-45 and
FASB ASC 325-30-50 in questions 6–16?

Presentation on the Statement of Financial Position
6.

To accomplish separate reporting, has the entity reported its
investments that are remeasured at fair value on the face of
the statement of financial position separately from those accounted for under the investment method by
a.

displaying separate line items on the statement of financial position for the fair value method and investment method carrying amounts?
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b.

presenting the aggregate of those fair value method
and investment method carrying amounts and parenthetically disclose the amount of those investments accounted for under the fair value method included in
the aggregate amount?
[FASB ASC 325-30-45-1]

Presentation in the Income Statement
7.

To accomplish separate reporting, has the entity reported the
investment income from its investments in life settlement
contracts that are remeasured at fair value on the face of the
income statement separately from the investment income
from those accounted for under the investment method by
a.

displaying separate line items on the income statement
for the investment income from the investments in life
settlement contracts that are accounted for under the
fair value method and investment method?

b.

presenting the aggregate of the investment income in
life settlement contracts and parenthetically disclose
the investment income from those investments accounted for under the fair value method that are included in the aggregate amount?
[FASB ASC 325-30-45-2]

Presentation in the Statement of Cash Flows
8.

Has the entity classified cash receipts and cash payments related to life settlement contracts pursuant to FASB ASC 230,
Statement of Cash Flows, based on the nature and purpose for
which the life settlements were acquired?
[FASB ASC 325-30-45-3]

Disclosure Requirements
9.

Has the entity disclosed its accounting policy for life settlement contracts including the classification of cash receipts
and cash disbursements in statement of cash flows? (Note:
The disclosure requirements in FASB ASC 325-30-50 do not
eliminate disclosure requirements included in elsewhere in
FASB ASC, including other disclosure requirements on the
use of fair value.)
[FASB ASC 325-30-50 par. 2–3]

Investment Method
10.
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Has the entity disclosed the following for life settlements contracts accounted for under the investment method based on
the remaining life expectancy for each of the first five succeeding years from the date of the statement of financial position and thereafter, as well as in the aggregate:
a.

The number of life settlement contracts?

b.

The carrying value of the life settlement contracts?

c.

The face value (death benefits) of the life insurance policies underlying the contracts?
[FASB ASC 325-30-50-4]
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11.

Has the entity disclosed the life insurance premiums anticipated to be paid for each of the five succeeding fiscal years to
keep the life settlement contracts in force as of the date of the
most recent statement of financial position presented?
[FASB ASC 325-30-50-5]
12. If the entity becomes aware of new or updated information
that causes it to change its expectations on the timing of the
realization of proceeds from the investments in life settlement
contracts, has the investor disclosed the nature of the information and the related effect on the timing of the realization
of proceeds from the life settlement contracts, including disclosing significant changes to the amounts disclosed in accordance with FASB ASC 325-30-50-4? (Note: The investor is required to actively seek out new or updated information to
update the assumptions used in determining the remaining
life expectancy of the life settlement contracts.)
[FASB ASC 325-30-50-6]
Fair Value Method
13.

Has the entity disclosed the method(s) and significant assumptions used to estimate the fair value of investments in
life settlement contracts, including any mortality assumptions?
[FASB ASC 325-30-50-7]

14.

Has the entity disclosed the following for life settlement contracts accounted for under the fair value method based on
remaining life expectancy for each of the first five succeeding
years from the date of the statement of financial position and
thereafter, as well as in the aggregate:
a.
The number of life settlement contracts?
b.
The carrying value of the life settlement contracts?
c.

15.

16.

The face value (death benefits) of the life insurance policies underlying the contracts?
[FASB ASC 325-30-50-8]

Has the entity disclosed the reasons for changes in its expectation of the timing of the realization of the investments in
life settlement contracts, including disclosing significant
changes to the amounts disclosed in accordance with FASB
ASC 325-30-50-8?
[FASB ASC 325-30-50-9]
Has the investor disclosed the following for each reporting
period presented in the income statement:
a.
The gains or losses recognized during the period on investments sold during the period?
b.
The unrealized gains or losses recognized during the
period on investments that are still held at the date of
the statement of financial position?
[FASB ASC 325-30-50-10]
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Other Matters
17.

K.

Has the policyholder disclosed when contractual restrictions
on the ability to surrender a policy exist?
[FASB ASC 325-30-50-1]

Intangible Assets and Goodwill
Notes: In April 2008, FASB issued FSP FAS 142-3 to improve the consistency between the useful life of a recognized intangible asset under
FASB Statement No. 142 and the period of expected cash flows used
to measure the fair value of the asset under FASB Statement No.
141(R) and other U.S. GAAP. This FSP applies to recognized intangible assets that are accounted for pursuant to FASB Statement No. 142
and applies regardless of the nature of the transaction that resulted in
the recognition of the intangible asset, that is, whether acquired in a
business combination or otherwise.
Among other significant provisions, FSP FAS 142-3 provides that, in
determining the useful life of the intangible asset for amortization
purposes, an entity should consider the period of expected cash flows
used to measure the fair value of the recognized intangible asset, adjusted for the entity-specific factors in paragraph 11 of FASB Statement No. 142. This FSP contains several disclosures requirements in
addition to the required disclosures in paragraphs 44–45 of FASB
Statement No. 142, including information that enables users of financial statements to assess the extent to which the expected future cash
flows associated with the intangible asset are affected by the entity’s
intent or ability to renew or extend the arrangement, or both.
FSP FAS 142-3 is effective for financial statements issued for fiscal
years beginning after December 15, 2008 , (that is, January 1, 2009, for
entities with calendar year-ends), and interim periods within those
fiscal years. Early adoption is prohibited.
This checklist has been updated to include the presentation and disclosure requirements of FASP FAS 142-3.
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should
consider all questions indicated with an “A” reference (for example,
question 1A and question 2A) and should place an “N/A” mark in
questions indicated with a “B” reference. Entities for which the guidance has been implemented should consider all questions indicated
by a “B” reference (for example, question 1B and question 2B) and
place an “N/A” mark by questions indicated with an “A” reference.
Therefore, based upon your entity’s year-end and decision to early
implement or not (if allowed), the following additional questions will
be answered when provided in this section (check one that applies for
your entity):
pppA pppB
Readers can refer to the full text of the FSP on the FASB Web site at
www.fasb.org.
(continued)
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This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 350-1065-1.
******
In December 2007, FASB issued Statement No. 141(R) to improve the
relevance, representational faithfulness, and comparability of the information that a reporting entity provides in its financial reports
about a business combination and its effects. FASB Statement No.
141(R) supersedes FASB Statement No. 141 but retains the fundamental requirements in FASB Statement No. 141 that the acquisition
method of accounting (formerly called the purchase method in FASB
Statement No. 141) be used for all business combinations and that an
acquirer be identified for each business combination.
Among many other significant amendments to existing pronouncements precipitated by FASB Statement No. 141(R), this statement redefines goodwill in FASB Statement No. 142 to mean an asset representing the future economic benefits arising from other assets
acquired in a business combination that are not individually identified and separately recognized.
FASB Statement No. 141(R) applies to all transactions or other events
in which an entity (the acquirer) obtains control of one or more businesses (the acquiree), including those sometimes referred to as true
mergers or mergers of equals and combinations achieved without the
transfer of consideration, for example, by contract alone or through
the lapse of minority veto rights. This statement applies to all business entities, including mutual entities that previously used the pooling-of-interests method of accounting for some business combinations. It does not apply to the following:
a.

The formation of a joint venture

b.

The acquisition of an asset or a group of assets that does not
constitute a business

c.

A combination between entities or businesses under common
control

d.

A combination between not-for-profit entities or the acquisition of a for-profit business by a not-for-profit entity.

This statement applies prospectively to business combinations for
which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008 (that
is, January 1, 2009, for entities with calendar year-ends). An entity
may not apply it before that date.
This checklist has been updated to include the presentation and disclosure requirements of FASB Statement No. 141(R).
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should
consider all questions indicated with an “A” reference (for example,
question 1A and question 2A) and should place an “N/A” mark in
questions indicated with a “B” reference. Entities for which the guid(continued)
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ance has been implemented should consider all questions indicated
by a “B” reference (for example, question 1B and question 2B) and
place an “N/A” mark by questions indicated with an “A” reference.
Therefore, based upon your entity’s year-end and decision to early
implement or not (if allowed), the following additional questions will
be answered when provided in this section (check one that applies for
your entity):
pppA pppB
Readers can refer to the full text of the statement on the FASB Web
site at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 805-1065-1.

Practice Tip
Entities that report segment information in accordance with FASB ASC 280, Segment Reporting, should provide the following information about goodwill in total and for each reportable segment and should disclose
any significant changes in the allocation of goodwill by reportable segment. If any portion of goodwill has
not yet been allocated to a reporting unit at the date the financial statements are issued, that unallocated
amount and the reasons for not allocating that amount should be disclosed.
[FASB ASC 350-20-50-1]
1.

Is the aggregate amount of goodwill presented as a separate
line item in the statement of financial position?
[FASB ASC 350-20-45-1]

2.

Is the aggregate amount of goodwill impairment losses presented as a separate line item in the income statement before
the subtotal income from continuing operations (or similar caption) unless a goodwill impairment loss is associated with a
discontinued operation?
[FASB ASC 350-20-45-2]

3.

Is a goodwill impairment loss associated with a discontinued
operation included (on a net-of-tax basis) within the results of
discontinued operations?
[FASB ASC 350-20-45-3]

4A.

Has the entity disclosed any changes in the carrying amount
of goodwill during the period, including the following (see
example 3 in FASC ASC 350-20-55-24):
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a.

The aggregate amount of goodwill acquired?

b.

The aggregate amount of impairment losses recognized?

c.

The amount of goodwill included in the gain or loss on
disposal of all or a portion of a reporting unit?
[FASB ASC 350-20-50-1]
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4B.

5.

No

N/A

(FASB Statement No. 141(R)) Has the entity disclosed any
changes in the carrying amount of goodwill during the period, including the following, (see example 3 in FASC ASC
350-20-55-24):
a.

The gross amount and accumulated impairment losses
at the beginning of the period?

b.

Additional goodwill recognized during the period, except goodwill included in a disposal group that, on acquisition, meets the criteria to be classified as held for
sale in accordance with FASB ASC 360-10-45-9?

c.

Adjustments resulting from the subsequent recognition
of deferred tax assets during the period in accordance
with paragraphs 2–4 of FASB ASC 805-740-25 and
FASB ASC 805-740-45-2?

d.

Goodwill included in a disposal group classified as
held for sale in accordance with FASB ASC 360-10-45-9
and goodwill derecognized during the period without
having previously been reported in a disposal group
classified as held for sale?

e.

Impairment losses recognized during the period in accordance with FASB ASC 350-10?

f.

Net exchange differences arising during the period in
accordance with FASB ASC 830, Foreign Currency Matters?

g.

Any other changes in the carrying amounts during the
period?

h.

The gross amount and accumulated impairment losses
at the end of the period?
[“Pending Content” in FASB ASC 350-20-50-1]

For each goodwill impairment loss recognized, has the entity
disclosed following information disclosed in the notes to the
financial statement that include the period in which the impairment loss is recognized:
a.

A description of the facts and circumstances leading to
the impairment?

b.

The amount of the impairment loss and the method of
determining the fair value of the associated reporting
unit (whether based on quoted market prices, prices of
comparable businesses, a present value or other valuation technique, or a combination thereof)?

c.

If a recognized impairment loss is an estimate that has
not yet been finalized (refer to paragraphs 18–19 of
FASB ASC 350-20-35), that fact and the reasons therefore and, in subsequent periods, the nature and amount
of any significant adjustments made to the initial estimate of the impairment loss?
[FASB ASC 350-20-50-2]

FSP §20,100.01

48

Life and Health Insurance Entities

Yes
6.

At a minimum, are all intangible assets aggregated and presented as a separate line item in the statement of financial
position? (This requirement does not preclude presentation of
individual intangible assets or classes of intangible assets as
separate line items.)
[FASB ASC 350-30-45-1]

7.

Are amortization expense and impairment losses for intangible assets presented in income statement line items within
continuing operations as deemed appropriate for each entity?
[FASB ASC 350-30-45-2]

No

N/A

Practice Tips
The information in question 8A also should be disclosed separately for each material business combination
or in the aggregate for individually immaterial business combinations that are material collectively if the
aggregate fair values of intangible assets acquired, other than goodwill, are significant.
[“Pending Content” in FASB ASC 350-30-50-1]
******
(FSP FAS 142-3) For intangible assets acquired either individually or with a group of assets (in either an
asset acquisition or business combination) and recognized under FASB Statement No. 142, the following
disclosure should be made in addition to those in question 8B:
For intangible assets with renewal or extension terms, the weighted-average period before the next
renewal or extension (both explicit and implicit), by major intangible asset class.
[“Pending Content” in FASB ASC 350-30-50-1]
●

8A.

For intangible assets acquired either individually or with a
group of assets, has the entity disclosed all of the following
in the notes to financial statements in the period of acquisition:
a.
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For intangible assets subject to amortization, all of the
following:
i.

The total amount assigned and the amount assigned to any major intangible asset class?

ii.

The amount of any significant residual value, in
total and by major intangible asset class?

iii.

The weighted-average amortization period, in total and by major intangible asset class?

b.

For intangible assets not subject to amortization, the total amount assigned and the amount assigned to any
major intangible asset class?

c.

The amount of research and development assets acquired and written off in the period and the line item
in the income statement in which the amounts written
off are aggregated?
[ FASB ASC 350-30-50-1]
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8B.

For intangible assets subject to amortization, all of the
following:
i.

The total amount assigned and the amount assigned to any major intangible asset class?

ii.

The amount of any significant residual value, in
total and by major intangible asset class?

iii.

The weighted-average amortization period, in total and by major intangible asset class?

b.

For intangible assets not subject to amortization, the total amount assigned and the amount assigned to any
major intangible asset class?

c.

The amount of research and development assets acquired and written off in the period and the line item
in the income statement in which the amounts written
off are aggregated?

d.

For intangible assets with renewal or extension terms,
the weighted-average period before the next renewal or
extension (both explicit and implicit), by major intangible asset class?
[“Pending Content” in FASB ASC 350-30-50-1]

Has the entity disclosed the following information in the financial statements or the notes to financial statements for
each period for which a statement of financial position is presented:
a.

b.

9B.

N/A

(FSP FAS 142-3) For intangible assets acquired either individually or with a group of assets (in either an asset acquisition
or business combination), has the entity disclosed all of the
following in the notes to financial statements in the period of
acquisition:
a.

9A.

No

For intangible assets subject to amortization, all of the
following:
i.

The gross carrying amount and accumulated amortization, in total and by major intangible asset
class?

ii.

The aggregate amortization expense for the
period?

iii.

The estimated aggregate amortization expense
for each of the five succeeding fiscal years?

For intangible assets not subject to amortization, the total carrying amount and the carrying amount for each
major intangible asset class?
[FASB ASC 350-30-50-2]

(FSP FAS 142-3) Has the entity disclosed the following information in the financial statements or the notes to financial
statements for each period for which a statement of financial
position is presented:
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a.

10.
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For intangible assets subject to amortization, all of the
following:
i.

The gross carrying amount and accumulated amortization, in total and by major intangible asset
class?

ii.

The aggregate amortization expense for the period?

iii.

The estimated aggregate amortization expense
for each of the five succeeding fiscal years?

b.

For intangible assets not subject to amortization, the total carrying amount and the carrying amount for each
major intangible asset class?

c.

The entity’s accounting policy on the treatment of costs
incurred to renew or extend the term of a recognized
intangible asset?

d.

For intangible assets that have been renewed or extended in the period for which a statement of financial
position is presented, both of the following:
i.

For entities that capitalize renewal or extension
costs, the total amount of costs incurred in the
period to renew or extend the term of a recognized intangible asset, by major intangible asset
class?

ii.

The weighted-average period before the next renewal or extension (both explicit and implicit),
by major intangible asset class?
[“Pending Content” in FASB ASC 350-30-50-2]

For each impairment loss recognized related to an intangible
asset, is the following information disclosed in the notes to
the financial statements that include the period in which the
impairment loss is recognized:
a.

A description of the impaired intangible asset and the
facts and circumstances leading to the impairment?

b.

The amount of the impairment loss and the method for
determining fair value?

c.

The caption in the income statement in which the impairment loss is aggregated?

d.

If applicable, the segment in which the impaired intangible asset is reported under FASB ASC 280, Segment
Reporting?
[FASB ASC 350-30-50-3]

No

N/A
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Yes

No

N/A

11B. (FSP FAS 142-3) For recognized intangible assets, has the entity disclosed information that enables users of financial statements to assess the extent to which the expected future cash
flows associated with the asset are affected by the entity’s intent or ability (or both intent and ability) to renew or extend
the arrangement?
[“Pending Content” in FASB ASC 350-30-50-4]
L.

Separate Account Assets
1.

Are separate account assets reported as summary totals in the
financial statements?
[FASB ASC 944-80-45-1]

2.

Has the insurance entity disclosed the following information
regarding separate accounts:
a.

The general nature of the contracts reporting in separate accounts, including the extent and terms of minimum guarantees?

b.

The basis of presentation for separate account assets
and liabilities and related separate account activity?

c.

The aggregate fair value of assets, by major investment
asset category, supporting separate accounts with additional insurance benefits and minimum investment
return guarantees as of each date for which a statement
of financial position is presented?

d.

The amount of gains and losses recognized on assets
transferred to separate accounts for the periods presented?

e.

A description of the liability valuation methods and assumptions used in estimating the liabilities for additional insurance benefits and minimum guarantees?

f.

All of the following amounts related to minimum guarantees:
i.

The separate account liability balances subject to
various types of benefits, for example: (1) Guaranteed minimum death benefit (2) Guaranteed
minimum income benefit (3) Guaranteed minimum accumulation benefit?

ii.

Disclosures within the categories of benefits identified in (f)(i) for the types of guarantees provided, such as: (1) return of net deposit (2) return
of net deposits accrued at a stated rate (3) return
of highest anniversary value?

iii.

The amount of liability reported for additional
insurance benefits, annuitization benefits and
other minimum guarantees, by type of benefit for
the most recent balance sheet date?

iv.

The incurred and paid amounts related to (f)(iii)
for all periods presented?
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Yes
v.

3.

4.

M.

For contracts for which an additional liability is
disclosed in (f)(iii), the net amount at risk and
weighted average attained age of contract holders?
[FASB ASC 944-80-50-1]

If the separate account arrangement meets all of the following
conditions, have the portion of separate account assets representing contract holder funds been measured at fair value
and reported in the insurance entity’s financial statements as
a summary total, with an equivalent summary total reported
for related liabilities:
a.

The separate account is legally recognized (that is, the
separate account is established, approved, and regulated under special rules such as state insurance laws,
federal securities laws, or similar foreign laws)?

b.

The separate account assets supporting the contract liabilities are legally insulated from the general account
liabilities of the insurance entity (that is, the contract
holder is not subject to insurer default risk to the extent
of the assets held in the separate account)?

c.

The insurer must, as a result of contractual, statutory,
or regulatory requirements, invest the contract holder’s
funds within the separate account as directed by the
contract holder in designated investment alternatives
or in accordance with specific investment objectives or
policies?

d.

All investment performance, net of contract fees and assessments, must as a result of contractual, statutory, or
regulatory requirements be passed through to the individual contract holder? Contracts may specify conditions under which there may be a minimum guarantee,
but not a ceiling, because a ceiling would prohibit all
investment performance from being passed through to
the contract holder.
[FASB ASC 944-80-45-2 and 944-80-25-2]

For the portion of separate account arrangements meeting the
preceding criteria, the related investment performance (including interest, dividends, realized gains and losses, and
changes in unrealized gains and losses) and the corresponding amounts credited to the contract holder are offset within
the same statement of operations line item, netting to zero?
[FASB ASC 944-80-45-3]

Deferred Acquisition Costs
1.
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Are the following disclosed related to deferred acquisition
costs?
a.

The nature of the acquisition costs capitalized?

b.

The method of amortizing capitalized acquisition costs?

No

N/A
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Yes
c.

N.

No

N/A

The amount of acquisition costs amortized for the period?
[FASB ASC 944-30-50-1]

Policy Liabilities
1.

Is the basis for estimating the liabilities for unpaid claims and
claim adjustment expenses disclosed?
[FASB ASC 944-40-50-1]

2.

Are the methods and assumptions used in estimating the liability for future policy benefits and the average rate of assumed investment yields in effect for the current year disclosed?
[FASB ASC 944-40-50 par. 6–8]

3.

Is the carrying amount of liabilities for unpaid claims and
claim adjustment expenses relating to short-duration contracts that are presented at present value in the financial
statements and the range of interest rates used to discount
those liabilities disclosed?
[FASB ASC 944-40-50-5]

4.

For each fiscal year for which an income statement is presented, is the following information about the liability for unpaid claims and claim adjustment expenses disclosed:

5.

a.

The balance in the liability for unpaid claims and claim
adjustment expenses at the beginning and end of the
period presented with, if net balances are presented,
separate disclosure of the related amount of reinsurance recoverable?

b.

Incurred claims and claim adjustment expenses with
separate disclosure of the provision of insured events
of the current period and for increases or decreases in
the provision for insured events of prior fiscal years?

c.

Payments of claims and claim adjustment expenses
with separate disclosure of payments of claims and
claim adjustment expenses attributable to insured
events of the current fiscal year and to insured events
of the prior period?
[FASB ASC 944-40-50-3]

If changes in incurred claims and claim adjustment expenses
recognized in the income statement are attributable to insured events of prior periods, are the following disclosed in
the financial statements:
a.

The reasons for the change?

b.

Whether additional premiums or return premiums
have been accrued as a result of the prior-period effects?
[FASB ASC 944-40-50-3(d)]
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Yes

O.

6.

Whether the entity considers anticipated investment income
in determining if a premium deficiency relating to short-duration contracts exists disclosed?
[FASB ASC 944-60-50-1]

7.

For participating insurance, does disclosure include
a.

the relative percentage of participating insurance?

b.

the method of accounting for policyholders’ dividends?

c.

the amount of dividends?

d.

the amount of any additional income allocated to participating policyholders?
[FASB ASC 944-50-50-1]

8.

Are annual policyholder dividends reported separately as an
expense in the statement of income?
[FASB ASC 944-50-45-1]

9.

Are the following disclosed in the financial statements with
respect to participating contracts:
a.

The methods and assumptions used in estimating the
liability for future policy benefits?

b.

The average rate of assumed investment yields used in
estimating expected gross margins?

c.

The nature of acquisition costs capitalized, the method
of amortizing those costs, and the amount of those costs
amortized for the period?
[FASB ASC 944-30-50-2 and FASB ASC 944-40-50-8]

No

N/A

Current Liabilities
Practice Tip

The SEC requires that public entities disclose separately significant categories of debt such as those in question 1 [Regulation S-X, Article 5]. Although not required for nonpublic entities, such separate disclosure is
common practice.
1.

Are significant categories of current liabilities, such as accounts payable, accrued expenses, deferred revenue, interest
payable, and amounts due to officers and employees segregated and presented separately?
[Common Practice]

2.

If a classified balance sheet is presented, is a total for current
liabilities shown?
[FASB ASC 210-10-45-5]

3.

Are short term obligations expected to be refinanced reclassified to long term liabilities?
[FASB ASC 470-10-45-13]
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Yes

P.

4.

If the reporting entity has not accrued compensated absences
(FASB ASC 710, Compensation—General, including sabbatical
leaves described in the FASB ASC glossary and FASB ASC
710-10-25-5) because the amount cannot be reasonably estimated, is that fact disclosed?
[FASB ASC 710-10-50-1]

5.

Are borrowings outstanding under revolving credit agreements that include both a subjective acceleration clause and a
requirement to maintain a lock-box arrangement, whereby remittances from the borrower’s customers reduce the debt outstanding, classified as short term obligations?
[FASB ASC 470-10-45-5]

No

N/A

Notes Payable and Other Debt
1.

Are major categories of debt (notes payable to banks, mortgages payable, notes to related parties) identified on the balance sheet or in the notes to the financial statements?
[Common Practice]

2.

Are interest rates, maturities, conversion features, and other
significant terms (for example, subordinated features) of long
term debt disclosed?
[FASB ASC 470-10-50-5]

3.

Are terms and conditions provided in loan agreements and
bond indentures (such as assets pledged as collateral and covenants to reduce debt, maintain working capital, and restrict
dividends) disclosed?
[FASB ASC 440-10-50-1]
Practice Tip

Some long term loans require compliance with certain covenants that must be met on a quarterly or semiannual basis. If a covenant violation occurs that would otherwise give the lender the right to call the debt, a
lender may waive its call right arising from the current violation for a period greater than one year while
retaining future covenant requirements. Unless facts and circumstances indicate otherwise, the borrower
should classify the obligation as noncurrent, unless both of the following conditions exist:
●

A covenant violation that gives the lender the right to call the debt has occurred at the balance sheet
date or would have occurred absent a loan modification.

●

It is probable that the borrower will not be able to cure the default (comply with the covenant) at
measurement dates that are within the next 12 months.

See example 1 in FASB ASC 470-10-55-2 for an illustration of this classification guidance.
[FASB ASC 470-10-45-1]
4.

Has the entity disclosed the following for each of the five
years following the latest balance sheet presented:
a.

The aggregate amount of payments for unconditional
purchase obligations that meet the criteria set forth in
FASB ASC 440-10-50-2 and that have been recognized
in the purchaser’s balance sheet?
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Yes
b.

5.

The combined aggregate amount of maturities and
sinking fund requirements for all long term borrowings?
[FASB ASC 440-10-50-4; FASB ASC 470-10-50-1]

If a note is noninterest bearing or has an inappropriate stated
interest rate,
a.

is the discount or premium presented as a direct deduction from or addition to the face amount of the note?

b.

is the effective interest rate disclosed?

c.

is the face amount of the note disclosed?

d.

is amortization of the discount or premium reported as
interest in the income statement?

e.

are issue costs reported as deferred charges?
[FASB ASC 835-30-45 par. 1A and 2–3]

6.

Are current portions of debt obligations presented as current
liabilities?
[FASB ASC 210-10-45-9]

7.

If short term obligations have been excluded from current liabilities pursuant to FASB ASC 470-10-45-14, do disclosures
include
a.

a general description of the financing agreement?

b.

terms of any new obligation incurred or expected to be
incurred, or equity securities issued, or expected to be
issued, as a result of the refinancing?
[FASB ASC 470-10-50-4]

8.

Are long term debt agreements subject to a subjective acceleration clause disclosed unless the likelihood of the acceleration of the due date is remote?
[FASB ASC 470-10-45-2; FASB ASC 470-10-50-3]

9.

Are long term obligations that are or will be callable by the
creditor, either because the debtor’s violation of the debt
agreement at the balance-sheet date makes the obligation callable or because the violation, if not cured within a specified
grace period, will make the obligation callable, classified as
current unless either of the following conditions is met:
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a.

The creditor has waived or subsequently lost the right
to demand repayment for more than one year (or operating cycle, if longer) from the balance-sheet date?

b.

The obligation contains a grace period within which the
debtor may cure the violation, and it is probable that
the violation will be cured within that period, thus preventing the violation from becoming callable?
[FASB ASC 470-10-45-11]

No

N/A

57

Financial Statements and Notes Checklist

Yes
10.

If an obligation under question 9 is included in long term liabilities (or in the case of an unclassified balance sheet is included as a long term liability in the disclosure of debt maturities), are the circumstances disclosed?
[FASB ASC 470-10-50-2]

11.

If the reporting entity has borrowed funds in the form of participating mortgage loans, are the following disclosed in the
financial statements:

12.

a.

The aggregate amount of participating mortgage obligations at the balance-sheet date, with separate disclosure of the aggregate participation liabilities and related debt discounts?

b.

Terms of the participations by the lender in either the
appreciation in the market value of the mortgaged real
estate project or the results of operations of the mortgaged real estate project, or both?
[FASB ASC 470-30-50-1]

No

N/A

For insurance-related assessments,
a.

if amounts relating to insurance-related assessments
have been discounted pursuant to the provisions of
paragraphs 9–10 of FASB ASC 405-30-30, has the entity
disclosed in the financial statements the undiscounted
amounts of the liability and any related asset for premium tax offsets or policy surcharges as well as the discount rate used?

b.

if amounts have not been discounted, has the entity disclosed in the financial statements the amounts of the
liability, any related asset for premium tax offsets or
policy surcharges, the periods over which the assessments are expected to be paid, and the period over
which the recorded premium tax offsets or policy surcharges are expected to be realized?
[FASB ASC 405-30-50-1]
Practice Tip

Disclosure is not required for a loss contingency involving an unasserted claim or assessment if there has
been no manifestation by a potential claimant of an awareness of a possible claim or assessment unless both
of the following conditions are met:
●

It is considered probable that a claim will be asserted.

●

There is a reasonable possibility that the outcome will be unfavorable.

Further, disclosure of noninsured or underinsured risks in encouraged but not required.
[FASB ASC 450-20-50 par. 6–7]
The Basis for Conclusions of the original standard (FASB Statement No. 5, Accounting for Contingencies) indicated that disclosure was not required because of the problems involved in developing operational criteria
for disclosure of noninsured or underinsured risks. Nonetheless, a 1987 AICPA report, Disclosure Concerning
Insurance Coverage, stated that disclosure of these risks should be encouraged rather than simply not discouraged. Questions 13–14 that follow are nonauthoritative suggestions from that report. The AICPA noted
(continued)
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Yes

No

N/A

that disclosure of this kind is experimental. Therefore, its location in a financial report would depend on the
judgment of preparers of the report.
13.

For publicly held entities and entities with public accountability, such as governments, are circumstances disclosed in
which
a.

b.

14.

they are exposed to risks of future material loss related
to
i.

torts?

ii.

theft of, damage to, expropriation of, or destruction of assets?

iii.

business interruption?

iv.

errors or omissions?

v.

injuries to employees?

vi.

acts of God?

those risks have not been transferred to unrelated third
parties through insurance? (Encouraged, but not required.)

In considering those matters to be disclosed that relate to certain uninsured risks of future material loss as described in
FASB ASC 720-20, has the entity considered the following:
a.

The actual and potential effects of losses from such
risks on the entity’s historical or planned operations,
including exposure to losses from claims, curtailment
of research and development or manufacturing, or contraction or cessation of other activities, such as discontinuance of a product line?

b.

Comparison of current insurance coverage by major
categories of risk to coverage in prior periods, without
necessarily quantifying such coverage or change in coverage?

c.

Recent claims experience?

d.

A description of the reporting entity’s risk management
programs? (Encouraged, but not required.)

15.

Is the domiciliary state insurance commissioner’s role and
ability to approve or disapprove any interest and principal
payments disclosed?
[FASB ASC 944-470-50-1]

16.

Are surplus notes presented as liabilities in the financial statements of the issuer (equity treatment for surplus notes is inappropriate)?
[FASB ASC 944-470-45-1]
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Yes
Q.

No

N/A

Shareholders’ Equity
Notes: In May 2008, FASB issued FSP APB 14-1, Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion
(Including Partial Cash Settlement). This FSP requires an issuer to separately account for the liability and equity components of convertible
debt instruments within its scope. Convertible debt instruments, including instruments within the scope of this FSP, consist of a liability
component with a below-market interest coupon (the debt instrument) and an equity component (the conversion option). Convertible
debt instruments within the scope of this FSP are required to be separated into its liability and equity components, with each component
accounted for pursuant to other U.S. GAAP applicable to that component.
This FSP applies to convertible debt instruments that, by their stated
terms, may be settled in cash (or other assets) upon conversion, including partial cash settlement, unless the embedded conversion option is required to be separately accounted for as a derivative under
FASB Statement No. 133, Accounting for Derivative Instruments and
Hedging Activities. Other scope limitations apply. This FSP is effective
for financial statements issued for fiscal years beginning after December 15, 2008 (that is, January 1, 2009, for entities with calendar yearends), and interim periods within those fiscal years. Early adoption is
not permitted.
This checklist has been updated to include the presentation and disclosure requirements of FSP APB 14-1.
Readers can refer to the full text of the statement on the FASB Web
site at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 470-2065-1.
1.

For each class of stock, do disclosures include the number of
shares authorized, issued, and outstanding, and par or stated
value per share?
[FASB ASC 505-10-50-3]

2.

Are classes of capital stock presented in order of priority in
liquidation?
[Common Practice]

3.

Do the financial statements include a description, in summary form, sufficient to explain the pertinent rights and privileges of the various securities outstanding, including
a.

possible conversion prices and dates as well as other
significant terms for each convertible instrument? (For
example, the entity is obligated to issue X shares and as
the market price of the common stock decreases, the entity is obligated to issue an additional X shares for each
$1 decrease in the stock price.)
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Yes
b.

4.

No

N/A

have the terms of the transaction been disclosed in the
footnotes to the financial statements, including the excess of the aggregate fair value of the instruments that
the holder would receive at conversion over the proceeds received and the period over which the discount
is amortized?
[FASB ASC 505-10-50 par. 3 and 7–8]

Has the entity considered disclosure of information about derivative instruments entered into in connection with the issuance of the contingently convertible securities that may be
useful in terms of fully explaining the potential impact of the
contingently convertible securities? That information might
include the terms of those derivative instruments, including
the terms of settlement, how those instruments relate to the
contingently convertible securities, and the number of shares
underlying the derivative instruments. One example is the
purchase of a call option such that the terms of the purchased
call option would be expected to substantially offset changes
in value of the written call option embedded in the convertible security. Derivative instruments are also subject to additional disclosure information, as required by FASB ASC 815,
Derivatives and Hedging.
[FASB ASC 505-10-50-10]
Practice Tip

(FSP APB 14-1) Incremental disclosures may be required for debt with conversion and other options. See
FASB ASC 470-20-10-2 and paragraphs 2–6 of FASB ASC 470-20-50.
[“Pending Content” in FASB ASC 505-10-50-10A]
5.

Do disclosures include the number of shares issued upon
conversion, exercise, or satisfaction of required conditions
during at least the most recent annual fiscal period and any
subsequent interim period presented?
[FASB ASC 505-10-50-3]

6.

For preferred stock that has a preference in involuntary liquidation considerably in excess of par or stated value of the
shares, is the liquidation preference disclosed in the equity
section of the balance sheet in the aggregate, either parenthetically or “in short,” rather than on a per share basis or in the
notes to the financial statements?
[FASB ASC 505-10-50-4]

7.

Are the following disclosed on the face of the balance sheet
or in the notes to the financial statements:
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a.

The aggregate or per-share amounts at which preferred
stock may be called or are subject to redemption
through sinking-fund operations or otherwise?

b.

The aggregate and per-share amounts of arrearages in
cumulative preferred dividends?
[FASB ASC 505-10-50-5]
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Yes
8.

For redeemable stock, do disclosures include the amount of
redemption requirements, separately by issue or combined,
for all issues of capital stock that are redeemable at fixed or
determinable prices on fixed or redeemable dates in each of
the five years following the date of the latest balance sheet?
[FASB ASC 505-10-50-11]

9.

Do disclosures for contingently convertible securities include
the significant quantitative and qualitative terms of the conversion features to enable users of the financial statements to
understand the circumstances of the contingency and the potential impact of conversion, including
a.

events or changes in circumstances that would cause
the contingency to be met and any significant features
necessary to understand the conversion rights and the
timing of those rights (for example, the periods in
which (1) the contingency might be met and (2) the securities may be converted if the contingency is met)?

b.

the conversion price and the number of shares into
which the security is potentially convertible?

c.

events or changes in circumstances, if any, that could
adjust or change the contingency, conversion price, or
number of shares, including significant terms of those
changes?

d.

the manner of settlement upon conversion and any alternative settlement methods (for example, cash,
shares, or a combination)?
[FASB ASC 505-10-50-6]

10.

Do disclosures indicate whether the shares that would be issued if the contingently convertible securities were converted
are included in the calculation of diluted earnings per share
(EPS), and the reasons why or why not?
[FASB ASC 505-10-50-9]

11.

Are appropriations of retained earnings for loss contingencies
clearly identified and included in shareholders’ equity?
[FASB ASC 505-10-45-3]

12.

Has the entity disclosed any restrictions on the payment of
dividends?
[FASB ASC 440-10-50-1]

13.

After completion of a quasi-reorganization, is a new retained
earnings account established and dated with the date being
disclosed in subsequent financial statements until it is no
longer deemed significant?
[FASB ASC 852-20-50-2]

14.

Are the carrying basis, cost and number of shares of any
treasury stock held by the reporting entity disclosed?
[Common Practice]

No

N/A
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Yes
15.

a.

Shown separately as a deduction from the total of capital stock, additional paid-in capital, and retained earnings? or

b.

Accorded the accounting treatment appropriate for retired stock?
[FASB ASC 505-30-45-1]

16.

If state laws relating to acquisition of stock restrict the availability of retained earnings for payment of dividends or other
significant effects, is appropriate disclosure made?
[FASB ASC 505-30-50-2]

17.

If treasury shares are purchased at a stated price significantly
in excess of the current market price of the shares, is the allocation of the amounts paid and the accounting treatment
for such amounts disclosed?
[FASB ASC 505-30-50 par. 3–4]

18.

If the pension asset or liability that is recognized pursuant to
FASB ASC 715-30-25-1, results in a temporary difference, as
defined in the FASB ASC glossary, are the deferred tax effects
of any temporary differences recognized in income tax expense or benefit for the year and allocated to various financial
statement components, including OCI, pursuant to FASB
ASC 740-20-45?
[FASB ASC 715-30-25-3]

19.

Is the following information relating to stockholders’ equity,
statutory capital and surplus, and the effects of statutory accounting practices on the ability to pay dividends to stockholders disclosed:

20.

R.

If treasury stock is purchased for purposes other than retirement or if ultimate disposition has not yet been decided is its
cost:

a.

The amount of statutory capital and surplus?

b.

The amount of statutory capital and surplus necessary
to satisfy regulatory requirements (based on current
operations) if significant in relation to the statutory
capital and surplus?

c.

The nature of statutory restrictions on the payment of
dividends and the amount of retained earnings that is
not available for the payment of dividends to stockholders?
[FASB ASC 944-505-50-1]

If statutory surplus is below the minimum required by law,
is disclosure of the relevant facts made?
[Common Practice]

Changes in Shareholders’ Equity
1.
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Are changes in the separate accounts of shareholders’ equity
disclosed?
[FASB ASC 505-10-50-2]

No

N/A
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Yes
2.

Are changes in the number of shares of equity securities disclosed?
[FASB ASC 505-10-50-2]

3.

If prior-period adjustments have been recorded during the
current year, are the resulting effects (both gross and net of
applicable income taxes and including the amounts of income
tax applicable to the prior period adjustments) appropriately
disclosed?
a.

For single-period statements, does the disclosure indicate the effects of such restatement on the balance of
retained earnings at the beginning of the period and on
the net income of the immediately preceding period?

b.

If financial statements of more than one period are presented, does disclosure include the effects for each of
the periods presented in the statements?
[FASB ASC 250-10-50 par. 8–9]

No

N/A

Note: See part B, “Accounting Changes and Error Corrections,” of the “Other Financial Statement Disclosures” section of this checklist for additional disclosures.

Practice Tip
Disclosure of restatements in financial statements of periods subsequent to the annual financial statements
of the year of change should not be repeated.
[FASB ASC 250-10-50-10]
4.

5.

If interim financial reports contain an adjustment related to
prior interim periods of the current fiscal year, do disclosures
include
a.

the effect on income from continuing operations, net income, and related per share amounts for each prior interim period of the current fiscal year?

b.

income from continuing operations, net income, and related per share amounts for each prior interim period
restated?
[FASB ASC 250-10-50-11]

If the entity (1) regularly reports interim information, (2)
makes an accounting change during the fourth quarter of its
fiscal year, and (3) does not report the data specified by FASB
ASC 270-10-50-1 in a separate fourth-quarter report or in its
annual report, has the entity included disclosure of the effects
of the accounting change on interim-period results (as required by FASB ASC 250-10-50-1) in a note to the annual financial statements for the fiscal year in which the change is
made?
[FASB ASC 250-10-45-15]
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Yes

III. Income Statement
A.

Revenue and Expenses
1.

Are the important components of income, such as sales or
other sources of revenue, cost of sales, selling and administrative expenses, interest expense and income taxes, separately
disclosed on the face of the income statement?
[Common Practice]

2.

Is the following information concerning interest costs disclosed:
a.

For accounting periods in which no interest is capitalized, the amount of interest cost incurred and charged
to expense during the period?

b.

For an accounting period in which some interest cost is
capitalized, the total amount of interest cost incurred
during the period and the amount thereof that has been
capitalized?
[FASB ASC 835-20-50-1]

3.

Are interest costs associated with product financing arrangements identified separately?
[FASB ASC 470-40-25-4]

4.

Are disclosures included in the financial statements of the total research and development costs charged to expense in
each period for which an income statement is presented?
[FASB ASC 730-10-50-1]

5.

Have all nonrefundable advance payments made for goods
or services that will be used or rendered for future research
and development activities pursuant to an executory contractual arrangement been deferred and capitalized, and recognized as an expense as the goods are delivered or the related
services are performed?
[FASB ASC 730-20-25-13; FASB ASC 730-20-35-1]

6.

If the entity has capitalized costs incurred for a computer
software product to be sold, leased, or otherwise marketed,
are the following disclosed in the financial statements:

7.
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a.

Unamortized computer software costs included in each
balance sheet presented?

b.

The total amount charged to expense in each income
statement presented for amortization of capitalized
computer software costs and for amounts written down
to net realizable value?
[FASB ASC 985-20-50-1]

Are research and development costs incurred for a computer
software product to be sold, leased, or otherwise marketed
disclosed either separately or as part of the total research and
development costs for each period presented?
[FASB ASC 985-20-50-2]

No

N/A
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8.

N/A

Has the entity made disclosures related to advertising that
include
a.

the accounting policy for reporting advertising including whether such costs are expensed as incurred or the
first time the advertising takes place?

b.

a description of direct-response-advertising reported as
assets (if any), the related accounting policy, and the
amortization method and period?

c.

the amount charged to advertising expense for each
statement of income presented, with separate disclosure of amounts, if any, representing a write-down of
capitalized advertising costs to net realizable value?

d.

the amount of advertising reported as assets in each
balance sheet presented?
[FASB ASC 720-35-50-1; FASB ASC 340-20-50-1]

9.

Is the amount of revenue and expense recognized from advertising barter transactions disclosed for each income statement period presented?
[FASB ASC 605-20-50-1]

10.

If the entity engages in advertising barter transactions for
which the fair value is not determinable within the limits of
paragraphs 15–18 of FASB ASC 605-20-25, is information regarding the volume and type of advertising surrendered and
received (such as the number of equivalent pages, the number of minutes, or the overall percentage of advertising volume) disclosed for each income statement period presented?
[FASB ASC 605-20-50-1]

11.

Has the entity disclosed the following information in the
notes to the financial statements in the period(s) in which
business interruption insurance recoveries are recognized:

12.

No

a.

The nature of the event resulting in business interruption losses?

b.

The aggregate amount of business interruption insurance recoveries recognized during the period and the
line item(s) in the statement of operations in which
those recoveries are classified (including amounts reported as an extraordinary item pursuant to FASB ASC
225-20)?
[FASB ASC 225-30-50-1]

Does a vendor disclose the following in regard to revenue arrangements with multiple deliverables:
a.

Its accounting policy for recognition of revenue from
multiple-deliverable arrangements (for example,
whether deliverables are separable into units of accounting)?
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b.

No

N/A

The description and nature of such arrangements, including performance, cancellation, termination, or refund-type provisions?
[FASB ASC 605-25-50-1]
Practice Tip

Question 14 is based on the presumption that cash consideration (including a sales incentive) given by a
vendor to a customer is a reduction of the selling prices of the vendor’s products or services. That presumption is overcome and the consideration should be characterized as a cost incurred (question 15) if, and to the
extent that, both of the conditions in FASB ASC 605-50-45-2 are met.
13.

Has the entity characterized as a reduction of revenue any
cash consideration (including a sales incentive) given to a
customer when recognized in the entity’s income statement?
[FASB ASC 605-50-45-2]

14.

If the entity provides a customer with a sales incentive or
other consideration which consists of a free product or service
(for example, a gift certificate from the vendor or a free airline
ticket that will be honored by another, unrelated entity), or
anything other than cash (including credits that the customer
can apply against trade amounts owed to the vendor) or equity instruments (see FASB ASC 605-50-55-43), has the cost of
the consideration been characterized as an expense (as opposed to a reduction of revenue) when recognized in the entity’s income statement?
[FASB ASC 605-50-45-3]

15.

If the entity is a service provider and provides incentives to a
third-party manufacturer or reseller that ultimately benefits
the service provider’s customer, has this fact been disclosed?
[FASB ASC 605-50-50-1]

Notes: In December 2007, FASB issued Emerging Issues Task Force
(EITF) Issue No. 07-1, “Accounting for Collaborative Agreements Related to the Development and Commercialization if Intellectual Property.” The objective of this issue is to define collaborative arrangements and to establish reporting requires for transactions between
participants in a collaborative arrangement and between participants
in the arrangement and third parties. FASB Statement No. 167, Amendments to FASB Interpretation No. 46(R). Among other things, EITF Issue
No. 07-1 changes income statement classification of costs and revenue
generated by participants in a collaborative arrangement from transactions with third parties, as opposed to applying the equity method
of accounting under Accounting Principles Board (APB) Opinion No.
18. The EITF also requires enhanced disclosures.
EITF Issue No. 07-1 is effective for financial statements issued for fiscal years beginning after December 15, 2008 (that is, January 1, 2009,
for entities with calendar year-ends), and interim periods within those
fiscal years. The guidance should be applied retrospectively to all
(continued)
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prior periods presented for all collaborative arrangements existing as
of the effective date.
This checklist has been updated to include the presentation and disclosure requirements of EITF Issue No. 07-1.
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should
consider all questions indicated with an “A” reference (for example,
question 1A and question 2A) and should place an “N/A” mark in
questions indicated with a “B” reference. Entities for which the guidance has been implemented should consider all questions indicated by
a “B” reference (for example, question 1B and question 2B) and place
an “N/A” mark by questions indicated with an “A” reference. Therefore, based upon your entity’s year-end and decision to early implement or not (if allowed), the following additional questions will be
answered when provided in this section (check one that applies for
your entity):
pppA pppB
Readers can refer to the full text of the issue on the FASB Web site at
www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 808-1065-1.
16B. (EITF Issue No. 07-1) If the entity is a participant in a collaborative arrangement, has it disclosed all following in the period in which a collaborative arrangement is entered into
(which may be an interim period) and all annual periods
thereafter:
a.

Information about the nature and purpose of its collaborative arrangements?

b.

Its rights and obligations under the collaborative arrangements?

c.

The accounting policy for collaborative arrangements
in accordance with FASB ASC 235-10?

d.

The income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants for each period an income statement is presented?
[“Pending Content” in FASB ASC 808-10-50-1]

Income Taxes Held for Remittance
17.

Is the accounting policy decision regarding the presentation
of taxes within the scope of FASB ASC 605-45-15-2(e), either
on a gross basis (included in revenues and costs) or a net basis (excluded from revenues), disclosed pursuant to FASB
ASC 235-10?
[FASB ASC 605-45-50-3]
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18.

For any such taxes that are reported on a gross basis, does the
entity disclose the amounts of those taxes in interim and annual financial statements for each period for which an income
statement is presented if those amounts are significant?
(Note: The disclosure of those taxes can be done on an aggregate basis.)
[FASB ASC 605-10-50-4]

19.

Are payments to policyholders that represent a return of policyholder balances not reported as expenses in the statement
of earnings?
[FASB ASC 944-20-45-1]

20.

Do amounts reported as expenses include benefit claims in
excess of the related policyholder balances, expenses of contract administration, interest accrued to policyholders, amortization of capitalized acquisition costs?
[FASB ASC 944-20-45-2]

21.

Are depreciation and other real estate operating costs recorded as investment expense or operating expense depending on the balance sheet classification of the underlying asset?
[FASB ASC 944-360-45-2]

22.

Are realized gains and losses on all investments (except those
that are accounted for as either hedges of net investments in
foreign operations or cash flow hedges) reported in the statement of earnings as a component of other income, on a pretax
basis?
[FASB ASC 944-325-45-3]

23.

Are realized gains and losses on all investments presented as
a separate item in the statement of earnings or disclosed in
the notes to the financial statements?
[FASB ASC 944-325-45-4]

24.

For contracts with death or other insurance benefit features,
has a change in the additional liability been recognized as a
component of benefit expense in the statement of operations?
[FASB ASC 944-40-45-1]

25.

For contracts that provide annuitization benefits, has the
change in the additional liability recognized under paragraphs 22–24 of FASB ASC 944-40-25 been reported as a component of benefit expense in the statement of operations?
[FASB ASC 944-40-45-2]

26.

Are premiums from universal life contracts no longer included in revenue but recorded in the balance sheet policyholder accounts?
[FASB ASC 944-605-25-5]

27.

Are changes in the allowance for estimated uncollectible
amounts relating to mortgage loans included in income as
prescribed in FASB ASC 310-10?
[FASB ASC 944-310-45-4]
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28.

B.

No

N/A

Is the amortization and other related charges or credits for
mortgage loans charged or credited to investment income?
[FASB ASC 944-310-45-3]

Income Taxes
Notes: In December 2007, FASB issued Statement No. 141(R) to improve the relevance, representational faithfulness, and comparability
of the information that a reporting entity provides in its financial reports about a business combination and its effects. FASB Statement
No. 141(R) supersedes FASB Statement No. 141 but retains the fundamental requirements in FASB Statement No. 141 that the acquisition
method of accounting (formerly called the purchase method in FASB
Statement No. 141) be used for all business combinations and that an
acquirer be identified for each business combination.
This statement applies prospectively to business combinations for
which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008 (that
is, January 1, 2009, for entities with calendar year-ends). An entity
may not apply it before that date.
This checklist has been updated to include the presentation and disclosure requirements of FASB Statement No. 141(R).
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should
consider all questions indicated with an “A” reference (for example,
question 1A and question 2A) and should place an “N/A” mark in
questions indicated with a “B” reference. Entities for which the guidance has been implemented should consider all questions indicated by
a “B” reference (for example, question 1B and question 2B) and place
an “N/A” mark by questions indicated with an “A” reference. Therefore, based upon your entity’s year-end and decision to early implement or not (if allowed), the following additional questions will be
answered when provided in this section (check one that applies for
your entity):
pppA pppB
Readers can refer to the full text of the statement on the FASB Web
site at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 805-1065-1.
******
In September 2009, FASB issued Accounting Standards Update (ASU)
No. 2009-006, Implementation Guidance on Accounting for Uncertainty in
Income Taxes and Disclosure Amendments for Nonpublic Entities. The
amendments apply only to nonpublic entities as defined in FASB ASC
740-10-20.
The amendments to FASB ASC in this ASU provide implementation
guidance, through examples, on how to apply the standards for un(continued)
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certainty in income taxes. In addition, the ASU eliminates for nonpublic entities the disclosures required by both FASB ASC 740-10-5015(a) (which requires a tabular reconciliation of the total amount of
unrecognized tax benefits at the beginning and end of the periods presented) and FASB ASC 740-10-50-15(b) (which requires the disclosure
of the total amount of unrecognized tax benefits that, if recognized,
would affect the effective tax rate).
For entities that are currently applying the guidance for accounting
and uncertainty in income taxes, this guidance and the disclosure
amendments are effective for financial statements issued for interim
and annual periods ending after September 15, 2009 (that is, December 31, 2009, for entities with calendar year-ends). For those entities
that have deferred the application of accounting for uncertainty in income taxes in accordance with FASB ASC 740-10-65-1(e), the guidance
and disclosure amendments are effective upon adoption of those standards.
This checklist has been updated to include the presentation and disclosure requirements of ASU No. 2009-006.
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should
consider all questions indicated with an “A” reference (for example,
question 1A and question 2A) and should place an “N/A” mark in
questions indicated with a “B” reference. Entities for which the guidance has been implemented should consider all questions indicated by
a “B” reference (for example, question 1B and question 2B) and place
an “N/A” mark by questions indicated with an “A” reference. Therefore, based upon your entity’s year-end and decision to early implement or not (if allowed), the following additional questions will be
answered when provided in this section (check one that applies for
your entity):
pppA pppB
Readers can refer to the full text of the ASU on the FASB Web site at
www.fasb.org.
1A.

1B.

Has the entity disclosed the following:
a.

The amounts and expiration dates of operating loss and
tax credit carryforwards for tax purposes?

b.

Any portion of the valuation allowance for deferred tax
assets for which subsequently recognized tax benefits
will be allocated to reduce goodwill or other noncurrent intangible assets of an acquired entity or directly
to contributed capital?
[FASB ASC 740-10-50-3]

(FASB Statement No. 141(R)) Has the entity disclosed the following:
a.
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The amounts and expiration dates of operating loss and
tax credit carryforwards for tax purposes?

No

N/A
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b.

2A.

2B.

No

N/A

Any portion of the valuation allowance for deferred tax
assets for which subsequently recognized tax benefits
will be credited directly to contributed capital?
[“Pending Content” in FASB ASC 740-10-50-3]

Has the entity disclosed the following significant components
of income tax expense attributable to continuing operations
for each year presented:
a.

Current tax expense (or benefit)?

b.

Deferred tax expense (or benefit) (exclusive of the effects of other components in this list)?

c.

Investment tax credits?

d.

Government grants (to the extent recognized as a reduction of income tax expense)?

e.

The benefits of operating loss carryforwards?

f.

Tax expense that results from allocating certain tax benefits directly to contributed capital?

g.

Adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax
status of the reporting entity?

h.

Adjustments of the beginning-of-the-year balance of a
valuation allowance because of a change in circumstances that causes a change in judgment about the
realizability of the related deferred tax asset in future
years?
[FASB ASC 740-10-50-9]

(FASB Statement No. 141(R)) Has the entity disclosed the following significant components of income tax expense attributable to continuing operations for each year presented:
a.

Current tax expense (or benefit)?

b.

Deferred tax expense (or benefit) (exclusive of the effects of other components in this list)?

c.

Investment tax credits?

d.

Government grants (to the extent recognized as a reduction of income tax expense)?

e.

The benefits of operating loss carryforwards?

f.

Tax expense that results from allocating certain tax benefits directly to contributed capital?

g.

Adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax
status of the reporting entity?
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h.

Adjustments of the beginning-of-the-year balance of a
valuation allowance because of a change in circumstances that causes a change in judgment about the
realizability of the related deferred tax asset in future
years (for example, any acquisition-date income tax
benefits or expenses recognized from changes in the acquirer’s valuation allowance for its previously existing
deferred tax assets as a result of a business combination
[see FASB ASC 805-740-30-3])?
[“Pending Content” in FASB ASC 740-10-50-9]

3.

Are the amount of income tax expense or benefit allocated to
continuing operations and the amounts separately allocated
to other items (in accordance with the intraperiod tax allocation provisions of paragraphs 2–14 of FASB ASC 740-20-45
and FASB ASC 852-740-45-3) disclosed for each year for
which those items are presented?
[FASB ASC 740-10-50-10]

4.

(Issuers Only) If the reporting entity is a public enterprise, is
there a reconciliation in both percentages and dollar amounts
of the reported amount of income tax expense attributable to
continuing operations for the year to the amount of income
tax expense that would result from applying domestic federal
statutory tax rates to pretax income from continuing operations?
[FASB ASC 740-10-50-12]

5.

(Nonissuers Only) Is there disclosure of the nature of significant items required to reconcile the reported amount of income tax expense attributable to continuing operations for
the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations?
[FASB ASC 740-10-50-13]

6A.

Has the entity disclosed the following at the end of each annual reporting period presented:
a.
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A tabular reconciliation of the total amounts of unrecognized tax benefits at the beginning and end of the
period, which include, at a minimum
i.

the gross amounts of the increases and decreases
in unrecognized tax benefits as a result of tax positions taken during a prior period?

ii.

the gross amounts of increases and decreases in
unrecognized tax benefits as a result of tax positions taken during the current period?

iii.

the amounts of decreases in the unrecognized tax
benefits relating to settlements with taxing authorities?

iv.

reductions to unrecognized tax benefits as a result of a lapse of the applicable statute of limitations?

No

N/A
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b.

The total amount of unrecognized tax benefits that, if
recognized, would affect the effective tax rate?

c.

The total amounts of interest and penalties recognized
in the statement of operations and the total amounts of
interest and penalties recognized in the statement of financial position?

d.

For positions for which it is reasonably possible that the
total amounts of unrecognized tax benefits will significantly increase or decrease within 12 months of the reporting date, has the following been disclosed:

e.

6B.

The nature of the uncertainty?

ii.

The nature of the event that could occur in the
next 12 months that would cause the change?

iii.

An estimate of the range of the reasonably possible change or a statement that an estimate of the
range cannot be made?

N/A

A description of tax years that remain subject to examination by major tax jurisdictions?
[FASB ASC 740-10-50-15]

(ASU No. 2009-006) Has the entity disclosed the following at
the end of each annual reporting period presented:
a.

The total amounts of interest and penalties recognized
in the statement of operations and the total amounts of
interest and penalties recognized in the statement of financial position?

b.

For positions for which it is reasonably possible that the
total amounts of unrecognized tax benefits will significantly increase or decrease within 12 months of the reporting date,

c.

7B.

i.

No

i.

the nature of the uncertainty?

ii.

the nature of the event that could occur in the
next 12 months that would cause the change?

iii.

an estimate of the range of the reasonably possible change or a statement that an estimate of the
range cannot be made?

A description of tax years that remain subject to examination by major tax jurisdictions?
[“Pending Content” in FASB ASC 740-10-50-15]

(ASU No. 2009-006) (Issuers Only) In addition to the items in
question 6B, has the entity also disclosed the following at the
end of each annual reporting period presented:
a.

A tabular reconciliation of the total amounts of unrecognized tax benefits at the beginning and end of the
period, which should include at a minimum
i.

the gross amounts of the increases and decreases
in unrecognized tax benefits as a result of tax positions taken during a prior period?
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b.

ii.

the gross amounts of increases and decreases in
unrecognized tax benefits as a result of tax positions taken during the current period?

iii.

the amounts of decreases in the unrecognized tax
benefits relating to settlements with taxing authorities?

iv.

reductions to unrecognized tax benefits as a result of a lapse of the applicable statute of limitations?

The total amount of unrecognized tax benefits that, if
recognized, would affect the effective tax rate?
[“Pending Content” in FASB ASC 740-10-50-15A]

8.

(Issuers Only) If the entity is not subject to income tax because its income is taxed directly to its owners, has that fact
and the net difference between the tax bases and the reported
amounts of the entity’s assets and liabilities been disclosed?
[FASB ASC 740-10-50-16]

9.

If the entity is a member of a group that files a consolidated
tax return, are the following items disclosed in its separately
issued financial statements:
a.

The aggregate amount of current and deferred tax expense for each income statement presented and the
amount of any tax-related balances due to or from affiliates as of the date of each balance sheet presented?

b.

The principal provisions of the method by which the
consolidated amount of current and deferred tax expense is allocated to members of the group and the nature and effect of any changes in that method (and in
determining related balances to or from affiliates) during the years for which the disclosures in item (a) are
presented?
[FASB ASC 740-10-50-17]

10.

Has the entity disclosed its policy on classification of interest
and penalties in accordance with FASB ASC 740-10-45-25 in
the footnotes to the financial statements?
[FASB ASC 740-10-50-19]

11.

If the entity presents a classified statement of financial position, does the entity classify a liability associated with an unrecognized tax benefit as a current liability (or the amount of
a net operating loss carryforward or amount refundable is reduced) to the extent the enterprise anticipates payment (or
receipt) of cash within one year or the operating cycle, if
longer? Furthermore, has the liability for unrecognized tax
benefits (or reduction in amounts refundable) not been combined with deferred tax liabilities or assets?
[FASB ASC 740-10-45-11]

FSP §20,100.01

No

N/A

75

Financial Statements and Notes Checklist

Yes

C.

12.

Is a liability that has been recognized as a result of applying
FASB ASC 740-10-25-17 not classified as a deferred tax liability unless it arises from a taxable temporary difference?
[FASB ASC 740-10-45-12]

13.

If the entity is an S corporation, partnership, or proprietorship, is the reason that no income tax expense is recorded disclosed?
[Common Practice]

No

N/A

Extraordinary Items
1.

Has the nature and financial effects of each event or transaction that is unusual in nature or occurs infrequently, but not
both, been disclosed on the face of the income statement, or
alternatively, in notes to the financial statements?
[FASB ASC 225-20-50-3]

2.

Have extraordinary items been disclosed separately and included in the determination of net income for the interim period or periods in which they occurred?
[FASB ASC 225-20-50-4]
Practice Tip

FASB ASC 270-10-45-11A requires that extraordinary items, gains or losses from disposal of a component of
an entity, and unusual or infrequently occurring items not be prorated over the balance of the fiscal year.
[FASB ASC 225-20-50-4]
3.

Are extraordinary items (as described in FASB ASC 225-1045-2) segregated and shown (including applicable income
taxes) following income before extraordinary items and before net income?
[FASB ASC 225-20-45-10]

4.

Is the caption extraordinary items used to identify separately
the effects of events and transactions, other than disposals of
components of an entity, that meet the criteria for classification as extraordinary as discussed in paragraphs 1–6 of FASB
ASC 225-20-45?
[FASB ASC 225-20-45-11]

5.

Are descriptive captions and amounts presented for individual extraordinary events or transactions, preferably on the
face of the income statement if practicable?
[FASB ASC 225-20-45-11]

6.

Are the nature of each extraordinary event or transaction and
the principle items entering into the determination of extraordinary gains or losses described?
[FASB ASC 225-20-45-11]

7.

Are income taxes applicable to any extraordinary items disclosed on the face of the income statement (preferable) or disclosed in the notes to the financial statements?
[FASB ASC 225-20-45-11]

FSP §20,100.01

76

Life and Health Insurance Entities

Yes
8.

9.

D.

No

N/A

Are material events or transactions that are either unusual in
nature or of infrequent occurrence, but not both (and therefore not meeting the criteria for extraordinary items)
a.

reported as a separate component of income from continuing operations?

b.

accompanied by disclosure of the nature and financial
effects of each event?
[FASB ASC 225-20-45-16]

If any extraordinary items that were reported in prior periods
are adjusted during the current period, are the adjustments
separately disclosed as to year of origin, nature, and amount
and classified separately on the current period as an extraordinary item?
[FASB ASC 225-20-45-13]

Earnings Per Share
Practice Tip

The guidance in FASB ASC 260, Earnings per Share, requires presentation of EPS by all entities that have
issued common stock or potential common stock (that is, securities such as options, warrants, convertible
securities, or contingent stock agreements) if those securities trade in a public market either on a stock
exchange (domestic or foreign) or in the over-the-counter market, including securities quoted only locally or
regionally. FASB ASC 260 also requires presentation of EPS by an entity that has made a filing or is in the
process of filing with a regulatory agency in preparation for the sale of those securities in a public market.
[FASB ASC 260-10-15-2]
Notes: In March 2008, FASB issued Statement No. 160 to establish accounting and reporting standards for the noncontrolling interests in a
subsidiary and for the deconsolidation of a subsidiary, areas for which
limited guidance previously existed. In addition to the overview of
this statement provided in a note appearing in this checklist, readers
should be aware that FASB Statement No. 160 clarifies that, if an entity has an outstanding noncontrolling interest (minority interest),
amounts for both comprehensive income attributable to the parent
and comprehensive income attributable to the noncontrolling interest
in a less-than-wholly-owned subsidiary are reported on the face of the
financial statement in which comprehensive income is presented in
addition to presenting consolidated comprehensive income. Additionally, if an entity has an outstanding noncontrolling interest, the components of OCI attributable to the parent and noncontrolling interest
in a less-than wholly-owned subsidiary are required to be disclosed
as part of its equity reconciliation. FASB Statement No. 160 is effective
for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2008 (that is, January 1, 2009, for entities
with calendar year-ends). Earlier adoption is prohibited.
This checklist has been updated to include the presentation and disclosure requirements of FASB Statement No. 160.
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should
(continued)
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consider all questions indicated with an “A” reference (for example,
question 1A and question 2A) and should place an “N/A” mark in
questions indicated with a “B” reference. Entities for which the guidance has been implemented should consider all questions indicated by
a “B” reference (for example, question 1B and question 2B) and place
an “N/A” mark by questions indicated with an “A” reference. Therefore, based upon your entity’s year-end and decision to early implement or not (if allowed), the following additional questions will be
answered when provided in this section (check one that applies for
your entity):
pppA pppB
Readers can refer to the full text of the statement on the FASB Web
site at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 810-1065-1.
1.

If the entity has a simple capital structure (only common
stock outstanding), are basic per-share amounts for income
from continuing operations and for net income presented on
the face of the income statement for all periods for which an
income statement or summary of earnings is presented?
[FASB ASC 260-10-45 par. 2 and 7]

2.

If the entity has other than a simple capital structure, are basic and diluted per-share amounts for income from continuing operations and for net income presented on the face of
the income statement with equal prominence for all periods
for which an income statement or summary of earnings is
presented? (Note: If diluted EPS data are reported for at least
one period, they should be reported for all periods presented,
even if they are the same amounts as basic EPS.)
[FASB ASC 260-10-45 par. 2 and 7]

3.

If discontinued operations, extraordinary items, or the cumulative effect of accounting changes are reported in the period, are the basic and diluted per share amounts for those
line items presented on the face of the income statement or in
the notes?
[FASB ASC 260-10-45-3]

4.

If per share amounts not required to be presented by FASB
ASC 260-10 are disclosed, are they disclosed only in the notes
and do the disclosures indicate whether the per share
amounts are pretax or net of tax?
[FASB ASC 260-10-45-5]

5.

Are the following disclosed for each period for which an income statement is presented:
a.

A reconciliation of the numerators and denominators of
the basic and diluted per share computations for income from continuing operations?
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b.

The effect that has been given to preferred dividends in
arriving at income available to common shareholders’
in computing basic EPS?

c.

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic EPS in the future that were not included in the computation of diluted EPS because to do so would have
been antidilutive for the period(s) presented?
[FASB ASC 260-10-50-1]

6.

For the latest period for which an income statement is presented, do disclosures include a description of any transaction that occurs after the end of the most recent period but
before the financial statements are issued or are available to
be issued (as discussed in FASB ASC 855-10-25) that would
have changed materially the number of common shares or
potential common shares outstanding at the end of the period
if the transaction had occurred before the end of the period?
[FASB ASC 260-10-50-2]

7.

If the number of common shares outstanding increases as a
result of a stock dividend or stock split (see FASB ASC 50520) or decreases as a result of a reverse stock split, the computations of basic and diluted EPS should be adjusted retroactively for all periods presented to reflect that change in
capital structure. If per-share computations reflect such
changes in the number of shares, is that fact disclosed?
[FASB ASC 260-10-55-12]

8.

If changes in common stock resulting from stock dividends,
stock splits, or reverse stock splits occur after the close of the
period but before the financial statements are issued or are
available to be issued (as discussed in FASB ASC 855-10-25),
the per-share computations for those and any prior-period financial statements presented should be based on the new
number of shares. If per-share computations reflect such
changes in the number of shares, is that fact disclosed?
[FASB ASC 260-10-55-12]

9.

When prior EPS amounts have been restated in compliance
with an accounting standard requiring restatement, is the effect of the restatement, expressed in per share terms, disclosed in the period of restatement?
[FASB ASC 260-10-55-16]

10B. (FASB Statement No. 160) For purposes of computing EPS in
consolidated financial statements (both basic and diluted), if
one or more less-than-wholly-owned subsidiaries are included in the consolidated group, has the income attributable
to the noncontrolling interest in subsidiaries been excluded
from income from continuing operations and net income?
[“Pending Content” in FASB ASC 260-10-45-11A]
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E.

No

N/A

Comprehensive Income
Notes: In March 2008, FASB issued Statement No. 160 to establish accounting and reporting standards for the noncontrolling interests in a
subsidiary and for the deconsolidation of a subsidiary, areas for which
limited guidance previously existed. In addition to the overview of
this statement provided in a note appearing in this checklist, readers
should be aware that FASB Statement No. 160 clarifies that, if an entity has an outstanding noncontrolling interest (minority interest),
amounts for both comprehensive income attributable to the parent
and comprehensive income attributable to the noncontrolling interest
in a less-than-wholly-owned subsidiary are reported on the face of the
financial statement in which comprehensive income is presented in
addition to presenting consolidated comprehensive income. Additionally, if an entity has an outstanding noncontrolling interest, the components of OCI attributable to the parent and noncontrolling interest
in a less-than wholly-owned subsidiary are required to be disclosed
as part of its equity reconciliation. FASB Statement No. 160 is effective
for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2008 (that is, January 1, 2009, for entities
with calendar year-ends). Earlier adoption is prohibited.
This checklist has been updated to include the presentation and disclosure requirements of FASB Statement No. 160.
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should
consider all questions indicated with an “A” reference (for example,
question 1A and question 2A) and should place an “N/A” mark in
questions indicated with a “B” reference. Entities for which the guidance has been implemented should consider all questions indicated by
a “B” reference (for example, question 1B and question 2B) and place
an “N/A” mark by questions indicated with an “A” reference. Therefore, based upon your entity’s year-end and decision to early implement or not (if allowed), the following additional questions will be
answered when provided in this section (check one that applies for
your entity):
pppA pppB
Readers can refer to the full text of the statement on the FASB Web
site at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 810-1065-1.
******
In April 2009, FASB issued FSP 115-2 and FAS 124-2 to determine
whether the holder on an investment in a debt or equity security for
which changes in fair value are not regularly recognized in earnings
(such as securities classified as held-to-maturity or available-for-sale)
should recognize a loss in earnings when the investment is impaired.
This FSP amends the other-than-temporary impairment guidance in
(continued)
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U.S. GAAP for debt securities to make the guidance more operational
and to improve the presentation and disclosure of other-than-temporary impairments on debt and equity securities in the financial statements. This FSP does not amend existing recognition and measurement guidance related to other-than-temporary impairments of equity
securities.
FSP FAS 115-2 and FAS 124-2 is effective for interim and annual reporting periods ending after June 15, 2009 (that is, December 31, 2009,
for entities with calendar year-ends), with early adoption permitted
for periods ending after March 15, 2009. Earlier adoption for periods
ending before March 15, 2009, is not permitted. If an entity elects to
adopt early either FSP FAS 157-4 or FSP FAS 107-1 and APB 28-1,
Interim Disclosures about Fair Value of Financial Instruments, then entity
is also required to adopt early this FSP. Additionally, if an entity elects
to adopt early this FSP, it is required to adopt FSP FAS 157-4. This
FSP does not require disclosures for earlier periods presented for comparative purposes at initial adoptions. In periods after initial adoption,
this FSP requires comparative disclosures only for periods ending after initial adoption.
This checklist has been updated to include the presentation and disclosure requirements of FSP FAS 115-2 and FAS 124-2.
Readers can refer to the full text of the statement on the FASB Web
site at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 320-1065-1.
1.

Are all components of comprehensive income reported in the
financial statements in the period in which they are recognized?
[FASB ASC 220-10-45-5]

2.

Is a total amount for comprehensive income displayed in the
financial statement where the components of OCI are reported?
[FASB ASC 220-10-45-5]

3B.

(FASB Statement No. 160) If the entity has an outstanding
noncontrolling interest, are amounts for both comprehensive
income attributable to the parent and comprehensive income
attributable to the noncontrolling interest reported on the face
of the financial statement in which comprehensive income is
presented in addition to presenting consolidated comprehensive income?
[“Pending Content” in FASB ASC 220-10-45-5; “Pending Content” in FASB ASC 810-10-50-1A]

4.

Is an amount for net income displayed and included as a
component of comprehensive income?
[FASB ASC 220-10-45-6]
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5.

6.

No

N/A

Are items included in OCI classified separately based on their
nature, including
a.

foreign currency translation adjustments?

b.

gains and losses on foreign currency transactions that
are designated as, and are effective as, economic
hedges of a net investment in a foreign entity, commencing as of the designation date (see FASB ASC 83020-35-3(a))?

c.

gains and losses on intraentity foreign currency transactions that are of a long term investment nature (that
is, settlement is not planned or anticipated in the foreseeable future), when the entities to the transaction are
consolidated, combined, or accounted for by the equity
method in the reporting entity’s financial statements
(see FASB ASC 830-20-35-3(b))?

d.

gains and losses (effective portion) on derivative instruments that are designated as, and qualify as, cash flow
hedges (see FASB ASC 815-20-35-1(c))?

e.

unrealized holding gains and losses that result from a
debt security being transferred into the available-forsale category from the held-to-maturity category (see
FASB ASC 320-10-35-10(c))?

f.

subsequent decreases (if not an other-than-temporary
impairment) or increases in the fair value of availablefor-sale securities previously written down as impaired
(see FASB ASC 320-10-35-18)?

g.

gains or losses associated with pension or other postretirement benefits (that are not recognized immediately
as a component of net periodic benefit cost) (see FASB
ASC 715-20-50-1(j))?

h.

prior service costs or credits associated with pension or
other postretirement benefits (see FASB ASC 715-20-501(j))?

i.

transition assets or obligations associated with pension
or other postretirement benefits (that are not recognized immediately as a component of net periodic benefit cost) (see FASB ASC 715-20-50-1(j))?
[“Pending Content” in FASB ASC 220-10-45-13; “Pending Content” in FASB ASC 220-10-55-2]

Are reclassification adjustments made to avoid double counting in comprehensive income of items that are displayed as
part of net income for a period that also had been displayed
as part of OCI in that period or other periods presented on
the face of the financial statement in which comprehensive
income is reported or disclosed in the notes?
[FASB ASC 220-10-45-15]
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7.

Are comprehensive income and its components displayed in
a financial statement that is displayed with the same prominence as the other financial statements? (Note: FASB ASC
220-10 encourages but does not require that the components
of OCI and total comprehensive income be displayed below
the total for net income in a statement that reports results of
operations or in a separate statement of comprehensive income that begins with net income.)
[FASB ASC 220-10-45 par. 8–9]

8B.

(FASB Statement No. 160) If the entity has an outstanding
noncontrolling interest, are the components of OCI attributable to the parent and noncontrolling interest in a less-thanwholly-owned subsidiary disclosed as part of its equity reconciliation?
[“Pending Content” in FASB ASC 220-10-45-8; “Pending Content” in FASB ASC 810-10-50-1A]

9.

Are the components of OCI displayed either net of related tax
effects, or before related tax effects with one amount shown
for the aggregate tax effect related to the total of OCI items?
[FASB ASC 220-10-45-11]

10.

Is the amount of income tax expense or benefit allocated to
each component of OCI (including reclassification adjustments) displayed on the face of the statement in which those
components are displayed or disclosed in the notes to the financial statements?
[FASB ASC 220-10-45-12]

11.

Is the total of OCI for a period transferred to a component of
equity that is displayed separately from retained earnings
and additional paid-in-capital in the balance sheet with a descriptive title such as “accumulated OCI”?
[FASB ASC 220-10-45-14]

12.

Are accumulated balances for each classification within accumulated OCI disclosed on the face of the balance sheet, in the
statement of changes in shareholders’ equity, or in the notes?
[FASB ASC 220-10-45-14]

13.

Has the enterprise reported a total for comprehensive income
in condensed financial statements of interim periods?
[FASB ASC 220-10-45-18]

14.

Has the entity displayed as a separate classification within
OCI the net gain or loss on derivative instruments designated
and qualifying as cash flow hedging instruments that are reported in comprehensive income pursuant to FASB ASC 81520-25-65 and FASB ASC 815-30-35-3?
[FASB ASC 815-30-45-1]

FSP §20,100.01

No

N/A

83

Financial Statements and Notes Checklist

Yes
15.

No

N/A

As part of the disclosures of accumulated OCI, pursuant to
FASB ASC 220-10-45-14, has the entity separately disclosed
the beginning and ending accumulated derivative gain or
loss, the related net change associated with current period
hedging transactions, and the net amount of any reclassification into earnings?
[FASB ASC 815-30-50-2]

IV. Statement of Cash Flows
1.

Does the statement of cash flows report net cash provided or used
by the operating, investing, and financing activities and the effect
of those flows on cash and cash equivalents during the period in a
manner that reconciles beginning and ending cash and cash equivalents?
[FASB ASC 230-10-45-24]

2.

Is the accounting policy for determining which items are treated as
cash equivalents disclosed?
[FASB ASC 230-10-50-1]

3.

If the direct method of reporting net cash flow from operating activities is used, do cash flows from operating activities separately
report
a.

cash received from customers?

b.

interest and dividends received?

c.

other operating cash receipts?

d.

cash paid to employees and suppliers?

e.

interest paid?

f.

income taxes paid and, separately, the cash that would have
been paid for income taxes if increases in the value of equity
instruments issued under share-based payment arrangements
that are not recognizable as a cost of goods or services for
accounting purposes also had not been deductible in determining taxable income (FASB ASC 230-10-45-14(e))?

g.

other operating cash payments (if any)?
[FASB ASC 230-10-45-25]
Practice Tip

FASB ASC 230-10-45-25 encourages reporting entities to use the direct method of reporting cash flows. The
sample financial statements in FSP section 6400 illustrate a statement of cash flows prepared using the direct
method.
4.

If the direct method is used, is a separate reconciling schedule provided to reconcile net income to net cash flow from operating activities?
[FASB ASC 230-10-45-30]
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5.

If the direct method of reporting net cash flow from operating activities is not used, is the net cash flow from operating activities reported indirectly by adjusting net income to reconcile it to net cash
flow from operating activities?
[FASB ASC 230-10-45-28]

6.

Is the reconciliation of net income to net cash flow from operating
activities, including separate reporting of all major classes of reconciling items, presented?
[FASB ASC 230-10-45-29]

7.

If the indirect method of reporting net cash flow from operating
activities is used, are amounts of interest paid (net of amounts capitalized) and income taxes paid during the period provided in related disclosures?
[FASB ASC 230-10-50-2]

8.

Are investing and financing activities that affect recognized assets
or liabilities, but that do not result in cash receipts or cash payments
in the period, disclosed?
[FASB ASC 230-10-50-3]

9.

Are cash receipts and cash payments for the following transactions
classified as cash flows from operating activities:
a.

Cash receipts from sales of goods or services, including receipts from collection or sale of accounts and both short and
long term notes receivable from customers arising from those
sales?

b.

Cash receipts from returns on loans, other debt instruments
of other entities, and equity securities—interest and dividends?

c.

All other cash receipts that do not stem from transactions defined as investing or financing activities, such as amounts received to settle lawsuits; proceeds of insurance settlements
except for those that are directly related to investing or financing activities, such as from destruction of a building; and
refunds from suppliers?

d.

Cash payments to acquire materials for manufacture or goods
for resale, including principal payments on accounts and both
short and long term notes payable to suppliers for those materials or goods?

e.

Cash payments to other suppliers and employees for other
goods or services?

f.

Cash payments to governments for taxes, duties, fines, and
other fees or penalties and the cash that would have been
paid for income taxes if increases in the value of equity instruments issued under share-based payment arrangements
that are not included in the cost of goods or services recognizable for financial reporting purposes also had not been deductible in determining taxable income?

g.

Cash payments to lenders and other creditors for interest?
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h.

10.

11.

12.

No

N/A

All other cash payments that do not stem from transactions
defined as investing or financing activities, such as payments
to settle lawsuits, cash contributions to charities, and cash refunds to customers?
[FASB ASC 230-10-45 par. 16–17]

Are cash receipts and cash payments for the following transactions
classified as cash flows from investing activities:
a.

Receipts from collections or sales of loans?

b.

Receipts from sales of property, plant, and equipment?

c.

Loans to others?

d.

Cash flows from purchases, sales, and maturities of availablefor-sale securities?

e.

Payments to acquire property, plant, and equipment?

f.

Receipts from sales of equity instruments of other enterprises
exclusive of those carried in the trading account?

g.

Payments to acquire equity instruments of other enterprises,
exclusive of those carried in the trading account?
[FASB ASC 230-10-45 par. 12–13; FASB ASC 310-10-45-11]

Are cash receipts and cash payments for the following transactions
classified as cash flows from investing activities:
a.

Proceeds from issuing debt?

b.

Issuance of equity instruments?

c.

Payment of dividends?

d.

Repayments for amounts borrowed?

e.

Purchases of treasury stock?

f.

Other principal payments to creditors who have extended
long term debt?

g.

Proceeds received from derivative instruments and distributions to counterparties of derivative instruments that include
financing elements at inception?

h.

Cash retained as a result of the tax deductibility of increases
in the value of equity instruments issued under share-based
payment arrangements that are not included in the cost of
goods or services that is recognizable for financial reporting
purposes? For this purpose, excess tax benefits should be determined on an individual award (or a portion thereof) basis?

i.

Payments for debt issue costs?
[FASB ASC 230-10-45 par. 14–15]

Are cash payments made to settle an asset retirement obligation
classified in the statement of cash flows as an operating activity?
[FASB ASC 230-10-45-17(e)]
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13.

Except for certain items whose turnover is quick, amounts are large,
and maturities are short, are cash receipts and cash payments from
investing and financing activities shown separately on the statement of cash flows?
[FASB ASC 230-10-45 par. 8–9 and 26]

14.

If an other-than-insignificant financing element is present at inception, other than a financing element inherently included in an atthe-market derivative instrument with no prepayments (that is, the
forward points in an at-the-money forward contract), does the borrower report all cash inflows and outflows associated with that derivative instrument as financing activities?
[FASB ASC 230-10-45-27]

No

N/A

Practice Tip
If there are only a few noncash transactions, it may be convenient to include them on the same page as the
statement of cash flows. Otherwise, the transactions may be reported elsewhere in the financial statements,
clearly referenced to the statement of cash flows.
[FASB ASC 230-10-50-6]

V. Summary of Significant Accounting Policies
Practice Tips
As you evaluate the completeness of the significant accounting policies, consider whether additions or revisions are required in response to recently issued accounting guidance. Also consider whether disclosures
of accounting policies covered in other sections of this checklist are included.
If the accounting policy disclosures called for in sections such as these are not included in notes elsewhere
in the financial statements, they should be included in the summary of accounting policies.
[FASB ASC 235-10-50-4]
******
Financial statement disclosure of accounting policies should not duplicate details (for example, composition
of inventories or of plant assets) presented elsewhere as part of the financial statements. In some cases, the
disclosure of accounting policies should refer to related details presented elsewhere as part of the financial
statements; for example, changes in accounting policies during the period should be described with crossreference to the disclosure required by FASB ASC 250.
[FASB ASC 235-10-50-5]
A.

Accounting Policies
1.

Is a description of all significant accounting policies of the reporting entity presented as either a separate summary preceding the notes to the financial statements or as the initial
note?
[FASB ASC 235-10-50-6]

2.

Do the summary or notes identify and describe all significant
accounting principles followed by the reporting entity and
the methods of applying those principles that materially affect the determination of financial position, cash flows, and
results of operations?
[FASB ASC 235-10-50-3]
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3.

No

N/A

Do those principles and methods identified in question 2 include all instances in which there
a.

is a selection from existing acceptable alternatives?

b.

are principles and methods peculiar to the industry in
which the reporting entity operates, even if such principles and methods are predominantly followed in that
industry?

c.

are unusual or innovative applications of U.S. GAAP?
[FASB ASC 235-10-50-3]

4.

Is a description of the method for recognizing interest income
on loan and trade receivables, including a statement about
the entity’s policy for treatment of related fees and costs, including the method of amortizing net deferred fees or costs
included in the notes to the financial statements?
[FASB ASC 310-20-50-1]

5.

If (a) state prescribed statutory accounting practices differ
from the National Association of Insurance Commissioners
(NAIC) statutory accounting practices or (b) permitted state
statutory accounting practices differ from either state prescribed statutory accounting practices or NAIC statutory accounting practices, is the following information about the use
of prescribed or permitted statutory accounting practices (individually or in the aggregate) results in reported statutory
surplus or risk-based capital that is significantly different
from the statutory surplus or risk-based capital that would
have been reported had NAIC statutory accounting practices
been followed, disclosed:
a.

If an insurance entity’s risk-based capital would have
triggered a regulatory event had it not used a permitted practice, is that fact disclosed in the financial statements?

b.

A description of the prescribed or permitted statutory
accounting practice by insurance entities at the date
each financial statement is presented?

c.

The related monetary effect on statutory surplus of using an accounting practice that differs from either state
prescribed statutory accounting practices or NAIC statutory accounting practices by insurance entities at the
date each financial statement is presented?1
[FASB ASC 944-505-50 par. 2–3]

1
Disclosures in this question should be applied by a U.S. insurance entity, a U.S. entity with a U.S. insurance subsidiary, or a foreign
entity with a U.S. insurance subsidiary, if the entity prepares U.S. generally accepted accounting principles (GAAP) financial statements.
If a foreign insurance entity that does not have a U.S. insurance subsidiary prepares U.S. GAAP financial statements or is included in its
parent’s consolidated U.S. GAAP financial statements, the notes to the financial statements should disclose permitted regulatory accounting practices that significantly differ from the prescribed regulatory accounting practices of its respective regulatory authority and their
monetary effects.
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6.

Are managements’ policies and methodologies for estimating
a liability for unpaid claims and claim adjustment expenses
for difficult-to-estimate liabilities such as for claims for toxic
waste cleanup, asbestos-related illnesses, or other environmental remediation exposures disclosed?
[FASB ASC 944-40-50-4]

7.

Do the notes to the accompanying insurance entity’s statutory
financial statements contain a summary of significant accounting policies that discuss the following:
a.

Statutory accounting practices?

b.

Describe how this basis differs from GAAP?
[AAG-LHI 3.21]

8.

For general-use statutory financial statements, are the effects
of the differences between statutory accounting practices and
GAAP, if quantified, disclosed?
[AAG-LHI 15.32–.33]

9.

Has the insurance entity disclosed its accounting policy for
internal replacements, including whether or not the entity has
availed itself of the alternative application guidance in paragraphs 44–45 of FASB ASC 944-30-35, and if so, for which
types of internal replacement transactions?
[FASB ASC 944-30-50-4]

10.

Has the insurance entity disclosed its accounting policy for
sales inducements, including:

11.

a.

The nature of the costs deferred?

b.

The method of amortizing those costs?
[FASB ASC 944-30-50-3(a)]

For sales inducements, are the amount of costs deferred and
amortized for each of the periods presented and the unamortized balance as of each balance sheet date disclosed?
[FASB ASC 944-30-50-3]

Notes: The amortization of a deferred sales inducement should be recognized as a component of benefit expense.
[FASB ASC 944-30-45-2]
******
See also part L, "Separate Account Assets" of the "Balance Sheet" section of this checklist for related accounting policy disclosures.
12.
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B.

No

N/A

Certain Significant Estimates
1.

If known information available before the financial statements are issued indicates that: (a) it is at least reasonably
possible that the effect on the financial statements of a condition, situation, or set of circumstances that existed the date of
the financial statements will change in the near term due to
one or more future confirming events, and (b) the effect of the
change would be material to the financial statements:
a.

Is disclosure made of the nature of the uncertainty, including an indication that it is at least reasonably possible that a change in the estimate will occur in the near
term?

b.

If the estimate involves a loss contingency covered by
FASB Statement No. 5, does the disclosure include an
estimate of the possible range of loss, or state that such
an estimate cannot be made?

c.

Does the disclosure describe the factors that cause the
estimate to be sensitive to change?
[FASB ASC 275-10-50 par. 8–9]
Practice Tip

For public entities, additional disclosures regarding concentration of credit risk may be required by applicable SEC rules and regulations (for example, Item 303 of Regulation S-K, Management’s Discussion and
Analysis of Financial Conditions and Results of Operations). For banks and bank holding companies subject to
the requirements of SEC Regulation S-X, Rule 9-03, and SEC Industry Guide 3, additional disclosures may
be required.

VI. Interim Reporting
Notes: In March 2008, FASB issued Statement No. 161, Disclosures
about Derivative Instruments and Hedging Activities—an amendment of
FASB Statement No. 133, to enhance the current disclosure framework
in FASB Statement No. 133. This statement has the same scope as
FASB Statement No. 133 and, accordingly, applies to all entities.
This statement changes the disclosure requirements for derivative instruments and hedging activities. Entities are required to provide enhanced disclosures about (a) how and why an entity uses derivative
instruments, (b) how derivative instruments and related hedged items
are accounted for under FASB Statement No. 133 and its related interpretations, and (c) how derivative instruments and related hedged
items affect an entity’s financial position, financial performance, and
cash flows.
FASB Statement No. 161 is effective for financial statements issued for
fiscal years and interim periods beginning after November 15, 2008
(that is, January 1, 2009, for entities with calendar year-ends). Early
application is encouraged. This statement encourages but does not re(continued)
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quire disclosures for earlier periods presented for comparative purposes at initial adoption. In years after initial adoption, it requires
comparative disclosures only for periods subsequent to initial adoption.
This checklist has been updated to include the presentation and disclosure requirements of FASB Statement No. 161.
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should consider all questions indicated with an “A” reference (for example, question 1A and question 2A) and should place an “N/A” mark in questions indicated with a “B” reference. Entities for which the guidance
has been implemented should consider all questions indicated by a
“B” reference (for example, question 1B and question 2B) and place an
“N/A” mark by questions indicated with an “A” reference. Therefore,
based upon your entity’s year-end and decision to early implement or
not (if allowed), the following additional questions will be answered
when provided in this section (check one that applies for your entity):
pppA pppB
Readers can refer to the full text of the statement on the FASB Web site
at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and
open effective date information discussed in FASB ASC 815-10-65-1.
******
In April 2009, FASB issued FSP 107-1 and APB 28-1 to require disclosures about fair value of financial instruments for interim reporting
periods of publicly traded entities as well as in annual financial statements. This FSP also amends APB Opinion No. 28, Interim Financial
Reporting, to require those disclosures in summarized financial information at interim reporting periods. This FSP applies to all financial
instruments within the scope of FASB Statement No. 107, Disclosures
about Fair Value of Financial Instruments, held by publicly traded companies, as defined by APB Opinion No. 28.
FSP FAS 107-1 and APB 28-1 is effective for interim reporting periods
ending after June 15, 2009 (that is, December 31, 2009, for entities with
calendar year-ends), with early adoption permitted for periods ending
after March 19, 2009. An entity may early adopt this FSP only if it also
elects to early adopt FSP FAS 157-4 and FSP FAS 115-2 and FAS 1242. This FSP does not require disclosures for earlier periods presented
for comparative purposes at initial adoptions. In periods after initial
adoption, this FSP requires comparative disclosures only for periods
ending after initial adoption.
This checklist has been updated to include the presentation and disclosure requirements of FSP FAS 107-1 and APB 28-1.
Readers can refer to the full text of the statement on the FASB Web site
at www.fasb.org.
(continued)
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No
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This guidance is labeled as "Pending Content" due to the transition and
open effective date information discussed in FASB ASC 825-10-65-1.
******
In April 2009, FASB issued FSP 115-2 and FAS 124-2 to determine
whether the holder on an investment in a debt or equity security for
which changes in fair value are not regularly recognized in earnings
(such as securities classified as held-to-maturity or available-for-sale)
should recognize a loss in earnings when the investment is impaired.
This FSP amends the other-than-temporary impairment guidance in
U.S. GAAP for debt securities to make the guidance more operational
and to improve the presentation and disclosure of other-than-temporary impairments on debt and equity securities in the financial statements. This FSP does not amend existing recognition and measurement guidance related to other-than-temporary impairments of equity
securities.
FSP FAS 115-2 and FAS 124-2 is effective for interim and annual reporting periods ending after June 15, 2009 (that is, December 31, 2009,
for entities with calendar year-ends). Earlier adoption for periods ending before March 15, 2009, is not permitted. If an entity elects to adopt
early either FSP FAS 157-4 or FSP FAS 107-1 and APB 28-1, then entity
is also required to adopt early this FSP. Additionally, if an entity elects
to adopt early this FSP, it is required to adopt FSP FAS 157-4. This FSP
does not require disclosures for earlier periods presented for comparative purposes at initial adoptions. In periods after initial adoption,
this FSP requires comparative disclosures only for periods ending after
initial adoption.
This checklist has been updated to include the presentation and disclosure requirements of FSP FAS 115-2 and FAS 124-2.
Readers can refer to the full text of the statement on the FASB Web site
at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and
open effective date information discussed in FASB ASC 320-10-65-1.
1A.

(Issuers Only) If the entity reports summarized financial information at interim dates (including reports on fourth quarters), has the following, at a minimum, been disclosed:
a.

Sales or gross revenues, provision for income taxes, extraordinary items (including related income tax effects),
net income, and comprehensive income?

b.

Basic and diluted EPS data for each period presented,
determined in accordance with the provisions of FASB
ASC 260?

c.

Seasonal revenue, costs, or expenses?

d.

Significant changes in estimates or provisions for income taxes?

e.

Disposal of a component of an entity and extraordinary, unusual, or infrequently occurring items?
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Yes
f.

Contingent items?

g.

Changes in accounting principles or estimates?

h.

Significant changes in financial position?

i.

All of the following information about reportable operating segments determined according to the provisions of FASB ASC 280, including provisions related to
restatement of segment information in previously issued financial statements:
i.

Revenues from external customers?

ii.

Intersegment revenues?

iii.

A measure of segment profit or loss?

iv.

Total assets for which there has been a material
change from the amount disclosed in the last annual report?

v.

A description of differences from the last annual
report in the basis of segmentation or in the
measurement of segment profit or loss?

vi.

A reconciliation of the total of the reportable segments’ measures of profit or loss to the entity’s
consolidated income before income taxes, extraordinary items, and discontinued operations?

No

N/A

Practice Tip
If an entity allocates items such as income taxes and extraordinary items to segments, the entity may choose
to reconcile the total of the segments’ measures of profit or loss to consolidated income after those items.
Significant reconciling items should be separately identified and described in that reconciliation.
[FASB ASC 270-10-50-1(i)(6)]
j.

All of the following information about defined benefit
pension plans and other defined benefit postretirement
benefit plans, disclosed for all periods presented pursuant to the provisions of FASB ASC 715-20:
i.

FSP §20,100.01

The amount of net periodic benefit cost recognized, for each period for which a statement of
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ii.

No
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The total amount of the employer’s contributions paid, and expected to be paid, during
the current fiscal year, if significantly different from amounts previously disclosed pursuant to FASB ASC 715-20-50-1? Estimated
contributions may be presented in the aggregate combining contributions required by
funding regulations or laws, discretionary
contributions, and noncash contributions.

k.

The information about the use of fair value to measure
assets and liabilities recognized in the statement of financial position pursuant to paragraphs 1–6 of FASB
ASC 820-10-50?

l.

The information about derivative instruments as required by FASB ASC 815-10-50, 815-20-50, 815-25-50,
815-30-50, and 815-35-50?

m.

The information about fair value of financial instruments as required by FASB ASC 825-10-50?

n.

The information about certain investments in debt and
equity securities as required by FASB ASC 320-10-50
and FASB ASC 942-320-50?

o.

The information about other-than-temporary impairments as required by FASB ASC 320-10-50, 325-25-50,
and 958-320-50?
[“Pending Content” in FASB ASC 270-10-50-1]
Practice Tip

If summarized financial data are regularly reported on a quarterly basis, the foregoing information with
respect to the current quarter and the current year-to-date or the last 12 months to date should be furnished
together with comparable data for the preceding year.
[“Pending Content” in FASB ASC 270-10-50-1]
1B.

(FASB Statement No. 161) (Issuers Only) If the publicly
traded entity reports summarized financial information at interim dates (including reports on fourth quarters), has the following, at a minimum, been disclosed:
a.

Sales or gross revenues, provision for income taxes, extraordinary items (including related income tax effects),
net income, and comprehensive income?

b.

Basic and diluted EPS data for each period presented,
determined in accordance with the provisions of FASB
ASC 260?

c.

Seasonal revenue, costs, or expenses?

d.

Significant changes in estimates or provisions for income taxes?

e.

Disposal of a component of an entity and extraordinary, unusual or infrequently occurring items?

f.

Contingent items?
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g.

Changes in accounting principles or estimates?

h.

Significant changes in financial position?

i.

All of the following information about reportable operating segments determined according to the provisions of FASB ASC 280, including provisions related to
restatement of segment information in previously issued financial statements:
i.

Revenues from external customers?

ii.

Intersegment revenues?

iii.

A measure of segment profit or loss?

iv.

Total assets for which there has been a material
change from the amount disclosed in the last annual report?

v.

A description of differences from the last annual
report in the basis of segmentation or in the
measurement of segment profit or loss?

vi.

A reconciliation of the total of the reportable segments’ measures of profit or loss to the entity’s
consolidated income before income taxes, extraordinary items, and discontinued operations?

No

N/A

Practice Tip
(FASB Statement No. 161) If an entity allocates items such as income taxes and extraordinary items to
segments, the entity may choose to reconcile the total of the segments’ measures of profit or loss to consolidated income after those items. Significant reconciling items should be separately identified and described
in that reconciliation.
[FASB ASC 270-10-50-1(i)(6)]
j.

All of the following information about defined benefit
pension plans and other defined benefit postretirement
benefit plans, disclosed for all periods presented pursuant to the provisions of FASB ASC 715-20:
i.
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The amount of net periodic benefit cost recognized, for each period for which a statement of income is presented, showing separately the service cost component, the interest
cost component, the expected return on plan
assets for the period, the gain or loss component, the prior service cost or credit component, the transition asset or obligation component, and the gain or loss recognized due
to a settlement or curtailment?
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ii.

No

N/A

The total amount of the employer’s contributions paid, and expected to be paid, during
the current fiscal year, if significantly different from amounts previously disclosed pursuant to FASB ASC 715-20-50-1. Estimated
contributions may be presented in the aggregate combining all of the following: (1) contributions required by funding regulations or
laws, (2) discretionary contributions, and (3)
noncash contributions?

k.

The information about the use of fair value to measure
assets and liabilities recognized in the statement of financial position pursuant to paragraphs 1–6 of FASB
ASC 820-10-50?

l.

The information about derivative instruments as required by FASB ASC 815-10-50, 815-20-50, 815-25-50,
815-30-50, and 815-35-50?
[“Pending Content” in FASB ASC 270-10-50-1]

2.

If the reporting entity is publicly traded and if interim financial data and disclosures are not separately reported for the
fourth quarter, are accounting changes made during the
fourth quarter, disposals of segments of a business, extraordinary, unusual, or infrequently occurring items recognized
in the fourth quarter, and the aggregate effect of year-end adjustments that are material to the results of that quarter disclosed in a note to the financial statements?
[FASB ASC 270-10-50-2]

3.

Has the disclosure of the impact of the financial results for
interim periods of the matters discussed in paragraphs 12–16
of FASB ASC 270-10-45 and paragraphs 5–6 of FASB ASC
270-10-50 been made?
[FASB ASC 270-10-50-3]

4.

Has balance sheet and cash flow data been published for the
interim periods? (Encouraged, but not required)
[FASB ASC 270-10-50-4]

5.

Have extraordinary items been disclosed separately and including in the determination of net income for the period in
which the occurred?
[FASB ASC 270-10-50-5]
Practice Tip

The disclosures in question 6 should be repeated in interim and annual reports until the contingencies have
been removed, resolved, or have become immaterial. The significance of a contingency or uncertainty
should be judged in relation to annual financial statements. Disclosures of such items should include, but
not be limited to, those matters that form the basis of a qualification of an independent auditor’s report.
[FASB ASC 270-10-50-6]
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6.

Have contingencies and other uncertainties that could be expected to affect the fairness of presentation of financial data
at an interim date been disclosed in the same manner required for annual reports?
[FASB ASC 270-10-50-6]

VII. Other Financial Statement Disclosures
A.

Business Combinations
Notes: For entities for which FASB Statement No. 141(R) is applicable, complete part A1, “Business Combinations (Subject to FASB
Statement 141(R)),” following.
Because FASB Statement No. 141(R) is to be applied prospectively,
based on the transition guidance, and because FASB used a target
effective date of December 31, 2008, when authoring FASB ASC,
FASB Statement No. 141 was not codified and included in FASB
ASC. FASB ASC 805, Business Combinations, was created using only
FASB Statement No. 141(R) and related content. As noted, it excluded content from FASB Statement No. 141 and related standards.
To maintain a consistent presentation, FASB ASC 805 presents all
content as pending content even though some content applies to
business combinations before the effective date of FASB Statement
No. 141(R). Accordingly, for business combinations applicable before
the effective date in FASB ASC 805-10-65-1, users need to access
FASB Statement No. 141 and any other relevant standards. This decision results in this section of the checklist containing references to
pre-FASB SFAS 141(R) guidance, which has not been codified.
In December 2007, FASB issued Statement No. 141(R) to improve the
relevance, representational faithfulness, and comparability of the information that a reporting entity provides in its financial reports
about a business combination and its effects. FASB Statement No.
141(R) supersedes FASB Statement No. 141 but retains the fundamental requirements in FASB Statement No. 141 that the acquisition
method of accounting (formerly called the purchase method in FASB
Statement No. 141) be used for all business combinations and that an
acquirer be identified for each business combination.
Among many other significant amendments to existing pronouncements precipitated by FASB Statement No. 141(R), this statement redefines goodwill in FASB Statement No. 142 to mean an asset representing the future economic benefits arising from other assets
acquired in a business combination that are not individually identified and separately recognized.
FASB Statement No. 141(R) applies to all transactions or other events
in which an entity (the acquirer) obtains control of one or more businesses (the acquiree), including those sometimes referred to as true
mergers or mergers of equals and combinations achieved without the
transfer of consideration, for example, by contract alone or through
the lapse of minority veto rights. This statement applies to all busi(continued)
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ness entities, including mutual entities that previously used the pooling-of-interests method of accounting for some business combinations. It does not apply to the following:
a.

The formation of a joint venture

b.

The acquisition of an asset or a group of assets that does not
constitute a business

c.

A combination between entities or businesses under common control

d.

A combination between not-for-profit entities or the acquisition of a for-profit business by a not-for-profit entity

This statement applies prospectively to business combinations for
which the acquisition date is on or after the beginning of the first
annual reporting period beginning on or after December 15, 2008
(that is, January 1, 2009, for entities with calendar year-ends). An
entity may not apply it before that date.
Part A1, “Business Combinations (Subject to FASB Statement No.
141(R)),” of this checklist (following) has been updated to include the
presentation and disclosure requirements of FASB Statement No.
141(R).
Readers can refer to the full text of the statement on the FASB Web
site at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 805-1065-1.
1.

Do the notes to the financial statements of a combined entity
disclose the following information in the period in which a
material business combination is completed:
a.

The name and a brief description of the acquired entity
and the percentage of voting equity interests acquired?

b.

The primary reasons for the acquisition, including a description of the factors that contributed to a purchase
price that results in recognition of goodwill?

c.

The period for which the results of operations of the
acquired entity are included in the income statement of
the combined entity?

d.

The cost of the acquired entity and, if applicable, the
number of shares of equity interests (such as common
shares, preferred shares, or partnership interests) issued or issuable, the value assigned to those interests,
and the basis for determining that value?

e.

A condensed balance sheet disclosing the amount assigned to each major asset and liability caption of the
acquired entity at the acquisition date?
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2.

f.

Contingent payments, options, or commitments specified in the acquisition agreement and the accounting
treatment that will be followed should any such contingency occur?

g.

The amount of purchased research and development
assets acquired and written off in the period (refer to
paragraph 42 of FASB Statement No. 141) and the line
item in the income statement in which the amounts
written off are aggregated?

h.

For any purchase price allocation that has not been finalized, that fact and the reasons therefore?

i.

In subsequent periods, the nature and amount of any
material adjustment made to the initial allocation of the
purchase price?
[SFAS 141 par. 51]

Is the following information disclosed in the notes to the financial statements in the period in which a material business
combination is completed if the amounts assigned to goodwill or to other intangible assets acquired are significant in
relation to the total cost of the acquired entity:
a.

3.

FSP §20,100.01

For intangible assets subject to amortization,
i.

the total amount assigned and the amount assigned to a major intangible asset class?

ii.

the amount of any significant residual value, in
total and by major intangible asset class?

iii.

the weighted-average amortization period, in total and by major intangible asset class?

b.

For intangible assets not subject to amortization the total amount assigned and the amount assigned to any
major intangible asset class?

c.

For goodwill,
i.

the total amount of goodwill and the amount that
is expected to be deductible for tax purposes?

ii.

the amount of goodwill by reportable segment (if
the combined entity is required to disclose segment information in accordance with FASB Statement No. 131), unless not practicable?
[SFAS 141 par. 52]

If a series of individually immaterial business combinations
completed during the period are material in the aggregate, is
the following disclosed:
a.

The number of entities acquired and a brief description
of those entities?

b.

The aggregate cost of the acquired entities, the number
of equity interests, (such as common shares, preferred
shares, or partnership interests) issued or issuable, and
the value assigned to those interests?

No

N/A
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Yes

4.

c.

The aggregate amount of any contingent payments, options, or commitments and the accounting treatment
that will be followed should any contingency occur (if
potentially significant in relation to the aggregate cost
of the acquired entities)?

d.

The information described in question 2, if the aggregate amount assigned to goodwill or to other intangible
assets acquired is significant in relation to the aggregate
cost of the acquired entities?
[SFAS 141 par. 53]

No

N/A

If the combined entity is a public business enterprises, is the
following supplemental information on a pro forma basis for
the period in which a material business combinations occurs
(or for the period in which a series of individually immaterial
business combinations occur that are material in the aggregate) disclosed:
a.

Results of operations for the current period as though
the business combination or combinations had been
completed at the beginning of the period unless the acquisition was at or near the beginning of the period?

b.

Results of operations for the comparable period as
though the business combination or combinations had
been completed at the beginning of that period if comparative financial statements are presented?
[SFAS 141 par. 54]

5.

Does the supplemental pro forma information display revenue, income before extraordinary items and the cumulative
effect of accounting changes, net income, and earnings per
share at a minimum? (Note: In determining the pro forma
amounts, income taxes, interest expense, preferred share dividends, and depreciation and amortization of assets should
be adjusted to the accounting base recognized for each in recording the combination. Pro forma information related to results of operations of periods prior to the combination should
be limited to the results of operations for the immediately
preceding period.)
[SFAS 141 par. 55]

6.

Does the supplemental pro forma information disclose the
nature and amount of material, nonrecurring items included
in the reported pro forma results of operations, if any?
[SFAS 141 par. 55]

7.

In the period in which an extraordinary gain is recognized
related to a business combination, do the notes to the financial statements disclose the information required by paragraph 11 of APB Opinion No. 30, Disclosure of Lease Commitments by Lessees?
[SFAS 141 par. 56]
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8.

If a material business combination is completed after the balance sheet date but before the financial statements are issued,
is the information required by questions 1–2 disclosed if practicable?
[SFAS 141 par. 57]

Interim Financial Information
9.

10.

For summarized interim financial information of a public
business enterprise is the following information disclosed if a
material business combination is completed during the current year up to the date of the most recent interim statement
of financial position presented:
a.

The name and a brief description of the acquired entity
and the percentage of voting equity interests acquired?

b.

The primary reasons for the acquisition, including a
brief description of the factors that contributed to a
purchase price that results in recognition of goodwill?

c.

The period for which the results of operations of the
acquired entity are included in the income statement of
the combined entity?

d.

The cost of the acquired entity and, if applicable, the
number of shares of equity interests (such as common
shares, preferred shares, or partnership interests) issued or issuable, the value assigned to those interests,
and the basis for determining that value?

e.

Supplemental pro forma information that discloses the
results of operations for the current interim period and
the current year up to the date of the most recent interim statement of financial position presented (and for
the corresponding periods in the preceding year) as
though the business combination had been completed
as of the beginning of the period reported on?

f.

The nature and amount of any material, nonrecurring
items included in the reported pro forma results of operations?

g.

Do the pro forma information disclosures in item (e)
display at a minimum, revenue, income before extraordinary items and the cumulative effect of accounting
changes (including those on an interim basis), net income and earnings per share?
[SFAS 141 par. 58]

If, as part of a business combination accounted for as a purchase, a material liability is recognized by the combined entity for costs incurred to (a) exit an activity, (b) involuntarily
terminate employees of an acquired entity, or (c) relocate employees of an acquired entity,
a.
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Yes

b.

11.

i.

If the plans to exit an activity or involuntarily terminate (relocate) employees of the acquired entity are not final as of the balance sheet date, a
description of any unresolved issues, the types of
additional liabilities that may result in an adjustment to the purchase price allocation, and how
any adjustment will be reported?

ii.

A description of the type and amount of liabilities assumed in the purchase price allocation for
costs to exit an activity or involuntary terminate
(relocate) employees?

iii.

A description of the major actions comprising the
plan to exit an activity or involuntarily terminate
(relocate) employees of an acquired entity?

iv.

A description of activities of the acquired entity
that will not be continued, including the method
of disposition, and the anticipated date of completion and description of employee group(s) to
be terminated (relocated)?

No

N/A

are the following disclosures made for all periods presented subsequent to the acquisition date in which a
purchase business combination occurred, until a plan
to exit an activity or involuntarily terminate or relocate
employees of an acquired entity is fully executed:
i.

A description of the type and amount of exit
costs, involuntary employee termination costs,
and relocation costs paid and charged against the
liability?

ii.

The amount of any adjustment to the liability account and whether the corresponding entry was
an adjustment of the costs of the acquired entity
or included in the determination of net income
for the period?
[EITF 95-3]

Are the following disclosures made for business combinations between parties with a preexisting relationship:
a.

The nature of the preexisting relationship?

b.

The measurement of the settlement amount of the preexisting relationship, if any, and the valuation method
used to determine the settlement amount?

c.

The amount of any settlement gain or loss recognized
and its classification in the statement of operations?
[EITF 04-1]
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12.

A1.

Amounts previously recognized as goodwill should not be
reclassified as an identifiable intangible asset, however, previously recognized goodwill should be tested for impairment
by applying the consensuses in step 2 of a goodwill impairment test. As a result of the application of EITF Issue No. 041, “Accounting for Preexisting Relationships between the Parties to a Business Combination,” is any effect on a goodwill
impairment charge reported in operating income?
[EITF 04-1]

Business Combinations (Subject to FASB Statement No. 141(R))
Notes: In December 2007, FASB issued Statement No. 141(R) to improve the relevance, representational faithfulness, and comparability
of the information that a reporting entity provides in its financial
reports about a business combination and its effects. FASB Statement
No. 141(R) supersedes FASB Statement No. 141 but retains the fundamental requirements in FASB Statement No. 141 that the acquisition method of accounting (formerly called the purchase method in
FASB Statement No. 141) be used for all business combinations and
that an acquirer be identified for each business combination.
Among many other significant amendments to existing pronouncements precipitated by FASB Statement No. 141(R), this statement redefines goodwill in FASB Statement No. 142 to mean an asset representing the future economic benefits arising from other assets
acquired in a business combination that are not individually identified and separately recognized.
FASB Statement No. 141(R) applies to all transactions or other events
in which an entity (the acquirer) obtains control of one or more businesses (the acquiree), including those sometimes referred to as true
mergers or mergers of equals and combinations achieved without the
transfer of consideration, for example, by contract alone or through
the lapse of minority veto rights. This statement applies to all business entities, including mutual entities that previously used the pooling-of-interests method of accounting for some business combinations. It does not apply to the following:
a.

The formation of a joint venture

b.

The acquisition of an asset or a group of assets that does not
constitute a business

c.

A combination between entities or businesses under common control

d.

A combination between not-for-profit entities or the acquisition of a for-profit business by a not-for-profit entity

This statement applies prospectively to business combinations for
which the acquisition date is on or after the beginning of the first
annual reporting period beginning on or after December 15, 2008
(that is, January 1, 2009, for entities with calendar year-ends). An
entity may not apply it before that date.
(continued)
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This checklist has been updated to include the presentation and disclosure requirements of FASB Statement No. 141(R).
As determined by the effective date or early implementation decision, entities for which this guidance has not been implemented
should consider all questions indicated with an “A” reference (for
example, question 1A and question 2A) and should place an “N/A”
mark in questions indicated with a “B” reference. Entities for which
the guidance has been implemented should consider all questions
indicated by a “B” reference (for example, question 1B and question
2B) and place an “N/A” mark by questions indicated with an “A”
reference. Therefore, based upon your entity’s year-end and decision
to early implement or not (if allowed), the following additional questions will be answered when provided in this section (check one that
applies for your entity):
pppA pppB
Readers can refer to the full text of the statement on the FASB Web
site at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 805-1065-1.
******
In April 2009, FASB amended FASB Statement No. 141(R) through
the issuance of FSP FAS 141(R)-1, Accounting for Assets Acquired and
Liabilities Assumed in a Business Combination That Arise from Contingencies. The FSP amends the initial recognition and measurement, subsequent measurement and accounting, and disclosure of assets and
liabilities arising from contingencies in a business combination. The
FSP is effective for assets or liabilities arising from contingencies in
business combinations for which the acquisition date is on or after
the beginning of the first annual reporting period beginning on or
after December 15, 2008 (that is, January 1, 2009, for entities with
calendar year-ends). As indicated in FASB ASC 270-10-50, the disclosures also apply to interim periods.
This checklist has been updated to include the presentation and disclosure requirements of FSP FAS 141(R)-1.
As determined by the effective date or early implementation decision, entities for which this guidance has not been implemented
should consider all questions indicated with an “A” reference (for
example, question 1A and question 2A) and should place an “N/A”
mark in questions indicated with a “B” reference. Entities for which
the guidance has been implemented should consider all questions
indicated by a “B” reference (for example, question 1B and question
2B) and place an “N/A” mark by questions indicated with an “A”
reference. Therefore, based upon your entity’s year-end and decision
to early implement or not (if allowed), the following additional questions will be answered when provided in this section (check one that
applies for your entity):
pppA pppB
(continued)
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Readers can refer to the full text of the statement on the FASB Web
site at www.fasb.org.
******
FASB Statement No. 141(R) and FSP FAS 141(R)-1 require disclosures that enable users of its financial statements to evaluate
a.

the nature and financial effect of a business combination that
occurs either during the current reporting period, or after
the reporting date but before the financial statements are issued or are available to be issued (see FASB ASC 855-10-25).

b.

the financial effects of adjustments recognized in the current
reporting period that relate to business combinations that occurred in the current or previous reporting periods.

Practice Tip
(FASB Statement No. 141(R)) The acquirer should disclose information that enables users of its financial
statements to evaluate the nature and financial effect of a business combination that occurs either during the
current reporting period or after the reporting date but before the financial statements are issued or are
available to be issued.
[“Pending Content” in FASB ASC 805-10-50-1]
1B.

(FASB Statement No. 141(R)) For each business combination
that occurs during the reporting period, has the entity disclosed
a.

the name and a description of the acquiree?

b.

the acquisition date?

c.

the percentage of voting equity interests acquired?

d.

the primary reasons for the business combination and
a description of how the acquirer obtained control of
the acquiree?

e.

for transactions that are recognized separately from the
acquisition of assets and assumptions of liabilities in
the business combination (see FASB ASC 805-10-25-20),
all of the following:

f.
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i.

A description of each transaction?

ii.

How the acquirer accounted for each transaction?

iii.

The amounts recognized for each transaction and
the line item in the financial statements in which
each amount is recognized?

iv.

If the transaction is the effective settlement of a
preexisting relationship, the method used to determine the settlement amount?

for separately recognized transactions required in item
(e),
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Yes

g.

h.

i.

the amount of acquisition-related costs, the
amount recognized as an expense, and the line
item or items in the income statement in which
those expenses are recognized?

ii.

the amount of any issuance costs not recognized
as an expense and how they were recognized?

No

N/A

in a business combination achieved in stages, both of
the following:
i.

The acquisition-date fair value of the equity interest in the acquiree held by the acquirer immediately before the acquisition date?

ii.

The amount of any gain or loss recognized as a
result of remeasuring to fair value the equity interest in the acquiree held by the acquirer before
the business combination (see FASB ASC 805-1025-10) and the line item in the income statement
in which that gain or loss is recognized?

(Issuers Only) if the acquirer is a public business entity,
are all of the following disclosed:
i.

The amounts of revenue and earnings of the acquiree since the acquisition date included in the
consolidated income statement for the reporting
period?

ii.

The revenue and earnings of the combined entity
for the current reporting period as though the acquisition date for all business combinations that
occurred during the year had been as of the beginning of the annual reporting period (supplemental pro forma information)?

iii.

If comparative financial statements are presented, the revenue and earnings of the combined entity for the comparable prior reporting
period as though the acquisition date for all business combinations that occurred during the current year had occurred as of the beginning of the
comparable prior annual reporting period (supplemental pro forma information)?
[“Pending Content” in FASB ASC 805-10-50-2]
Practice Tips

(FASB Statement No. 141(R)) If disclosure of any of the information required by item (h) is impracticable,
the acquirer should disclose that fact and explain why the disclosure is impracticable.
[“Pending Content” in FASB ASC 805-10-50-2(h)]
******
(continued)
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Yes

No

N/A

(FASB Statement No. 141(R)) If the acquisition date of a business combination is after the reporting date but
before the financial statements are issued or are available to be issued, the acquirer should disclose the
information required by question 1B unless the initial accounting for the business combination is incomplete
at the time the financial statements are issued or are available to be issued. In that situation, the acquirer
should describe which disclosures could not be made and the reason why they could not be made.
[“Pending Content” in FASB ASC 805-10-50-4]
******
(FASB Statement No. 141(R)) If the acquisition date of a business combination is in the previous reporting
period, the acquirer should disclose information that enables users of its financial statements to evaluate the
financial effects of adjustments recognized in the current reporting period related to that prior business
combination.
[“Pending Content” in FASB ASC 805-10-50-5]
2B.

(FASB Statement No. 141(R)) For individually immaterial
business combinations occurring during the reporting period
that are material collectively, has the entity disclosed the information required by items (e)–(g) in question 1B in the aggregate?
[“Pending Content” in FASB ASC 805-10-50-3]

3B.

(FASB Statement No. 141(R)) If the initial accounting for a
business combination is incomplete (see paragraphs 13–14 of
FASB ASC 805-10-25) and the amounts recognized in the financial statements have been determined only provisionally,
has the entity disclosed the following information for each
material business combination (or, in the aggregate for individually immaterial business combinations that are material
collectively):

4B.

a.

The reasons why the initial accounting is incomplete?

b.

The assets, liabilities, equity interests, or items of consideration for which the initial accounting is incomplete?

c.

The nature and amount of any measurement period adjustments recognized during the reporting period in accordance with FASB ASC 805-10-25-17?
[“Pending Content” in FASB ASC 805-10-50-6]

(FASB Statement No. 141(R) and FSP FAS 141(R)-1) With respect to identifiable assets and liabilities and any noncontrolling interest, has the entity disclosed all of the following for
each business combination that occurs during the reporting
period:
a.
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For indemnification assets, all of the following:
i.

The amount recognized as of the acquisition
date?

ii.

A description of the arrangement and the basis
for determining the amount of the payment?
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Yes
iii.

b.

N/A

An estimate of the range of outcomes (undiscounted) or, if a range cannot be estimated, that
fact and the reasons why a range cannot be estimated? (If the maximum amount of the payment
is unlimited, the entity should disclose that fact.)

For acquired receivables not subject to the requirements
of FASB ASC 310-30, all of the following (provided by
major class of receivable, such as loans, direct financing
leases in accordance with FASB ASC 840-30, and any
other class of receivables):
i.

The fair value of the receivables?

ii.

The gross contractual amounts receivable?

iii.

The best estimate at the acquisition date of the
contractual cash flows not expected to be collected?

c.

The amounts recognized as of the acquisition date for
each major class of assets acquired and liabilities assumed (see example 5 in FASB ASC 805-10-55-37)?

d.

For contingencies, in the footnote that describes the
business combination,

e.

No

i.

for assets and liabilities arising from contingencies recognized at the acquisition date (which
may be aggregated for assets or liabilities arising
from contingencies that are similar in nature), (1)
the amounts recognized at the acquisition date
and the measurement basis applied (that is, at
fair value or at an amount recognized in accordance with FASB ASC 450, Contingencies, and
FASB ASC 450-20-25), and (2) the nature of the
contingencies?

ii.

for contingencies that are not recognized at the
acquisition date, the disclosures required by
FASB ASC 450 if the criteria for disclosures
therein are met (which may be aggregated for assets and liabilities arising from contingencies that
are similar in nature)?

For each business combination in which the entity
holds less than 100 percent of the equity interests in the
acquiree,
i.

the fair value of the noncontrolling interest in the
acquiree at the acquisition date?

ii.

the valuation technique(s) and significant inputs
used to measure the fair value of the noncontrolling interest?
[“Pending Content” in FASB ASC 805-20-50-1]
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Yes
5B.

(FASB Statement No. 141(R)) For individually immaterial
business combinations occurring during the reporting period
that are material collectively, has the entity disclosed the information required by question 4B in the aggregate?
[“Pending Content” in FASB ASC 805-20-50-2]

6B.

(FASB Statement No. 141(R)) If the acquisition date of a business combination is after the reporting date but before the financial statements are issued or are available to be issued (as
discussed in FASB ASC 855-10-25), has the entity disclosed

7B.

a.

the information required by question 4B (FASB ASC
805-20-50-1)?

b.

if the initial accounting for the business combination is
incomplete at the time the financial statements are issued or are available to be issued, a description of
which disclosures could not be made and the reason
why they could not be made?
[“Pending Content” in FASB ASC 805-20-50-3]

(FASB Statement No. 141(R)) With respect to goodwill, has
the entity disclosed all of the following information for each
business combination that occurs during the reporting period:
a.

A qualitative description of the factors that make up
the goodwill recognized, such as expected synergies
from combining operations of the acquiree and the acquirer, intangible assets that do not qualify for separate
recognition, or other factors?

b.

The acquisition-date fair value of the total consideration transferred and the acquisition-date fair value of
each major class of consideration, such as the following:

c.
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i.

Cash?

ii.

Other tangible or intangible assets, including a
business or subsidiary of the acquirer?

iii.

Liabilities incurred, for example, a liability for
contingent consideration?

iv.

Equity interests of the acquirer, including the
number of instruments or interests issued or issuable and the method of determining the fair
value of those instruments or interests?

For contingent consideration arrangements, all of the
following:
i.

The amount recognized as of the acquisition
date?

ii.

A description of the arrangement and the basis
for determining the amount of the payment?

No

N/A
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Yes
iii.

No

N/A

An estimate of the range of outcomes (undiscounted) or, if a range cannot be estimated, that
fact and the reasons why a range cannot be estimated? If the maximum amount of the payment
is unlimited, the acquirer should disclose that
fact.

d.

The total amount of goodwill that is expected to be deductible for tax purposes?

e.

If the acquirer is required to disclose segment information in accordance with FASB ASC 280-10, the amount
of goodwill by reportable segment? (If the assignment
of goodwill to reporting units required by paragraphs
41–44 of FASB ASC 350-20-35 has not been completed
as of the date the financial statements are issued or are
available to be issued, the acquirer should disclose that
fact.)

f.

In a bargain purchase (see paragraphs 2–4 of FASB
ASC 805-30-25), both of the following:
i.

The amount of any gain recognized in accordance with FASB ASC 805-30-25-2 and the line
item in the income statement in which the gain is
recognized?

ii.

A description of the reasons why the transaction
resulted in a gain?
[“Pending Content” in FASB ASC 805-30-50-1]

8B.

(FASB Statement No. 141(R)) For individually immaterial
business combinations occurring during the reporting period
that are material collectively, has the entity disclosed the information required by question 7B in the aggregate?
[“Pending Content” in FASB ASC 805-30-50-2]

9B.

(FASB Statement No. 141(R)) If the acquisition date of a business combination is after the reporting date but before the financial statements are issued or are available to be issued (as
discussed in FASB ASC 855-10-25), has the entity disclosed
a.

the information required by questions 1B, 4B, and 7B?

b.

if the initial accounting for the business combination is
incomplete at the time the financial statements are issued or are available to be issued, a description of
which disclosures could not be made and the reason
why they could not be made?
[“Pending Content” in FASB ASC 805-10-50-4, FASB
ASC 805-20-50-3, and FASB ASC 805-30-50-3]

10B. (FASB Statement No. 141(R)) With respect to adjustments
that relate to business combinations that occurred in the current or previous reporting periods, has the entity disclosed
the following information for each material business combination:
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Yes
a.

b.

No

N/A

For each reporting period after the acquisition date until the entity collects, sells, or otherwise loses the right
to a contingent consideration asset, or until the entity
settles a contingent consideration liability or the liability is cancelled or expires, all of the following:
i.

Any changes in the recognized amounts, including any differences arising upon settlement?

ii.

Any changes in the range of outcomes (undiscounted) and the reasons for those changes?

iii.

The fair value disclosures required by paragraphs 1–3 of FASB ASC 820-10-50?

A reconciliation of the carrying amount of goodwill at
the beginning and end of the reporting period as required by FASB ASC 350-20-50-1?
[“Pending Content” in FASB ASC 805-30-50-4]
Practice Tip

(FASB Statement No. 141(R)) Paragraphs 1–5 of FASB ASC 805-50-45 provide guidance on financial statement presentation in the period of transfer and for periods before the transfer of assets and liabilities between entities under common control. Question 11B addresses incremental disclosures related to such a
transaction. The receiving entity also should consider whether additional disclosures are required in accordance with FASB ASC 850-10-50, which provides guidance on related party transactions and certain common control relationships.
[“Pending Content” of FASB ASC 805-50-50 par. 1–4]
11B. (FASB Statement No. 141(R)) If the entity is the receiving entity in transactions between entities under common control,
has the following been disclosed for the period in which the
transfer of assets and liabilities or exchange of equity interests
has occurred:
a.

The name and brief description of the entity included
in the reporting entity as a result of the net asset transfer or exchange of equity interests?

b.

The method of accounting for the transfer of net assets
or exchange of equity interests?
[“Pending Content” in FASB ASC 805-50-50-3]
Practice Tip

(FASB Statement No. 141(R)) FASB ASC 805-740-30-3 describes a situation in which an acquirer reduces its
valuation allowance for deferred tax assets as a result of a business combination. FASB ASC 740-10-50-9(h)
requires disclosure of adjustments of the beginning-of-the-year balance of a valuation allowance because of
a change in circumstances that causes a change in judgment about the realizability of the related deferred
tax asset in future years. That would include, for example, any acquisition date income tax benefits or expenses recognized from changes in the acquirer’s valuation allowance for its previously existing deferred
tax assets as a result of a business combination.
[“Pending Content” in FASB ASC 805-740-50-1]
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Yes
B.

No

N/A

Accounting Changes and Error Corrections
Practice Tip

In determining materiality for the purpose of reporting the correction of an error, amounts should be related
to the estimated income for the full fiscal year and also to the effect on the trend of earnings. Changes that
are material with respect to an interim period but not material with respect to the estimated income for the
full fiscal year or to the trend of earnings should be separately disclosed in the interim period.
[FASB ASC 250-10-45-27]
Change in Accounting Principle
1.

Is the following disclosed in the fiscal period in which a
change in accounting principle is made (not required for subsequent periods):
a.

The nature of and reason for the change in accounting
principle, including an explanation of why the newly
adopted accounting principle is preferable?

b.

The method of applying the change, including all of the
following:

c.

i.

A description of the prior-period information
that has been retrospectively adjusted, if any?

ii.

The effect of the change on income from continuing operations, net income (or other appropriate
captions of changes in the applicable net assets or
performance indicator), any other affected financial statement line item, and any affected pershare amounts for the current period and any
prior periods retrospectively adjusted? Presentation of the effect on financial statement subtotals
and totals other than income from continuing operations and net income (or other appropriate
captions of changes in the applicable net assets or
performance indicator) is not required.

iii.

The cumulative effect of the change on retained
earnings or other components of equity or net assets in the statement of financial position as of the
beginning of the earliest period presented?

iv.

If retrospective application to all prior periods is
impracticable, disclosure of the reasons therefore,
and a description of the alternative method used
to report the change (see paragraphs 5–7 of FASB
ASC 250-10-45)?

If indirect effects of a change in accounting principle
are recognized,
i.

a description of the indirect effects of a change in
accounting principle, including the amounts that
have been recognized in the current period, and
the related per-share amounts, if applicable?
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Yes
ii.

No

N/A

unless impracticable, the amount of the total recognized indirect effects of the accounting change
and the related per-share amounts, if applicable,
that are attributable to each prior period presented?
[FASB ASC 250-10-50-1]

2.

If a change in accounting principle has no material effect in
the period of change but is reasonably certain to have a material effect in later periods, are the disclosures required by
question 1a provided whenever the financial statements of
the period of change are presented?
[FASB ASC 250-10-50-1]

3.

In the fiscal year in which a new accounting principle is
adopted, does financial information reported for interim periods after the date of adoption include disclosure of the effect
of the change on income from continuing operations, net income (or other appropriate captions of changes in the applicable net assets or performance indicator), and related pershare amounts, if applicable, for those postchange interim
periods?
[FASB ASC 250-10-50-3]
Practice Tip

(Issuers Only) A change in accounting principle made in an interim period should be reported by retrospective application in accordance with FASB ASC 250-10-45-5. However, the impracticability exception in FASB
ASC 250-10-45-9 may not be applied to prechange interim periods of the fiscal year in which the change is
made. When retrospective application to prechange interim periods is impracticable, the desired change may
only be made as of the beginning of a subsequent fiscal year.
[FASB ASC 250-10-45-14]
4.
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(Issuers Only) If a public entity that regularly reports interim
information makes an accounting change during the fourth
quarter of its fiscal year and does not report the data specified
by FASB ASC 270-10-50-1, in a separate fourth-quarter report
or in its annual report, does the entity include disclosure of
the effects of the accounting change on interim-period results,
as required by FASB ASC 250-10-50-1, in a note to the annual
financial statements for the fiscal year in which the change is
made?
[FASB ASC 250-10-45-15]
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Yes

No

N/A

Change in Accounting Estimate
5.

Is the effect on income from continuing operations, net income (or other appropriate captions of changes in the applicable net assets or performance indicator), and any related
per-share amounts of the current period disclosed for a
change in estimate that affects several future periods, such as
a change in service lives of depreciable assets? Disclosure of
those effects is not necessary for estimates made each period
in the ordinary course of accounting for items such as uncollectible accounts or inventory obsolescence; however, if the
effect of a change in the estimate is material, is it disclosed?
[FASB ASC 250-10-50-4]

6.

When an entity effects a change in estimate by changing an
accounting principle, are the disclosures required by questions 1–3 made?
[FASB ASC 250-10-50-4]

7.

If a change in estimate does not have a material effect in the
period of change but is reasonably certain to have a material
effect in later periods, is a description of that change in estimate disclosed whenever the financial statements of the
period of change are presented?
[FASB ASC 250-10-50-4]

Change in the Reporting Entity
8.

When there has been a change in the reporting entity, do the
financial statements of the period of the change describe the
nature of the change and the reason for it?
[FASB ASC 250-10-50-6]

9.

Is the effect of the change on income before extraordinary
items, net income (or other appropriate captions of changes
in the applicable net assets or performance indicator), other
comprehensive income, and any related per-share amounts
disclosed for all periods presented?
[FASB ASC 250-10-50-6]

10.

If a change in reporting entity does not have a material effect
in the period of change but is reasonably certain to have a
material effect in later periods, is the nature of and reason for
the change disclosed whenever the financial statements of the
period of change are presented?
[FASB ASC 250-10-50-6]
Practice Tip

FASB ASC 805-10-50, FASB ASC 805-20-50, FASB ASC 805-30-50, and FASB ASC 805-740-50 describe the
manner of reporting and the disclosures required for a business combination.
[FASB ASC 250-10-50-6]
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Yes
11.

If a change in reporting entity results in financial statements
that are, in effect, the statements of a different reporting entity, has the change been retrospectively applied to all periods presented?
[FASB ASC 250-10-45-21]

Correction of an Error in Previously Issued Financial Statements
12.

13.
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When financial statements are restated to correct an error,
does the entity disclose that its previously issued financial
statements have been restated, along with a description of the
nature of the error? Does the entity also disclose the following:
a.

The effect of the correction on each financial statement
line item and any per-share amounts affected for each
prior period presented?

b.

The cumulative effect of the change on retained earnings or other appropriate components of equity or net
assets in the statement of financial position, as of the
beginning of the earliest period presented?
[FASB ASC 250-10-50-7]

In addition, does the entity make the following disclosures of
prior-period adjustments and restatements (see also FASB
ASC 205-10-45 and FASB ASC 205-10-50-1):
a.

For single period financial statements, the effects (including applicable income taxes) of such restatement
on the balance of retained earnings at the beginning of
the period and on the net income of the immediately
preceding period?

b.

For multiple-period financial statements, the effects (including applicable income taxes) for each of the periods
included in the statements, in total and by class, of the
correction on change in net assets for each of the periods presented?
[FASB ASC 250-10-50-9]

No

N/A
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Yes
C.

No

N/A

Commitments and Contingencies (See also part I,
“Guarantees.”)
Notes: In June 2008, FASB issued a proposed Statement of Financial
Accounting Standards titled Disclosure of Certain Loss Contingencies—an amendment of FASB Statements No. 5 and 141(R) that would
replace the disclosure requirements in FASB Statement No. 5 for loss
contingencies that are recognized as liabilities in a statement of financial position and for unrecognized loss contingencies that would be
recognized as liabilities if the criteria for recognition in paragraph 8
of FASB Statement No. 5 were met. Loss contingencies that are (or
would be) recognized as asset impairments would continue to be disclosed in accordance with FASB Statement No. 5. This proposed
statement would also amend FASB Statement No. 141(R) to require
the disclosures included in this statement for loss contingencies recognized in a business combination. This proposed statement would
not change the recognition and measurement guidance for loss contingencies contained in FASB Statement No. 5 and in FASB Statement
No. 141(R).
On September 24, 2008, FASB decided on a plan for redeliberations
and directed the staff to prepare an alternative model that will attempt to address the concerns that certain constituents raised about
this proposed statement. This alternative model will be field tested
along with the model in the exposure draft. The board also decided
that any final statement on this topic will be effective no sooner than
for fiscal years ending after December 15, 2009 (that is, December 31,
2009, for entities with calendar year-ends).
FASB began redeliberation of disclosure of certain loss contingencies
at the August 19, 2009 meeting. They plan to continue redeliberations
in a future meeting. FASB did not rule out the possibility that final
guidance on this project could be effective for fiscal years ending after
December 15, 2009 (that is, December 31, 2009, for entities with calendar year-ends).
This checklist has not been updated to include the presentation and
disclosure requirements of this proposed statement. Readers may
continue to check the status of this proposed statement on the FASB
Web site at www.fasb.org.
1.

Is disclosure made of the nature of estimated loss contingencies accrued when (a) information available prior to issuance
of the financial statements indicates that it is probable that an
asset has been impaired or a liability incurred at the date of
the financial statements and (b) the amount of loss can be reasonably estimated?
[FASB ASC 450-20-25-2; FASB ASC 450-20-50-1]

2.

If necessary to keep the financial statements from being misleading, are the amounts of contingencies accrued as described in question 1 disclosed?
[FASB ASC 450-20-50-1]
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Yes
3.

If the criteria in FASB ASC 275-10-50-8 are met, has the entity
disclosed that it is at least reasonably possible that a change
in an entity’s estimate of its liability could occur in the near
term? (FASB ASC 450-20-55-36 illustrates this disclosure for
an entity involved in litigation.)
[FASB ASC 450-20-50-2; FASB ASC 275-10-50-9]

4.

For loss contingencies not accrued because one or both of the
conditions described in question 1 are not met or if an exposure to loss exists in excess of the amount accrued for a loss
contingency, do disclosures indicate the
a.

nature of the contingency?

b.

estimate of possible loss or range of loss, or a statement
that such estimate cannot be made?
[FASB ASC 450-20-50 par. 3–4 ]

No

N/A

Practice Tips
Disclosure is preferable to accrual when a reasonable estimate of loss cannot be made. For example, disclosure should be made of any loss contingency that meets the condition in FASB ASC 450-20-25-2(a), question
1, but that is not accrued because the amount of loss cannot be reasonably estimated. Disclosure also should
be made of some loss contingencies that do not meet the condition in FASB ASC 450-20-25-2(a), question 1,
namely, those contingencies for which there is a reasonable possibility that a loss may have been incurred
even though information may not indicate that it is probable that an asset had been impaired or a liability
had been incurred at the date of the financial statements.
[FASB ASC 420-10-50-5]
******
Disclosure is not required of a loss contingency involving an unasserted claim or assessment if there has
been no manifestation by a potential claimant of an awareness of a possible claim or assessment unless both
of the following conditions are met:
●

It is considered probable that a claim will be asserted.

●

There is a reasonable possibility that the outcome will be unfavorable.

Further, disclosure of noninsured or underinsured risks in encouraged but not required.
[FASB ASC 450-20-50 par. 6–7]
******
Disclosure of a loss, or a loss contingency, arising after the date of an entity’s financial statements but before
those financial statements are issued, as described in paragraphs 6–7 of FASB ASC 450-20-25, may be necessary to keep the financial statements from being misleading if an accrual is not required. If disclosure is
deemed necessary, the financial statements should include both of the following:
●

The nature of the loss or loss contingency

●

An estimate of the amount or range of loss or possible loss or a statement that such an estimate
cannot be made

Occasionally, in the case of a loss arising after the date of the financial statements if the amount of asset
impairment or liability incurrence can be reasonably estimated, disclosure may best be made by supplementing the historical financial statements with pro forma financial data giving effect to the loss as if it had
occurred at the date of the financial statements. It may be desirable to present pro forma statements, usually
a balance sheet only, in columnar form on the face of the historical financial statements.
[FASB ASC 450-20-50 par. 9–10]

FSP §20,100.01

117

Financial Statements and Notes Checklist

Yes
5.

Are the nature and amount of guarantees disclosed (for example, guarantees of indebtedness of others, guarantees to repurchase receivables (or, in some cases, the related property)
that have been sold or otherwise assigned) even though the
possibility of loss may be remote?
[FASB ASC 460-10-50 par. 2–3]

6.

Are gain contingencies adequately disclosed with care to
avoid any misleading implications about likelihood of realization?
[FASB ASC 450-30-50-1]

7.

Has the entity disclosed the following items:

8.

a.

Unused letters of credit?

b.

Long term leases?

c.

Assets pledged as securities for loans?

d.

Pension plans?

e.

The existence of cumulative preferred stock dividends
in arrears?

f.

Commitments for plant acquisitions to reduce debts,
maintain working capital, or restrict dividends?
[FASB ASC 440-10-50-1]

No

N/A

Have any unconditional purchase obligations, exhibiting all
of the following characteristics been disclosed in accordance
with FASB ASC 440-10-50-4, question 10, (if not on the balance sheet) or in accordance with FASB ASC 440-10-50-6,
question 11 (if recorded on the balance sheet):
a.

It is noncancelable, or cancelable only in any of the following circumstances:
i.

Upon the occurrence of some remote contingency?

ii.

With the permission of the other party?

iii.

If a replacement agreement is signed between the
same parties?

iv.

Upon payment of a penalty in an amount such
that continuation of the agreement appears reasonably assured?

b.

It was negotiated as part of arranging financing for the
facilities that will provide the contracted goods or services or for costs related to those goods or services (for
example, carrying costs for contracted goods)? A purchaser is not required to investigate whether a supplier
used an unconditional purchase obligation to help secure financing, if the purchaser would otherwise be unaware of that fact.

c.

It has a remaining term in excess of one year?
[FASB ASC 440-10-50-2]
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9.

For long term unconditional purchase obligations that are not
recorded in the purchaser’s balance sheet, are the following
disclosed:
a.

Nature and term of the obligations?

b.

Amount of the fixed and determinable portion of the
obligations as of the date of the latest balance sheet presented in the aggregate and, if determinable, for each
of the next five years?

c.

Nature of any variable components of the obligation?

d.

Amounts of purchases under the obligations for each
year for which an income statement is presented?
[FASB ASC 440-10-50-4]

10.

If an unconditional purchase obligation is subject to the requirements of both FASB ASC 440-10 and FASB ASC 815-10,
has the entity complied with theose disclosure requirements
of FASB ASC, including question 8? (See also part I “Guarantees” in the “Other Financial Statement Disclosures” section of this checklist.)
[FASB ASC 440-10-50-7]

11.

For unconditional purchase obligations that meet the criteria
of FASB ASC 440-10-50-2 and that have been recognized on
the purchaser’s balance sheet, has the entity disclosed for
each of the 5 years following the date of the latest balance
sheet presented the aggregate amount of payments?
[FASB ASC 440-10-50-6]

Notes: In May, 2009, FASB Statement No. 163, Accounting for Financial
Guarantee Insurance Contracts—an Interpretation of FASB Statement No.
60, was released to amend FASB Statement No. 107 to eliminate inconsistencies in the recognition and measurement of claim liabilities.
This statement clarifies how FASB Statement No. 60 applies to financial guarantee insurance contracts, including the recognition and
measurement of premium revenue and claim liabilities. This statement also requires expanded disclosures about financial guarantee
insurance contracts.
This statement applies to financial guarantee insurance (and reinsurance) contracts issued by entities that are included within the scope
of paragraph 6 of FASB Statement No. 60 and that are not accounted
for as derivative instruments.
FASB Statement No. 163 is effective for financial statements issued
for fiscal years beginning after December 15, 2008 (that is, January 1,
2009, for entities with calendar year-ends), and interim periods
within those fiscal years. However, many of the disclosure requirements are effective for the first period (including interim periods) beginning after issuance.
This checklist has been updated to include the presentation and disclosure requirements of FASB Statement No. 163.
(continued)
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Readers can refer to the full text of the statement on the FASB Web
site at www.fasb.org. This guidance is labeled as "Pending Content"
due to the transition and open effective date information discussed in
FASB ASC 944-20-65-1.
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should
consider all questions indicated with an “A” reference (for example,
question 1A and question 2A) and should place an “N/A” mark in
questions indicated with a “B” reference. Entities for which the guidance has been implemented should consider all questions indicated
by a “B” reference (for example, question 1B and question 2B) and
place an “N/A” mark by questions indicated with an “A” reference.
Therefore, based upon your entities year-end and decision to early
implement or not (if allowed), the following additional questions will
be answered when provided in this section (check one that applies
for your entity):
pppA pppB
Readers can refer to the full text of the statement on the FASB Web
site at www.fasb.org.

Practice Tip
(FASB Statement No. 163) Fair value disclosures are required for all financial instruments, whether recognized or not recognized in the statement of financial position, except that the disclosures about fair value in
paragraphs 10-16 of FASB ASC 825-10-50 are not required for several classes of financial instruments (see
“Pending Content” in FASB ASC 825-10-50-8).
[“Pending Content” in FASB ASC 825-10-50-8]
12B. In each annual period (and interim period), for financial
guarantee insurance contracts where premiums are received
as payments over the period of the contract, rather than at
inception, has the insurance entity disclosed:
a.

The premium receivable and the unearned premium
revenue as of the date(s) of the statement of financial
position and the line item in the statement of financial
position where those amounts are reported (if not presented separately)?

b.

The amount of accretion on the premium receivable
and the line item in the statement of income where that
amount is reported (if not presented separately)?

c.

The weighted-average risk-free rate used to discount
the premiums expected to be collected and the
weighted-average period of the premium receivable?
[FASB ASC 944-310-50-3]

13B. In each annual period (and interim period), has the insurance
entity disclosed a schedule of premiums expected to be collected related to the premium receivable detailing both of the
following:
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a.

The four quarters of the subsequent annual period and
each of the next four annual periods?

b.

The remaining periods aggregated in five-year increments?
[FASB ASC 944-310-50-3]

14B. In each annual period (and interim period), has the insurance
entity disclosed a rollforward of the premium receivable for
the period, including all of the following:
a.

The beginning premium receivable?

b.

Premium payments received?

c.

New business written?

d.

Adjustments to the premium receivable, including all
of the following:

e.

i.

Adjustments for changes in the period of a financial guarantee insurance contract?

ii.

An explanation of why the adjustments in (d)(i)
occurred?

iii.

Accretion of the premium receivable discount?

iv.

Other adjustments with explanations provided?

The ending premium receivable?
[FASB ASC 944-310-50-3]

15B. In each annual period (and interim period), for premium revenue recognition that has been accelerated, has the insurance
entity disclosed the amount and reasons for acceleration?
[FASB ASC 944-605-50-4]
16B. In each annual period (and interim period), has the insurance
entity disclosed a schedule of the future expected premium
revenue as of the latest date of the statement of financial position detailing both of the following:
a.

The four quarters of the subsequent annual period and
each of the next four annual periods?

b.

The remaining periods aggregated in five-year increments?
[FASB ASC 944-605-50-4]

17B. In each annual period (and in an interim period if a significant change has occurred in that interim period) has the insurance entity disclosed the following for the claim liability:
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a.

The weighted-average risk-free rate used to discount
the claim liability?

b.

The significant component(s) of the change in the claim
liability for the period (such as changes in the discount
rate, the accretion of the discount on the claim liability,
changes in the timing, changes in the likelihood of default)?

c.

The amount relating to the component(s) in item (b)?

No

N/A

121

Financial Statements and Notes Checklist

Yes
d.

No

N/A

The line item in the statement of income where the
amount or amounts in item (b) are reported (unless separately disclosed)?
[FASB ASC 944-40-50-9]

18B. For each interim period, has the insurance entity disclosed for
the claim liability a schedule of insured financial obligations
at the end of each interim period detailing, at a minimum, all
of the following for each category or grouping of these financial obligations:
a.

Number of issued and outstanding financial guarantee
insurance contracts?

b.

Remaining weighted-average contract period?

c.

Insured contractual payments outstanding, segregating
principal and interest?

d.

Gross claim liability?

e.

Gross potential recoveries?

f.

Discount, net (both claim liability and potential recoveries)?

g.

Net claim liability?

h.

Reinsurance recoverables?

i.

Unearned premium revenue?
[FASB ASC 944-40-50-9]

19B. For each annual period (and in an interim period if a significant change has occurred in that interim period), has the insurance entity disclosed a description of the insurance entity’s risk management activities used to track and monitor
deteriorating insured financial obligations, including all of
the following:
a.

A description of each grouping or category used to
track and monitor deteriorating insured financial obligations?

b.

The insurance entity’s policies for placing an insured
financial obligation in, and monitoring, each grouping
or category?

c.

The insurance entity’s policies for avoiding or mitigating claim liabilities?

d.

The related expense and liability reported during the
period for risk mitigation activities (not including reinsurance)?

e.

A description of where the risk mitigation activities expense and liability are reported in the statement of income and the statement of financial position, respectively?
[FASB ASC 944-40-50-9]
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No

N/A

20B. Has the insurance entity disclosed information that enables
users of its financial statements to understand the factors affecting the present and future recognition and measurement
of financial guarantee insurance contracts?
[FASB ASC 944-20-50-7]
D.

Current Vulnerability Due to Certain Concentrations
1.

If the entity has concentrations that exist at the date of the
financial statements, those concentrations make the entity
vulnerable to the risk of a near term severe impact, and it is
at least reasonably possible that the events that could cause
the severe impact will occur in the near term, have the concentrations been disclosed, including information that is adequate to inform users of the general nature of the risk associated with the concentration?
[FASB ASC 275-10-50 par. 16 and 20]
Practice Tip

Concentrations, including known group concentrations, described in the following list require disclosure if
they meet the criteria of FASB ASC 275-10-50-16 (question 1). (Group concentrations exist if a number of
counterparties or items that have similar economic characteristics collectively expose the reporting entity to
a particular kind of risk.) Some concentrations may fall into more than one of the following categories:
●

Concentrations in the volume of business transacted with a particular customer, supplier, lender, grantor, or
contributor. The potential for the severe impact can result, for example, from total or partial loss of
the business relationship. For purposes of FASB ASC 275-10, it is always considered at least reasonably possible that any customer, grantor, or contributor will be lost in the near term.

●

Concentrations in revenue from particular products, services, or fund-raising events. The potential for the
severe impact can result, for example, from volume or price changes or the loss of patent protection
for the particular source of revenue.

●

Concentrations in the available sources of supply of materials, labor, or services, or of licenses or other rights
used in the entity’s operations. The potential for the severe impact can result, for example, from
changes in the availability to the entity of a resource or a right.

●

Concentrations in the market or geographic area in which an entity conducts its operations. The potential
for the severe impact can result, for example, from negative effects of the economic and political
forces within the market or geographic area. For purposes of FASB ASC 275-10, it is always considered at least reasonably possible that operations located outside an entity’s home country will be
disrupted in the near term.

The concentrations of financial instruments, and other concentrations not described in the preceding list,
may be required to be disclosed pursuant to other guidance included in FASB ASC. If adequate information
about concentrations is presented in other parts of the financial statements in accordance with other guidance included in FASB ASC, that information need not be repeated.
[FASB ASC 275-10-50 par. 18–19]
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For those concentrations of labor subject to collective bargaining agreements and concentrations of operations located outside the reporting entity’s home country that (a) exist at the
date of the financial statements and (b) make the reporting
entity vulnerable to the risk of a near term severe impact,
where it is at least reasonably possible that the events that
could cause the severe impact will occur in the near term, are
the following disclosed:
a.

The percentage of labor force covered by a collective
agreement and the percentage of the labor force covered by a collective bargaining agreement that will expire in one year?

b.

For operations located outside the reporting entity’s
home country, the carrying amounts of net assets and
the geographic areas in which they are located?
[FASB ASC 275-10-50-20]
Practice Tip

FASB ASC 275-10-50 does not prohibit entities from also stating in disclosures of concentrations related to
customers, grantors, or contributors or operations located outside the entity’s home country that the entity
does not expect that the business relationship will be lost or does not expect that the foreign operations will
be disrupted if such is the case.
[FASB ASC 275-10-50-20]
3.

Certain loan products have contractual terms that expose entities to risks and uncertainties that fall into one or more categories, as discussed in FASB ASC 275-10-50-1. If they meet
the requirements of FASB ASC 275-10-50-16, are other concentrations disclosed?
[FASB ASC 310-10-50-25; FASB ASC 275-10-50-16]
Practice Tip

The guidance in FSP SOP 94-6-1, Terms of Loan Products That May Give Rise to a Concentration of Credit Risk,
addresses the adequacy of disclosures for all lending products (including both secured and unsecured loans)
and the effect of changes in market or economic conditions on the adequacy of those disclosures. An entity
should provide the disclosures required by FASB ASC 825-10 for products that are determined to represent
a concentration of credit risk. Examples of possible shared characteristics on which significant concentrations
may be determined are in FASB ASC 825-10-55-1.
[FASB ASC 825-10-50 par. 20–21; FASB ASC 825-10-55-1]
E.

Employee Stock Ownership Plans
1.

For any employee stock ownership plans (ESOPs) sponsored
by the entity, do the financial statements include disclosure of
a.

a description of the plan?

b.

the basis for determining contributions?

c.

the employee groups covered?

d.

the nature and effect of significant matters affecting
comparability of information for all periods presented?
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e.

2.

for leveraged ESOPs and pension reversion ESOPs, the
basis for releasing shares and how dividends on allocated and unallocated shares are used?
[FASB ASC 718-40-50-1(a)]

A description of the accounting policies followed for ESOP
transactions, including
a.

the method of measuring compensation?

b.

the classification of dividends on ESOP shares?

c.

the treatment of ESOP shares for EPS computation?
[FASB ASC 718-40-50-1(b)]

3.

If the entity has both old ESOP shares for which it does not
adopt the guidance in FASB ASC 718-40 [see FASB ASC 10510-70-2(c)], and new ESOP shares for which the guidance in
FASB ASC 718-40 is required, are the accounting policies set
forth in question 2 disclosed for both blocks of shares?
[FASB ASC 718-40-50-1(b)]

4.

Is the amount of compensation cost recognized during the
period disclosed?
[FASB ASC 718-40-50-1(c)]

5.

Is the number of allocated shares, committed-to-be-released
shares, and suspense shares held by the ESOP at the balancesheet date disclosed? (Note: This disclosure should be made
separately for shares accounted for under FASB ASC 718-40
and for grandfathered employee stock ownership plan shares
[see FASB ASC 105-10-70-2(c)].)
[FASB ASC 718-40-50-1(d)]

6.

Is the fair value of unearned ESOP shares at the balance-sheet
date for shares accounted for under FASB ASC 718-40 disclosed?
[FASB ASC 718-40-50-1(e)]

7.

Is disclosure made of the existence and nature of any repurchase obligation, including disclosure of the fair value (see
FASB ASC 718-40-30-4) of the shares allocated as of the balance-sheet date, which are subject to a repurchase obligation?
[FASB ASC 718-40-50-1(f)]

8.

The amount and treatment in the EPS computation of the tax
benefit related to dividends paid to any employee stock ownership plan, if material.
[FASB ASC 718-40-50-1(g)]

9.

If the reporting entity issues shares or sells treasury shares to
an ESOP or if a leveraged ESOP buys outstanding shares on
the market rather than from the employer, has a corresponding charge to unearned ESOP shares, a contra-equity account
presented as a separate item in the balance sheet, been reported?
[FASB ASC 718-40-45-2]
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F.

10.

If the ESOP used assets from a terminated defined benefit
pension plan to purchase employer shares, has a corresponding charge to unearned ESOP shares, a contra-equity account
presented as a separate item in the balance sheet, been reported?
[FASB ASC 718-40-25-4]

11.

If the employer sponsors an ESOP with an indirect loan, is
the outside loan reported as a liability and the receivable
from the ESOP not reported on the employer’s balance sheet?
[FASB ASC 718-40-25-9(b)]

12.

If the employer sponsors an ESOP with an employer loan, is
the employer’s note receivable from the ESOP not reported in
the employer’s balance sheet?
[FASB ASC 718-40-25-9(e)]

13.

If any grandfathered shares (FASB ASC 105-10-70-2[c]) are
still being accounted for in accordance with SOP 76-3, Accounting Practices for Certain Employee Stock Ownership Plans
(AICPA, Technical Practice Aids, ACC sec. 10,130), is still being
followed for ESOP shares purchased before December 31,
1992, and if the reporting entity has guaranteed the debt of
an ESOP or made a commitment to make future contributions
to the ESOP sufficient to meet debt service requirements, are
the compensation element and the interest element of annual
contributions reported separately and are the interest rate
and debt terms disclosed in the notes to the financial statements?
[SOP 76-3 par. 10 (ACC 10,130.10)]

No

N/A

Employers’ Disclosures for Defined Benefit Pension and Other
Postretirement Plans

Notes: In September 2006, FASB issued Statement No. 158, Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans—an amendment of FASB Statements No. 87, 88, 106, and 132(R). FASB Statement No. 158
requires, among other provisions, an employer to recognize the overfunded
or underfunded status of a defined benefit postretirement plan (other than
a multiemployer plan) as an asset or liability in its statement of financial
position and to recognize changes in that funded status in the year in which
the changes occur through comprehensive income. This statement also requires an employer to measure the funded status of a plan as of the date of
its year-end statement of financial position, with limited exceptions.
The requirement to measure plan assets and benefit obligations as of the
date of the employer’s fiscal year-end statement of financial position (see
paragraphs 5–6 and 9 of FASB Statement No. 158) is effective for fiscal years
ending after December 15, 2008 (that is, December 31, 2008, for entities with
calendar year-ends). If in the last quarter of the preceding fiscal year an
employer enters into a transaction that results in a settlement or experiences
an event that causes a curtailment of the plan, the related gain or loss pursuant to FASB Statement No. 88 or FASB Statement No. 106 is required to
(continued)
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be recognized in earnings or changes in unrestricted net assets of that quarter.
Earlier application of the recognition or measurement date provisions is encouraged; however, early application must be for all of an employer’s benefit plans. Retrospective application of the statement is not permitted.
This checklist has been updated to include the presentation and disclosure
requirements of FASB Statement No. 158.
Readers can refer to the full text of FASB Statement No. 158 on the FASB
Web site at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and
open effective date information discussed in FASB ASC 715-20-65-1.
******
In December 2008, FASB issued FSP FAS 132(R)-1, Employers’ Disclosures
about Postretirement Benefit Plan Assets, to provide guidance on an employer’s disclosures about plan assets of a defined benefit pension or other
postretirement plan. One objective is to disclose information about fair
value measurements of plan assets that would be similar to the disclosures
required by FASB Statement No. 157, Fair Value Measurements.
The disclosures about plan assets required by this FSP should be provided
for fiscal years ending after December 15, 2009 (that is, December 31, 2009,
for entities with calendar year-ends). Upon initial application, the provisions of this FSP are not required for earlier periods presented for comparative purposes. Earlier application is permitted.
This FSP also includes a technical amendment to FASB Statement No.
132(R) that requires a nonpublic entity to disclose net periodic benefit cost
for each annual period for which a statement of income is presented. This
amendment was effective upon issuance.
This checklist has been updated to include the presentation and disclosure
requirements of FSP FAS 132(R)-1.
As determined by the effective date or early implementation decision, entities for which this guidance has not been implemented should consider all
questions indicated with an “A” reference (for example, question 1A and
question 2A) and should place an “N/A” mark in questions indicated with
a “B” reference. Entities for which the guidance has been implemented
should consider all questions indicated by a “B” reference (for example,
question 1B and question 2B) and place an “N/A” mark by questions indicated with an “A” reference. Therefore, based upon your entity’s year-end
and decision to early implement or not (if allowed), the following additional questions will be answered when provided in this section (check one
that applies for your entity):
pppA pppB
Readers can refer to the full text of the statement on the FASB Web site at
www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and
open effective date information discussed in FASB ASC 715-20-65-2.
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1A.

No

N/A

(Issuers Only) If an employer sponsors one or more defined
benefit pension plans or one or more defined benefit postretirement plans has the following information been provided,
separately for pension plans and other postretirement benefit
plans:
a.

b.

c.

For each annual statement of income presented, the
amounts recognized in OCI, showing separately the net
gain or loss and net prior service cost or credit? Those
amounts shall be separated into the following amounts
arising during the period and reclassification adjustments of OCI as a result of being recognized as components of net periodic benefit cost for the period:
i.

Service cost?

ii.

Interest cost?

iii.

Contributions by plan participants?

iv.

Actuarial gains and losses?

v.

Foreign currency rate changes (the effects of foreign currency exchange rate changes that are to
be disclosed are those applicable to plans of a foreign operation whose functional currency is not
the reporting currency pursuant to FASB ASC
830-10-45)?

vi.

Benefits paid?

vii.

Plan amendments?

viii.

Business combinations?

ix.

Divestitures?

x.

Curtailments, settlements, and special and contractual termination benefits?

A reconciliation of beginning and ending balances of
the fair value of plan assets showing separately, if applicable, the effects during the period attributable to
each of the following:
i.

Actual return on plan assets?

ii.

Foreign currency exchange rate changes?

iii.

Contributions by the employer?

iv.

Contributions by plan participants?

v.

Benefits paid?

vi.

Business combinations?

vii.

Divestitures?

viii.

Settlements?

The funded status of the plans and the amounts recognized in the statement of financial position showing
separately the assets and current and noncurrent liabilities recognized?
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d.
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The following information about plan assets:
i.

For each major category of plan assets (which
should include but is not limited to equity securities, debt securities, real estate, and all other assets), the percentage of the fair value of total plan
assets held as of the measurement date used for
each statement of financial position presented?

ii.

A narrative description of investment policies
and strategies, including target allocation percentages or range of percentages for each major
category of plan assets presented on a weightedaverage basis as of the measurement date(s) of
the latest statement of financial position presented, if applicable, and other factors that are
pertinent to an understanding of the policies or
strategies such as investment goals, risk management practices, permitted and prohibited investments including the use of derivatives, diversification, and the relationship between plan assets
and benefit obligations?

iii.

A narrative description of the basis used to determine the overall expected long term rate-of-return-on-assets assumption, such as the general
approach used, the extent to which the overall
rate-of-return-on-assets assumption was based
on historical returns, the extent to which adjustments were made to those historical returns in
order to reflect expectations of future returns,
and how those adjustments were determined?

iv.

Disclosure of additional asset categories and additional information about specific assets within
a category is encouraged if that information is expected to be useful in understanding the risks associated with each asset category and the overall
expected long term rate of return on assets?

e.

For defined benefit pension plans, the accumulated
benefit obligation?

f.

The benefits (as of the date of the latest statement of
financial position presented) expected to be paid in
each of the next five fiscal years, and in the aggregate
for the five fiscal years thereafter? The expected benefits should be estimated based on the same assumptions used to measure the entity’s benefit obligation at
the end of the year and should include benefits attributable to estimated future employee service.

No

N/A
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g.

The employer’s best estimate, as soon as it can reasonably be determined, of contributions expected to be
paid to the plan during the next fiscal year beginning
after the date of the latest statement of financial position presented. Estimated contributions may be presented in the aggregate combining all of the following:
(1) contributions required by funding regulations or
laws, (2) discretionary contributions, and (3) noncash
contributions.

h.

The amount of net benefit cost recognized, showing
separately all of the following:
i.

The service cost component?

ii.

The interest cost component?

iii.

The expected return on plan assets for the period?

iv.

The gain or loss component?

v.

The prior service cost or credit component?

vi.

The transition asset or obligation component?

vii.

The gain or loss recognized due to settlements or
curtailments?

i.

Separately the net gain or loss and net prior service cost
or credit recognized in OCI for the period pursuant to
FASB ASC 715-30-35-11, FASB ASC 715-30-35-21, FASB
ASC 715-60-35-16, and FASB ASC 715-60-35-25, and reclassification adjustments of OCI for the period, as
those amounts, including amortization of the net transition asset or obligation, are recognized as components
of net periodic benefit cost?

j.

The amounts in accumulated OCI that have not yet
been recognized as components of net periodic benefit
cost, showing separately the net gain or loss, net prior
service cost or credit, and net transition asset or obligation?

k.

On a weighted-average basis, all of the following assumptions used in the accounting for the plans, specifying in a tabular format, the assumptions used to determine the benefit obligation and the assumptions
used to determine net benefit cost:

l.

i.

Assumed discount rates?

ii.

Rates of compensation increase (for pay-related
plans)?

iii.

Expected long term rates of return on plan assets?

No

N/A

The funded status of the plans and the amounts recognized in the statement of financial position showing
separately the assets and current and noncurrent liabilities recognized?
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m.

The effect of a one percentage point increase and the
effect of a one percentage point decrease in the assumed health care cost trend rates on the aggregate of
the service and interest cost components of net periodic
postretirement health care benefit costs and the accumulated postretirement benefit obligation (APBO) for
health care benefits? Measuring the sensitivity of the
APBO and the combined service and interest cost components to a change in the assumed health care cost
trend rates requires remeasuring the APBO as of the
beginning and end of the year.

n.

If applicable, the amounts and types of securities of the
employer and related parties included in plan assets,
the approximate amount of future annual benefits of
plan participants covered by insurance contracts, including annuity contracts issued by the employer or related parties, and any significant transactions between
the employer or related parties and the plan during the
period?

o.

If applicable, any alternative method used to amortize
prior service amounts or net gains and losses pursuant
to FASB ASC 715-30-35-13 and FASB ASC 715-30-35-25
or FASB ASC 715-60-35-18 and FASB ASC 715-60-3531?

p.

If applicable, any substantive commitment, such as past
practice or a history of regular benefit increases, used
as the basis for accounting for the benefit obligation?

q.

If applicable, the cost of providing special or contractual termination benefits recognized during the period
and a description of the nature of the event?

r.

An explanation of any significant change in the benefit
obligation or plan assets not otherwise apparent in the
other disclosures required by FASB ASC 715-20?

s.

The amounts in accumulated OCI expected to be recognized as components of net periodic benefit cost over
the fiscal year that follows the most recent annual statement of financial position presented, showing separately the net gain or loss, net prior service cost or
credit, and net transition asset or obligation?

t.

The amount and timing of any plan assets expected to
be returned to the employer during the 12 month period, or operating cycle if longer, that follows the most
recent annual statement of financial position presented?
[“Pending Content” in FASB ASC 715-20-50-1]

No

N/A
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Yes
1B.

No

N/A

(FSP FAS 132(R)-1) (Issuers Only) If an employer sponsors
one or more defined benefit pension plans or one or more
defined benefit postretirement plans has the following information been provided, separately for pension plans and other
postretirement benefit plans:
a.

b.

A reconciliation of beginning and ending balances of
the benefit obligation showing separately, if applicable,
the effects during the period attributable to each of the
following:
i.

Service cost?

ii.

Interest cost?

iii.

Contributions by plan participants?

iv.

Actuarial gains and losses?

v.

Foreign currency rate changes (the effects of foreign currency exchange rate changes that are to
be disclosed are those applicable to plans of a foreign operation whose functional currency is not
the reporting currency pursuant to FASB ASC
830-10-45)?

vi.

Benefits paid?

vii.

Plan amendments?

viii.

Business combinations?

ix.

Divestitures?

x.

Curtailments, settlements, and special and contractual termination benefits?

A reconciliation of beginning and ending balances of
the fair value of plan assets showing separately, if applicable, the effects during the period attributable to
each of the following:
i.

Actual return on plan assets?

ii.

Foreign currency exchange rate changes (see preceding practice tip)?

iii.

Contributions by the employer?

iv.

Contributions by plan participants?

v.

Benefits paid?

vi.

Business combinations?

vii.

Divestitures?

viii.

Settlements?

c.

The funded status of the plans and the amounts recognized in the statement of financial position showing
separately the assets and current and noncurrent liabilities recognized?

d.

Have disclosures been made to provide users of financial statements with an understanding of the following
(see FASB ASC 715-20-50-1 for example disclosures):
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i.

For each major category of plan assets (which
should include but is not limited to equity securities, debt securities, real estate, and all other assets), the percentage of the fair value of total plan
assets held as of the measurement date used for
each statement of financial position presented?

ii.

The major categories of plan assets?

iii.

The inputs and valuation techniques used to
measure the fair value of plan assets?

iv.

The effect of fair value measurements using significant unobservable inputs (level 3) on changes
in plan assets for the period?

v.

Significant concentrations of risk within plan assets?

e.

For defined benefit pension plans, the accumulated
benefit obligation?

f.

The benefits (as of the date of the latest statement of
financial position presented) expected to be paid in
each of the next five fiscal years, and in the aggregate
for the five fiscal years thereafter? The expected benefits should be estimated based on the same assumptions used to measure the entity’s benefit obligation at
the end of the year and should include benefits attributable to estimated future employee service.

g.

The employer’s best estimate, as soon as it can reasonably be determined, of contributions expected to be
paid to the plan during the next fiscal year beginning
after the date of the latest statement of financial position presented. Estimated contributions may be presented in the aggregate combining all of the following:
(1) contributions required by funding regulations or
laws, (2) discretionary contributions, and (3) noncash
contributions.

h.

The amount of net benefit cost recognized, showing
separately all of the following:
i.

The service cost component?

ii.

The interest cost component?

iii.

The expected return on plan assets for the period?

iv.

The gain or loss component?

v.

The prior service cost or credit component?

vi.

The transition asset or obligation component?

vii.

The gain or loss recognized due to settlements or
curtailments?

No

N/A
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Yes
i.

Separately the net gain or loss and net prior service cost
or credit recognized in OCI for the period pursuant to
FASB ASC 715-30-35-11, FASB ASC 715-30-35-21, FASB
ASC 715-60-35-16, and FASB ASC 715-60-35-25, and reclassification adjustments of OCI for the period, as
those amounts, including amortization of the net transition asset or obligation, are recognized as components
of net periodic benefit cost?

j.

The amounts in accumulated OCI that have not yet
been recognized as components of net periodic benefit
cost, showing separately the net gain or loss, net prior
service cost or credit, and net transition asset or obligation?

k.

On a weighted-average basis, all of the following assumptions used in the accounting for the plans, specifying in a tabular format, the assumptions used to determine the benefit obligation and the assumptions
used to determine net benefit cost:
i.

Assumed discount rates?

ii.

Rates of compensation increase (for pay-related
plans)?

iii.

Expected long term rates of return on plan assets?

l.

The assumed health care cost trend rate(s) for the next
year used to measure the expected cost of benefits covered by the plan (gross eligible charges), and a general
description of the direction and pattern of change in the
assumed trend rates thereafter, together with the ultimate trend rate(s) and when that rate is expected to be
achieved?

m.

The effect of a one-percentage-point increase and the
effect of a one-percentage-point decrease in the assumed health care cost trend rates on the aggregate of
the service and interest cost components of net periodic
postretirement health care benefit costs and the APBO
for health care benefits? Measuring the sensitivity of
the APBO and the combined service and interest cost
components to a change in the assumed health care cost
trend rates requires remeasuring the APBO as of the
beginning and end of the year.

n.

If applicable, the amounts and types of securities of the
employer and related parties included in plan assets,
the approximate amount of future annual benefits of
plan participants covered by insurance contracts, including annuity contracts issued by the employer or related parties, and any significant transactions between
the employer or related parties and the plan during the
period?

No

N/A
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o.

If applicable, any alternative method used to amortize
prior service amounts or net gains and losses pursuant
to FASB ASC 715-30-35-13 and FASB ASC 715-30-35-25
or FASB ASC 715-60-35-18 and FASB ASC 715-60-3531?

p.

If applicable, any substantive commitment, such as past
practice or a history of regular benefit increases, used
as the basis for accounting for the benefit obligation?

q.

If applicable, the cost of providing special or contractual termination benefits recognized during the period
and a description of the nature of the event?

r.

An explanation of any significant change in the benefit
obligation or plan assets not otherwise apparent in the
other disclosures required by FASB ASC 715-20?

s.

The amounts in accumulated OCI expected to be recognized as components of net periodic benefit cost over
the fiscal year that follows the most recent annual statement of financial position presented, showing separately the net gain or loss, net prior service cost or
credit, and net transition asset or obligation?

t.

The amount and timing of any plan assets expected to
be returned to the employer during the 12 month period, or operating cycle if longer, that follows the most
recent annual statement of financial position presented?
[“Pending Content” in FASB ASC 715-20-50-1]

No

N/A

Practice Tips
The disclosures required by FASB ASC 715-20 should be aggregated for all of an employer’s defined benefit
pension plans and for all of an employer’s other defined benefit postretirement plans unless disaggregating
in groups is considered to provide useful information or is otherwise required by FASB ASC 715-20-50-3
and FASB 715-20-50-4.
[FASB ASC 715-20-50-2]
******
Disclosures about pension plans with assets in excess of the accumulated benefit obligation generally may
be aggregated with disclosures about pension plans with accumulated benefit obligations in excess of assets.
The same aggregation is permitted for other postretirement benefit plans. If aggregate disclosures are presented, an employer should disclose both of the following:
●

The aggregate benefit obligation and aggregate fair value of plan assets for plans with benefit obligations in excess of plan assets as of the measurement date of each statement of financial position
presented

The aggregate pension accumulated benefit obligation and aggregate fair value of plan assets for
pension plans with accumulated benefit obligations in excess of plan assets
[FASB ASC 715-20-50-3]
●
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2A.

No

N/A

(Nonissuers Only) If the entity sponsors one or more defined
benefit pension plans or one or more other defined benefit
postretirement plans has the following information been disclosed, separately for pension plans and other postretirement
benefit plans:
a.

The benefit obligation, fair value of plan assets, and
funded status of the plan?

b.

Employer contributions, participant contributions, and
benefits paid?

c.

The following information about plan assets:

d.

i.

For each major category of plan assets (which
should include but is not limited to equity securities, debt securities, real estate, and all other assets), the percentage of the fair value of total plan
assets held as of the measurement date used for
each statement of financial position presented?

ii.

A narrative description of investment policies
and strategies, including target allocation percentages or range of percentages for each major
category of plan assets presented on a weightedaverage basis as of the measurement date(s) of
the latest statement of financial position presented, if applicable, and other factors that are
pertinent to an understanding of the policies or
strategies such as investment goals, risk management practices, permitted and prohibited investments including the use of derivatives, diversification, and the relationship between plan assets
and benefit obligations?

iii.

A narrative description of the basis used to determine the overall expected long term rate-of-return-on-assets assumption, such as the general
approach used, the extent to which the overall
rate-of-return-on-assets assumption was based
on historical returns, the extent to which adjustments were made to those historical returns in
order to reflect expectations of future returns and
how those adjustments were determined?

iv.

Disclosure of additional asset categories and additional information about specific assets within
a category is encouraged if that information is expected to be useful in understanding the risks associated with each asset category and the overall
expected long term rate of return on assets?

For defined benefit pension plans, the accumulated
benefit obligation?
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e.

The benefits (as of the date of the latest statement of
financial position presented) expected to be paid in
each of the next five fiscal years, and in the aggregate
for the five fiscal years thereafter? The expected benefits should be estimated based on the same assumptions used to measure the entity’s benefit obligation at
the end of the year and should include benefits attributable to estimated future employee service.

f.

The employer’s best estimate, as soon as it can reasonably be determined, of contributions expected to be
paid to the plan during the next fiscal year beginning
after the date of the latest statement of financial position presented? Estimated contributions may be presented in the aggregate combining any of the following:
(1) contributions required by funding regulations or
laws, (2) discretionary contributions, and (3) noncash
contributions.

g.

The amounts recognized in the statements of financial
position, showing separately the postretirement benefit
assets and current and noncurrent postretirement benefit liabilities?

h.

Separately, the net gain or loss and net prior service
cost or credit recognized in OCI for the period pursuant
to FASB ASC 715-30-35-11, 715-30-35-21, 715-60-35-16,
and 715-60-35-25 and reclassification adjustments of
OCI for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost?

i.

The amounts in accumulated OCI that have not yet
been recognized as components of net periodic benefit
cost, showing separately the net gain or loss, net prior
service cost or credit, and net transition asset or obligation?

j.

On a weighted-average basis, all of the following assumptions used in the accounting for the plans, specifying in a tabular format, the assumptions used to determine the benefit obligation and the assumptions
used to determine net benefit cost:
i.

Assumed discount rates (refer to FASB ASC 71530-35-45 for a discussion of representationally
faithful disclosure)?

ii.

Rates of compensation increase (for pay-related
plans)?

iii.

Expected long term rates of return on plan assets?

No

N/A
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Yes

2B.

k.

The assumed health care cost trend rate(s) for the next
year used to measure the expected cost of benefits covered by the plan (gross eligible charges), and a general
description of the direction and pattern of change in the
assumed trend rates thereafter, together with the ultimate trend rate(s) and when that rate is expected to be
achieved?

l.

If applicable, the amounts and types of securities of the
employer and related parties included in plan assets,
the approximate amount of future annual benefits of
plan participants covered by insurance contracts, including annuity contracts, issued by the employer or
related parties, and any significant transactions between the employer or related parties and the plan during the period?

m.

The nature and effect of significant nonroutine events,
such as amendments, combinations, divestitures, curtailments, and settlements?

n.

The amounts in accumulated OCI expected to be recognized as components of net periodic benefit cost over
the fiscal year that follows the most recent annual statement of financial position presented, showing separately the net gain or loss, net prior service cost or
credit, and net transition asset or obligation?

o.

The amount and timing of any plan assets expected to
be returned to the employer during the 12 month period, or operating cycle if longer, that follows the most
recent annual statement of financial position presented?
[“Pending Content” in FASB ASC 715-20-50-5]

No

N/A

(FSP FAS 132(R)-1) (Nonissuers Only) If the entity sponsors
one or more defined benefit pension plans or one or more
other defined benefit postretirement plans, has the following
information been disclosed, separately for pension plans and
other postretirement benefit plans:
a.

The benefit obligation, fair value of plan assets, and
funded status of the plan?

b.

Employer contributions, participant contributions, and
benefits paid?

c.

Have disclosures been made to provide users of financial statements with an understanding of the following
(see FASB ASC 715-20-50-5(c) for example disclosures):
i.

How investment allocation decisions are made,
including the factors that are pertinent to an understanding of investment policies and strategies?

ii.

The major categories of plan assets?
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iii.

The inputs and valuation techniques used to
measure the fair value of plan assets?

iv.

The effect of fair value measurements using significant unobservable inputs (level 3) on changes
in plan assets for the period?

v.

Significant concentrations of risk within plan assets?

d.

For defined benefit pension plans, the accumulated
benefit obligation?

e.

The benefits (as of the date of the latest statement of
financial position presented) expected to be paid in
each of the next five fiscal years, and in the aggregate
for the five fiscal years thereafter? The expected benefits should be estimated based on the same assumptions used to measure the entity’s benefit obligation at
the end of the year and should include benefits attributable to estimated future employee service.

f.

The employer’s best estimate, as soon as it can reasonably be determined, of contributions expected to be
paid to the plan during the next fiscal year beginning
after the date of the latest statement of financial position presented? Estimated contributions may be presented in the aggregate combining any of the following:
(1) contributions required by funding regulations or
laws, (2) discretionary contributions, and (3) noncash
contributions.

g.

The amounts recognized in the statements of financial
position, showing separately the postretirement benefit
assets and current and noncurrent postretirement benefit liabilities?

h.

Separately, the net gain or loss and net prior service
cost or credit recognized in OCI for the period pursuant
to FASB ASC 715-30-35-11, 715-30-35-21, 715-60-35-16,
and 715-60-35-25 and reclassification adjustments of
OCI for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost?

i.

The amounts in accumulated OCI that have not yet
been recognized as components of net periodic benefit
cost, showing separately the net gain or loss, net prior
service cost or credit, and net transition asset or obligation?

j.

On a weighted-average basis, all of the following assumptions used in the accounting for the plans, specifying in a tabular format, the assumptions used to determine the benefit obligation and the assumptions
used to determine net benefit cost:

No

N/A
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3.

i.

Assumed discount rates (refer to FASB ASC 71530-35-45 for a discussion of representationally
faithful disclosure)?

ii.

Rates of compensation increase (for pay-related
plans)?

iii.

Expected long term rates of return on plan assets?

k.

The assumed health care cost trend rate(s) for the next
year used to measure the expected cost of benefits covered by the plan (gross eligible charges), and a general
description of the direction and pattern of change in the
assumed trend rates thereafter, together with the ultimate trend rate(s) and when that rate is expected to be
achieved?

l.

If applicable, the amounts and types of securities of the
employer and related parties included in plan assets,
the approximate amount of future annual benefits of
plan participants covered by insurance contracts, including annuity contracts, issued by the employer or
related parties, and any significant transactions between the employer or related parties and the plan during the period?

m.

The nature and effect of significant nonroutine events,
such as amendments, combinations, divestitures, curtailments, and settlements?

n.

The amounts in accumulated OCI expected to be recognized as components of net periodic benefit cost over
the fiscal year that follows the most recent annual statement of financial position presented, showing separately the net gain or loss, net prior service cost or
credit, and net transition asset or obligation?

o.

The amount and timing of any plan assets expected to
be returned to the employer during the 12 month period, or operating cycle if longer, that follows the most
recent annual statement of financial position presented?

p.

The amount of net periodic benefit cost recognized?
[“Pending Content” in FASB ASC 715-20-50-5]

No

N/A

(Issuers Only) Has the following been disclosed in the entities
interim financial statements that include a statement of income:
a.

The amount of net benefit cost recognized, for each period for which a statement of income is presented,
showing separately each of the following:
i.

The service cost component?

ii.

The interest cost component?

iii.

The expected return on plan assets for the period?
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b.

iv.

The gain or loss component?

v.

The prior service cost or credit component?

vi.

The transition asset or obligation component?

vii.

The gain or loss recognized due to a settlement
or curtailment?

No

N/A

The total amount of the employer’s contributions paid,
and expected to be paid, during the current fiscal year,
if significantly different from amounts previously disclosed pursuant to FASB ASC 715-20-50-1(g)? Estimated contributions may be presented in the aggregate
combining all of the following: (1) contributions required by funding regulations or laws, (2) discretionary
contributions, and (3) noncash contributions.
[FASB ASC 715-20-50-6]
Practice Tip

With respect to question 4, estimated contributions may be presented in the aggregate combining all of the
following:
●

Contributions required by funding regulations or laws

●

Discretionary contributions

● Noncash contributions
[FASB ASC 715-20-50-7]
4.

(Nonissuers Only) Has the entity disclosed, in interim periods for which a complete set of financial statements is presented, the total amount of the employer’s contributions paid,
and expected to be paid, during the current fiscal year, if significantly different from amounts previously disclosed pursuant to FASB ASC 715-20-50-5(f) (question 2A)?
[FASB ASC 715-70-50-1]

Defined Contribution Plans
5.

Does the entity disclose the amount of cost recognized for defined contribution pension plans and for other defined contribution postretirement benefit plans for all periods presented
separately from the amount of cost recognized for defined
benefit plans?
[FASB ASC 715-70-50-1]

6.

Do the disclosures include a description of the nature and effect of any significant changes during the period affecting
comparability, such as a change in the rate of employer contributions, a business combination, or a divestiture?
[FASB ASC 715-70-50-1]

Multiemployer Plans
7.
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Has the entity disclosed the amount of contributions to multiemployer plans for each annual period for which a statement of income is presented?
[FASB ASC 715-80-50-1]
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Yes
8.

If the entity chooses to disclose total contributions to multiemployer plans without disaggregating the amounts attributable to pension plans and other postretirement benefit
plans, do the disclosures include a description of the nature
and effect of any changes affecting comparability, such as a
change in the rate of employer contributions, a business combination, or a divestiture?
[FASB ASC 715-80-50-1]

9.

If it is either probable or reasonably possible that (a) an entity
would withdraw from the plan under circumstances that
would give rise to an obligation or (b) an entity’s contribution
to the fund would be increased during the remainder of the
contract period to make up a shortfall in the funds necessary
to maintain the negotiated level of benefit coverage (a “maintenance of benefits” clause), has the entity applied the provisions of FASB ASC 450?
[FASB ASC 715-80-50-2]

No

N/A

Other Matters
10.

If the matters addressed in paragraphs 69–79 of FASB ASC
715-30-55 (Japanese governmental settlement transactions)
apply, are the disclosure requirements of FASB ASC 715-2050-10 complied with?
[FASB ASC 715-20-50 par. 9–10]

Medicare Prescription Drug, Improvement, and Modernization Act
11.

12.

Until the entity is able to determine whether benefits provided by its plan are actuarially equivalent, does it disclose
the following in financial statements for interim or annual
periods:
a.

The existence of the act?

b.

That measures of the APBO or net periodic postretirement benefit cost do not reflect any amount associated
with the subsidy because the employer is unable to
conclude whether the benefits provided by the plan are
actuarially equivalent to Medicare Part D under the
act?
[FASB ASC 715-60-50-6]

In interim and annual financial statements for the first period
in which the entity includes the effects of the subsidy in
measuring the APBO and the first period in which the entity
includes the effects of the subsidy in measuring net periodic
postretirement benefit cost, has it disclosed the following:
a.

The reduction in the APBO for the subsidy related to
benefits attributed to past service?
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13.

G.

b.

The effect of the subsidy on the measurement of net periodic postretirement benefit cost for the current period? That effect includes (1) any amortization of the
actuarial experience gain in a as a component of the net
amortization called for by paragraphs 29–30 of FASB
ASC 715-60-35, (2) the reduction in current period service cost due to the subsidy, and (3) the resulting reduction in interest cost on the APBO as a result of the
subsidy.

c.

Any other disclosures required by FASB ASC 715-2050-1(r)?
[FASB ASC 715-60-50-3]

No

N/A

For purposes of the disclosures required by paragraphs 1(a)
and (f) of FASB ASC 715-20-50, does the entity disclose gross
benefit payments (paid and expected, respectively), including
prescription drug benefits, and separately the gross amount
of the subsidy receipts (received and expected, respectively)?
[FASB ASC 715-60-50-4]

Environmental Remediation Liabilities
Practice Tip

FASB ASC 450-20 provides the primary guidance applicable to disclosures of environmental remediation
loss contingencies. The disclosure requirements of FASB ASC 275-10 also apply to environmental remediation liabilities. Example 1 (FASB ASC 410-30-55-7) illustrates the application of those disclosure requirements.
[FASB ASC 410-30-50 par. 5–6]
1.

FSP §20,100.01

Has the entity made the following disclosures:
a.

Whether accruals for environmental remediation liabilities are measured on a discounted basis?
[FASB ASC 410-30-50-4]

b.

With respect to recorded accruals for environmental remediation loss contingencies and assets for third-party
recoveries related to environmental remediation obligations: if any portion of the accrued obligation is discounted, the undiscounted amount of the obligation,
and the discount rate used in the present-value determinations?
[FASB ASC 410-30-50-7]

c.

The policy concerning the timing of recognition of recoveries? (Encouraged, but not required.)
[FASB ASC 410-30-50-8]

d.

Any other additional specific disclosures with respect
to environmental remediation loss contingencies that
would be useful to further users’ understanding of the
entity’s financial statements. (Encouraged, but not required.)
[FASB ASC 410-30-50-9]
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2.

No

N/A

Do the financial statements disclose the event, situation, or set
of circumstances that triggered recognition of loss contingencies that arose out of the reporting entity’s environmental remediation-related obligations? (Encouraged, but not required.)
[FASB ASC 410-30-50-8]

Reasonably Possible Loss Exposures
3.

With respect to reasonably possible loss contingencies, including reasonably possible loss exposures in excess of the
amount accrued, are the following disclosed (Encouraged, but
not required.):
a.

The estimated time frame of disbursements for recorded amounts if expenditures are expected to continue over the long term?

b.

The estimated time frame for realization of recognized
probable recoveries, if realization is not expected in the
near term?

c.

If an estimate of the probable or reasonably possible
loss or range of loss cannot be made, the reasons why
it cannot be made?

d.

If information about the reasonably possible loss or the
recognized and additional reasonably possible loss for
an environmental remediation obligation related to an
individual site is relevant to an understanding of the
financial position, cash flows, or results of operations
of the entity, the following with respect to the site:
i.

The total amount accrued for the site?

ii.

The nature of any reasonably possible loss contingency or additional loss, and an estimate of
the possible loss or the fact that an estimate cannot be made and the reasons why it cannot be
made?

iii.

Whether other potentially responsible parties are
involved and the entity’s estimated share of the
obligation?

iv.

The status of regulatory proceedings?

v.

The estimated time frame for resolution of the
contingency?
[FASB ASC 410-30-50-10]

Probable But Not Reasonably Estimable Losses
4.

If the reporting entity’s probable but not reasonably estimable
environmental remediation obligations may be material, are
the nature of the probable contingency (that is, a description
of the remediation obligation) and the fact that a reasonable
estimate cannot currently be made disclosed?
[FASB ASC 450-20-5-5]
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5.

Is the estimated time frame for resolution of the uncertainty
as to the amount of the loss disclosed? (Encouraged, but not
required.)
[FASB ASC 410-30-50-11]

Environmental Remediation Costs Recognized Currently
6.

Is the amount of environmental remediation costs recognized
in the income statement disclosed in the following detail: (Encouraged, but not required.)
a.

The amount recognized for environmental remediation
loss contingencies in each period?

b.

The amount of any recovery from third parties that is
credited to environmental remediation costs in each period?

c.

The income statement caption in which environmental
remediation costs and credits are included?
[FASB ASC 410-30-50-12]

Other Matters

H.

7.

Do the financial statements include a contingency conclusion
that addresses the estimated total unrecognized exposure to
environmental remediation and other loss contingencies? (Encouraged, but not required.)
[FASB ASC 410-30-50-14]

8.

Is there a description of the general applicability and impact
of environmental laws and regulations upon their business
and how the existence of such laws and regulations may give
rise to loss contingencies for future environmental remediation? (Encouraged, but not required.)
[FASB ASC 410-30-50-17]

Financial Instruments
Derivative Instruments and Hedging Activities (Including Hybrid
Financial Instruments)
Notes: In March 2008, FASB issued Statement No. 161 to enhance the
current disclosure framework in FASB Statement No. 133. This statement has the same scope as FASB Statement No. 133 and, accordingly,
applies to all entities.
This statement changes the disclosure requirements for derivative instruments and hedging activities. Entities are required to provide enhanced disclosures about (a) how and why an entity uses derivative
instruments, (b) how derivative instruments and related hedged items
are accounted for under FASB Statement No. 133 and its related interpretations, and (c) how derivative instruments and related hedged
items affect an entity’s financial position, financial performance, and
cash flows.
FASB Statement No. 161 is effective for financial statements issued for
fiscal years and interim periods beginning after November 15, 2008
(that is, January 1, 2009, for entities with calendar year-ends). Early
(continued)
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No

N/A

application is encouraged. This statement encourages but does not require disclosures for earlier periods presented for comparative purposes at initial adoption. In years after initial adoption, it requires
comparative disclosures only for periods subsequent to initial adoption.
This checklist has been updated to include the presentation and disclosure requirements of FASB Statement No. 161.
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should
consider all questions indicated with an “A” reference (for example,
question 1A and question 2A) and should place an “N/A” mark in
questions indicated with a “B” reference. Entities for which the guidance has been implemented should consider all questions indicated by
a “B” reference (for example, question 1B and question 2B) and place
an “N/A” mark by questions indicated with an “A” reference. Therefore, based upon your entity’s year-end and decision to early implement or not (if allowed), the following additional questions will be
answered when provided in this section (check one that applies for
your entity):
pppA pppB
Readers can refer to the full text of FASB Statement No. 161 on the
FASB Web site at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 815-1065-1.
1B.

(FASB Statement No. 161) Have the following disclosures
been made by the entity with derivative instruments (or nonderivative instruments that are designated and qualify as
hedging instruments pursuant to FASB ASC 815-20-25-58 and
FASB ASC 815-20-25-66), which enable the users of the financial statements to understand the following:
a.
How and why an entity uses derivative instruments (or
such nonderivative instruments)?
b.

c.

2A.

How derivative instruments (or such nonderivative instruments) and related hedged items are accounted for
under FASB ASC 815?
How derivative instruments (or such nonderivative instruments) and related hedged items affect the entity’s
financial position, performance and cash flows?
[”Pending Content” in FASB ASC 815-10-50-1]

If an entity holds or issues derivative instruments (or nonderivative instruments that are designated and qualify as hedging instruments pursuant to FASB ASC 815-20-25-58 and
FASB ASC 815-20-25-66) have the following disclosures been
made for every annual and interim reporting period for
which a statement of financial position and statement of financial performance are presented:
a.

Its objectives for holding or issuing those instruments?
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Yes

2B.

b.

The context needed to understand those objectives?

c.

Its strategies for achieving those objectives?
[”Pending Content” in FASB ASC 815-10-50-1A]

(FASB Statement No. 161) If an entity holds or issues derivative instruments (or nonderivative instruments that are designated and qualify as hedging instruments pursuant to
FASB ASC 815-20-25-58 and FASB ASC 815-20-25-66) have
the following disclosures been made for every annual and interim reporting period for which a statement of financial position and statement of financial performance are presented:
a.

Its objectives for holding or issuing those instruments?

b.

The context needed to understand those objectives?

c.

Its strategies for achieving those objectives?

d.

Information that would enable users of its financial
statements to understand the volume of its activity in
those instruments? (An entity should select the format
and the specifics of disclosures relating to its volume of
such activity that are most relevant and practicable for
its individual facts and circumstances.)
[”Pending Content” in FASB ASC 815-10-50-1]

3B.

(FASB Statement No. 161) Are the disclosures described in
question 2B in the context of each instrument’s primary underlying risk exposure (for example, interest rate, credit, foreign exchange rate, interest rate and foreign exchange rate, or
overall price)?
[”Pending Content” in FASB ASC 815-10-50-1B]

4B.

(FASB Statement No. 161) Are the financial instruments described in question 2B distinguished between those used or
risk management purposes and those used for other purposes
and is such information disclosed? Derivative instruments
(and nonderivative instruments that are designated and qualify as hedging instruments pursuant to FASB ASC 815-20-2558 and FASB ASC 815-20-25-66) used for risk management
purposes include those designated as hedging instruments
under FASB ASC 815-20 as well as those used as economic
hedges and for other purposes related to the entity’s risk exposures.
[”Pending Content” in FASB ASC 815-10-50-1B]

5A.

Do the disclosures required by FASB ASC 815-10-50-1A
(question 2A) distinguish between each of the following (including the entity’s risk management policy for each):
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a.

Fair value hedging instruments?

b.

Cash flow hedging instruments?

c.

Hedges of foreign currency exposure of net investments in foreign operations?

d.

All other instruments?
[FASB ASC 815-10-50 par. 2–3]

No

N/A
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Yes
5B.

N/A

(FASB Statement No. 161) Do the disclosures required by
question 2B distinguish between each of the following:
a.

b.
6.

No

Instruments used for risk management purposes, distinguished between each of the following:
i.

Derivative instruments designated as hedging instruments, distinguished between each of the following: (1) fair value hedging instruments, (2)
cash flow hedging instruments, and (3) hedges of
foreign currency exposure of net investments in
foreign operations?

ii.

Instruments used as economic hedges and for
other purposes related to the entity’s risk exposure?

Instruments used for other purposes?
[”Pending Content” in FASB ASC 815-10-50-2]

Do the entities disclosures describe the purpose of holding or
issuing derivatives which are not designated as hedging instruments?
[“Pending Content” in FASB ASC 815-10-50-4]
Practice Tip

(FASB Statement No. 161) The qualitative disclosures required by FASB ASC 815-10-50-4A(a)–(b), question
7B, should be presented in tabular format except for the information required for hedged items by FASB
ASC 815-10-50-4C(a). Information about hedged items can be presented in a tabular or nontabular format.
[“Pending Content” in FASB ASC 815-10-50-4E]
7B.

(FASB Statement No. 161) For every annual and interim reporting period for which a statement of financial position and
statement of financial performance are presented, has the entity disclosed the location and amounts of the gains and
losses for derivative instruments (or nonderivative instruments it holds or issues that are designated and qualify as
hedging instruments pursuant to FASB ASC 815-20-25-58 and
FASB ASC 815-20-25-66) reported in the statement of financial performance (or when applicable, the statement of financial position) (for example, gains and losses initially recognized in OCI)?
[”Pending Content” in FASB ASC 815-10-50-4A]

8B.

(FASB Statement No. 161) Do the disclosures required by
FASB ASC 815-10-50-A(a), as discussed in question 7B, provide the following:
a.

The fair value of derivative instruments on a gross basis (even if the derivative instruments qualify for net
presentation in the statement of financial position in accordance with FASB ASC 210-20 [general hedging activities])?
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Yes

9B.

b.

Separate asset and liability values segregated between
derivatives that are designated and qualifying as hedging instruments under FASB ASC 815-20 and those that
are not, and within those two broad categories, by type
of derivative contract (for example, interest rate contracts, foreign exchange contracts, equity contracts,
commodity contracts, credit contracts, and so forth)?

c.

The line item(s) in the statement of financial position in
which the fair value amounts for the above categories
of derivative instruments are included?
[”Pending Content” in FASB ASC 815-10-50-4B]

(FASB Statement No. 161) Are the following gains and losses
disclosed pursuant to FASB ASC 815-10-50-4A(b) presented
separately for all of the following by type of contracts:
a.

Derivative instruments designated and qualifying as
hedging instruments in fair value hedges and related
hedged items designated and qualifying in fair value
hedges?

b.

The effective portion of gains and losses on derivative
instruments designated and qualifying in cash flow
hedges and net investment hedges that was recognized
in OCI during the current period?

c.

The effective portion of gains and losses on derivative
instruments designated and qualifying in cash flow
hedges and net investment hedges recorded in accumulated OCI during the term of the hedging relationship and reclassified into earnings during the current
period?

d.

The portion of gains and losses on derivative instruments designated and qualifying in cash flow hedges
and net investment hedges representing (i) the amount
of the hedges’ ineffectiveness and (ii) the amount, if
any, excluded from the assessment of hedge effectiveness?

e.

Derivative instruments not designated or qualifying as
hedging instruments under FASB ASC 815-20?
[”Pending Content” in FASB ASC 815-10-50-4C]

10B. (FASB Statement No. 161) Do the disclosures pursuant to
question 9B, present information separately by type of derivative contract (for example, interest rate contracts, foreign
exchange contracts, equity contracts, commodity contracts,
credit contracts, and so forth)?
[”Pending Content” in FASB ASC 815-10-50-4D]
11B. (FASB Statement No. 161) Do the disclosures pursuant to
question 9B, identify the line item(s) in the statement of financial performance in which the gains and losses for the categories of derivative instruments are included?
[”Pending Content” in FASB ASC 815-10-50-4D]
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Yes

No

N/A

Practice Tip
(FASB Statement No. 161) If the disclosure option in question 12B is elected, the entity should include a
footnote in the required tables referencing the use of alternative disclosures for trading activities.
[“Pending Content” in FASB ASC 815-10-50-4F]
12B. (FASB Statement No. 161) If an entity’s policy is to include
derivative instruments that are not designated or qualifying
as hedging instruments under FASB ASC 815-20 in its trading
activities, and the entity elects to exclude those derivative instruments from the disclosures pursuant to question 9B, has
the entity disclosed the following information:
a.

The gains and losses on its trading activities (including
both derivative and nonderivative instruments) recognized in the statement of financial performance, separately by major types of items (such as fixed income/
interest rates, foreign exchange, equity, commodity,
and credit)?

b.

The line items in the statement of financial performance
in which trading activities gains and losses are included?

c.

A description of the nature of its trading activities and
related risks, and how the entity manages those risks?
[”Pending Content” in FASB ASC 815-10-50-4F]

13B. (FASB Statement No. 161) For every annual and interim reporting period for which a statement of financial position and
statement of financial performance are presented, does the
entity disclose the following information about derivative instruments it holds or issues (or nonderivative instruments it
holds or issues that are designated and qualify as hedging
instruments pursuant to FASB ASC 815-20-25-58 and FASB
ASC 815-20-25-66) that have credit-risk-related contingent
features and that are in a net liability position at the end of
the reporting period:
a.

The existence and nature of credit-risk-related contingent features and the circumstances in which the features could be triggered in derivative instruments that
are in a net liability position at the end of the reporting
period?

b.

The aggregate fair value amounts of derivative instruments that contain credit-risk-related contingent features that are in a net liability position at the end of the
reporting period?
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Yes
c.

The aggregate fair value of assets that are already
posted as collateral at the end of the reporting period
and (1) the aggregate fair value of additional assets that
would be required to be posted as collateral or (2) the
aggregate fair value of assets needed to settle the instrument immediately, if the credit-risk-related contingent features were triggered at the end of the reporting
period?
[”Pending Content” in FASB ASC 815-10-50-4H]

14B. (FASB Statement No. 161) If the disclosures related to derivative instruments (or nonderivative instruments that are designated and qualify as hedging instruments pursuant to
FASB ASC 815-20-25-58 and FASB ASC 815-20-25-66) are presented in more than a single footnote, does each derivative
note cross-reference the other notes in which derivative-related information is disclosed?
[”Pending Content” in FASB ASC 815-10-50-4I]
Fair Value Hedges
15A. For each reporting period for which a complete set of financial statements is presented, does the entity disclose the following for derivative instruments, as well as nonderivative
instruments that may give rise to foreign currency transaction
gains or losses under FASB ASC 830-20, that have been designated and have qualified as fair value hedging instruments
and for the related hedged items:
a.

The net gain or loss recognized in earnings during the
reporting period representing (i) the amount of the
hedges’ ineffectiveness, (ii) the component of the derivative instruments’ gain or loss, if any, excluded from
the assessment of hedge effectiveness, and (iii) a description of where the net gain or loss is reported in the
statement of income or other statement of financial performance?

b.

The amount of net gain or loss recognized in earnings
when a hedged firm commitment no longer qualifies as
a fair value hedge?
[FASB ASC 815-25-50-1]

16B. (FASB Statement No. 161) For every annual and interim reporting period for which a statement of financial position and
statement of financial performance are presented, does the
entity disclose the following for derivative instruments, as
well as nonderivative instruments that may give rise to foreign currency transaction gains or losses under FASB ASC
830-20, that have been designated and have qualified as fair
value hedging instruments and for the related hedged items:
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a.

The net gain or loss recognized in earnings during the
reporting period representing (i) the amount of the
hedges’ ineffectiveness, (ii) the component of the derivative instruments’ gain or loss, if any, excluded from
the assessment of hedge effectiveness, and (iii) a description of where the net gain or loss is reported in the
statement of income or other statement of financial performance?

b.

The amount of net gain or loss recognized in earnings
when a hedged firm commitment no longer qualifies as
a fair value hedge?
[”Pending Content” in FASB ASC 815-25-50-1]

No

N/A

Cash Flow Hedges
17A. For every annual and interim reporting period for which a
statement of financial position and statement of financial performance are presented, does the entity disclose the following
for derivative instruments that have been designated and
have qualified as cash flow hedging instruments and for the
related hedged transactions:
a.

The net gain or loss recognized in earnings during the
reporting period representing each of the following:
i.

The amount of the hedges’ ineffectiveness?

ii.

The component of the derivative instruments’
gain or loss, if any, excluded from the assessment
of hedge effectiveness?

iii.

A description of where the net gain or loss is reported in the statement of income or other statement of financial performance?

b.

A description of the transactions or other events that
will result in the reclassification into earnings of gains
and losses that are reported in accumulated OCI, and
the estimated net amount of the existing gains or losses
at the reporting date that is expected to be reclassified
into earnings within the next 12 months?

c.

The maximum length of time over which the entity is
hedging its exposure to the variability in future cash
flows for forecasted transactions excluding those forecasted transactions related to the payment of variable
interest on existing financial instruments?

d.

The amount of gains and losses reclassified into earnings as a result of the discontinuance of cash flow
hedges because it is probable that the original forecasted transactions will not occur by the end of the
originally specified time period or within the additional period of time discussed in paragraphs 4–5 of
FASB ASC 815-30-40-4?
[FASB ASC 815-30-50-1]
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17B. (FASB Statement No. 161) For every annual and interim reporting period for which a statement of financial position and
statement of financial performance are presented, does the
entity disclose the following for derivative instruments that
have been designated and have qualified as cash flow hedging instruments and for the related hedged transactions:

18.

a.

A description of the transactions or other events that
will result in the reclassification into earnings of gains
and losses that are reported in accumulated OCI, and
the estimated net amount of the existing gains or losses
at the reporting date that is expected to be reclassified
into earnings within the next 12 months?

b.

The maximum length of time over which the entity is
hedging its exposure to the variability in future cash
flows for forecasted transactions excluding those forecasted transactions related to the payment of variable
interest on existing financial instruments?

c.

The amount of gains and losses reclassified into earnings as a result of the discontinuance of cash flow
hedges because it is probable that the original forecasted transactions will not occur by the end of the
originally specified time period or within the additional period of time discussed in paragraphs 4–5 of
FASB ASC 815-30-40?
[”Pending Content” in FASB ASC 815-30-50-1]

The quantitative disclosures about derivative instruments
may be more useful, and less likely to be perceived to be out
of context or otherwise misunderstood, if similar information
is disclosed about other financial instruments or nonfinancial
assets and liabilities to which the derivative instruments are
related by activity. Accordingly, in such situations, an entity
is encouraged, but not required, to present a more complete
picture of its activities by disclosing that information. Have
such disclosures been made (for every annual and interim reporting period for which a statement of financial position and
statement of financial performance are presented)?
[FASB ASC 815-35-50-2]

19A. Qualitative disclosures about an entity’s objectives and strategies for using derivative instruments may be more meaningful if such objectives and strategies are described in the context of an entity’s overall risk management profile. If
appropriate, an entity is encouraged, but not required, to provide such additional qualitative disclosures. Have such disclosures been made (for every annual and interim reporting
period for which a statement of financial position and statement of financial performance are presented)?
[FASB ASC 815-10-50-5]
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Yes

No

N/A

19B. (FASB Statement No. 161) Qualitative disclosures about an
entity’s objectives and strategies for using derivative instruments may be more meaningful if such objectives and strategies are described in the context of an entity’s overall risk exposures relating to interest rate risk, foreign currency
exchange rate risk, commodity price risk, credit risk, and equity price risk. If appropriate, an entity is encouraged, but not
required, to provide such additional qualitative disclosures.
Have such disclosures been made (for every annual and interim reporting period for which a statement of financial position and statement of financial performance are presented)?
[”Pending Content” in FASB ASC 815-10-50-5]
Disclosure About Concentrations of Credit Risk of All Financial
Instruments (including Reinsurance Receivables and Prepaid Reinsurance Premiums)
20.

Except as indicated in FASB ASC 825-10-50-22, has the entity
disclosed all significant concentrations of credit risk arising
from all financial instruments, whether from an individual
counterparty or groups of counterparties? (Group concentrations of credit risk exist if a number of counterparties are engaged in similar activities and have similar economic characteristics that would cause their ability to meet contractual
obligations to be similarly affected by changes in economic or
other conditions.)
[“Pending Content” in FASB ASC 825-10-50-20]

Notes: In September 2008, FASB issued FSP FAS 133-1 and FIN 45-5,
Disclosures about Credit Derivatives and Certain Guarantees: An Amendment of FASB Statement No. 133 and FASB Interpretation No. 45; and Clarification of the Effective Date of FASB Statement No. 161, to amend current
disclosures by sellers of credit derivatives under FASB Statement No.
161. This FSP applies to credit derivatives within the scope of FASB
Statement No. 133, hybrid instruments that have embedded credit derivatives.
This FSP changes the disclosure requirements related to credit derivatives in that a seller of credit derivatives should disclose information
about its credit derivatives and hybrid instruments that have embedded credit derivatives to enable users of financial statements to assess
their potential effect on on its financial position, financial performance, and cash flows.
This FSP clarifies FASB’s intent that the disclosures required by FASB
Statement No. 161 should be provided for any reporting period (annual or quarterly interim) beginning after November 15, 2008.
The FSP is effective for financial statements issued for fiscal years and
interim periods beginning after November 15, 2008 (that is, January 1,
2009, for entities with calendar year-ends). Early application is encouraged. This statement encourages but does not require disclosures for
earlier periods presented for comparative purposes at initial adoption.
In years after initial adoption, it requires comparative disclosures only
for periods subsequent to initial adoption.
(continued)
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This checklist has been updated to include the presentation and disclosure requirements of FSP FAS 133-1 and FIN 45-5.
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should consider all questions indicated with an “A” reference (for example, question 1A and question 2A) and should place an “N/A” mark in questions indicated with a “B” reference. Entities for which the guidance
has been implemented should consider all questions indicated by a
“B” reference (for example, question 1B and question 2B) and place an
“N/A” mark by questions indicated with an “A” reference. Therefore,
based upon your entity’s year-end and decision to early implement or
not (if allowed), the following additional questions will be answered
when provided in this section (check one that applies for your entity):
pppA pppB
Readers can refer to the full text of the statement on the FASB Web
site at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 815-1065-2.
Credit Derivatives
20B. (FSP FAS 133-1 and FIN 45-5) Is the following information
disclosed by a seller of credit derivative, (as defined in FASB
ASC 815-10-50-4J as a guarantor in a guarantee type contract
or any party that provides the credit protection in an option
type contract, a credit default swap, or any other credit derivative), even if the likelihood of the seller’s having to make
any payments under the credit derivative is remote:
a.

b.
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The nature of the credit derivative, including all of the
following:
i.

The approximate term of the credit derivative?

ii.

The reasons for entering into the credit derivative?

iii.

The events or circumstances that would require
the seller to perform under the credit derivative?

iv.

The current status (that is, as of the date of the
statement of financial position) of the payment/
performance risk of the credit derivative?

v.

If the entity uses internal groupings for the purposes of item (iv), how those groupings are determined and used for managing risk?

The maximum potential amount of future payments
(undiscounted) that the seller could be required to
make under the credit derivative, which should not be
reduced by the effect of any amounts that may possibly
be recovered under recourse or collateralization provisions in the credit derivative?

No

N/A
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Yes
c.

If the terms of the credit derivative provide for no limitation to the maximum potential future payments under the credit derivative, is that fact disclosed?

d.

If the seller is unable to develop an estimate of the maximum potential amount of future payments under the
credit derivative, are the reasons why the maximum
potential amount cannot be estimated disclosed?

e.

Is the fair value of the credit derivative as of the date of
the statement of financial position disclosed?

f.

The nature of

g.

i.

any recourse provisions that would enable the
guarantor to recover from third parties any of the
amounts paid under the guarantee?

ii.

any assets held either as collateral or by third
parties that, upon the occurrence of any triggering event or condition under the guarantee, the
guarantor can obtain and liquidate to recover all
or a portion of the amounts paid under the guarantee?

No

N/A

If estimable, the approximate extent to which the proceeds from liquidation of those assets would be expected to cover the maximum potential amount of future payments under the guarantee?
[“Pending Content” in FASB ASC 815-10-50-4J; “Pending Content” in FASB ASC 815-10-50-4K]

21B. (FSP FAS 133-1 and FIN 45-5) With respect to hybrid instruments that have embedded credit derivatives, has the seller
of the embedded credit derivative disclosed the information
required by FASB ASC 815-10-50-4K, question 20, for the entire hybrid instrument, not just the embedded credit derivatives?
[“Pending Content” in FASB ASC 850-10-50-4L]
22.

Has the entity disclosed its accounting policy for the premium paid (time value) to acquire an option that is classified
as held to maturity or available for sale, if applicable?
[FASB ASC 815-10-50-9]

Unconditional Purchase Obligations
23.

If the entity has unconditional purchase obligations which are
subject to the requirements of FASB ASC 440 and FASB ASC
815, are the disclosures required by both topics complied
with, including FASB ASC 440-10-50-4?
[FASB ASC 815-10-50-6]

Balance Sheet Offsetting
24.

Is the entity’s policy for offsetting or not offsetting in accordance with FASB ASC 815-10-45-6 disclosed?
[FASB ASC 815-10-50-7]
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Yes

No

N/A

Practice Tip
A reporting entity should make an accounting policy decision to offset fair value amounts pursuant to FASB
ASC 815-10-45-5. The reporting entity’s choice to offset or not must be applied consistently. A reporting
entity should not offset fair value amounts recognized for derivative instruments without offsetting fair
value amounts recognized for the right to reclaim cash collateral or the obligation to return cash collateral.
A reporting entity that makes an accounting policy decision to offset fair value amounts recognized for
derivative instruments pursuant to FASB ASC 815-10-45-5 but determines that the amount recognized for
the right to reclaim cash collateral or the obligation to return cash collateral is not a fair value amount should
continue to offset the derivative instruments.
[FASB ASC 815-10-45-6]
25.

Has the entity disclosed the amounts recognized at the end of
each reporting period for the right to reclaim cash collateral
or the obligation to return cash collateral as follows:
a.

If the entity has made an accounting policy decision to
offset fair value amounts it should separately disclose
amounts recognized for the right to reclaim cash collateral or the obligation to return cash collateral that have
been offset against net derivative positions in accordance with FASB ASC 815-10-45-5?
Practice Tip

A reporting entity may offset fair value amounts recognized for derivative instruments and fair value
amounts recognized for the right to reclaim cash collateral (a receivable) or the obligation to return cash
collateral (a payable) arising from derivative instrument(s) recognized at fair value executed with the same
counterparty under a master netting arrangement. Solely as it relates to the right to reclaim cash collateral
or the obligation to return cash collateral, fair value amounts include amounts that approximate fair value.
[FASB ASC 815-10-45-5]
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b.

Has the entity separately disclosed amounts recognized
for the right to reclaim cash collateral or the obligation
to return cash collateral under master netting arrangements that have not been offset against net derivative
instrument positions?

c.

If the entity has made an accounting policy decision to
not offset fair value amounts, have they separately disclosed the amounts recognized for the right to reclaim
cash collateral or the obligation to return cash collateral
under master netting arrangements?
[FASB ASC 815-10-50-8]
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Yes

No

N/A

Certain Hybrid Financial Instruments
Note: In February 2007, FASB issued Statement No. 159, The Fair Value
Option for Financial Assets and Financial Liabilities—Including an amendment of FASB Statement No. 115, which is effective for financial statements issued for fiscal years beginning after November 15, 2007 (that
is, January 1, 2008, for entities with calendar year-ends). Early adoption is permitted as of the beginning of a fiscal year that begins on or
before November 15, 2007, provided the entity also elects to apply the
provisions of FASB Statement No. 157. The choice to adopt early
should be made after issuance of this statement but within 120 days of
the beginning of the fiscal year of adoption, provided the entity has
not yet issued financial statements, including required notes to those
financial statements, for any interim period of the fiscal year of adoption.
This statement applies to all entities, including not-for-profit entities.
Most of the provisions of this guidance apply only to entities that elect
the fair value option. However, the amendment to FASB Statement
No. 115, Accounting for Certain Investments in Debt and Equity Securities,
applies to all entities with available-for-sale and trading securities.
Some requirements apply differently to entities that do not report net
income.
This statement is primarily codified in FASB ASC 825, Financial Instruments.
See part BB, “Fair Value Measurements,” in the "Other Financial Statement Disclosures" section of this checklist for more information.
26.

If the entity measures hybrid instruments (financial instruments containing embedded derivatives) at fair value in accordance with the election and under the practicability exception in FASB ASC 815-15-30-1 on earnings (or other
performance indicators for entities that do not report earnings), is the aggregate fair value of those instruments reported separately on the face of the statement of financial position from the aggregate carrying amounts of assets and
liabilities measured using another measurement attribute?
[FASB ASC 815-15-45-1]

27.

For those hybrid financial instruments measured at fair value
under the election and under the practicability exception in
FASB ASC 815-15-30-1 on earnings (or other performance indicators for entities that do not report earnings), has the entity disclosed the information in paragraphs 28–32 of FASB
ASC 825-10-50?
[FASB ASC 815-15-50-1]
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Yes
28.

Has the entity provided information that will allow users to
understand the effect of changes in the fair value of hybrid
financial instruments measured at fair value under the election and under the practicability exception in FASB ASC 81515-30-1 on earnings (or other performance indicators for entities that do not report earnings)?
[FASB ASC 815-15-50-2]

29.

For those embedded conversion options previously accounted for as a derivative instrument under FASB ASC 81515 (embedded derivatives) which no longer meet the separation criteria has a description of the principal changes causing
the embedded conversion option to not longer require bifurcation and the amount of the liability for the conversion option which has been reclassified to stockholders’ equity been
disclosed?
[FASB ASC 815-15-50-3]
Fair Value Hedges

30A. For every annual and interim reporting period for which a
statement of financial position and statement of financial performance are presented, does the entity disclose the following
for derivative instruments, as well as nonderivative instruments that may give rise to foreign currency transaction gains
or losses under FASB ASC 830-20, that have been designated
and have qualified as fair value hedging instruments and for
the related hedged items:
a.

The net gain or loss recognized in earnings during the
reporting period representing (a) the amount of the
hedges’ ineffectiveness, (b) the component of the derivative instruments’ gain or loss, if any, excluded from
the assessment of hedge effectiveness, and (c) a description of where the net gain or loss is reported in the
statement of income or other statement of financial performance?

b.

The amount of net gain or loss recognized in earnings
when a hedged firm commitment no longer qualifies as
a fair value hedge?
[FASB ASC 815-25-50-1]

30B. (FASB Statement No. 161) For every annual and interim reporting period for which a statement of financial position and
statement of financial performance are presented, does the
entity disclose the following for derivative instruments, as
well as nonderivative instruments that may give rise to foreign currency transaction gains or losses under FASB ASC
830-20, that have been designated and have qualified as fair
value hedging instruments and for the related hedged items:
a.
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The net gain or loss recognized in earnings during the
reporting period representing (a) the amount of the
hedges’ ineffectiveness and (b) the component of the
derivative instruments’ gain or loss, if any, excluded
from the assessment of hedge effectiveness?

No

N/A
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b.

No

N/A

The amount of net gain or loss recognized in earnings
when a hedged firm commitment no longer qualifies as
a fair value hedge?
[”Pending Content” in FASB ASC 815-25-50-1]

Cash Flow Hedges
31.

Has the entity displayed, as a separate classification within
OCI, the net gain or loss on any derivative instruments designated and qualifying as cash flow hedging instruments that
are reported in comprehensive income pursuant to FASB
ASC 815-20-25-65 and FASB ASC 815-30-35-3?
[FASB ASC 815-30-45-1]

32A. For every reporting period for which a statement of financial
position and statement of financial performance are presented, does the entity disclose the following for derivative
instruments that have been designated and have qualified as
cash flow hedging instruments and for the related hedged
transactions:
a.

The net gain or loss recognized in earnings during the
reporting period representing (i) the amount of the
hedges’ ineffectiveness, (ii) the component of the derivative instruments’ gain or loss, if any, excluded from
the assessment of hedge effectiveness, and (iii) a description of where the net gain or loss is reported in the
statement of income or other statement of financial performance?

b.

A description of the transactions or other events that
will result in the reclassification into earnings of gains
and losses that are reported in accumulated OCI, and
the estimated net amount of the existing gains or losses
at the reporting date that is expected to be reclassified
into earnings within the next 12 months?

c.

The maximum length of time over which the entity is
hedging its exposure to the variability in future cash
flows for forecasted transactions excluding those forecasted transactions related to the payment of variable
interest on existing financial instruments?

d.

The amount of gains and losses reclassified into earnings as a result of the discontinuance of cash flow
hedges because it is probable that the original forecasted transactions will not occur by the end of the
originally specified time period or within the additional period of time discussed in paragraphs 4–5 of
FASB ASC 815-30-40?
[FASB ASC 815-30-50-1]
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Yes

No

N/A

32B. (FASB Statement No. 161) For every annual and interim reporting period for which a statement of financial position and
statement of financial performance are presented, does the
entity disclose the following for derivative instruments that
have been designated and have qualified as cash flow hedging instruments and for the related hedged transactions:

33.

a.

A description of the transactions or other events that
will result in the reclassification into earnings of gains
and losses that are reported in accumulated OCI, and
the estimated net amount of the existing gains or losses
at the reporting date that is expected to be reclassified
into earnings within the next 12 months?

b.

The maximum length of time over which the entity is
hedging its exposure to the variability in future cash
flows for forecasted transactions excluding those forecasted transactions related to the payment of variable
interest on existing financial instruments?

c.

The amount of gains and losses reclassified into earnings as a result of the discontinuance of cash flow
hedges because it is probable that the original forecasted transactions will not occur by the end of the
originally specified time period or within the additional period of time discussed in paragraphs 4–5 of
FASB ASC 815-30-40?
[”Pending Content” in FASB ASC 815-30-50-1]

Has the entity disclosed, as a separate component of OCI, the
beginning and ending accumulated derivative instrument
gain or loss, the related net change associated with current
period hedging transactions, and the net amount of any reclassification into earnings?
[FASB ASC 815-30-50-2]
Practice Tips

The entity should display as a separate classification within OCI the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments that are reported in comprehensive income pursuant to FASB ASC 815-20-25-65 and FASB ASC 815-30-35-3.
[FASB ASC 815-30-45-1]
******
The quantitative disclosures about derivative instruments may be more useful, and less likely to be perceived to be out of context or otherwise misunderstood, if similar information is disclosed about other financial instruments or nonfinancial assets and liabilities to which the derivative instruments are related by
activity. Accordingly, in such situations, an entity is encouraged, but not required, to present a more complete picture of its activities by disclosing that information.
[FASB ASC 815-35-50-2]
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No

N/A

Contracts in Entity’s Own Equity
34.

Have changes in the fair value of all contracts classified as
assets or liabilities disclosed, as long as the contracts remain
classified as assets or liabilities?
[FASB ASC 815-40-50-1]

35.

If contracts that are classified as assets or liabilities meet the
FASB ASC glossary definition of a derivative instrument and
meet the criteria under the provisions of FASB ASC 815-10,
are the related disclosures required by FASB ASC 815-10-50,
FASB ASC 815-25-50, FASB ASC 815-30-50, and FASB ASC
815-35-50 disclosed, as detailed in questions preceding?
[FASB ASC 815-40-50-2]

36.

If contracts within the scope of FASB ASC 815-40 are reclassified into (or out of) equity during their lives (in whole or in
part) pursuant to the provisions of paragraphs 8–13 of FASB
ASC 815-40-35, related to reclassification of contracts, is the
contract reclassification, the reason for the reclassification and
the effect on the entity’s financial statements disclosed?
[FASB ASC 815-40-50-3]

37.

If the entity partially reclassifies a contract(s) subject to FASB
ASC 815-40, is the accounting policy decision disclosed pursuant to FASB ASC 235, Notes to the Financial Statements?
[FASB ASC 815-40-50-4]

38.

If the entity has contracts related to their capital structure of
the following nature, have the following disclosures, pursuant to FASB ASC 505-10-50 (equity disclosures) been displayed?
a.

If the entity has an option or forward contract, has relevant information including (i) the forward rate, (ii) the
option strike price, (iii) the number of shares to which
the contract is indexed, (iv) the settlement date(s), and
(v) the issuers accounting for the contract (asset, liability, or equity) been disclosed?

b.

If the entity’s contract(s) provide settlement alternatives, has the relevant information including (i) who
controls the settlement alternatives and (ii) the maximum number of shares that could be required to be issued to net share settle the contract been disclosed?

c.

If the entity’s contract(s) does not have a fixed or determinable maximum number of shares that may be required to be issued, is the fact that an infinite number
may be required to settle the contract(s) disclosed?

d.

For each of the entity’s contract(s) has disclosure been
made of the current fair value for each settlement alternative and how changes in the price of the issuer’s equity instruments affect those settlement amounts? (For
some issuers, a tabular format may provide the most
concise and informative presentation of these data.)
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Yes
e.

No

N/A

If the entity has temporary equity (for example redeemable stock issued by nonpublic entities) have the disclosures required by FASB ASC 505-10-50-11 been made?
[FASB ASC 815-40-50-5]

Weather Derivatives
39.

Weather derivative contracts within the scope of FASB ASC
815-45 are financial instruments, therefore, are the existing
U.S. GAAP disclosures for financial instruments such as those
required in FASB ASC 825-10-50 included?
[FASB ASC 815-45-50-1]

Disclosures About Fair Value of Financial Instruments
Notes: In April 2009, FASB issued FSP 107-1 and APB 28-1 to require
disclosures about fair value of financial instruments for interim reporting periods of publicly traded entities as well as in annual financial statements. This FSP also amends APB Opinion No. 28 to require
those disclosures in summarized financial information at interim reporting periods. This FSP applies to all financial instruments within
the scope of FASB Statement No. 107 held by publicly traded companies, as defined by APB Opinion No. 28.
FSP FAS 107-1 and APB 28-1 is effective for interim reporting periods
ending after June 15, 2009 (that is, December 31, 2009, for entities with
calendar year-ends), with early adoption permitted for periods ending
after March 19, 2009. An entity may early adopt this FSP only if it also
elects to early adopt FSP FAS 157-4 and FSP FAS 115-2 and FAS 1242. This FSP does not require disclosures for earlier periods presented
for comparative purposes at initial adoptions. In periods after initial
adoption, this FSP requires comparative disclosures only for periods
ending after initial adoption.
This checklist has been updated to include the presentation and disclosure requirements of FSP FAS 107-1 and APB 28-1.
Readers can refer to the full text of the statement on the FASB Web
site at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 825-1065-1.

Practice Tips
For interim reporting periods, the disclosure guidance in FASB ASC 825-10-50 applies to all entities but is
optional for those entities that do not meet the FASB ASC definition of a publicly traded company.
[“Pending Content” in FASB ASC 825-10-50-2A]
******
U.S. GAAP requires disclosure of or subsequent measurement at fair value for many classes of financial
instruments. Those requirements are not superseded or modified by FASB ASC 825-10-50.
FASB ASC 825-10-50-13 does not prohibit an entity from disclosing separately the estimated fair value of
any of its nonfinancial intangible and tangible assets and nonfinancial liabilities.
(continued)
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Yes

No

N/A

FASB ASC 825-10-50-14 does not require separate disclosure of trade receivables and payables if the carrying
amount approximates fair value.
[FASB ASC 825-10-50 par. 9 and 13–14]
******
The disclosure about fair values of financial instruments is optional (for annual reporting periods) for reporting entities that
●

are nonpublic entities as defined in the FASB ASC glossary,

●

have total assets of less than $100 million on the date of the financial statements, and

have no instrument that, in whole or in part, is accounted for as a derivative instrument under FASB
ASC 815, Derivatives and Hedging, other than commitments related to the origination of mortgage
loans to be held for sale during the reporting period.
[“Pending Content” in FASB ASC 825-10-50-3]
●

This criterion should be applied to the most recent year presented in comparative financial statements to
determine the applicability of FASB ASC 825-10-50.
[FASB ASC 825-10-50-4]
******
The following table clarifies the requirements for disclosures if prior periods are presented in comparative
financial statements.
If Disclosures for the Current
Period Are:
Optional
Optional
Required
Required
[FASB ASC 825-10-50 par. 5–7]

And Disclosures for Prior
Periods Were:

Then Disclosures for Prior
Periods Presented in
Comparative Statements Are:

Optional
Required
Optional
Required

Optional
Optional
Optional
Required

40.

Has the entity disclosed, either in the body of the financial
statements or in the accompanying notes, the fair value of financial instruments for which it is practicable to estimate fair
value, the method(s), significant assumptions used to estimate the fair value of the financial instruments and a description of the changes in the method(s) and significant assumptions used, if any, during the period?
[“Pending Content” in FASB ASC 825-10-50-10]

41.

Has the fair value disclosed in the notes been presented together with the related carrying amount in a form that makes
it clear whether the fair value and carrying amount represent
assets or liabilities and how the carrying amounts relate to
what is reported in the statement of financial position?
[FASB ASC 825-10-50-11]

42.

If fair value information is disclosed in more than a single
note, does one of the notes include a summary table of the
fair value and related carrying amounts, and does the note
cross-reference to the location(s) of the remaining required
disclosures?
[FASB ASC 825-10-50-12]
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Yes
43.

In disclosing the fair value of a financial instrument, has the
entity taken care not to net that fair value with the fair value
of other financial instruments—even if those financial instruments are of the same class or are otherwise considered to be
related, for example, by a risk management strategy—except
to the extent that the offsetting of carrying amounts in the
statement of financial position is permitted under the general
principle in FASB ASC 210-20-45-1, or the exceptions for master netting arrangements in FASB ASC 815-10-45-5 and for
amounts related to certain repurchase and reverse repurchase
agreements in paragraphs 11–17 of FASB ASC 210-25-45?
[FASB ASC 825-10-50-15]

44.

If it is not practicable (see paragraphs 16–19 of FASB ASC
825-10-50 for definition of practicable in this context) to estimate the fair value of a financial instrument or a class of financial instruments, are the following disclosed:
a.

Information pertinent to estimating the fair value of
that financial instrument or class of financial instruments, such as the carrying amount, effective interest
rate, and maturity?

b.

The reasons why it is not practicable to estimate fair
value?
[FASB ASC 825-10-50-16]

No

N/A

Practice Tips
Fair value disclosures are required for all financial instruments, whether recognized or not recognized in the
statement of financial position, except that the disclosures about fair value in paragraphs 10–16 of FASB
ASC 825-10-50 are not required for several classes of financial instruments (see FASB ASC 825-10-50-8).
[FASB ASC 825-10-50-8]
Disclosure About Concentrations of Credit Risk of All Financial
Instruments
Practice Tip
The disclosure requirements of FASB ASC 825-10-50-21 do not apply to the following financial instruments,
whether written or held:
●

The financial instruments described in FASB ASC 825-10-50-8(a), (c), (e), and (f), except for reinsurance receivables and prepaid reinsurance premiums.

Financial instruments of a pension plan, including plan assets, when subject to the accounting and
reporting requirements of FASB ASC 715, Compensation—Retirement Benefits (financial instruments
of a pension plan, other than the obligations for pension benefits, if subject to the accounting and
reporting requirements of FASB ASC 960, Plan Accounting—Defined Benefit Pension Plans, are subject
to the requirements of paragraphs 20–21 of FASB ASC 825-10-50).
[FASB ASC 825-10-50-22]
●

45.
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Yes

46.

a.

Information about the (shared) activity, region, or economic characteristic that identifies the concentration?
Possible shared characteristics on which significant
concentrations may be determined include, but are not
limited to (1) borrowers subject to significant payment
increases, (2) loans with terms that permit negative amortization, and (3) loans with high loan-to-value ratios.

b.

The maximum amount of loss due to credit risk that,
based on the gross fair value of the financial instrument, the entity would incur if parties to the financial
instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the
amount due proved to be of no value to the entity?

c.

The entity’s policy of requiring collateral or other security to support financial instruments subject to credit
risk, information about the entity’s access to that collateral or other security, and the nature and a brief description of the collateral or other security supporting
those financial instruments?

d.

The entity’s policy of entering into master netting arrangements to mitigate the credit risk of financial instruments, information about the arrangements for
which the entity is a party, and a brief description of
the terms of those arrangements, including the extent
to which they would reduce the entity’s maximum
amount of loss due to credit risk?
[FASB ASC 825-10-50-21]

No

N/A

Has the entity disclosed quantitative information, such as
those listed below, about the market risks of financial instruments that is consistent with the way it manages or adjusts
those risks? (Encouraged, but not required.)
a.

More details about current positions and perhaps activity during the period?

b.

The hypothetical effects on comprehensive income (or
net assets), or annual income, of several possible
changes in market prices?

c.

A gap analysis of interest rate repricing or maturity
dates?

d.

The duration of the financial instruments?

e.

The entity’s value at risk from derivatives and from
other positions at the end of the reporting period and
the average value at risk during the year?
[FASB ASC 825-10-50-23]
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Yes
47.

No

N/A

Are gains and losses (realized and unrealized) on all derivative instruments within the scope of FASB ASC 815, shown
net when recognized in the income statement, whether or not
settled physically, if the derivative instruments are held for
trading purposes?
[FASB ASC 815-10-45-9]

Registration Payment Arrangements
48.

If the entity is an issuer of a registration payment arrangement, has the following been disclosed:
a.

The nature of the registration payment, including all of
the following:
i.

The approximate term of the arrangement?

ii.

The financial instrument(s) subject to the arrangement?

iii.

The events or circumstances that would require
the issuer to transfer consideration under the arrangement?

b.

Any settlement alternatives contained in the terms of
the registration payment arrangement, including the
party that controls the settlement alternatives?

c.

The maximum potential amount of consideration, undiscounted, that the issuer could be required to transfer
under the registration payment arrangement (including
the maximum number of shares that may be required
to be issued)?

d.

If the terms of the arrangement provide for no limitation to the maximum potential consideration (including
shares) to be transferred, that fact has been disclosed?

e.

The current carrying amount of the liability representing the issuer’s obligations under the registration payment arrangement?

f.

The income statement classification of any gains or
losses resulting from changes in the carrying amount of
the liability representing the issuer’s obligations under
the registration payment arrangement?
[FASB ASC 825-20-50-1]
Practice Tip

The preceding disclosures are incremental to the disclosures that may be required under other applicable
U.S. GAAP and are required even if the likelihood of the issuer having to make any payments under the
arrangement is remote.
[FASB ASC 825-20-50-2]
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No

N/A

Disclosures About Certain Financial Instruments With Characteristics of Both Liabilities and Equity
Notes: In November 2003, FASB issued FSP FAS 150-3, Effective Date,
Disclosures, and Transition for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable
Noncontrolling Interests under FASB Statement No. 150, to clarify and
defer specific implementation of the provisions of FASB Statement No.
150, Accounting for Certain Financial Instruments with Characteristics of
both Liabilities and Equity.
FASB Statement No. 150 as issued is effective for mandatorily redeemable financial instruments of nonpublic entities for the first fiscal period beginning after December 15, 2003. For mandatorily redeemable
instruments of other entities, FASB Statement No. 150 as issued is effective for financial instruments entered into or modified after May 31,
2003, and for all other instruments for interim periods beginning after
June 15, 2003.
FSP FAS 150-3 deferred the effective date for mandatorily redeemable
financial instruments issued by nonpublic entities that are not SEC
registrants, as follows:
1.

For instruments that are mandatorily redeemable on fixed
dates for amounts that either are fixed or are determined by
reference to an interest rate index, currency index, or another
external index, the classification, measurement, and disclosure
provisions of FASB ASC 480-10-50 were effective for fiscal
periods beginning after December 15, 2004.

2.

For all other financial instruments that are mandatorily redeemable, the classification, measurement, and disclosure provisions of FASB ASC 480-10-50 are deferred indefinitely pending further FASB action.

Note that the effective dates for entities that are not nonpublic and are
not SEC registrants differ and that early adoption for instruments
within the scope of this deferral is prohibited during the deferral period. Readers should review this FSP or the relevant transition guidance to understand the various effective dates of FASB Statement No.
150, as discussed in FASB ASC 480-10-65-1.
This checklist has been updated to include the presentation and disclosure requirements of FSP FAS 150-3.
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should consider all questions indicated with an “A” reference (for example, question 1A and question 2A) and should place an “N/A” mark in questions indicated with a “B” reference. Entities for which the guidance
has been implemented should consider all questions indicated by a
“B” reference (for example, question 1B and question 2B) and place an
“N/A” mark by questions indicated with an “A” reference. Therefore,
based upon your entity’s year-end and decision to early implement or
not (if allowed), the following additional questions will be answered
(continued)
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Yes
when provided in this section (check one that applies for your entity):
pppA pppB
Readers can refer to the full text of the statement on the FASB Web
site at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 480-1065-1.
49B. (FSP FAS 150-3) For items within the scope of FASB ASC 48010, are they presented as liabilities (or assets in some circumstances), and are those items not presented between the liabilities section and the equity section of the statement of
financial position?
[”Pending Content” in FASB ASC 480-10-45-1]
50B. (FSP FAS 150-3) For issuers of financial instruments with the
scope of FASB ASC 480-10:
a.

Are the nature and terms of the financial instruments
and the rights and obligations embodied in those instruments disclosed?

b.

Does that disclosure include information about settlement alternatives, if any, in the contract and identify
the entity that controls the settlement alternatives?
[”Pending Content” in FASB ASC 480-10-50-1]

51B. (FSP FAS 150-3) For all outstanding financial instruments
within the scope of FASB ASC 480-10 and for each settlement
alternative, does the entity disclose
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a.

the amount that would be paid, or the number of
shares that would be issued and their fair value, determined under the conditions specified in the contract if
the settlement were to occur at the reporting date?

b.

how changes in the fair value of the issuer’s equity
shares would affect those settlement amounts (for example, “the issuer is obligated to issue an additional x
shares or pay an additional y dollars in cash for each
$1 decrease in the fair value of one share”)?

c.

the maximum amount that the issuer could be required
to pay to redeem the instrument by physical settlement,
if applicable?

d.

the maximum number of shares that could be required
to be issued, if applicable?

e.

that a contract does not limit the amount that the issuer
could be required to pay or the number of shares that
the issuer could be required to issue, if applicable?

No

N/A
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f.

No

N/A

for a forward contract or an option indexed to the issuer’s equity shares, the forward price or option strike
price, the number of issuer’s shares to which the contract is indexed, and the settlement date or dates of the
contract, as applicable?
[”Pending Content” in FASB ASC 480-10-50-2]

52B. (FSP FAS 150-3) If the entity has no equity instruments outstanding but has financial instruments in the form of shares,
all of which are mandatorily redeemable financial instruments,
a.

are they classified as liabilities?

b.

are they described in the statement of financial position
as “shares subject to mandatory redemption”?

c.

are payments to holders of such instruments and related accruals presented separately from payments to
and interest due to other creditors in statements of cash
flows and income?
[”Pending Content” in FASB ASC 480-10-45-2]

53B. (FSP FAS 150-3) Do the entities referred to in question 38 disclose the components of the liability that would otherwise be
related to shareholders’ interest and OCI, if any, subject to the
redemption feature (for example, par value and other paid-in
amounts of mandatorily redeemable instruments should be
disclosed separately from the amount of retained earnings or
accumulated deficit)?
[”Pending Content” in FASB ASC 480-10-50-4]
54B. (FSP FAS 150-3) Is the cumulative transition adjustment and
any subsequent adjustments reported as an excess of liabilities over assets (a deficit) and changes thereto even though
the mandatorily redeemable shares are reported as a liability?
[”Pending Content” in FASB ASC 480-10-45-2A]
55B. (FSP FAS 150-3) Are unconditional mandatorily redeemable
financial instruments classified as liabilities if those instruments are mandatorily redeemable on fixed dates unless the
redemption is required to occur only upon the liquidation or
termination of the reporting entity? (Note: A mandatorily redeemable financial instrument is conditional if the obligation
depends upon the occurrence of an event not certain to occur.
Death is not uncertain of occurrence; thus, death is not a condition.)
[”Pending Content” in FASB ASC 480-10-25 par. 4–5]
56B. (FSP FAS 150-3) Are financial instruments, other than an outstanding share, that, at inception, (a) embodies an obligation
to repurchase the issuer’s equity shares or is indexed to such
an obligation, and (b) requires or may require the issuer to
settle the obligation by transferring assets, classified as liabilities (or assets in some circumstances)?
[”Pending Content” in FASB ASC 480-10-25-8]
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57B. (FSP FAS 150-3) Are financial instruments that embody an
unconditional obligation, or financial instruments other than
an outstanding share that embodies a conditional obligation,
that the issuer must or may settle by issuing a variable number of its equity shares, classified as liabilities (or assets in
some circumstances) if, at inception, the monetary value of
the obligation is based solely or predominantly on any one of
the following:

I.

a.

A fixed monetary amount known at inception (for example, a payable settable with a variable number of the
issuer’s equity shares)?

b.

Variations in something other than the fair value of the
issuer’s equity shares (for example, a financial instrument indexed to the Standard and Poor’s S&P 500 Index and settleable with a variable number of the issuer’s equity shares)?

c.

Variations inversely related to changes in the fair value
of the issuer’s equity shares (for example, a written put
option that could be net share settled)?
[”Pending Content” in FASB ASC 480-10-25-14]

58.

Has the entity disclosed information about the pertinent
rights and privileges of the various securities outstanding, including mandatory redemption requirements, in summary
form?
[FASB ASC 505-10-50-3]

59.

Has the entity disclosed the amount of redemption requirements for all issues of stock that are redeemable at fixed or
determinable prices on fixed or determinable dates in each of
the next five years?
[FASB ASC 505-10-50-11]

Guarantees
Notes: In September 2008, FASB issued FSP FAS 133-1 and FIN 45-5
to amend disclosures related to the current status of the payment/
performance risk of a guarantee under FASB Interpretation No. 45,
Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others—an interpretation
of FASB Statements No. 5, 57 and 107 and rescission of FASB Interpretation No. 34. This FSP applies guarantees within the scope of FASB
Interpretation No. 45.
This FSP also amends paragraph 13(a) of FASB Interpretation No. 45
to require disclosure of the current status of the payment/performance risk of the guarantee.
The FSP is effective for financial statements issued for fiscal years
and interim periods beginning after November 15, 2008 (that is, January 1, 2009, for entities with calendar year-ends). Early application
is encouraged. This statement encourages but does not require disclosures for earlier periods presented for comparative purposes at
(continued)
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initial adoption. In years after initial adoption, it requires comparative disclosures only for periods subsequent to initial adoption.
This checklist has been updated to include the presentation and disclosure requirements of FSP FAS 133-1 and FIN 45-5.
As determined by the effective date or early implementation decision, entities for which this guidance has not been implemented
should consider all questions indicated with an “A” reference (for
example, question 1A and question 2A) and should place an “N/A”
mark in questions indicated with a “B” reference. Entities for which
the guidance has been implemented should consider all questions
indicated by a “B” reference (for example, question 1B and question
2B) and place an “N/A” mark by questions indicated with an “A”
reference. Therefore, based upon your entity’s year-end and decision
to early implement or not (if allowed), the following additional questions will be answered when provided in this section (check one that
applies for your entity):
pppA pppB
Readers can refer to the full text of the FSP on the FASB Web site at
www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition
and open effective date information discussed in FASB ASC 815-1065-2.
Practice Tip
An entity should disclose certain loss contingencies even though the possibility of loss may be remote. The
common characteristic of those contingencies is a guarantee that provides a right to proceed against an
outside party in the event that the guarantor is called on to satisfy the guarantee. Examples include the
following:
1.

Guarantees of indebtedness of others, including indirect guarantees of indebtedness of others

2.

Obligations of commercial banks under standby letters of credit

3.

Guarantees to repurchase receivables (or, in some cases, to repurchase the related property) that
have been sold or otherwise assigned

4.

Other agreements that in substance have the same guarantee characteristic

The disclosure should include the nature and amount of the guarantee. Consideration should be given to
disclosing, if estimable, the value of any recovery that could be expected to result, such as from the guarantor’s right to proceed against an outside party.
[FASB ASC 460-10-50 par. 2–3 ]
1A.

Is the following information disclosed by a guarantor about
each guarantee, or each group of similar guarantees, even if
the likelihood of the guarantor’s having to make any payments under the guarantee is remote:
a.

The nature of the guarantee, including the approximate
term, how the guarantee arose, and the events or circumstances that would require the guarantor to perform under the guarantee?
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Yes
b.

The maximum potential amount of future payments
(undiscounted) the guarantor could be required to
make under the guarantee?

c.

If the terms of the guarantee provide for no limitation
to the maximum potential future payments under the
guarantee, is that fact disclosed?

d.

If the guarantor is unable to develop an estimate of the
maximum potential amount of future payments under
its guarantee, are the reasons why the maximum potential amount cannot be estimated disclosed?

e.

The current carrying amount of the liability, if any, for
the guarantor’s obligations under the guarantee, including the amount, if any, recognized under FASB
ASC 450-20-30, regardless of whether the guarantee is
freestanding or embedded in another contract?

f.

The nature of

g.

1B.

any recourse provisions that would enable the
guarantor to recover from third parties any of the
amounts paid under the guarantee?

ii.

any assets held either as collateral or by third
parties that, upon the occurrence of any triggering event or condition under the guarantee, the
guarantor can obtain and liquidate to recover all
or a portion of the amounts paid under the guarantee?

If estimable, the approximate extent to which the proceeds from liquidation of those assets would be expected to cover the maximum potential amount of future payments under the guarantee?
[FASB ASC 460-10-50-4]

(FSP FAS 133-1 and FIN 45-5) Is the following information
disclosed by a guarantor about each guarantee, or each group
of similar guarantees, even if the likelihood of the guarantor’s
having to make any payments under the guarantee is remote:
a.

FSP §20,100.01

i.

The nature of the guarantee, including all of the following:
i.

The approximate term of the guarantee?

ii.

How the guarantee arose?

iii.

The events or circumstances that would require
the guarantor to perform under the guarantee?

iv.

The current status (that is, as of the date of the
statement of financial position) of the payment/
performance risk of the guarantee?

v.

If the entity uses internal groupings for the purposes of item (iv), how those groupings are determined and used for managing risk?

No

N/A
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Yes
b.

The maximum potential amount of future payments
(undiscounted) the guarantor could be required to
make under the guarantee?

c.

If the terms of the guarantee provide for no limitation
to the maximum potential future payments under the
guarantee, is that fact disclosed?

d.

If the guarantor is unable to develop an estimate of the
maximum potential amount of future payments under
its guarantee, are the reasons why the maximum potential amount cannot be estimated disclosed?

e.

The current carrying amount of the liability, if any, for
the guarantor’s obligations under the guarantee, including the amount, if any, recognized under FASB
ASC 450-20-30, regardless of whether the guarantee is
freestanding or embedded in another contract?

f.

The nature of

g.

i.

any recourse provisions that would enable the
guarantor to recover from third parties any of the
amounts paid under the guarantee?

ii.

any assets held either as collateral or by third
parties that, upon the occurrence of any triggering event or condition under the guarantee, the
guarantor can obtain and liquidate to recover all
or a portion of the amounts paid under the guarantee?

No

N/A

If estimable, the approximate extent to which the proceeds from liquidation of those assets would be expected to cover the maximum potential amount of future payments under the guarantee?
[FASB ASC 460-10-50-4]

2.

Are the disclosure requirements in paragraphs 4–6 of FASB
ASC 460-10-50 applied to all minimum revenue guarantees in
financial statements of interim or annual periods?
[FASB ASC 460-10-50 par. 4–6]

3.

For product warranties and other guarantee contracts required to be disclosed by FASB ASC 460-10-15-9, is the following information disclosed:
a.

The information required to be disclosed in question
1a, except that a guarantor is not required to disclose
the maximum potential amount of future payments in
question 1b?

b.

The guarantor’s accounting policy and methodology
used in determining its liability for product warranties
(including any liability associated with extended warranties)?

c.

A tabular reconciliation of the changes in the guarantor’s aggregate product warranty liability for the reporting period?
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Yes
d.

4.

J.

Does the tabular reconciliation present
i.

the beginning balance of the aggregate product
warranty liability?

ii.

the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty?

iii.

the aggregate changes in the liability for accruals
related to product warranties issued during the
reporting period, and the aggregate changes in
the liability for accruals related to preexisting
warranties, including adjustments related to
changes in estimates?

iv.

the ending balance of the aggregate product warranty liability?
[FASB ASC 460-10-50-8]

Are the disclosure requirements in paragraphs 30–35 of FASB
ASC 460-10-55 for intellectual property infringement indemnifications complied with?
[FASB ASC 460-10-55 par. 30–35]

Foreign Currency Matters
Foreign Currency Transactions
1.

If not disclosed in the financial statements, as discussed in
FASB ASC 830-20-45-2, is the aggregate transaction gain or
loss included in determining net income for the period disclosed in the notes to the financial statements?
[FASB ASC 830-20-50-1]

2.

If significant rate changes have occurred after the date of the
financial statements, are the effects on unsettled balances related to foreign currency transactions disclosed?
[FASB ASC 830-20-50-2]

3.

Has management supplemented the preceding disclosures
with an analysis and discussion of the effects of rate changes
on the reported results of operations? This type of disclosure
might include the mathematical effects of translating revenue
and expenses at rates that are different from those used in a
preceding period as well as the economic effects of rate
changes, such as the effects on selling prices, sales volume,
and cost structures. The purpose is to assist financial report
users in understanding the broader economic implications of
rate changes and to compare recent results with those of prior
periods. (Encouraged but not required.)
[FASB ASC 830-20-50-3]
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Yes

No

N/A

Foreign Currency Translations

K.

4.

Has an analysis of the changes during the period in the accumulated amount of translation adjustments reported in equity been disclosed either in a separate financial statement, as
a part of the statement of changes in equity or in the notes to
the financial statements? (See FASB ASC 830-30-45-50 for
minimum disclosure requirements.)
[FASB ASC 830-30-50-1]

5.

If significant rate changes have occurred after the date of the
financial statements, are the effects on unsettled balances related to foreign currency transactions disclosed?
[FASB ASC 830-30-50-2]

6.

Are any foreign earnings reported beyond amounts received
in the United States disclosed, if significant?
[FASB ASC 280-10-50-41]

Long-Lived Assets and Disposal Groups to Be Disposed Of
Reporting Discontinued Operations
1.

Are the results of operations of a component of an entity (as
that phrase is defined in FASB ASC glossary) that either has
been disposed of or is classified as held for sale under the
requirements of FASB ASC 360-10-45-9, reported in discontinued operations in accordance with FASB ASC 205-20-45-3
if both of the following conditions are met:
a.

The operations and cash flows of the component have
been (or will be) eliminated from the ongoing operations of the entity as a result of the disposal transaction?

b.

The entity will not have any significant continuing involvement in the operations of the component after the
disposal transaction?
[FASB ASC 205-20-45-1]

2.

In a period in which a component of an entity either has been
disposed of or is classified as held for sale, does the income
statement for current and prior periods report the results of
operations of the component, including any gain or loss recognized in accordance with FASB ASC 360-10-35-40 and 36010-40-5, in discontinued operations?
[FASB ASC 205-20-45-3]

3.

Are the results of operations of a component classified as held
for sale reported in discontinued operations in the period(s)
in which they occur?
[FASB ASC 205-20-45-3]

4.

Are the results of discontinued operations, less applicable income taxes (benefit), reported as a separate component of income before extraordinary items and the cumulative effect of
accounting changes (if applicable)?
[FASB ASC 205-20-45-3]
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Yes
5.

Is the gain or loss recognized on the disposal disclosed either
on the face of the income statement or in the notes to the financial statements?
[FASB ASC 205-20-45-3]

6.

Are adjustments to amounts previously reported in discontinued operations that are directly related to the disposal of a
component of an entity in a prior period classified separately
in the current period in discontinued operations?
[FASB ASC 205-20-50-5]

7.

Are the nature and amount of such adjustments (as discussed
in question 6) disclosed?
[FASB ASC 205-20-45-4]

8.

Has interest expense on debt assumed by the buyer and interest on debt that is required to be repaid as a result of a
disposal transaction allocated to discontinued operations?
(The allocation to discontinued operations of other consolidated interest that is not directly attributable to or related to
other operations of the entity is permitted, but not required.)
[FASB ASC 205-20-45 par. 6–7]

No

N/A

Reporting Disposal Gains or Losses in Continuing Operations
9.

Is a gain or loss that is recognized on the sale of a long-lived
asset (disposal group) that is not a component of an entity
included in income from continuing operations before income taxes in the income statement?
[FASB ASC 360-10-45-5]

10.

If a subtotal such as “income from operations” is presented,
does it include the amounts of those gains or losses considered in question 9?
[FASB ASC 360-10-45-5]

Reporting a Long-Lived Asset or Disposal Group Sold or Classified
as Held for Sale
Practice Tip
A long-lived asset (disposal group) to be sold shall be classified as held for sale in the period in which all of
the criteria at FASB ASC 360-10-45-9 are met.
[FASB ASC 360-10-45-9]
11.

Is the following information disclosed in the notes to the financial statements that cover the period in which a long-lived
asset (disposal group) either has been sold or is classified as
held for sale:
a.
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A description of the facts and circumstances leading to
the expected disposal, the expected manner and timing
of that disposal, and, if not separately presented on the
face of the statement, the carrying amount(s) of the major classes of assets and liabilities included as part of a
disposal group?
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Yes
b.

The gain or loss recognized in accordance with FASB
ASC 360-10-35-40 and FASB ASC 360-10-40-5 and if not
separately presented on the face of the income statement, the caption in the income statement that include
that gain or loss?

c.

If applicable, amounts of revenue and pretax profit or
loss reported in discontinued operations?

d.

If applicable, the segment in which the long-lived asset
(disposal group) is reported under FASB ASC 280?
[FASB ASC 205-20-50-1]

12.

Are the major classes of assets and liabilities that are classified as held for sale separately disclosed either on the face of
the statement of financial position or in the notes to financial
statements?
[FASB ASC 205-20-50-2]

13.

If either paragraph 44 or 45 of FASB ASC 360-10-35 applies,
is a description of the facts and circumstances leading to the
decision to change the plan to sell the long-lived asset (disposal group) and its effect on the results of operations for the
period and any prior periods presented disclosed in the notes
to the financial statements that include the period of that decision?
[FASB ASC 205-20-50-3]

14.

For each discontinued operation that generates continuing
cash flows, has the following been disclosed:

15.

a.

The nature of the activities that give rise to continuing
cash flows?

b.

The period of time continuing cash flows are expected
to be generated?

c.

The principal factors used to conclude that the expected
continuing cash flows are not direct cash flows of the
disposed component?
[FASB ASC 205-20-50-4]

No

N/A

For each discontinued operation in which the ongoing entity
will engage in a continuation of activities with the disposed
component after its disposal and for which the amounts presented in continuing operations after the disposal transaction
include a continuation of revenues and expenses that were
intra-entity transactions (eliminated in consolidated financial
statements) before the disposal transaction, have intra-entity
amounts before the disposal transaction been disclosed for all
periods presented? Further have the types of continuing involvement, if any, that the entity will have after the disposal
transaction been disclosed? (That information should be disclosed in the period in which operations are initially classified as discontinued.)
[FASB ASC 205-20-50-6]
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Yes
16.

If the criteria of FASB ASC 360-10-45-9 are met (and thus a
long-lived asset is classified as held for sale) after the balance
sheet date but before issuance of the financial statements,
does the long-lived asset continue to be classified as held and
used in those financial statements when issued and is the information required by FASB ASC 205-20-50-1(a) (question 11)
disclosed in the notes to the financial statements?
[FASB ASC 360-10-45-13]

17.

Is a long-lived asset that is classified as held for sale presented separately in the statement of financial position?
[FASB ASC 360-10-45-14]

18.

Are the assets and liabilities of a disposal group that is classified as held for sale presented separately in the asset and
liability sections, respectively, of the statement of financial
position?
[FASB ASC 205-20-45-10]

19.

Are those assets and liabilities considered in question 18 not
offset and presented as a single amount?
[FASB ASC 205-20-45-10]

20.

If a long-lived asset is to be disposed of other than by sale,
does it continue to be classified as held and used until it is
disposed of?
[FASB ASC 360-10-45-15]

No

N/A

Practice Tip
If circumstances arise that previously were considered unlikely and, as a result, an entity decides not to sell
a long-lived asset (disposal group) previously classified as held for sale, the asset (disposal group) should
be reclassified as held and used.
[FASB ASC 360-10-45-6]
L.

Impaired Loans
1.
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Is the following information about loans that meet the definition of impaired loans in paragraphs 16–17 of FASB ASC
310-10-35 disclosed as of the date of each balance sheet presented:
a.

The total recorded investment in the impaired loans?

b.

The amount of that recorded investment for which
there is a related allowance for credit losses determined
in accordance with FASB ASC 310-10-35 and the
amount of that allowance?

c.

The amount of that recorded investment for which
there is no related allowance for credit losses determined in accordance with FASB ASC 310-10-35?
[FASB ASC 310-10-50-15]
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Yes
2.

Is the policy for recognizing interest income on impaired
loans, including how cash receipts are handled, disclosed?
[FASB ASC 310-10-50-15]

3.

Are the following disclosures made for each period for which
an income statement is presented:
a.

The average recorded investment in the impaired loans
during the period?
[FASB ASC 310-10-50-15]

b.

The related amount of interest income recognized during the time within the period that the loans were considered impaired?
[FASB ASC 310-10-50-15]

c.

Unless not practicable, the amount of interest income
recognized using a cash-basis method of accounting
during the time within the period that the loans were
impaired?
[FASB ASC 310-10-50-15]

d.

Activity in the total allowance for credit losses related
to loans, including the balance in the allowance for
credit losses account at the beginning and end of each
period, additions charged to operations, direct writedowns charged against the allowance, and recoveries of
amounts previously charged off?
[FASB ASC 310-10-50-12]

No

N/A

Practice Tip
Information about impaired loans that have been restructured in a troubled debt restructuring involving a
modification of terms need not be included in the disclosures required by questions 1 and 3(a)–(c) in years
after the restructuring if (a) the restructuring agreement specifies an interest rate equal to or greater than the
rate that the creditor was willing to accept at the time of the restructuring for a new loan with comparable
risk and (b) the loan is not impaired based on the terms specified in the restructuring agreement. That
exception must be applied consistently for questions 1 and 3(a)–(c) to all loans restructured in a troubled
debt restructuring that meet the specified criteria.
4.

Has the amount of write-down and recorded investment of a
loan modified in a troubled debt restructuring been disclosed
in the year of writedown?
[FASB ASC 310-40-50-4]

5.

In years after a restructuring, are loans that are restructured
in a troubled debt restructuring into 2 (or more) loan agreements considered separately when assessing the applicability
of the disclosures in FASB ASC 310-10-50-15(a) and FASB
ASC 310-10-50-15(c) (questions 1 and 3(a)–(c))?
[FASB ASC 310-40-50-5]
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Yes
M.

Impairment of Long-Lived Assets to Be Held and Used
1.

Is an impairment loss recognized for a long-lived asset (asset
group) to be held and used included in income from continuing operations before income taxes in the income statement?
If a subtotal such as income from operations is presented,
does it include the amount of the loss?
[FASB ASC 360-10-45-4]

2.

Is the following information disclosed in the notes to the financial statements that include the period in which an impairment loss is recognized:
a.

A description of the impaired long-lived asset (asset
group) and the facts and circumstances leading to the
impairment?

b.

If not separately presented on the face of the statement,
the amount of the impairment loss and the caption in
the income statement that includes the loss?

c.

The method or methods for determining fair value
(whether based on a quoted market price, prices for
similar assets, or another valuation technique)?

d.

If applicable, the segment in which the impaired longlived asset (asset group) is reported under FASB ASC
280?
[FASB ASC 360-10-50-2]

3.

If the occurrence of a significant event or circumstance at any
time during the assessment period results in an expectation
that the criteria for reporting discontinued operations in
FASB ASC 205-20-45-1 will be met by the end of the assessment period, is the component’s operations presented as discontinued operations?
[FASB ASC 205-20-55-22]

4.

Is the following information disclosed in the notes to the financial statements for each discontinued operation that generates continuing cash flows:
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a.

The nature of the activities that give rise to continuing
cash flows?

b.

The period of time continuing cash flows are expected
to be generated?

c.

The principal factors used to conclude that the expected
continuing cash flows are not direct cash flows of the
disposed component?

No

N/A
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Yes

N.

d.

Additionally, for each discontinued operation in which
the ongoing entity will engage in a “continuation of activities” with the disposed component after its disposal
and for which the amounts presented in continuing operations after the disposal transaction include a continuation of revenues and expenses that were intra-entity
transactions before the disposal transaction, are those
intra-entity amounts before the disposal transaction
disclosed for all periods for comparability purposes?

e.

Are the types of continuing involvement, if any, that
the entity will have after the disposal transaction disclosed in the period in which the operations are initially classified as discontinued?
[FASB ASC 205-20-55 par. 9–12]

No

N/A

Leases—Lessors
1.

For leasing transactions with related parties, are the nature
and extent of the transaction disclosed?
[FASB ASC 840-10-50-1]

2.

If leasing, exclusive of leveraged leasing, is a significant part
of the lessor’s business activities in terms of revenue, net income, or assets, is a general description of the lessor’s leasing
arrangements disclosed?
[FASB ASC 840-10-50-4]

3.

For sales-type and direct financing leases, do disclosures include
a.

the components of the net investment in sales-type and
direct financing leases as of each balance-sheet date:
i.

Future minimum lease payments to be received,
with separate deductions for (a) amounts representing executory costs, including any profit
thereon, included in minimum lease payments
and (b) the accumulated allowances for uncollectible minimum lease payments receivable?

ii.

The unguaranteed residual values accruing to the
benefit of the lessor?

iii.

For direct financing leases only, initial direct
costs?

iv.

Unearned income?

b.

future minimum lease payments to be received for each
of the five succeeding fiscal years as of the latest balance sheet presented?

c.

total contingent rentals included in income for each period for which an income statement is presented?
[FASB ASC 840-30-50-4]
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Yes
4.

5.

For operating leases, do disclosures include
a.

the cost and carrying amount (if different) of property
on lease or held for leasing by major classes of property
according to nature and function, and the amount of
accumulated depreciation in total as of the latest balance-sheet date?

b.

minimum future rentals on noncancelable leases as of
the latest balance-sheet date presented, in the aggregate
and for each of the five succeeding fiscal years?

c.

total contingent rentals included in income for each period for which an income statement is presented?
[FASB ASC 840-20-50-4]

For investments in leveraged leases, do disclosures include
a.

in the balance sheet, the amount of deferred taxes presented separately from the remainder of the net investment?
[FASB ASC 840-30-45-5]

b.

in the income statement or the notes thereto, separate
presentation (from each other) of pretax income from
the leveraged lease, the tax effect of pretax income, and
the amount of investment tax credit recognized as income during the period?
[FASB ASC 840-30-45-5]

c.

when leveraged leasing is a significant part of the lessor’s business activities in terms of revenue, net income, or assets, the components of the net investment
balance in leveraged leases in the notes to the financial
statements?
[FASB ASC 840-30-45-5]

6.

If accounting for the effect on leveraged leases of the change
in tax rates results in a significant variation from the customary relationship between income tax expense and pretax accounting income and the reason for that variation is not otherwise apparent, has the entity disclosed the reason for that
variation?
[FASB ASC 840-30-50-6]

7.

For contingent rental income
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a.

has disclosure been made of the lessor’s accounting
policy for contingent rental income?

b.

if the lessor accrues contingent rental income prior to
the lessee’s achievement of the specified target (provided achievement of that target is considered probable), has disclosure been made of the impact on rental
income as if the lessor’s accounting policy was to defer
contingent rental income until the specified target is
met?
[FASB ASC 840-10-50-5]

No

N/A
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Yes
O.

No

N/A

Leases—Lessees
1.

For leasing transactions with related parties, are the nature
and extent of transactions disclosed?
[FASB ASC 840-10-50-1]

2.

For capital leases, do disclosures include
a.

the gross amounts of assets recorded as of each balance-sheet date presented by major classes according to
nature or function? (Note: This information may be
combined with comparable information for owned assets.)
[FASB ASC 840-30-50-1]

b.

future minimum lease payments as of the latest balance
sheet presented in the aggregate and for each of the five
succeeding fiscal years with separate deductions from
the total for the amount representing executory costs,
including any profit thereon, included in the minimum
lease payments and for the amount of imputed interest
necessary to reduce net minimum lease payments to
present value?
[FASB ASC 840-30-50-1]

c.

total of future minimum sublease rentals to be received
in the future under noncancelable subleases as of the
latest balance-sheet date?
[FASB ASC 840-30-50-1]

d.

total contingent rentals actually incurred for each period for which an income statement is presented?
[FASB ASC 840-30-50-1]

e.

are the following separately identified in the balance
sheet or in the notes to the financial statements:

f.

3.

i.

Assets recorded under capital leases and the accumulated amortization thereon related obligations under the lease?
[FASB ASC 840-30-45-1]

ii.

The related obligations under the lease?
[FASB ASC 840-30-45-2]

amortization expense, unless it is included in depreciation expense and that fact is disclosed?
[FASB ASC 840-30-45-3]

For operating leases that have initial or remaining noncancelable lease terms in excess of one year, do disclosures include
a.

future minimum rental payments required as of the latest balance sheet presented, in the aggregate, and for
each of the five succeeding fiscal years?

b.

total of future minimum rentals under noncancelable
subleases as of the date of the latest balance sheet presented?
[FASB ASC 840-20-50-2]
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Yes
4.

5.

P.

For all operating leases
a.

do disclosures include rental expense for each period
for which an income statement is presented?

b.

are separate amounts presented for
i.

minimum rentals?

ii.

contingent rentals?

iii.

sublease rentals?
[FASB ASC 840-20-50-1]

Do disclosures include a general description of the lessee’s
leasing arrangements including but not limited to
a.

the basis on which contingent rental payments are determined?

b.

the existence and terms of renewal or purchase options
or escalation clauses?

c.

restrictions imposed by lease agreements, such as those
concerning dividends, additional debt, or further leasing?
[FASB ASC 840-10-50-2]

6.

If there is a modification of lease terms and the increase in
lease payments is a termination penalty, is the accounting
policy disclosed in accordance with FASB ASC 235?
[FASB ASC 840-20-55-6]

7.

Do the financial statements of a seller-lessee include a description of the terms of the sale-leaseback transaction including future commitments, obligations, provisions, or circumstances that require or result in the seller-lessee’s continuing
involvement?
[FASB ASC 840-40-50-1]

8.

If a sale-leaseback transaction is accounted for using the deposit method or as a financing arrangement, are the following
disclosures made:
a.

The obligation for future minimum lease payments as
of the date of the latest balance sheet presented in the
aggregate and for each of the five succeeding fiscal
years?

b.

The total of minimum sublease rentals, if any, to be received in the future under noncancelable subleases in
the aggregate and for each of the five succeeding fiscal
years?
[FASB ASC 840-40-50-2]

Nonmonetary Transactions
1.
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Do disclosures for nonmonetary transactions during the period include
a.

nature of the transactions?

b.

basis of accounting for the assets transferred?

No

N/A
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Yes
c.
2.

No

N/A

gains or losses recognized on the transfers?
[FASB ASC 845-10-50-1]

Has disclosure been made, in each period’s financial statements, of the amount of gross operating revenue recognized
as a result of nonmonetary transactions (see FASB ASC 50550)?
[FASB ASC 845-10-50-2]
Practice Tip

Examples 1–3 in paragraphs 11–26 of FASB ASC 845-10-55 discuss issues that develop when an entity sells
inventory to another entity from which it also purchases inventory to be sold in the same line of business.
The inventory purchase and sales transactions may be pursuant to a single arrangement or separate arrangements, and the inventory purchased or sold may be in the form of raw materials, work-in-process (WIP), or
finished goods.

Q.

3.

If nonmonetary exchanges of inventory within the same line
of business are recognized at fair value, is the classification of
inventory as raw materials, WIP, and finished goods for purposes of FASB ASC 845-10 the same classification that an entity uses for external financial reporting purposes?
[FASB ASC 845-10-45-1]

4.

If nonmonetary exchanges of inventory within the same line
of business are recognized at fair value, does an entity disclose the amount of revenue and costs (or gains and losses)
associated with those inventory exchanges recognized at fair
value?
[FASB ASC 845-10-50-3]

Postemployment Benefits
1.

R.

If an obligation for postemployment benefits (for example,
salary continuation, supplemental unemployment benefits,
severance benefits, disability related benefits, job training and
counseling, and continuation of health and insurance coverage [paragraphs 4–6 of FASB ASC 712-10-05]) has not been
accrued because the amount cannot be reasonably estimated,
is that fact disclosed in the financial statements?
[FASB ASC 712-10-50-2]

Related-Party Transactions and Economic Dependency
1.

For related-party transactions, do disclosures include
a.

the nature of the relationships involved?

b.

for each period for which an income statement is presented
i.

a description of the transaction, including transactions to which no amounts or nominal amounts
were ascribed?

ii.

other information deemed necessary to an understanding of the effects of the transaction on the
financial statements?

iii.

the dollar amount of transactions?

FSP §20,100.01

186

Life and Health Insurance Entities

Yes
iv.

the effect of any changes in the method of establishing the terms from that used in the preceding
period?

c.

amounts due from or to related parties as of the date of
each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement?

d.

if the entity is a member of a group that files a consolidated tax return, have the following been disclosed in
its separately issued financial statements:
i.

The aggregate amount of current and deferred
tax expense for each statement of earnings presented and the amount of any tax-related balances due to or from affiliates as of the date of
each statement of financial position presented?

ii.

The principal provisions of the method by which
the consolidated amount of current and deferred
tax expense is allocated to members of the group
and the nature and effect of any changes in that
method (and in determining related balances to
or from affiliates) during the years for which the
preceding disclosures are presented?
[FASB ASC 850-10-50-1; FASB ASC 740-10-50-17]

2.

Have notes or accounts receivable from officers, employees,
or affiliated entities been shown separately and have not been
included under a general heading (such as notes receivable or
accounts receivable)?
[FASB ASC 850-10-50-2]

3.

If representations about transactions with related parties are
made, do they avoid the implication that the related party
transactions were consummated at arm’s length, or if such
implications are made, can they be substantiated?
[FASB ASC 850-10-50-5]

4.

If (a) the reporting entity and one or more other enterprises
are under common ownership or management control and (b)
the existence of the control could result in operating results
or financial position of the reporting entity being significantly
different from that if the enterprise were autonomous, is the
nature of the control relationships disclosed (even if there are
no transactions between the enterprises)?
[FASB ASC 850-10-50-6]

5.

Are the nature and extent of leasing transactions with related
parties appropriately disclosed?
[FASB ASC 840-10-50-1]

6.

Are combined financial statements considered for entities under common control?
[FASB ASC 810-10-55-1B]
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Practice Tip
In some cases, aggregation of similar transactions by type of related party may be appropriate. Sometimes,
the effect of the relationship between the parties may be so pervasive that disclosure of the relationship
alone will be sufficient. If necessary to the understanding of the relationship, the name of the related party
should be disclosed.
Further, it is not necessary to duplicate disclosures in a set of separate financial statements that is presented
in the financial report of another entity (the primary reporting entity) if those separate financial statements
also are consolidated or combined in a complete set of financial statements and both sets of financial statements are presented in the same financial report.
[FASB ASC 810-10-50 par. 3–4]
S.

Demutualizations and Formations of Mutual Insurance Holding
Companies
1.

Are the nature and terms of a demutualization or formation
of and MIHC and the basis of presentation and terms of operation of the closed block disclosed?
[FASB ASC 944-805-50-2]

2.

Is a general description of the method of emergence of earnings from the closed block, presentation of assets and liabilities of the closed block, and policyholder dividend obligation
provided?
[FASB ASC 944-805-50-2]

3.

If the entity has formed a closed block, are the following disclosed:
a.

b.

A general description of the closed block, including:
i.

The purpose of the closed block?

ii.

The types of insurance policies included?

iii.

The nature of the cash flows that increase and decrease the amount of closed block assets and liabilities?

iv.

An indication of the continuing responsibility of
the insurance entity to support the payment of
contractual benefits?

v.

The nature of expenses charged to the closed
block operations?

Summarized financial data of the closed block as of, or
for periods ending on the date of, the financial statements presented, which should include, at a minimum,
all of the following:
i.

The carrying amounts for the major types of invested assets of the closed block?

ii.

Future policy benefits and policyholders’ account
balances?

iii.

Policyholder dividend obligation?

iv.

Premiums?
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v.

Net investment income?

vi.

Realized investment gains and losses?

vii.

Policyholder benefits?

viii.

Policyholder dividends?

ix.

The amount of maximum future earnings remaining to inure to the benefit of stockholders
from the assets and liabilities of the closed block?

x.

An analysis of the changes in the policyholder
dividend obligation?
[FASB ASC 944-805-50-3]

No

N/A

Practice Tips
Disclosures that typically would be required by the preceding item for the various specific elements included in the closed block need not be made separately for the closed block if the nature of the information
for the closed block would not differ significantly from that already included for the reporting entity as a
whole. For example, it is not necessary to show a separate schedule of contractual maturities of closed block
fixed maturity securities if the relative composition of contractual maturities is similar to those of the reporting entity taken as a whole. However, if the relative maturities of the closed block fixed maturities
securities differ from those of the reporting entity taken as a whole, separate disclosures should be made.
In addition, closed block assets, liabilities, revenues, and expenses should be displayed together with all
other assets, liabilities, revenues, and expenses of the insurance entity based on the nature of the particular
item, with appropriate disclosures relating to the closed block.
[FASB ASC 944-805-50-4 and 944-805-45-1]
4.

Are unrealized investment gains and losses, other items of
accumulated other comprehensive income, and the amount of
offsetting policyholder dividend obligation not netted in the
presentation of other comprehensive income?
[FASB ASC 944-805-45-2]

5.

Are direct and incremental costs related to a demutualization
or formation of a mutual insurance entity classified as a single line item within income from continuing operations and
not classified as an extraordinary item?
[FASB ASC 944-805-45-3]

6.

If an insurance entity demutualizes in a distribution-form demutualization, has all of its retained earnings as of the date
of demutualization been reclassified to capital stock and additional paid-in capital?
[FASB ASC 944-805-45-4]

7.

If the entity distributed cash or policy credits to policyholders
in lieu of capital stock, as part of the demutualization, has the
distribution been recorded as a direct reduction to the appropriate capital accounts?
FASB ASC 944-805-45-4]
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Note: The equity accounts of a mutual insurance holding entity at the
formation date should be determined using the principles for transactions of entities under common control, with the amount of retained
earnings of the demutualized insurance entity, before reclassification to
the capital accounts, being reported as retained earnings of the mutual
insurance holding entity. Because the accounting bases and carrying
amounts of assets and liabilities are not changed as a consequence of
demutualization or formation of a mutual insurance holding entity, the
amounts in accumulated other comprehensive income also should not
be changed as a consequence of demutualization or formation of a mutual insurance holding entity.
T.

Exit or Disposal Activities
1.

Is the following information disclosed in notes to the financial
statements that include the period in which an exit or disposal activity is initiated and any subsequent period until the
activity is completed:
a.

A description of the exit or disposal activity, including
the facts and circumstances leading to the expected activity and the expected completion date?

b.

For each major type of cost associated with the activity
(for example, one-time termination benefits, contract
termination costs, and other associated costs)
i.

the total amount expected to be incurred in connection with the activity, the amount incurred in
the period, and the cumulative amount incurred
to date?

ii.

a reconciliation of the beginning and ending liability balances showing separately the changes
during the period attributable to costs incurred
and charged to expense, costs paid or otherwise
settled, and any adjustments to the liability with
an explanation of the reason(s) therefore?

c.

The line item(s) in the income statement in which the
costs in item (b) are aggregated?

d.

For each reportable segment, as defined in FASB ASC
280-10-50-10

e.

i.

the total amount of costs expected to be incurred
in connection with the activity?

ii.

the amount incurred in the period?

iii.

the cumulative amount incurred to date, net of
any adjustments to the liability with an explanation of the reason(s) why?

If a liability for a cost associated with the activity is not
recognized because fair value cannot be reasonably estimated, that fact and the reasons why?
[FASB ASC 420-10-50-1]
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U.

2.

Are costs associated with an exit or disposal activity that involves a discontinued operation included in the results of discontinued operations in accordance with FASB ASC 205-2045?
[FASB ASC 420-10-45-2]

3.

Are costs associated with an exit or disposal activity that does
not involve a discontinued operation included in income
from continuing operations before income taxes, for example,
in a subtotal such as “income from operations”?
[FASB ASC 420-10-45-3]

4.

If an event or circumstance occurs that discharges or removes
an entity’s responsibility to settle a liability for a cost associated with an exit or disposal activity recognized in a prior
period, is the liability reversed?
[FASB ASC 420-10-40-1]

5.

Are the related costs reversed through the same line item(s)
in the income statement used when those costs were recognized initially?
[FASB ASC 420-10-40-1]

No

N/A

Segment Reporting
Note: The guidance in the FASB ASC 280 applies to all public entities,
with certain exceptions as follows. Entities other than public entities are
also encouraged to provide the disclosures described in FASB ASC 28010.
The guidance in FASB ASC 280-10 does not apply to the following entities:
●

Parent entities, subsidiaries, joint ventures, or investees accounted for by the equity method if those entities’ separate
company statements also are consolidated or combined in a
complete set of financial statements and both the separate company statements and the consolidated or combined statements
are included in the same financial report. However, FASB ASC
280-10 does apply to those entities if they are public entities
and their financial statements are issued separately.

●

Not-for-profit entities (regardless of whether the entity meets
the definition of a public entity as defined in the preceding list
item).

● Nonpublic entities.
[FASB ASC 280-10-15 par. 2–3]
Practice Tips
A public entity should report separately information about each operating segment that meets both of the
following criteria:
●

Has been identified in accordance with FASB ASC 280-10-50-1 and paragraphs 3–9 of FASB ASC
280-10-50 or results from aggregating 2 or more of those segments in accordance with the following
paragraph
(continued)
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●

No

N/A

Exceeds the quantitative thresholds in FASB ASC 280-10-50-12

Public entities are encouraged to report information about segments that do not meet the quantitative
thresholds if management believes that it is material.
Paragraphs 13–18 of FASB ASC 280-10-50 specify other situations in which separate information about an
operating segment should be reported. FASB ASC 280-10-55-26 and examples 1–2 (see paragraphs 27–45 of
FASB ASC 280-10-55) illustrate how to apply the main provisions in this section for identifying reportable
operating segments.
A public entity should report separately information about an operating segment that meets any of the
following quantitative thresholds:
●

Its reported revenue, including both sales to external customers and intersegment sales or transfers,
is 10 percent or more of the combined revenue, internal and external, of all operating segments.

●

The absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute
amount, of either
— the combined reported profit of all operating segments that did not report a loss or
— the combined reported loss of all operating segments that did report a loss.

●

Its assets are 10 percent or more of the combined assets of all operating segments.

Operating segments that do not meet any of the quantitative thresholds may be considered reportable, and
separately disclosed, if management believes that information about the segment would be useful to readers
of the financial statements.
[FASB ASC 280-10-50 par. 10 and 12–19]
If total of external revenue reported by operating segments constitutes less than 75 percent of total consolidated revenue, additional operating segments should be identified as reportable segments (even if they do
not meet the criteria in FASB ASC 280-10-50-12) until at least 75 percent of total consolidated revenue is
included in reportable segments.
[FASB ASC 280-10-50-14]
If management judges an operating segment identified as a reportable segment in the immediately preceding period to be of continuing significance, information about that segment should continue to be reported
separately in the current period even if it no longer meets the criteria for reportability in FASB ASC 280-1050-12.
[FASB ASC 280-10-50-16]
1.

2.

(Issuers Only) Have the following disclosures been made for
each period for which an income statement is presented:
a.

Factors used to identify the public entity’s reportable
segments, including the basis of organization (for example, whether management has chosen to organize
the reporting entity around differences in products and
services, geographic areas, regulatory environments, or
a combination of factors and whether operating segments have been aggregated)?

b.

Types of products and services from which each reportable segment derives its revenues?
[FASB ASC 280-10-50-21]

(Issuers Only) Has a measure of profit or loss and total assets
been reported for each reportable segment?
[FASB ASC 280-10-50-22]
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3.

(Issuers Only) If the following specified amounts (a) are included in the measure of segment profit or loss reviewed by
the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if
not included in that measure of segment profit or loss, are
they disclosed for each reportable segment:
a.

Revenues from external customers?

b.

Revenues from transactions with other operating segments of the reporting entity?

c.

Interest revenue?

d.

Interest expense?

e.

Depreciation, depletion, and amortization expense?

f.

Unusual items as described in FASB ASC 225-20-45-16?

g.

Equity in the net income of investees accounted for by
the equity method?

h.

Income tax expense or benefit?

i.

Extraordinary items?

j.

Significant noncash items other than depreciation, depletion, and amortization expense?
[FASB ASC 280-10-50-22]

4.

(Issuers Only) Unless a segment has no or immaterial financial operations, has the entity reported interest revenue separately from interest expense for each reportable segment (unless a majority of the segment’s revenues are from interest
and the chief operating decision maker relies primarily on net
interest revenue to assess the performance of the segment and
make decisions about resources to be allocated to the segment)? (In that situation, a public entity may report that segment’s interest revenue net of its interest expense and disclose that it has done so.)
[FASB ASC 280-10-50 par. 22–24]

5.

(Issuers Only) If the following specified amounts are (a) included in the determination of segment assets reviewed by
the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if
not included in that measure of segment assets, are they disclosed for each reportable segment:
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a.

The amount of investment in equity method investees?

b.

Total expenditures for additions to long-lived assets
other than any of the following: financial instruments,
long term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, or deferred tax assets?
[FASB ASC 280-10-50-25]

No

N/A
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No

N/A

Practice Tips
If no asset information is provided for a reportable segment, that fact and the reason therefore should be
disclosed.
[FASB ASC 280-10-50-26]
Reconciliations of balance sheet amounts for reportable segments to consolidated balance sheet amounts are
required only for each year for which a balance sheet is presented. Previously reported information for prior
periods should be restated as described in paragraphs 34–35 of FASB ASC 380-10-50.
[FASB ASC 280-10-50-20]
6.

(Issuers Only) Is an explanation of the measurements of segment profit or loss and segment assets that discloses the following for each reportable segment provided:
a.

The basis of accounting for any transactions between
reportable segments?

b.

The nature of any differences between the reporting entity’s consolidated income before taxes, extraordinary
items, discontinued operations, and the cumulative effect of changes in accounting principle?

c.

The nature of any differences between the measurements of the reportable segments’ assets and the reporting entity’s consolidated assets?

d.

The nature of any changes from prior periods in the
measurement methods used to determine reported segment profit or loss and the effect, if any, of those
changes on the measure of segment profit or loss?

e.

The nature and effect of any asymmetrical allocations
to segments?
[FASB ASC 280-10-50-29]

7.

(Issuers Only) Are reconciliations of the totals of the reportable segments’ revenues, measures of profit or loss, assets, and
every other significant item of information disclosed to corresponding consolidated amounts presented with all significant reconciling items separately identified and described?
[FASB ASC 280-10-50 par. 30–31]

8.

(Issuers Only) Has the following information about each reportable segment in condensed financial statements of interim periods been disclosed for current quarter and year-todate amounts:
a.

Revenues from external customers?

b.

Intersegment revenues?

c.

A measure of segment profit or loss?

d.

Total assets for which there has been a material change
from the amount disclosed in the last annual report?

e.

A description of differences from the last annual report
in the basis of segmentation or in the basis of measurement of segment profit or loss?
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f.

A reconciliation of the total of the reportable segments’
measures of profit or loss to the public entity’s consolidated income before income taxes, extraordinary items,
and discontinued operations? If a public entity allocates
items such as income taxes and extraordinary items to
segments, the public entity may choose to reconcile the
total of the segments’ measures of profit or loss to consolidated income after those items. Significant reconciling items should be separately identified and described
in that reconciliation.
[FASB ASC 280-10-50 par. 32–33]

9.

(Issuers Only) If the reporting entity changes the structure of
its internal organization in a manner that changes the composition of its reportable segments, is the corresponding information for prior periods restated and is the fact that the
corresponding items of segment information for earlier periods have been restated disclosed?
[FASB ASC 280-10-50-34]

10.

(Issuers Only) If the reporting entity changes the structure of
its internal organization in a manner that changes the composition of its reportable segments and the corresponding information for prior periods is not restated, does disclosure in
the year in which the change occurs include segment information for the current period under both the old basis and
the new basis?
[FASB ASC 280-10-50-35]

11.

(Issuers Only) For all reporting entities subject to FASB ASC
280-10, including those that have a single reportable segment,
are the following enterprise-wide items disclosed:
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a.

Revenues from external customers for each product
and service or each group of similar products and services unless it is impracticable to do so?
[FASB ASC 280-10-50-40]

b.

The following geographic information unless it is impracticable to do so:
i.

Revenues from external customers (a) attributed
to the reporting entity’s country of domicile and
(b) attributed to all foreign countries in total from
which the reporting entity derives revenue?

ii.

Revenues from external customers attributed to
an individual foreign country, if material?

iii.

The basis for attributing revenues from external
customers to individual countries?

No

N/A
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c.

iv.

Long-lived assets other than financial instruments, long term customer relationships of a financial institution, mortgage and other servicing
rights, deferred policy acquisition costs, and deferred tax assets (a) located in the reporting entity’s country of domicile and (b) located in all
foreign countries in total in which the reporting
entity holds assets?

v.

Long-lived assets as described above in an individual foreign country, if material?
[FASB ASC 280-10-50-41]

V.

N/A

Information about the extent of the reporting entity’s
reliance on its major customers, including the following:
i.

12.

No

If revenues from transactions with any single
customer amount to 10 percent or more of the reporting entity’s revenues, that fact, the total
amount of revenues from each such customer,
and the identity of the segment or segments reporting the revenue?
[FASB ASC 280-10-50-42]

(Issuers Only) If the information described in questions
12(a)–(b) has not been disclosed because it is impracticable, is
that fact disclosed?
[FASB ASC 280-10-50 par. 40–41]

Stock Compensation Plans
1.

2.

If the entity has one or more share-based payment arrangements, does it disclose information that enables users of the
financial statements to understand
a.

the nature and terms of such arrangements that existed
during the period and the potential effects of those arrangements on shareholders?

b.

the effect of compensation cost arising from sharebased payment arrangements on the income statement?

c.

the method of estimating the fair value of the goods or
services received, or the fair value of the equity instruments granted (or offered to grant), during the period?

d.

the cash flow effects resulting from share-based payment arrangements?
[FASB ASC 718-10-50-1]

If the entity acquires goods or services other than employee
services in share-based payment transactions, does it provide
disclosures similar to those in question 1 required by FASB
ASC 718-10-50-1 and FASB ASC 718-10-50-2 to the extent that
those disclosures are important to an understanding of the
effects of those transactions on the financial statements?
[FASB ASC 505-50-50-1]
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3.

Has the following, at a minimum, been disclosed with regards to stock-based compensation:
a.

i.

the requisite service period(s) and any other substantive conditions (including those related to
vesting)?

ii.

the maximum contractual term of equity (or liability) share options or similar instruments?

iii.

the number of shares authorized for awards of
equity share options or other equity instruments?

b.

The method it uses for measuring compensation cost
from share-based payment arrangements with employees?

c.

For the most recent year for which an income statement
is provided, both of the following:

d.
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A description of the share-based payment arrangement(s), including the general terms of awards under
the arrangement(s), such as

i.

The number and weighted-average exercise
prices (or conversion ratios) (a) shares outstanding at the beginning of the year, (b) shares outstanding at the end of the year, (c) shares exercisable or convertible at the end of the year, and (d)
those during the year that were granted, exercised or converted, forfeited and expired?

ii.

The number and weighted-average grant-date
fair value (or calculated value for a nonpublic entity that uses that method or intrinsic value for
awards measured pursuant to FASB ASC 718-1030-21) of equity instruments not specified in
(c)(i), for (a) equity instruments nonvested at the
beginning of the year, (b) nonvested at the end of
the year, and (c) those during the year that were
granted, vested and forfeited?

For each year for which an income statement is provided
i.

the weighted average grant-date fair values (or
calculated value for a nonpublic entity that uses
that method or intrinsic value for awards measured at that value pursuant to FASB ASC 718-1030-21 and FASB ASC 718-10-30-22) of equity options or other equity instruments granted during
the year?

ii.

the total intrinsic value of options exercised (or
share units converted), share-based liabilities
paid, and the total fair value of shares vested
during the year?

No

N/A
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e.

f.

No

N/A

For fully vested share options (or share units) and share
options expected to vest at the dated of the latest statement of financial position
i.

the number, weighted-average exercise price (or
conversion ratio), aggregate intrinsic value (except for nonpublic entities), and weighted-average remaining contractual term of options (or
share units) outstanding?

ii.

the number, weighted-average exercise price (or
conversion ratio), aggregate intrinsic value (except for nonpublic entities), and weighted-average remaining contractual term of options (or
share units) currently exercisable (or convertible)?

For each year for which an income statement is presented, both of the following (an entity that uses the
intrinsic value method pursuant to FASB ASC 718-1030-21 and FASB ASC 718-10-30-22 is not required to
disclose the following information for awards accounted for under that method):
i.

A description of the method used during the year
to estimate the fair value (or calculated value) of
awards under share-based payment arrangements?

ii.

A description of the significant assumptions used
during the year to estimate the fair value (or calculated value) of share-based compensation
awards, including (if applicable)
(1)

expected term of share options and similar
instruments, including a discussion of the
method used to incorporate the contractual
term of the instruments and employees’ expected exercise and postvesting employment termination behavior into the fair
value (or calculated value) of the instrument?
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(2)

expected volatility of the entity’s shares
and the method used to estimate it? An entity that uses a method that employs different volatilities during the contractual term
should disclose the range of expected volatilities used and the weighted-average expected volatility. A nonpublic entity that
uses the calculated value method should
disclose the reasons why it is not practicable for it to estimate the expected volatility
of its share price, the appropriate industry
sector index that it has selected, the reasons
for selecting that particular index, and how
it has calculated historical volatility using
that index.

(3)

expected dividends? An entity that uses a
method that employs different dividend
rates during the contractual term should
disclose the range of expected dividends
used and the weighted-average expected
dividends.

(4)

risk-free rate(s)? An entity that uses a
method that employs different risk-free
rates should disclose the range of risk-free
rates used.

(5)

discount for post-vesting restrictions and
the method for estimating it?

g.

An entity that grants equity or liability instruments under multiple share-based payment arrangements with
employees should provide the information specified in
questions 3(a)–(f) separately for different types of
awards to the extent that the differences in the characteristics of the awards make separate disclosure important to an understanding of the entity’s use of sharebased compensation.

h.

For each year for which an income statement is presented, both of the following:
i.

Total compensation cost for share-based payment
arrangements (including recognized in income as
well as the total recognized tax benefit related
thereto and capitalized as part of the cost of an
asset)?

ii.

A description of the significant modifications, including the terms of the modifications, the number of employees affected, and the total incremental compensation cost resulting from the
modifications?

No

N/A
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i.

As of the latest balance sheet date presented, the total
compensation cost related to nonvested awards not yet
recognized and the weighted-average period over
which it is expected to be recognized?

j.

If not separately disclosed elsewhere, the amount of
cash received from exercise of share options and similar instruments granted under share-based payment arrangements and the tax benefit realized from stock options exercised during the annual period?

k.

If not separately disclosed elsewhere, the amount of
cash used to settle equity instruments granted under
share-based payment arrangements?

l.

Description of the entity’s policy, if any, for issuing
shares upon share option exercise (or share unit conversion), including the source of those shares (that is,
new shares or treasury shares). If as a result of its policy, an entity expects to repurchase shares in the following annual period, the entity should disclose an estimate of the amount (or a range, if more appropriate)
of shares to be repurchased during that period?
[FASB ASC 718-10-50-2]

No

N/A

Practice Tip
Question 3 indicates the minimum information needed to achieve those objectives and illustrate how the
disclosure requirements might be satisfied. In some circumstances, an entity may need to disclose information beyond that listed to achieve the disclosure objectives.
[FASB ASC 718-10-50-2]

W.

4.

Has the entity disclosed the nature of any changes in their
accounting policy for income tax benefits of dividends on
share-based-payment awards resulting in the adoption of the
requirements in FASB ASC 718-740-45-8 through FASB ASC
718-740-45-12?
[FASB ASC 718-740-50-1]

5.

Have additional disclosures been made, as necessary, that
would be useful to investors and creditors, such as a range of
values calculated on the basis of different assumptions, provided that the supplemental information is reasonable and
does not lessen the prominence and credibility of the information required by FASB ASC 718-10-50?
[FASB ASC 718-10-50-4]

Subsequent Events
Notes: In May 2009, FASB issued Statement No. 165, Subsequent Events,
to establish principles and requirements for subsequent events. In particular, this statement sets forth
a.

the period after the balance sheet date during which management of a reporting entity should evaluate events or transac(continued)
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tions that may occur for potential recognition or disclosure in
the financial statements.
b.

the circumstances under which an entity should recognize
events or transactions occurring after the balance sheet date in
its financial statements.

c.

the disclosures that an entity should make about events or
transactions that occurred after the balance sheet date.

This statement should be applied to the accounting for and disclosure
of subsequent events not addressed in other applicable U.S. GAAP.
This statement moved the type I and type II subsequent event guidance
from GAAS into U.S. GAAP and added disclosures that an entity
should make about events or transactions that occurred after the balance sheet date.
This statement is effective for interim or annual financial periods ending after June 15, 2009 (that is, December 31, 2009, for entities with calendar year-ends), and should be applied prospectively.
This checklist has been updated to include the presentation and disclosure requirements of FASB Statement No. 165.
Readers can refer to the full text of the statement on the FASB Web site
at www.fasb.org.
1.

Has the entity disclosed (in both originally issued financial
statements and any reissued financial statements) the date
through which subsequent events have been evaluated, as
well as whether that date is the date the financial statements
were issued or the date the financial statements were available to be issued?
[FASB ASC 855-10-50-1; FASB ASC 855-10-50-4]

2.

For nonrecognized subsequent events that are of such a nature that they must be disclosed to keep the financial statements from being misleading, has the entity disclosed

3.

FSP §20,100.01

a.

the nature of the event?

b.

an estimate of its financial effect, or a statement that
such an estimate cannot be made?
[FASB ASC 855-10-50-2]

For nonrecognized subsequent events, has the entity considered supplementing the historical financial statements with
pro forma financial data, including the presentation of pro
forma statements (usually a balance sheet only, in columnar
form on the face of the historical statements)?
[FASB ASC 855-10-50-3]

No

N/A
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X.

No

N/A

Accounting for Servicing of Financial Assets
Notes: In December 2008, FASB issued FSP FAS 140-4 and FIN 46(R)-8
to amend FASB Statement No. 140 and to require public entities to provide additional disclosures about transfers of financial assets. It also
amends FASB Interpretation No. 46 (revised December 2003) to require
public enterprises, including sponsors that have a variable interest in a
VIE, to provide additional disclosures about their involvement with
VIEs. Additionally, this FSP requires certain disclosures to be provided
by a public enterprise that is (a) a sponsor of a QSPE that holds a variable interest in the QSPE but was not the transferor (nontransferor) of
financial assets to the QSPE and (b) a servicer of a QSPE that holds a
significant variable interest in the QSPE but was not the transferor
(nontransferor) of financial assets to the QSPE. The disclosures required
by this FSP are intended to provide greater transparency to financial
statement users about a transferor’s continuing involvement with transferred financial assets and an enterprise’s involvement with VIEs and
QSPEs.
This FSP applies to public entities that are subject to the disclosure requirements of FASB Statement No. 140 and public enterprises that are
subject to the disclosure requirements of FASB Interpretation No. 46(R)
as amended by this FSP.
This FSP is effective for the first reporting period (interim or annual)
ending after December 15, 2008 (that is, December 31, 2008, for entities
with calendar year-ends), with earlier application encouraged. This FSP
applies to each annual and interim reporting period thereafter. An entity (enterprise) is encouraged, but not required, to disclose comparative information in periods earlier than the effective date for disclosures
that were not previously required for public entities (enterprises) by
FASB Statement No. 140 and FASB Interpretation No. 46(R). In periods
after initial adoption, comparative disclosures for those disclosures that
were not previously required for public entities (enterprises) by FASB
Statement No. 140 and FASB Interpretation No. 46(R) are required only
for periods subsequent to the effective date.
This checklist has been updated to include the presentation and disclosure requirements of FSP FAS 140-4 and FIN 46(R)-8.
Readers can refer to the full text of the FSP on the FASB Web site at
www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and
open effective date information discussed in FASB ASC 860-10-65-2.
Readers should be aware that this FSP was superseded by FASB Statement No. 166 and FASB Statement No. 167. Both FASB Statement No.
167 and FASB Statement No. 166 are effective as of the beginning of
each reporting entity’s first annual reporting period that begins after
November 15, 2009 (that is, January 1, 2010, for entities with calendar
year-ends), for interim periods within that first annual reporting period, and for interim and annual reporting periods thereafter. Earlier
application is prohibited.
(continued)
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Yes

No

N/A

This checklist has not been updated to include the presentation and disclosure requirements of FASB Statement No. 166 nor FASB Statement
No. 167.
Readers can refer to the full texts of these statements on the FASB Web
site at www.fasb.org.
Practice Tip
(Issuers Only) The principal objectives of the public-entity disclosure requirements of FASB ASC 860-10-50
are to provide financial statement users with an understanding of all of the following:
●

A transferor’s continuing involvement with financial assets that it has transferred in a securitization
or asset-backed financing arrangement

●

The nature of any restrictions on assets reported by an entity in its statement of financial position
that relate to a transferred financial asset, including the carrying amounts of such assets

●

How servicing assets and servicing liabilities are reported under FASB ASC 860-50

●

For securitization or asset-backed financing arrangements accounted for as sales if a transferor has
continuing involvement with the transferred financial assets and transfers of financial assets accounted for as secured borrowings, how the transfer of financial assets affects an entity’s financial
position, financial performance, and cash flows

The entity should consider these objectives in providing the required public-entity disclosures required by
FASB ASC 860. The disclosures should be presented in a manner that clearly and fully explains to financial
statements users the risks related to the transferred financial assets and any restrictions on the assets of the
entity.
Public-entity disclosures required by FASB ASC 860 may be reported in the aggregate for similar transfers
if separate reporting of each transfer would not provide more useful information to financial statement
users. A transferor should distinguish between transfers that are accounted for as secured borrowings and
transfers that are accounted for as sales. A transferor should further distinguish between transfers to QSPE
accounted for as sales and all other transfers accounted for as sales. In determining whether to aggregate
the disclosures for multiple transfers, the reporting entity should consider quantitative and qualitative information about the characteristics of the transferred financial assets.
The entity should determine, in light of the facts and circumstances, how much detail it must provide to
satisfy the public-entity disclosure requirements of FASB ASC 860, how much emphasis it places on different
aspects of the requirements, and how it aggregates information for assets with different risk characteristics.
[“Pending Content” in FASB ASC 860-10-50 par. 2–6]
Collateral
1.

(Nonissuers Only) Is the policy for requiring collateral or
other security disclosed if the reporting entity has entered
into repurchase agreements or securities lending transactions?
[FASB ASC 860-30-50-1]

2.

(Nonissuers Only) If the entity has pledged any of its assets
as collateral that are not reclassified and separately reported
in the statement of financial position pursuant to FASB ASC
860-30-25-5(a), is the carrying amount and classification of
those assets as of the date of the latest statement of financial
position presented?
[FASB ASC 860-30-50-1]
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3.

(Nonissuers Only) If the entity has accepted collateral that it
is permitted by contract or custom to sell or repledge, is the
fair value (as of the date of each statement of financial position presented) of that collateral and of the portion of that
collateral that it has sold or repledged disclosed?
[FASB ASC 860-30-50-1]

4.

If debt was considered to be extinguished by in-substance defeasance under the provisions of FASB Statement No. 76, Extinguishment of Debt, prior to the effective date of FASB Statement No. 125, Accounting for Transfers and Servicing of
Financial Assets and Extinguishments of Liabilities, do the disclosures include a general description of the transaction and the
amount of debt that is considered extinguished at the end of
the period so long as that debt remains outstanding?
[FASB ASC 470-50-50-1]

5.

(Nonissuers Only) If the entity sets aside assets solely for the
purpose of satisfying scheduled payments of a specific obligation, is disclosure made of the nature of restrictions placed
on those assets?
[“Pending Content” in FASB ASC 860-30-50-2]

6.

(Issuers Only) Has the following been disclosed regarding
collateral:

7.

a.

The policy for requiring collateral or other security disclosed if the reporting entity has entered into repurchase agreements or securities lending transactions?

b.

If the entity has pledged any assets as collateral, the
carrying amount, and classification of those assets and
associated liabilities as of the date of the latest statement of financial position presented, including qualitative information about the relationship(s) between
those assets and associated liabilities?

c.

If the entity has accepted collateral that is permitted by
contract or custom to sell or repledge, the following:
i.

The fair value, as of the date of each statement of
financial position presented of that collateral?

ii.

The fair value, as of the date of each statement of
financial position presented of the portion of that
collateral that it has sold or repledged?

iii.

Information about the sources and uses of that
collateral?
[“Pending Content” in FASB ASC 860-30-50-4]

No

N/A

If it is not practicable to estimate the fair value of certain assets obtained or liabilities incurred in transfers of financial assets during the period, are those items and the reasons why
it is not practicable to estimate fair value described in the
notes to the financial statements?
[FASB ASC 860-10-50-1]
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Servicing Assets and Servicing Liabilities
8.

9.

For all servicing assets and servicing liabilities, are the following disclosures made:
a.

Management’s basis for determining its classes of servicing assets and servicing liabilities?

b.

A description of the risks inherent in servicing assets
and servicing liabilities and, if applicable, the instruments used to mitigate the income statement effect of
changes in fair value of the servicing assets and servicing liabilities? (Disclosure of quantitative information
about the instruments used to manage the risks inherent in servicing assets and servicing liabilities, including the fair value of those instruments at the beginning
and end of the period, is encouraged but not required.)

c.

The amount of contractually specified servicing fees (as
defined in the FASB ASC glossary), late fees, and ancillary fees earned for each period for which results of operations are presented, including a description of where
each amount is reported in the statement of income?
[FASB ASC 860-50-50-2]

For servicing assets and servicing liabilities subsequently
measured at fair value, are the following disclosures made:
a.
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For each class of servicing assets and servicing liabilities, the activity in the balance of servicing assets and
the activity in the balance of servicing liabilities (including a description of where changes in fair value are
reported in the statement of income for each period for
which results of operations are presented), including,
but not limited to, the following:
i.

The beginning and ending balances?

ii.

Additions (through purchases of servicing assets,
assumptions of servicing obligations, and servicing obligations that result from transfers of financial assets)?

iii.

Disposals?

iv.

Changes in the fair value during the period resulting from changes in valuation inputs or assumptions used in the valuation model?

v.

Changes in the fair value during the period resulting from other changes in fair value and a description of those changes?

vi.

Other changes that affect the balance and a description of those changes?

No

N/A

205

Financial Statements and Notes Checklist

Yes
b.

10.

No

N/A

A description of the valuation techniques or other
methods used to estimate the fair value of servicing assets and servicing liabilities? If a valuation model is
used, the description should include the methodology
and model validation procedures, as well as quantitative and qualitative information about the assumptions
used in the valuation model (for example, discount
rates and prepayment speeds). (An entity that provides
quantitative information about the instruments used to
manage the risks inherent in the servicing assets and
servicing liabilities, the entity is also encouraged, but
not required, to disclose a description of the valuation
techniques, as well as quantitative and qualitative information about the assumptions used to estimate the
fair value of those instruments.)
[FASB ASC 860-50-50-3]

For servicing assets and servicing liabilities subsequently amortized in proportion to and over the period of estimated net
servicing income or loss and assessed for impairment or increased obligation:
a.

b.

For each class of servicing assets and servicing liabilities, the activity in the balance of servicing assets and
the activity in the balance of servicing liabilities (including a description of where changes in the carrying
amount are reported in the statement of income for
each period for which results of operations are presented), including, but not limited to, the following:
i.

The beginning and ending balances?

ii.

Additions (through purchases of servicing assets,
assumption of servicing obligations, and servicing obligations that result from transfers of financial assets)?

iii.

Disposals?

iv.

Amortization?

v.

Application of valuation allowance to adjust carrying value of servicing assets?

vi.

Other-than-temporary impairments?

vii.

Other changes that affect the balance and a description of those changes?

For each class of servicing assets and servicing liabilities, the fair value of recognized servicing assets and
servicing liabilities at the beginning and end of the period if it is practicable to estimate the value?

FSP §20,100.01

206

Life and Health Insurance Entities

Yes
c.

A description of the valuation techniques or other
methods used to estimate fair value of the servicing assets and servicing liabilities? If a valuation model is
used, the description should include the methodology
and model validation procedures, as well as quantitative and qualitative information about the assumptions
used in the valuation model (for example, discount
rates and prepayment speeds). (An entity that provides
quantitative information about the instrument used to
manage the risks inherent in the servicing assets and
servicing liabilities, the entity is also encouraged, but
not required, to disclose a description of the valuation
techniques as well as quantitative and qualitative information about the assumptions used to estimate the fair
value of those instruments.)

d.

The risk characteristics of the underlying financial assets used to stratify recognized servicing assets for purposes of measuring impairment in accordance with
FASB ASC 860-50-35-9?

e.

The activity by class in any valuation allowance for impairment of recognized servicing assets—including beginning and ending balances, aggregate additions
charged and recoveries credited to operations, and aggregate write-downs charged against the allowance—for each period for which results of operations
are presented?
[FASB ASC 860-50-50-4]

No

N/A

Practice Tip
The entity should report recognized servicing assets and servicing liabilities that are subsequently measured
using the fair value measurement method in a manner that separates those carrying amounts on the face of
the statement of financial position from the carrying amounts for separately recognized servicing assets and
servicing liabilities that are subsequently measured using the amortization method.
To accomplish that separate reporting, the entity may do either of the following:
●

Display separate line items for the amounts that are subsequently measured using the fair value
measurement method and amounts that are subsequently measured using the amortization method

Present the aggregate of those amounts that are subsequently measured at fair value and those
amounts that are subsequently measured using the amortization method and disclose parenthetically the amount that is subsequently measured at fair value that is included in the aggregate
amount
[FASB ASC 860-50-45 par. 1–2]
●

11.

FSP §20,100.01

If the entity (public or nonpublic) has elected, under FASB
ASC 860-50-35-3(d), to subsequently measure a class of servicing assets and servicing liabilities at fair value at the beginning of the fiscal year, has the amount of the cumulative-effect adjustment to retained earnings been separately
disclosed?
[FASB ASC 860-50-50-5]
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Yes
12.

13.

N/A

(Issuers Only) Have the following disclosures been made for
all servicing assets and servicing liabilities:
a.

Management’s basis for determining its classes of servicing assets and servicing liabilities?

b.

A description of the risks inherent in servicing assets
and servicing liabilities?

c.

If applicable, a description of the instruments used to
mitigate the income statement effect of changes in fair
value of the servicing assets and servicing liabilities?

d.

The amount of contractually specified servicing fees,
late fees, and ancillary fees earned for each period for
which results of operations are presented, including a
description of where each amount is reported in the
statement of income?

e.

Quantitative and qualitative information about the assumptions used to estimate the fair value?
[“Pending Content” in FASB ASC 860-50-50-7]

(Issuers Only) Have the following disclosures been made for
all servicing assets and servicing liabilities subsequently
measured at fair value:
a.

14.

No

For each class of servicing assets and servicing liabilities, the activity in the balance of servicing assets and
the activity in the balance of servicing liabilities (including a description of where changes in fair value are
reported in the statement of income for each period for
which results of operations are presented), including,
but not limited to, all of the following:
i.

The beginning and ending balances?

ii.

Additions (through purchases of servicing assets,
assumption of servicing obligations, and servicing obligations that result from transfers of financial assets)?

iii.

Disposals?

iv.

Changes in fair value during the period resulting
from (1) changes in valuation inputs or assumptions used in the valuation models and (2) other
changes in fair value and a description of those
changes?

v.

Other changes that affect the balance and a description of those changes?
[“Pending Content” in FASB ASC 860-50-50-8]

(Issuers Only) Have the following disclosures been made for
all servicing assets and servicing liabilities subsequently amortized in proportion to and over the period of estimated net
servicing income or loss:
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a.

For each class of servicing assets and servicing liabilities, the activity in the balance of servicing assets and
the activity in the balance of servicing liabilities (including a description of where changes in the carrying
amount are reported in the statement of income for
each period for which results of operations are presented), including, but not limited to, the following:
i.

The beginning and ending balances?

ii.

Additions (through purchases of servicing assets,
assumption of servicing obligations, and servicing obligations that result from transfers of financial assets)?

iii.

Disposals?

iv.

Amortization?

v.

Application of valuation allowance to adjust carrying value of servicing assets?

vi.

Other-than-temporary impairments?

vii.

Other changes that affect the balance and a description of those changes?

b.

For each class of servicing assets and servicing liabilities, the fair value of recognized servicing assets and
servicing liabilities at the beginning and end of the period if it is practicable to estimate the value?

c.

The risk characteristics of the underlying financial assets used to stratify recognized servicing assets for purposes of measuring impairment in accordance with the
guidance in paragraphs 9–14 of FASB ASC 860-50-35?

d.

For each period for which results of operations are presented, the activity by class in any valuation allowance
for impairment of recognized servicing assets, including (a) beginning and ending balances, (b) aggregate
additions charged and recoveries credited to operations, and (c) aggregate write-downs charged against
the allowance?
[“Pending Content” in FASB ASC 860-50-50-9]

Securitized Financial Assets Accounted for as a Sale
15.

If the entity has securitized financial assets during any period
presented and accounts for that transfer as a sale, are the following items disclosed for each major asset type (for example, mortgage loans, credit card receivables, and automobile
loans):
a.

FSP §20,100.01

Its accounting policies for initially measuring the interests that continue to be held by the transferor, if any,
and servicing assets or servicing liabilities, if any, including the methodology (whether quoted market
price, prices based on sales of similar assets and liabilities, or prices based on valuation techniques) used in
determining their fair value?

No

N/A
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b.

No

N/A

The characteristics of securitizations (a description of
the transferor’s continuing involvement with the transferred assets, including, but not limited to, servicing,
recourse, and restrictions on interests that continue to
be held by the transferor) and the gain or loss from sale
of financial assets in securitizations?
Practice Tip

With regard to question 15(c) following, if an entity has made multiple securitizations of the same major
asset type during a period, it may disclose the range of assumptions.
[FASB ASC 860-20-50-3]

16.

c.

The key assumptions used in measuring the fair value
of interests that continue to be held by the transferor
and servicing assets or servicing liabilities, if any, at the
time of securitization (including, at a minimum, quantitative information about discount rates, expected prepayments including the expected weighted-average life
of prepayable financial assets, and anticipated credit
losses, if applicable)?

d.

Cash flows between the securitization special purpose
entity and the transferor, unless reported separately
elsewhere in the financial statements or notes (including proceeds from new securitizations, proceeds from
collections reinvested in revolving-period securitizations, purchases of delinquent or foreclosed loans, servicing fees, and cash flows received on interests that continue to be held by the transferor)?
[FASB ASC 860-20-50-3]

(Issuers Only) Has the entity disclosed, for each income statement presented, the following related to securitization or asset-backed financing arrangements accounted for as sales:
a.

Its accounting policies for subsequently measuring
those interests, if any?

b.

The characteristics of the transfer including a description of the transferor’s continuing involvement with the
transferred financial assets and the gain or loss from
the sale of transferred assets?

c.

Cash flows between a transferee and the transferor, including proceeds from new transfers, proceeds from
collections reinvested in revolving-period transfers,
purchases of previously transferred financial assets,
servicing fees, and cash flows received on interests that
continue to be held by the transferor?
[“Pending Content” in FASB ASC 860-20-50-8]

FSP §20,100.01

210

Life and Health Insurance Entities

Yes

No

N/A

Interests in Financial Assets That Continue to Be Held by the
Transferor
17.

If the entity has interest that continues to be held by the transferor in financial assets that it has securitized or servicing assets or servicing liabilities relating to assets that it has securitized, at the date of the latest statement of financial position
presented, are the following items disclosed for each major
asset type (for example, mortgage loans, credit card receivables, and automobile loans):
a.

Its accounting policies for subsequently measuring
those interests, including the methodology (whether
quoted market price, prices based on sales of similar
assets and liabilities, or prices based on valuation techniques) used in determining their fair value?

b.

The key assumptions used in subsequently measuring
the fair value of those interests (including, at a minimum, quantitative information about discount rates,
expected prepayments including the expected
weighted-average life of prepayable financial assets,
and anticipated credit losses, including expected static
pool losses, if applicable)?

c.

A sensitivity analysis or stress test showing the hypothetical effect on the fair value of those interests (including any servicing assets or servicing liabilities) of
two or more unfavorable variations from the expected
levels for each key assumption that is reported under
item (b) independently from any change in another key
assumption, and a description of the objectives, methodology, and limitations of the sensitivity analysis or
stress test?
Practice Tip

With regard to question 17(d) following, this question excludes securitized assets that an entity continues to
service but with which it has no other continuing involvement.
[FASB ASC 860-20-50-4]
d.
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For the securitized assets and any other financial assets
that it manages together with them,
i.

the total principal amount outstanding, the portion that has been derecognized, and the portion
that continues to be recognized in each category
reported in the statement of financial position, at
the end of the period?

ii.

delinquencies at the end of the period?

iii.

credit losses, net of recoveries, during the period?
[FASB ASC 860-20-50-4]
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Yes
18.

No

N/A

(Issuers Only) Have the following disclosures been made, in
each statement of financial position presented, related to securitization or asset-backed financing arrangements accounted for sales if the transferor has continuing involvement:
a.

Qualitative and quantitative information about the
transferor’s continuing involvement with transferred financial assets that provides financial statement users
with sufficient information to assess the reasons for the
continuing involvement and the risks related to the
transferred financial assets to which the transferor continues to be exposed after the transfer and the extent
that the transferor’s risk profile has changed as a result
of the transfer (including, but not limited to, credit risk,
interest rate risk, and other risks), including the following:
i.

The nature, purpose, size, and activities of special-purpose entities used to facilitate a transfer
of financial assets, if applicable, including how
the special-purpose entities are financed?

ii.

The total principal amount outstanding, the portion that has been derecognized, and the portion
that continues to be recognized in each category
reported in the statement of financial position, at
the end of the period?

iii.

The terms of any arrangements that could require the transferor to provide financial support
(for example, liquidity arrangements and obligations to purchase assets) to the transferee or its
beneficial interest holders, including a description of any events or circumstances that could expose the transferor to loss. All available evidence
should be considered, including, but not limited
to all of the following: (1) explicit written arrangements, (2) communications between the
transferor and the transferee or its beneficial interest holders, and (3) unwritten arrangements
customary to similar transfers?

iv.

Whether the transferor has provided financial or
other support during the periods presented that
it was not previously contractually required to
provide to the transferee or its beneficial interest
holders, including—when the transferor assisted
the transferee or its beneficial interest holders in
obtaining support—both the type and amount of
support and the primary reasons for the support?

FSP §20,100.01

212

Life and Health Insurance Entities

Yes

No

N/A

Practice Tip
(Issuers Only) The entity also is encouraged to disclose information about any liquidity arrangements, guarantees, or other commitments by third parties related to the transferred financial assets that may affect the
fair value or risk of interest that continues to be held by the transferor.
[“Pending Content” in FASB ASC 860-20-50-9]
b.

The accounting policies for subsequently measuring assets or liabilities that relate to the continuing involvement?

c.

The key inputs and assumptions used in measuring the
fair value of assets or liabilities that relate to the transferor’s continuing involvement including, at a minimum, (1) quantitative information about discount rates,
(2) expected prepayments, including the expected
weighted-average life of prepayable financial assets,
and (3) anticipated credit losses, including expected
static pool losses?
Practice Tip

(Issuers Only) If the entity has aggregated multiple transfers during a period in accordance, it may disclose
the range of assumptions for each aggregated group provided it does not obscure important information.
[“Pending Content” in FASB ASC 860-20-50-9]
d.

For interests that continue to be held by the transferor
in financial assets, both of the following:
i.

A sensitivity analysis or stress test showing the
hypothetical effect on the fair value of those interests, including any servicing assets or servicing liabilities, of two or more unfavorable variations from the expected levels for each key
assumption that is reported under item (c), independently from any change in another key assumption?

ii.

A description of the objectives, methodology,
and limitations of the sensitivity analysis or
stress test?
Practice Tip

(Issuers Only) The information in question 18(e) following should be separated between assets that have
been derecognized and assets that continue to be recognized in the statement of financial position. This
information is intended to provide financial statement users with an understanding of the risks inherent in
the transferred financial assets as well as in other financial assets and liabilities that it manages together with
transferred financial assets. In determining the information that should be disclosed, an entity should consider other U.S. GAAP disclosure requirements applicable to the transferred financial asset.
[“Pending Content” in FASB ASC 860-20-50-9]
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Yes
e.

Y.

No

N/A

Information about the asset quality of transferred financial assets and any other financial assets that it
manages together with them.
[“Pending Content” in FASB ASC 860-20-50-9]

Troubled Debt Restructurings—Creditors
1.

Is the amount of commitments, if any, to lend additional
funds to debtors owing receivables whose terms have been
modified in troubled debt restructurings disclosed either in
the body of the financial statements or in the notes thereto as
of the date of each balance sheet presented?
[FASB ASC 310-40-50-1]
Practice Tip

For Restructurings in Fiscal Years Beginning Before December 16, 1994. Per “Pending Content” in FASB ASC
105-10-70-2(d), an entity may continue to account for “grandfathered” loans (restructured in a troubled debt
restructuring before the effective date of FASB Statement No. 114, Accounting by Creditors for Impairment of a
Loan, described in paragraph 24 of FASB Statement No. 118, Accounting by Creditors for Impairment of a
Loan—Income Recognition and Disclosures) in accordance with the provisions of FASB Statement No. 15 prior
to its amendment by FASB Statement No. 118.
For Restructurings in Fiscal Years Beginning Before December 16,
1994
2.

For outstanding “grandfathered” receivables whose terms
have been modified in troubled debt restructurings, are the
following disclosed by major category either in the body of
the financial statements or the notes thereto as of the date of
each balance sheet presented:
a.

The aggregate recorded investment?

b.

The gross interest income that would have been recorded in the period then ended if those receivables
had been current in accordance with their original
terms and had been outstanding throughout the period
or since origination?

c.

The amount of interest income on those receivables that
was included in net income for the period?
[SFAS 15 par. 40a]

(See part H, “Financial Instruments,” and part L, “Impaired
Loans,” for possible additional disclosure requirements.)
Z.

Troubled Debt Restructurings—Debtors
1.

For a troubled debt restructuring occurring during the current period, do disclosures include
a.

a description of the principal changes in terms, the major features of settlement, or both?

b.

aggregate gain on restructuring of payables?

c.

aggregate net gain or loss on transfers of assets recognized during the period?
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d.

2.

No

N/A

per-share amount of the aggregate gain on restructuring of payables?
[FASB ASC 470-60-50-1]

For periods after a troubled debt restructuring, do disclosures
include
a.

the extent to which amounts contingently payable are
included in the carrying amount of restructured payables pursuant to the provisions of FASB ASC 470-60-357?

b.

if required by paragraphs 1–6 and 9–10 of FASB ASC
450-20-50, total amounts contingently payable on restructured payables and conditions under which those
amounts would become payable or forgiven?
[FASB ASC 470-60-50-2]
Practice Tip

A troubled debt restructuring of a short term obligation after the date of a debtor’s balance sheet but before
that balance sheet is issued or is available to be issued may affect the classification of that obligation in
accordance with FASB ASC 470-10.
[FASB ASC 470-60-45-2A]
AA. Asset Retirement Obligations
1.

2.
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Does the entity disclose the following information about its
asset retirement obligations:
a.

A general description of the asset retirement obligations and the associated long-lived assets?

b.

The fair value of assets that are legally restricted for
purposes of settling asset retirement obligations?

c.

A reconciliation of the beginning and ending aggregate
carrying amount of asset retirement obligations showing separately the changes attributable to (1) liabilities
incurred in the current period, (2) liabilities settled in
the current period, (3) accretion expense, and (4) revisions in estimated cash flows, whenever there is a significant change in one or more of those four components during the reporting period?
[FASB ASC 410-20-50-1]

If the fair value of an asset retirement obligation cannot be
reasonably estimated, is that fact and the reasons therefore
disclosed?
[FASB ASC 410-20-50-2]
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3.

No

N/A

Is, on a pro forma basis, in the footnotes to the financial statements, for the beginning of the earliest period presented and
at the end of all periods presented during the year of adoption, the amount of liability for asset retirement obligations as
if FASB ASC 410-20 had been applied during all periods affected presented? (These pro forma amounts should be measured using the information, assumptions, and interest rates
used to measure the obligation recognized upon adoption of
the provisions of FASB ASC 410-20.)
[FASB ASC 410-20]
Practice Tip

For environmental asset retirement obligations under the requirements of FASB ASC 410-30, see part G,
“Environmental Remediation Liabilities,” in the “Other Financial Statement Disclosures” section of this
checklist.
BB.

Fair Value Measurements
Notes: In February 2007, FASB issued Statement No. 159, primarily
codified in FASB ASC 825, which was effective for financial statements
issued for fiscal years beginning after November 15, 2007.
This statement applies to all entities, including not-for-profit entities.
Most of the provisions of this statement apply only to entities that elect
the fair value option. However, the amendment to FASB Statement No.
115 applies to all entities with available-for-sale and trading securities.
Some requirements apply differently to entities that do not report net
income.
The statement permits an organization to irrevocably elect fair value as
the initial and subsequent measurement attribute for certain financial
assets and financial liabilities on a contract-by-contract basis, with
changes in fair value recognized in earnings (or another performance
indicator if the business entity does not report earnings) at each subsequent reporting date. The provisions of this statement need not be applied to immaterial items.
******
In September 2006, FASB issued Statement No. 157, codified in FASB
ASC 820, Fair Value Measurements and Disclosures, which was effective
for financial statements issued for fiscal years beginning after November 15, 2007, and interim periods within those fiscal years. However,
FSP FAS 157-2, Effective Date of FASB Statement No. 157, delayed the
effective date of FASB Statement No. 157 for all nonfinancial assets and
nonfinancial liabilities, except those that are recognized or disclosed at
fair value in the financial statements on a recurring basis (at least annually), to fiscal years beginning after November 15, 2008 (that is, January 1, 2009, for entities with calendar year-ends), and interim periods
within those fiscal years for items within the scope of this FSP. This FSP
does not apply to entities that have issued interim or annual financial
statements that include the application of the measurement and disclosure provisions of FASB Statement No. 157.
(continued)
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FASB Statement No. 157 establishes a single definition of fair value and
a framework for measuring fair value in U.S. GAAP and also expands
disclosures about fair value measurements. The statement applies under other accounting pronouncements that require or permit fair value
measurements because FASB previously concluded in those accounting
pronouncements that fair value is the relevant measurement attribute.
Accordingly, this statement does not require any new fair value measurements, but the application of it will change current practice. However, FSP FAS 157-1, Application of FASB Statement No. 157 to FASB
Statement No. 13 and Other Accounting Pronouncements That Address Fair
Value Measurements for Purposes of Lease Classification or Measurement under Statement 13, established that FASB Statement No. 157 does not apply under FASB Statement No. 13, Accounting for Leases, and other accounting pronouncements that address fair value measurements for
purposes of lease classification or measurement under FASB Statement
No. 13. This scope exception does not apply to assets acquired and liabilities assumed in a business combination that are required to be measured at fair value under FASB Statement No. 141 or FASB Statement
No. 141(R), regardless of whether those assets and liabilities are related
to leases.
FASB Statement No. 157 retains the exchange price notion already established within U.S. GAAP but clarifies, among other matters, that fair
value is the price that would be received to sell the asset or paid to
transfer the liability (that is, an exit price) and not the price that would
be paid to acquire the asset or paid to transfer the liability (that is, an
entry price). Additionally, the statement establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure
fair value into 3 broad levels.
This checklist has been updated to include the presentation and disclosure requirements of FASB Statement No. 157 and FSP FAS 157-2.
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should consider all questions indicated with an “A” reference (for example, question 1A and question 2A) and should place an “N/A” mark in questions indicated with a “B” reference. Entities for which the guidance has
been implemented should consider all questions indicated by a “B” reference (for example, question 1B and question 2B) and place an “N/A”
mark by questions indicated with an “A” reference. Therefore, based
upon your entity’s year-end and decision to early implement or not (if
allowed), the following additional questions will be answered when
provided in this section (check one that applies for your entity):
pppA pppB
Readers can refer to the full text of the statement on the FASB Web site
at www.fasb.org.
******
In September 2008, FASB issued EITF Issue No. 08-5, “Issuer’s Accounting for Liabilities Measured at Fair Values with a Third-Party Credit
(continued)
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Enhancement,” to determine an issuer’s unit of accounting for a liability
issued with an inseparable third-party credit enhancement when it is
measured or disclosed at fair value on a recurring basis and to amend
the required disclosures. This issue applies to liabilities issued with an
inseparable third-party credit enhancement (for example, debt that is
issued with a contractual third-party guarantee) when they are measured or disclosed at fair value on a recurring basis.
This EITF issue states that the issuer of a liability with a third-party
credit enhancement that is inseparable from the liability should not include the effect of the credit enhancement in the fair value measurement of the liability. For example, in determining the fair value of debt
with a third-party guarantee, the issuer would consider its own credit
standing and not that of the third-party guarantor. Further, this issue
requires an issuer disclose the existence of a third-party credit enhancement on its issued liability that is within the scope of this issue.
This EITF issue is effective on a prospective basis in the first reporting
period beginning on or after December 15, 2008 (that is, January 1, 2009,
for entities with calendar year-ends). The effect of initially applying the
guidance in this Issue should be included in the change in fair value in
the period of adoption. Earlier application is permitted.
The EITF reached a consensus that in the period of adoption an entity
should disclose the valuation technique(s) used to measure the fair
value of liabilities in the scope of this issue and include a discussion of
changes, if any, from the valuation techniques used to measure those
liabilities in prior periods.
This checklist has been updated to include the presentation and disclosure requirements of EITF Issue No. 08-5.
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should consider all questions indicated with an “A” reference (for example, question 1A and question 2A) and should place an “N/A” mark in questions indicated with a “B” reference. Entities for which the guidance has
been implemented should consider all questions indicated by a “B” reference (for example, question 1B and question 2B) and place an “N/A”
mark by questions indicated with an “A” reference. Therefore, based
upon your entity’s year-end and decision to early implement or not (if
allowed), the following additional questions will be answered when
provided in this section (check one that applies for your entity):
pppA pppB
Readers can refer to the full text of the statement on the FASB Web site
at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and
open effective date information discussed in FASB ASC 820-10-65-3.
******
In April, 2009, FSP FAS 157-4, Determining Fair Value When the Volume
and Level of Activity for the Asset or Liability Have Significantly Decreased
and Identifying Transactions That Are Not Orderly, was released to pro(continued)
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vide additional guidance for estimating fair value in accordance with
FASB Statement No. 157 when the volume and level of activity for the
asset or liability have significantly decreased and to provide guidance
on identifying circumstances that indicate a transaction is not orderly.
Further, this FSP superseded FSP FAS 157-3, Determining the Fair Value
of a Financial Asset When the Market for That Asset Is Not Active.
This FSP is effective for interim and annual reporting periods ending
after June 15, 2009 (that is, December 31, 2009, for entities with calendar
year-ends), and should be applied prospectively. This FSP does not require disclosures for earlier periods presented for comparative purposes at initial adoption. In periods after initial adoption, this FSP requires comparative disclosures only for periods ending after initial
adoption.
This checklist has been updated to include the presentation and disclosure requirements of FSP FAS 157-4.
Readers can refer to the full text of the FSP on the FASB Web site at
www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and
open effective date information discussed in FASB ASC 820-10-65-4.
******
In September 2009, FASB issued ASU No. 2009-012, Fair Value Measurements and Disclosures.
The amendments in this ASU apply to all reporting entities that hold
an investment that is required or permitted to be measured or disclosed
at fair value on a recurring or nonrecurring basis and, as of the reporting entity’s measurement date, if the investment meets both of the following criteria:
1.

The investment does not have a readily determinable fair
value.

2.

The investment is in an entity that has all of the attributes specified in FASB ASC 946-10-15-2 (those attributes include investment activity, unit ownership, pooling of funds, and reporting
entity) or, if one or more of the attributes in FASB ASC 946-1015-2 are not present, is an entity for which it is industry practice
to issue financial statements using guidance that is consistent
with the measurement principles in FASB ASC 946.

This ASU provides amendments to FASB ASC 820 for the fair value
measurement of investments in certain entities that calculate net asset
value per share (or its equivalent). Further, this ASU requires disclosures by major category of investment about the attributes of investments within the scope of the amendments in the update.
The amendments in this ASU are effective for interim and annual periods ending after December 15, 2009 (that is, December 31, 2009, for
entities with calendar year-ends). Early application is permitted in financial statements for earlier interim and annual periods what have not
been issued. (If an entity elects to early adopt ASU No. 2009-012, the
(continued)
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entity is permitted to defer the adoption of the disclosure provisions of
FASB 820-10-50-6A until periods ending after December 15, 2009.
This checklist has been updated to include the presentation and disclosure requirements of ASU No. 2009-012.
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should consider all questions indicated with an “A” reference (for example, question 1A and question 2A) and should place an “N/A” mark in questions indicated with a “B” reference. Entities for which the guidance has
been implemented should consider all questions indicated by a “B” reference (for example, question 1B and question 2B) and place an “N/A”
mark by questions indicated with an “A” reference. Therefore, based
upon your entity’s year-end and decision to early implement or not (if
allowed), the following additional questions will be answered when
provided in this section (check one that applies for your entity):
pppA pppB
Readers can refer to the full text of the ASU on the FASB Web site at
www.fasb.org.

Practice Tips
With regards to question 1, for equity and debt securities major category is defined as major security type as
described in FASB ASC 942-320-50-2, even if the equity securities or debt securities are not within the scope
of FASB ASC 942-320.
[“Pending Content” in FASB ASC 820-10-50-2]
(ASU 2009-012) With regards to question 1, for equity and debt securities major category is defined as major
security type as described in FASB ASC 320-10-50-1B, even if the equity securities or debt securities are not
within the scope of FASB ASC 320-10 and, for a reporting entity within the scope of FASB ASC 942, as
described in FASB ASC 942-320-50-2.
[“Pending Content” in FASB ASC 820-10-50-2]
1.

For assets and liabilities that are measured at fair value on a
recurring basis in periods subsequent to initial recognition
(for example, trading securities), the reporting entity should
disclose information that enables users of its financial statements to assess the inputs used to develop those measurements and for recurring fair value measurements using significant unobservable inputs (level 3), the effect of the
measurements on earnings (or changes in net assets) for the
period. To meet that objective, the reporting entity should
disclose the following information for each interim and annual period (except as otherwise specified) separately for
each major category of assets and liabilities:
a.

The fair value measurements at the reporting date?
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b.

The level within the fair value hierarchy in which the
fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (level 1),
significant other observable inputs (level 2), and significant unobservable inputs (level 3)?

c.

For fair value measurements using significant unobservable inputs (level 3), a reconciliation of the beginning and ending balances, separately presenting
changes during the period attributable to the following
(may be presented net):
i.

Total gains or losses for the period (realized and
unrealized), segregating those gains or losses included in earnings (or changes in net assets), and
a description of where those gains or losses included in earnings (or changes in net assets) are
reported in the statement of income (or activities)?

ii.

Purchases, sales, issuances, and settlements (net)?

iii.

Transfers in and out, or both, of level 3 (for example, transfers due to changes in the observability of significant inputs)?

d.

The amount of the total gains or losses for the period
in question 1(c)(1) included in earnings (or changes in
net assets) that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date and a description of
where those unrealized gains or losses are reported in
the statement of income (or activities)?

e.

The inputs and valuation technique(s) used to measure
fair value and a discussion of changes in valuation
techniques and related inputs, if any, during the period?
[FASB ASC 820-10-50 par. 1 and 3; “Pending Content”
in FASB ASC 820-10-50-2]

No

N/A

Practice Tip
(EITF Issue No. 08-05) With regards to question 2B following, FASB ASC 820-10-35-18A states that, for the
issuer, the unit of accounting for a liability measured or disclosed at fair value does not include the thirdparty credit enhancement.
[“Pending Content” in FASB ASC 820-10-50-4A]
2B.
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(EITF Issue No. 08-05) For a liability having the characteristics set forth in FASB ASC 820-10-25-1, has the entity disclosed the existence of a third-party credit enhancement on
its issued liability, if such an enhancement exists?
[“Pending Content” in FASB ASC 820-10-50-4A]
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3.

Are the quantitative disclosures required by FASB ASC 82010-50 presented using a tabular format?
[FASB ASC 820-10-50-8]

4A.

If the entity has not voluntarily applied the guidance of FASB
ASC 820 in interim or annual financial statements to the nonfinancial assets and nonfinancial liabilities as discussed in
FASB ASC 820-10-15-1A, have disclosures been made (a) that
the entity has not applied the guidance of FASB ASC 820 to
such nonfinancial assets and nonfinancial liabilities and (b) to
detail each major category of assets and liabilities that are recognized or disclosed at fair value for which the entity has not
voluntarily applied the guidance in FASB ASC 820?
[FASB ASC 820-10-50-8A]

4B.

(FSP FAS 157-2) [Not used. The item preceding has been removed due to the effective date of FSP FAS 157-2.]

5.

Is the fair value information disclosed under FASB ASC 82010-50 and the fair value information disclosed as required by
other FASB ASC topics (for example, FASB ASC 825-10-50)
combined in the periods in which those disclosures are required, if practicable? (Encouraged, but not required.)
[FASB ASC 820-10-50-9]

6.

Is information about other similar measurements (for example, inventories measured at market value under FASB ASC
330, Inventory) disclosed, if practicable? (Encouraged, but not
required.)
[FASB ASC 820-10-50-9]

7.

If the organization reports assets and liabilities at fair value
pursuant to the fair value option in FASB ASC 825, has it either (a) presented the aggregate of fair value and non-fairvalue amounts in the same line item in the statement of financial position and parenthetically disclosed the amount
measured at fair value included in the aggregate amount or
(b) presented 2 separate line items to display the fair value
and non-fair-value carrying amounts of similar assets and liabilities?
[FASB ASC 825-10-45 par. 1–2]

No

N/A

Practice Tip
The principal objectives of the disclosures required by paragraphs 28–32 of FASB ASC 825-10-50 (questions
8–11 following) are to facilitate (a) comparisons between entities that choose different measurement attributes for similar assets and liabilities and (b) comparisons between assets and liabilities in the financial statements of an entity that selects different measurement attributes for similar assets and liabilities.
The disclosure requirements are expected to result in the following:
●

Information to enable users of its financial statements to understand management’s reasons for electing or partially electing the fair value option

●

Information to enable users to understand how changes in fair values affect earnings for the period
(continued)
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●

The same information about certain items (such as equity investments and nonperforming loans)
that would have been disclosed if the fair value option had not been elected

●

Information to enable users to understand the differences between fair values and contractual cash
flows for certain items

To meet those objectives, the disclosures described in questions 8–11 are required for items measured at fair
value under the option in FASB ASC 825-10 and the fair value option for hybrid instruments in FASB ASC
815-15-25-4. Those disclosures are not required for securities classified as trading securities under FASB ASC
320, life settlement contracts measured at fair value pursuant to FASB ASC 325-30, or servicing rights measured at fair value pursuant to FASB ASC 860-50. Guidance therein includes disclosure requirements not
affected by FASB ASC 825-10.
Entities should provide the disclosures in questions 8–11 in both interim and annual financial statements.
These disclosure requirements do not eliminate disclosure requirements otherwise required by U.S. GAAP,
including other disclosure requirements relating to fair value measurement. Entities are encouraged but are
not required to present the disclosures required by FASB ASC 825-10 in combination with related fair value
information required to be disclosed by other FASB ASC topics.
[FASB ASC 825-10-50 par. 24–27]
8.

As of each date for which a statement of financial position is
presented, has the organization disclosed the following information about items measured at fair value under the option
in FASB ASC 825:
a.

Management’s reasons for electing a fair value option
for each eligible item or group of similar eligible items?

b.

The following information if the fair value option is
elected for some but not all eligible items within a
group of similar eligible items:

c.

d.
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i.

A description of those similar items and the reasons for partial election?

ii.

Information to enable users to understand how
the group of similar items relates to individual
line items on the statement of financial position?

The following information for each line item in the
statement of financial position that includes an item or
items for which the fair value option has been elected:
i.

Information to enable users to understand how
each line item in the statement of financial position relates to major categories of assets and liabilities presented in accordance with the fair
value disclosure requirements in FASB ASC 820?

ii.

The aggregate carrying amount of items included
in each line item in the statement of financial position that are not eligible for the fair value option, if any?

The difference between the aggregate fair value and the
aggregate unpaid principal balance of
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e.

f.

i.

Loans and long term receivables (other than securities subject to FASB ASC 320) that have contractual principal amounts and for which the fair
value option has been elected?

ii.

Long term debt instruments that have contractual principal amounts and for which the fair
value option has been elected?

No

N/A

For loans held as assets for which the fair value option
has been elected
i.

The aggregate fair value of loans that are 90 days
or more past due?

ii.

If the entity’s policy is to recognize interest income separately from other changes in fair value,
the aggregate fair value of loans in nonaccrual
status?

iii.

The difference between the aggregate fair value
and the aggregate unpaid principal balance for
loans that are 90 days or more past due, in nonaccrual status, or both?

The information required by FASB ASC 323-10-50-3
(equity method and joint venture investments) for investments that would have been accounted for under
the equity method if the entity had not chosen to apply
the fair value option?
[FASB ASC 825-10-50-28]
Practice Tip

Per FASB ASC 825-10-50-29, the disclosure in FASB ASC 825-10-50-28(f), question 8 applies to investments
in common stock, investments in in-substance common stock, and other investments (for example, partnerships and certain limited liability corporations) that both
1.

would otherwise be required to be accounted for under the equity method under other U.S. GAAP,
and

2.

would be required to satisfy the disclosure requirements of FASB ASC 323-10-50-3.

When applying this item, an entity should apply the guidance from paragraphs 2 and 3(a)–(c) of FASB ASC
323-10-50.
[FASB ASC 825-10-50-29]
9.

As of each period for which an interim or annual income
statement is presented, has the entity disclosed the following
information about items measured at fair value under the option in FASB ASC 825:
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a.

For each line item in the statement of financial position,
the amounts of gains and losses from fair value
changes during the period included in earnings and in
an intermediate measure of operations, if one is presented, and in which line in the income statement those
gains and losses are reported? (An entity may meet this
requirement by disclosing amounts of gains and losses
that include amounts of gains and losses for other items
measured at fair value, such as items required to be
measured at fair value.)

b.

A description of how interest and dividends are measured and where they are reported in the income statement?

c.

For loans and other receivables held as assets, (1) the
estimated amount of gains or losses included in earnings during the period attributable to changes in instrument-specific credit risk and (2) how the gains or losses
attributable to changes in instrument-specific credit risk
were determined?

d.

For liabilities with fair values that have been significantly affected during the reporting period by changes
in the instrument-specific credit risk, (1) the estimated
amount of gains and losses from fair value changes included in earnings that are attributable to changes in
the instrument-specific credit risk, (2) qualitative information about the reasons for those changes, and (3)
how the gains and losses attributable to changes in instrument-specific credit risk were determined?
[FASB ASC 825-10-50-30]

10.

In its annual period only, has the entity disclosed the methods and significant assumptions used to estimate the fair
value of items for which the fair value option has been
elected?
[FASB ASC 825-10-50-31]

11.

If an entity elects the fair value option at a remeasurement
event, has it disclosed the following for the period of the election:
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a.

Qualitative information about the nature of the event?

b.

Quantitative information by line item in the statement
of financial position indicating which line items in the
income statement include the effect of initially electing
the fair value option for an item?
[FASB ASC 825-10-50-32]

No

N/A
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Practice Tip
(ASU No. 2009-012) ASU No. 2009-012 changes the definition of major category, as used in the questions
12–13 following, to be defined as a major security type as described in FASB ASC 320-15-50-1B, even if the
equity securities or debt securities are not within the scope of FASB ASC 320-10 and, for a reporting entity
within the scope of FASB ASC 942, Financial Services–Depository and Lending, as described in FASB ASC 942320-50-2.
[“Pending Content” in FASB ASC 820-10-50-2; “Pending Content” in FASB ASC 820-10-50-5]
12.

For assets and liabilities that are measured at fair value on a
recurring basis in periods subsequent to initial recognition
(for example, trading securities), the reporting entity should
disclose information that enables users of its financial statements to assess the inputs used to develop those measurements and for recurring fair value measurements using significant unobservable inputs (level 3), the effect of the
measurements on earnings (or changes in net assets) for the
period. To meet that objective, the reporting entity should
disclose the following information for each interim and annual period (except as otherwise specified) separately for
each major category of assets and liabilities:
a.

The fair value measurements at the reporting date?

b.

The level within the fair value hierarchy in which the
fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (level 1),
significant other observable inputs (level 2), and significant unobservable inputs (level 3)?

c.

For fair value measurements using significant unobservable inputs (level 3), a reconciliation of the beginning and ending balances, separately presenting
changes during the period attributable to the following
(may be presented net):
i.

Total gains or losses for the period (realized and
unrealized), segregating those gains or losses included in earnings (or changes in net assets), and
a description of where those gains or losses included in earnings (or changes in net assets) are
reported in the statement of income (or activities)?

ii.

Purchases, sales, issuances, and settlements (net)?

iii.

Transfers in and out, or both, of level 3 (for example, transfers due to changes in the observability of significant inputs)?
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d.

The amount of the total gains or losses for the period
in question 12(c)(1) included in earnings (or changes in
net assets) that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date and a description of
where those unrealized gains or losses are reported in
the statement of income (or activities)?

e.

The inputs and valuation technique(s) used to measure
fair value and a discussion of changes in valuation
techniques, if any, during the period?
[“Pending Content” in FASB ASC 820-10-50-2; FASB
ASC 820-10-50-3]

For assets and liabilities that are measured at fair value on a
nonrecurring basis in periods subsequent to initial recognition (for example, impaired assets), the reporting entity
should disclose information that enables users of its financial
statements to assess the inputs used to develop those measurements? To meet that objective, the reporting entity should
disclose the following information for each interim and annual period (except as otherwise specified) separately for
each major category of assets and liabilities:
a.

The fair value measurements recorded during the period and the reasons for the measurements?

b.

The level within the fair value hierarchy in which the
fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (level 1),
significant other observable inputs (level 2), and significant unobservable inputs (level 3)?

c.

For fair value measurements using significant unobservable inputs (level 3), a description of the inputs and
the information used to develop the inputs?

d.

The inputs and valuation technique(s) used to measure
fair value and a discussion of changes, if any, in the
valuation technique(s) used to measure similar assets
and/or liabilities in prior periods?
[“Pending Content” in FASB ASC 820-10-50-5]

14B. (ASU No. 2009-012) For investments that are within the scope
of paragraphs 4–5 of FASB ASC 820-10-15 and that are measured at fair value (on a recurring or nonrecurring basis), has
the entity disclosed information that enables that users of its
financial statements to understand the nature and risks of the
investments and whether the investments are probable of being sold at amounts different from net asset value (or its
equivalent)? (See FASB ASC 820-10-50-6A for example disclosures.)
[“Pending Content” in FASB ASC 820-10-50-6A]
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15B. (EITF Issue No. 08-5) For a liability having the characteristics
set forth in FASB ASC 820-10-25-1, has the entity disclosed
the existence of the third-party credit enhancement on its issued liability? (Note: FASB ASC 820-10-35-18A states that, for
the issuer, the unity of accounting for a liability measured or
disclosed at fair value does not include the third-party credit
enhancement.)
[“Pending Content” in FASB ASC 820-10-50-4A]
Practice Tip
The disclosure provisions in FASB ASC 250 for a change in accounting estimate are not required for revisions resulting from a change in a valuation technique of its application.
[FASB ASC 820-10-50-7]

Notes: In December 2008, FASB issued FSP FAS 132(R)-1 to provide
guidance on an employer’s disclosures about plan assets of a defined
benefit pension or other postretirement plan. One objective is to disclose information about fair value measurements of plan assets that
would be similar to the disclosures required by FASB Statement No.
157.
The disclosures about plan assets required by this FSP should be provided for fiscal years ending after December 15, 2009 (that is, December
31, 2009, for entities with calendar year-ends). Upon initial application,
the provisions of this FSP are not required for earlier periods presented
for comparative purposes. Earlier application is permitted.
This FSP also includes a technical amendment to FASB Statement No.
132(R) that requires a nonpublic entity to disclose net periodic benefit
cost for each annual period for which a statement of income is presented. This amendment was effective upon issuance.
This checklist has been updated to include the presentation and disclosure requirements of FSP FAS 132(R)-1.
As determined by the effective date or early implementation decision,
entities for which this guidance has not been implemented should consider all questions indicated with an “A” reference (for example, question 1A and question 2A) and should place an “N/A” mark in questions indicated with a “B” reference. Entities for which the guidance has
been implemented should consider all questions indicated by a “B” reference (for example, question 1B and question 2B) and place an “N/A”
mark by questions indicated with an “A” reference. Therefore, based
upon your entity’s year-end and decision to early implement or not (if
allowed), the following additional questions will be answered when
provided in this section (check one that applies for your entity):
pppA pppB
Readers can refer to the full text of the statement on the FASB Web site
at www.fasb.org.
This guidance is labeled as "Pending Content" due to the transition and
open effective date information discussed in FASB ASC 715-20-65-2.
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16B. (FSP FAS 132(R)-1) Plan assets of a defined pension or other
postretirement plan that are accounted for under FASB ASC
715 are not subject to the disclosure requirements in paragraphs 1–9 of FASB ASC 820-10-50 but are subject to disclosure requirements under FASB ASC 715-20-50-1(d)(iv) and
FASB ASC 715-20-50-5(c)(iv). Have the proper disclosures
been made under the listed paragraphs of FASB ASC 715?
[“Pending Content” in FASB ASC 820-10-50-10]
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Auditors’ Reports Checklist
.01 This section of the checklist has been developed primarily to address the requirements most likely
to be encountered when reporting on financial statements of life and health insurance entities in accordance
with generally accepted auditing standards (GAAS) as issued by the Auditing Standards Board (ASB), a
senior technical committee of the AICPA. Certain key differences in reporting requirements between audits
conducted in accordance with GAAS and audits conducted in accordance with the rules and standards of
the Public Company Accounting Oversight Board (PCAOB) are identified in bold text throughout this section of the checklist. However, the differences identified are not intended to be all inclusive, and readers
should seek appropriate guidance for a comprehensive source of reporting requirements associated with
audits conducted in accordance with the rules and standards of the PCAOB.
Yes
1.

Is each financial statement audited specifically identified in the introductory paragraph of the auditor’s report?
[AU 508.06]

2.

Do the titles of the financial statements referred to in the introductory paragraph of the auditor’s report match the titles of the financial statements presented?
[Common Practice]

3.

Do the dates of the financial statements referred to in the introductory paragraph of the auditor’s report match the dates of the financial statements presented?
[Common Practice]

4.

Is the report appropriately addressed?
[AU 508.09]

No

N/A

Practice Tip
Interpretation No. 17, “Clarification in the Audit Report of the Extent of Testing of Internal Control Over
Financial Reporting in Accordance With Generally Accepted Auditing Standards,” of AU section 508, Reports on Audited Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 9508 par. .85–.88), provides language that may be added to the auditor’s standard report on the financial statements of a nonissuer
to clarify differences between a GAAS audit and an audit conducted in accordance with the standards of
the PCAOB. Interpretation No. 18, “References to PCAOB Standards in an Audit Report on a Nonissuer,”
of AU section 508 (AICPA, Professional Standards, vol. 1, AU sec. 9508 par. .89–.92) explains how the auditor
should report if engaged to also follow PCAOB auditing standards in the audit of a nonissuer.
5.

Does the independent auditor’s report include the following elements:
a.

A title that includes the word independent?
[AU 508.08a]

b.

The titles of each financial statement in the introductory paragraph of the report?
[AU 508.06]
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c.

If the financial statements include a separate statement of
changes in stockholders’ equity accounts, it is identified in the
introductory paragraph of the report?
[AU 508.06]

d.

A statement that the financial statements are the responsibility of management and that the auditor’s responsibility is to
express an opinion on the financial statements based on his
or her audit?
[AU 508.08c]

e.

For audits conducted in accordance with GAAS in the United
States, a statement that the audit was conducted in accordance with GAAS and an identification of the country of origin of those standards (for example, auditing standards generally accepted in the United States of America or U.S.
GAAS)?
[AU 508.08d]

f.

(Audits of Issuers Only) A statement that the audit was conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States)?
[PCAOB Auditing Standard No. 1 par. 3]

g.

A statement that those standards require that the auditor plan
and perform the audit to obtain reasonable assurance about
whether the financial statements are free of material misstatement?
[AU 508.08e]

h.

A statement that an audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements; assessing the accounting principles used
and significant estimates made by management; and evaluating the overall financial statement presentation?
[AU 508.08f]

i.

A statement that the auditor believes that his or her audit
provides a reasonable basis for his or her opinion?
[AU 508.08g]

j.

When the auditor reports on financial statements presented
in conformity with U.S. generally accepted accounting principles (GAAP), an opinion concerning whether the financial
statements present fairly, in all material respects, the financial
position of the reporting entity as of the balance sheet date
and the results of its operations and its cash flows for the period then ended in conformity with GAAP? The opinion
should include an identification of the United States of America as the country of origin of those accounting principles.
[AU 508.08h]

Notes: Interpretation No. 19, “Financial Statements Prepared in Conformity
With International Financial Reporting Standards as Issued by the International Accounting Standards Board,” of AU section 508 (AICPA, Professional Standards, vol. 1, AU sec. 9508 par. .93–.97) provides that, when the
(continued)
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auditor of a nonissuer reports on financial statements prepared in conformity with International Financial Reporting Standards (IFRSs), the auditor
would refer, in the auditor’s report, to the IFRSs rather than U.S. GAAP.
When an auditor of a nonissuer reports on financial statements presented
in conformity with both the IFRSs as issued by the International Accounting Standards Board (IASB) and a jurisdictional variation of the IFRSs, the
auditor would refer, in the auditor’s report, to both the IFRSs and the IFRSs
as endorsed by [insert name of endorsing country or economic union].
When an auditor of a nonissuer reports on financial statements presented
in conformity with a jurisdictional variation of the IFRSs such that the entity’s financial statements do not contain an explicit and unreserved statement of compliance with the IFRSs as issued by the IASB, paragraphs
.14–.15 of AU section 534, Reporting on Financial Statements Prepared for Use
in Other Countries (AICPA, Professional Standards, vol. 1), and paragraphs
.35–.60 of AU section 508 (AICPA, Professional Standards, vol. 1) apply to
financial statements prepared for more than limited distribution in the
United States.
k.

When the auditor reports on financial statements presented
in conformity with the IFRSs, an opinion concerning whether
the financial statements present fairly, in all material respects,
the financial position of the reporting entity as of the balance
sheet date and the results of its operations and its cash flows
for the period then ended in conformity with the IFRSs as
issued by the IASB?
[AU 9508.93–.97]

l.

When the auditor reports on financial statements presented
both in conformity with the IFRSs and a jurisdictional variant
of the IFRSs, an opinion concerning whether the financial
statements present fairly, in all material respects, the financial
position of the reporting entity as of the balance sheet date
and the results of its operations and its cash flows for the period then ended in conformity with the IFRSs as issued by the
IASB and with the IFRSs as endorsed by [insert name of endorsing country or economic union]?
[AU 9508.93–.97]

m.

When the auditor reports on financial statements presented
in conformity with a jurisdictional variation of the IFRSs such
that the entity’s financial statements do not contain an explicit
and unreserved statement of compliance with the IFRSs as
issued by the IASB, a variation of the standard report that
reflects the guidance in paragraphs .14–.15 of AU section 534
and paragraphs .35–.60 of AU section 508 (AICPA, Professional Standards, vol. 1) for financial statements prepared for
more than limited distribution in the United States?
[AU 9508.93–.97]

n.

The manual or printed signature of the auditor’s firm?
[AU 508.08i]

o.

The date of the audit report?
[AU 508.08j; AU 530.05]
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Practice Tip
The independent auditor has 2 methods available for dating the report when a subsequent event disclosed
in the financial statements occurs after the original date of the auditor’s report but before the issuance of the
related financial statements. The auditor may use "dual dating" (for example, "February 16, 20pp, except for
Note pp, for which the date is March 1, 20pp,") or may date the report as of the later date. In the former
instance, the responsibility for events occurring subsequent to the original report date is limited to the specific event referred to in the note (or otherwise disclosed). In the latter instance, the independent auditor’s
responsibility for subsequent events extends to the date of the report, and, accordingly, the procedures outlined in paragraph .12 of AU section 560, Subsequent Events (AICPA, Professional Standards, vol. 1), generally
should be extended to that date.
6.

7.

Does the reporting language conform with the auditor’s standard
report on
a.

financial statements of a single year or period?

b.

comparative financial statements?
[AU 508.08]

Does the report include appropriate language for the following situations:
a.

Only one basic financial statement is presented and there are
no scope limitations?
[AU 508.33–.34]

b.

Audited and unaudited financial statements are presented in
comparative form?
[AU 504.15–.17]

c.

Different opinions are expressed on comparative financial
statements?
[AU 508.05]

Note: Interpretation No. 14, “Reporting on Audits Conducted in Accordance With Auditing Standards Generally Accepted in the United States of
America and in Accordance With International Standards on Auditing,” of
AU section 508 (AICPA, Professional Standards, vol. 1, AU sec. 9508 par.
.56–.59) provides that, when the audit of a nonissuer is conducted both in
accordance with standards generally accepted in the United States of
America and in accordance with the International Standards on Auditing
(ISAs), the auditor may so indicate in the auditor’s report. To determine
whether an audit was conducted in accordance with the ISAs, it is necessary to consider the text of the ISAs in their entirety, including the basic
principles and essential procedures together with the related guidance included in the ISAs.

Practice Tip
If the audit of financial statements to be used in the United States was conducted in accordance with auditing standards generally accepted in the United States of America and ISAs as issued by the International
Auditing and Assurance Standards Board, in their entirety, although not required, has the auditor considered indicating in the auditor‘s report that the audit was also conducted in accordance with ISA as allowed.
[AU 9508.57–.59]
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8.
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Is the reporting form, content, and timing of paragraphs .20–.30 of
AU section 325A, Communicating Internal Control Related Matters
Identified in an Audit (AICPA, Professional Standards, vol. 1), followed
when communicating matters related to an organization’s internal
control over financial reporting identified in an audit of financial
statements?
[AU 325A.20–.30]

Note: Auditors are required to communicate control deficiencies identified
during an audit that are significant deficiencies or material weaknesses as
defined by AU section 325A, including significant deficiencies or material
weaknesses that were communicated in previous audits and have not yet
been remediated. Those control deficiencies must be communicated in
writing to management and those charged with governance. In October
2008, the ASB issued Statement on Auditing Standards (SAS) No. 115, Communicating Internal Control Related Matters Identified in an Audit (AICPA, Professional Standards, vol. 1, AU sec. 325), to eliminate differences within the
AICPA’s Audit and Attest Standards resulting from the issuance of Statement on Standards for Attestation Engagements (SSAE) No. 15, An Examination of an Entity’s Internal Control Over Financial Reporting That Is Integrated
With an Audit of Its Financial Statements (AICPA, Professional Standards, vol.
1, AT sec. 501). SAS No. 115 supersedes SAS No. 112 and revises the information in AU section 325A. SAS No. 115 is effective for audits of financial
statements for periods ending on or after December 15, 2009. Earlier application is permitted. Due to the issuance of SAS No. 115, the content of SAS
No. 112 has been moved to AU section 325A of Professional Standards until
the effective date of SAS No. 115.
9.

10.

If a subsequent event disclosed in the financial statements occurs
after the original date of the independent auditor’s report but before the issuance of the related financial statements, has the auditor
followed one of the following two methods available for dating the
report:
a.

Dual dating, in which the independent auditor’s responsibility for events occurring subsequent to the original report date
is limited to the specific event referred to in an explanatory
note in the report (or otherwise disclosed)?

b.

Dating the report as of the later date, in which the independent auditor’s responsibility for subsequent events extends to
the date of the report?
[AU 530.03–.05]

(Audits of Issuers Only) If the auditor obtains knowledge about a
subsequent event that
a.

materially and adversely affects the effectiveness of the entity’s internal control over financial reporting as of the date
specified in the assessment, has the auditor either
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Yes
i.

issued an adverse opinion on internal control over financial reporting (and followed the direction in paragraph C2 of PCAOB Auditing Standard No. 5 if management’s assessment states that internal control over
financial reporting is effective)?

ii.

disclaimed an opinion if the auditor is unable to determine the effect of the subsequent event on the effectiveness of the entity’s internal control over financial reporting?
relates to conditions that did not exist at the date specified in
the assessment but arose subsequent to that date and before
issuance of the auditor’s report, and the subsequent event has
a material effect on the entity’s internal control over financial
reporting, has the auditor included in his or her report an
explanatory paragraph describing the event and its effects or
directed the reader’s attention to the event and its effects as
disclosed in management’s report?
[PCAOB Auditing Standard No. 5 par. .96–.97]

b.

11.

If the accountant is not independent, has he or she followed one of
the two reporting alternatives available:
a.

Disclaiming the opinion with respect to the financial statements and specifically stating that he or she is not independent?
Issuing a compilation report in accordance with Statements
on Standards for Accounting and Review Services indicating
the lack of independence (nonpublic entities only)?
[AU 504.05 and .09–.10; AR 100.21 and .48]

b.

Note: The Accounting and Review Services Committee (ARSC) issued
an exposure draft that would revise the standards for compilation
and review engagements. Significant changes to SSARSs include the
following:
●

●
●

●

The introduction of new terms, such as review evidence and
review risk, to the review literature to harmonize with international review standards.
A discussion of materiality in the context of a review engagement.
A requirement that an accountant document the establishment of an understanding with management through a written communication (that is, an engagement letter) regarding
the services to be performed.
The establishment of enhanced documentation requirements
for compilation and review engagements.

The ability for an accountant to include a general description
in the accountant’s compilation report regarding the reason(s)
for an independence impairment.
The ARSC voted to issue these revisions as a final standard, SSARS
No. 19, Compilation and Review Engagements. The standard is expected
to be issued in December 2009. The effective date is for compilations
(continued)
●
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and reviews of financial statements for periods beginning on or after
December 15, 2010. Early application would be permitted with respect to permitting an accountant to disclose the reasons for a lack of
independence in a compilation report.
12.

13.

14.

If the opinion is based in part on the report of another auditor,
a.

does the introductory paragraph of the standard report disclose the fact that the opinion is based, in part, on the report
of other auditors?

b.

does the opinion paragraph include a reference to the report
of the other auditor?
[AU 508.11a, .12, and .13]

If, to prevent the financial statements from being misleading because of unusual circumstances, the financial statements contain a
departure from an accounting principle promulgated by a body
designated by the AICPA Council to establish such principles, does
the report include, in a separate paragraph or paragraphs, the information required by the rule?
[AU 508.11b and .15]
If the auditor uses the work of a specialist in performing an audit,
have they added an optional explanatory paragraph?
[AU 336.16]
Note: Reference to and identification of the specialist may be added if
the auditor believes such a reference will facilitate an understanding
of the reason for the explanatory paragraph.
[AU 336.16]

15.

If there is substantial doubt about the entity’s ability to continue as
a going concern for a reasonable period of time, not to exceed one
year beyond the date of the financial statements being audited,
a.
does the report include an explanatory paragraph, following
the opinion paragraph, to reflect that conclusion?
b.
is that conclusion expressed through the use of the phrase
“substantial doubt about its (the entity’s) ability to continue
as a going concern” or similar wording that includes the
terms substantial doubt and going concern?
[AU 508.11c; AU 341.12]
Practice Tip

In evaluating whether there is substantial doubt about the entity’s ability to continue as a going concern, the
auditor’s evaluation is based on his or her knowledge of relevant conditions that exist at or have occurred
prior to the date of the auditor’s report. If, after considering identified conditions and events and management’s
plans, the auditor concludes that substantial doubt about the entity’s ability to continue as a going concern
for a reasonable period of time remains, the audit report should include an explanatory paragraph to reflect
that conclusion.
In a going concern paragraph, the auditor should not use conditional language in expressing a conclusion
concerning the existence of substantial doubt about the entity’s ability to continue as a going concern. See
paragraph .13 of AU section 341, The Auditor’s Consideration of an Entity’s Ability to Continue as a Going Concern (AICPA, Professional Standards, vol. 1), for an example.
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16.

Is the report dated no earlier than the date on which the auditor has
obtained sufficient appropriate audit evidence to support the auditor’s opinion on the financial statements?
[AU 530.01]

17.

(Audits of Issuers Only) Is the report dated no earlier than the date
on which the auditor has obtained sufficient competent evidence to
support the auditor‘s opinion on the financial statements?
[PCAOB Auditing Standard No. 5 par. 89]

18.

(Audits of Issuers Only) When performing an integrated audit of
financial statements and internal control over financial reporting,
are the auditor’s reports on the entity’s financial statements and on
internal control over financial reporting dated the same?
[PCAOB Auditing Standard No. 5 par. 89]

19.

(Audits of Issuers Only) Prior to the report release date, among
other matters, has the auditor obtained sufficient evidence to support the representations in the auditor’s reports?
[PCAOB Auditing Standard No. 3 par. 15]

No

N/A

Practice Tip
Changes in Accounting Estimates
Paragraph .15 of AU section 420, Consistency of Application of Generally Accepted Accounting Principles (AICPA,
Professional Standards, vol. 1), clarifies that the change in an accounting estimate that does not include a
change in accounting principle does not require an explanatory paragraph in the auditor’s report. However,
an accounting change of this type having a material effect on the financial statements may require disclosure
in a note to the financial statements.
Changes in Classification
Paragraph .17 of AU section 420 clarifies that changes in classification from the prior year’s financial statements are usually not of sufficient importance to necessitate disclosure; however, material changes in classification should be indicated and explained in the financial statements or notes.
Error Corrections
Paragraph .16 of AU section 420 states that the correction of an error in previously issued financial statements resulting from mathematical mistakes, oversight, or misuse of facts that existed at the time the financial statements were originally prepared does not involve the consistency standard if no element of accounting principles or their application is included. Accordingly, the independent auditor need not recognize the
correction in his report. However, if the independent auditor had previously reported on the financial statements containing the error, the auditor has concluded, based on the considerations in paragraph .05 of AU
section 561, Subsequent Discovery of Facts Existing at the Date of the Auditor’s Report (AICPA, Professional Standards, vol. 1), that action should be taken to prevent future reliance on his report, and the issuance of financial statements accompanied by the auditor’s report for a subsequent period is imminent, the auditor should
disclose the revision in such statements instead of reissuing the earlier statements.

Notes: For audits of issuers, certain circumstances, although not affecting
the auditor’s unqualified opinion, may require that the auditor add explanatory language to the standard report as described in paragraphs .11–.19 of
AU section 508, Reports on Audited Financial Statements (AICPA, PCAOB
Standards and Related Rules, Interim Standards).
(continued)
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Other circumstances may require a departure from an unqualified opinion,
either in the form of a qualified opinion, an adverse opinion, or a disclaimed opinion as described in paragraphs .20–.63 of AU section 508
(AICPA, PCAOB Standards and Related Rules, Interim Standards).
For special reporting situations relating to the auditor’s report on internal
control over financial reporting, refer to appendix C, Special Reporting Situations, of Auditing Standard No. 5.
******
PCAOB Auditing Standard No. 6, Evaluating Consistency of Financial Statements (AICPA, PCAOB Standards and Related Rules, Auditing Standards),
updated the auditor’s responsibilities to evaluate and report on the consistency of an entity’s financial statements and align the auditor’s responsibilities with Financial Accounting Standards Board (FASB) Statement No. 154,
Accounting Changes and Error Corrections.
One significant difference in terminology between FASB Statement No. 154
(which is codified in FASB Accounting Standards Codification (ASC) 250, Accounting Changes and Error Corrections) and Auditing Standard No. 6 is the
use of the term error in the FASB standard whereas the PCAOB standard
uses the term misstatement and specifically states that the meaning is the
same for purposes of the PCAOB Auditing Standards. Auditing Standard
No. 6 also establishes that the auditor’s report should indicate whether an
adjustment to previously issued financial statements results from a change
in accounting principle or the correction of a misstatement.
Auditing Standard No. 6 contains numerous amendments to AU section
508 (AICPA, PCAOB Standards and Related Rules, Interim Standards) and
other interim PCAOB Auditing Standards. If Auditing Standard No. 6 is
applicable to issuers’ financial statements, answer questions 21–22; otherwise, skip questions 21–22. For more information and for the full text of
the auditing standard, refer to the PCAOB Web site at www.pcaob.org.
Also refer to the Securities and Exchange Commission (SEC) Web site at
www.sec.gov.
20.

If there has been a material change between periods in accounting
principles or in the method of their application, including a change
from an accounting principle that is not generally accepted to one
that is generally accepted and a change in accounting principle that
is inseparable from the effect of a change in estimate, that has a
material effect on the comparability of the reporting entity’s financial statements,
a.

does the report include an explanatory paragraph, following
the opinion paragraph that refers to the change?

b.

does the explanatory paragraph identify the nature of the
change and refer the reader to the note to the financial statements that discusses the change in detail?
[AU 508.05–.06 and .12–.13]

FSP §20,200.01

238

Life and Health Insurance Entities

Yes
c.

21.

22.

23.

if the change in the accounting principle is a change in reporting entity that did not result from a transaction or an
event, is an explanatory paragraph included in the auditor’s
report? (Note: A change in the reporting entity resulting from
a transaction or event, such the creation, cessation, or complete or partial purchase or disposition of a subsidiary or
other business unit, does not require that an explanatory paragraph about consistency be included in the auditor’s report.)
[AU 420.08]

(Audits of Issuers Only) If there has been a change in accounting
principle that has a material effect on the financial statements, including a change in the method of applying an accounting principle, a change in estimate effected by a change in accounting principle, and a change in classification that represents a change in
accounting principle, and meets the four criteria established in paragraph 7 of PCAOB Auditing Standard No. 6,
a.

does the report include an explanatory paragraph, following
the opinion paragraph, in the year of the change and in subsequent years until the new accounting principle is applied in
all periods presented?

b.

does the explanatory paragraph identify the nature of the
change and include a reference to the note disclosure describing the change?

c.

if the change in the accounting principle is a change in reporting entity that did not result from a transaction or an
event, is an explanatory paragraph included in the auditor’s
report? (Note: A change in the reporting entity resulting from
a transaction or event, such the creation, cessation, or complete or partial purchase or disposition of a subsidiary or
other business unit, does not require recognition in the auditor’s report.)
[PCAOB Auditing Standard No. 6 par. 4–8 and 11]

(Audits of Issuers Only) If there has been a correction of a material
misstatement in previously issued financial statements, including a
change from an accounting principle that is not generally accepted
to one that is generally accepted and a change in classification that
represents the correction of a material misstatement, does the auditor’s report contain an explanatory paragraph, following the
opinion paragraph, that includes
a.

a statement that the previously issued financial statements
have been restated for the correction of a misstatement in the
respective period?

b.

a reference to the entity’s disclosure of the correction of the
misstatement?
[PCAOB Auditing Standard No. 6 par. 5 and 9–11]

In an updated report on the individual financial statements of one
or more prior periods presented on a comparative basis with those
of the current period, if the opinion is different from the opinion
previously expressed on the financial statements of a prior period,
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24.

a.

does the report include an explanatory paragraph, preceding
the opinion paragraph that discloses all of the substantive
reasons for the different opinion?

b.

does the explanatory paragraph disclose
the date of the auditor’s previous report?

ii.

the type of opinion previously expressed?

iii.

the circumstances or events that caused the auditor to
express a different opinion?

iv.

that the auditor’s updated opinion on the financial
statements of the prior period is different from his or
her previous opinion on those statements?
[AU 508.11e and .69]

N/A

If financial statements of a prior period (presented for comparative
purposes) have been audited by a predecessor auditor whose report
is not presented,
a.

b.

25.

i.

No

does the introductory paragraph of the report indicate
i.

that the financial statements of the prior period were
audited by another auditor?

ii.

the date of the predecessor auditor’s report?

iii.

the type of report issued by the predecessor auditor?

iv.

if the report was other than a standard report, the substantive reasons therefore, including a description of
the nature of and reasons for the explanatory paragraph added to the predecessor’s report or his or her
opinion qualification?

if the financial statements have been restated, does the introductory paragraph indicate that the predecessor auditor reported on the financial statements of the prior period before
restatement?
[AU 508.11e and .74]

Is an explanatory paragraph (or other explanatory language) added
to the standard auditor’s report if
a.

the auditor wishes to clarify that an audit performed in accordance with GAAS does not require the same level of testing
and reporting on internal control over financial reporting as
an audit of an issuer when Section 404(b) of the SarbanesOxley Act is applicable? (Note: Not required—Interpretation
No. 17 of AU section 508 [AICPA, Professional Standards, vol.
1] provides an example report.)
[AU 9508.85–.88]

b.

the audit is conducted in accordance with both GAAS and the
PCAOB’s Auditing Standards as allowed by Interpretation
No. 18 of AU section 508 (AICPA, Professional Standards, vol.
1)? (Note: Not required—Interpretation No. 18 of AU section
508 [AICPA, Professional Standards, vol. 1] provides an example report.)
[AU 9508.89–.92]
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26.

Is an explanatory paragraph (or other explanatory language) added
to the standard auditor’s report if the prior period’s financial statements are audited by a predecessor auditor who has ceased operations?
[AU 9508.60–.75]

27.

If selected quarterly financial data required by SEC Regulation S-K
has been omitted or has not been reviewed, does the report include
an additional paragraph stating that fact?
[AU 508.11f; AU 722.50]

Note: In February 2009, the ASB issued SAS No. 116, Interim Financial Information (AICPA, Professional Standards, vol. 1, AU sec. 722). SAS No. 116
amends AU section 722 to accommodate reviews of interim financial information of nonissuers, including companies offering securities pursuant to
SEC Rule 144A or participating in private equity exchanges. SAS No. 116
is effective for audits of financial statements for periods beginning on or
after December 15, 2009. Earlier application is permitted.
28.

If other information in a document containing audited financial
statements is materially inconsistent with information appearing in
the financial statements, has it been determined whether the financial statements, the auditor’s report, or both require revision?
[AU 508.11h; AU 550.04]

29.

If the auditor decides to emphasize a matter regarding the financial
statements in the report, is the matter being emphasized disclosed
in the financial statements’ and is the explanatory information presented in a separate paragraph that avoids use of phrases such as
“with the foregoing (following) explanation”?
[AU 508.11 and .19; AU 9410.18; AU 9342.03]

30.

If it has not been possible to conduct the audit in accordance with
GAAS or to apply all of the procedures considered necessary in the
circumstances, has consideration been given to the need to issue a
qualified opinion or to disclaim an opinion?
[AU 508.22]

31.

If a qualified opinion is to be expressed because of a scope limitation,
a.

are all of the substantive reasons for the qualification disclosed in one or more explanatory paragraphs preceding the
opinion paragraph?

b.

does the qualified opinion include the word except or exception in a phrase such as except for or with the exception of?

c.

is the situation described and referred to in both the scope
and opinion paragraphs?

d.

does the wording in the opinion paragraph indicate that the
qualification pertains to the possible effects on the financial
statements and not to the scope limitation itself?
[AU 508.22–.32; AU 318.76]
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Practice Tip
Scope limitations can be imposed by the client or by circumstances such as the timing of the auditor’s work,
the inability to obtain sufficient appropriate audit evidence, or an inadequacy in the accounting records.
Sufficient appropriate audit evidence includes, among other things, management having asserted responsibility for the final financial statements. As provided in Technical Questions and Answers (TIS) section
9100.06, “The Effect of Obtaining the Management Representation Letter on Dating the Auditor’s Report”
(AICPA, Technical Practice Aids), the auditor will need to have the signed management representation letter
in hand prior to releasing the auditor’s report because management’s refusal to furnish written representations constitutes a limitation on the scope of the audit sufficient to preclude an unqualified opinion.
In circumstances in which the auditor is unable to obtain sufficient appropriate audit evidence to support
management’s assertions about the nature of a matter involving an uncertainty and its presentation or disclosure in the financial statements, the auditor should consider the need to express a qualified opinion or to
disclaim an opinion because of a scope limitation.
It also includes situations in which the auditor’s only evidence of the existence, valuation, or both, of (a)
investments without readily determinable fair value, or (b) interests held in trust by a third-party trustee, is
receiving confirmation from a third party for those assets.
In circumstances in which the auditor is unable to audit the existence or measurement of interests in investments in securities and interests in trusts, the auditor should consider whether that scope limitation requires
the auditor to either qualify his or her opinion or to disclaim an opinion, as discussed in paragraphs .22–.26
of AU section 508 (AICPA, Professional Standards, vol. 1); Interpretation No. 1, “Auditing Interests in Trusts
Held by a Third-Party Trustee and Reported at Fair Value,” of AU section 328, Auditing Fair Value Measurements and Disclosures (AICPA, Professional Standards, vol. 1, AU sec. 9328 par. .01–.04); and Interpretation No.
1, “Auditing Investments in Securities Where a Readily Determinable Fair Value Does Not Exist,” of AU
section 332, Auditing Derivative Instruments, Hedging Activities, and Investments in Securities (AICPA, Professional Standards, vol. 1, AU sec. 9332 par. .01–.04).
32.

33.

Is a qualified opinion or disclaimer of opinion expressed if the auditor’s understanding of internal control raises doubts about the auditability of an entity’s financial statements, such as
a.

concerns about the integrity of an entity’s management cause
the auditor to conclude that the risk of management misrepresentation in the financial statements is such that an audit
cannot be conducted?

b.

concerns about the condition and reliability of an entity’s records cause the auditor to conclude that it is unlikely that sufficient appropriate audit evidence will be available to support
an unqualified opinion on the financial statements?
[AU 314.109]

If, in the auditor’s judgment, the two-way communication between
the auditor and those charged with governance as described in AU
section 380 is not adequate and the situation cannot be resolved,
thereby prohibiting the auditor from obtaining all the audit evidence required to form an opinion on the financial statements, has
the auditor considered the following:
a.

Modifying the audit opinion on the basis of a scope limitation?

b.

Obtaining legal advice about the consequences of different
courses of action?
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c.

Communicating with an appropriate third party, (for example, a regulator)

d.

Withdrawing from the engagement?
[AU 380.63]

34.

If, in the auditor’s judgment, significant difficulties in dealing with
management such as those described in AU section 380, have been
encountered, has the auditor considered modifying the audit opinion on the basis of a scope limitation?
[AU 380.39]

35.

If an opinion is disclaimed because of a scope limitation,
a.

are all of the substantive reasons for the disclaimer stated in
a separate paragraph or paragraphs?

b.

does the report state that the scope of the audit was not sufficient to warrant the expression of an opinion?

c.

does the report avoid identifying procedures that were performed?

d.

is the scope paragraph omitted?

e.

if there are reservations about fair presentation of the financial statements in conformity with GAAP, are they described
in the report?
[AU 508.62–.63]

Note: Consult the Topical Index to AICPA Professional Standards under
“Scope of Audit—Limitations” for additional references to specific types of
scope limitations that could result in either a qualified or disclaimer of
opinion.
36.

If the financial statements are materially affected by a departure
from GAAP (including, for example, inadequate disclosure, inappropriate accounting principles, and unreasonable accounting estimates), has the auditor issued a qualified opinion or an adverse
opinion?
[AU 508.35]

37.

If a qualified opinion is to be expressed because of a GAAP departure,
a.

are all of the substantive reasons that have led to the conclusion that there is a departure from GAAP disclosed in one or
more separate explanatory paragraphs preceding the opinion
paragraph?

b.

does the qualified opinion include the word except or exception in a phrase such as except for or with the exception of and a
reference to the explanatory paragraph?

c.

does the explanatory paragraph disclose the principle effects
of the departure on financial position, results of operations,
and cash flows, if practicable, or state that the effects are not
reasonably determinable?
[AU 508.21 and AU 508.37–.39]
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38.

No
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If an adverse opinion is to be expressed because of a GAAP departure,
a.

are all of the substantive reasons for the adverse opinion disclosed in one or more separate explanatory paragraphs preceding the opinion paragraph?

b.

does the explanatory paragraph disclose the principle effects
of the departure on financial position, results of operations,
and cash flows, if practicable, or state that the effects are not
reasonably determinable?

c.

state that the financial statements do not present fairly the
financial position, or results of operations or cash flows in
conformity with GAAP?
[AU 508.58–.59]

39.

If essential data concerning an impending change in GAAP and the
future resulting restatement are not disclosed, has the auditor issued a qualified or adverse opinion?
[AU 9410.15]

40.

If the auditor concludes that an illegal act has a material effect on
the financial statements and the act has not been properly accounted for or disclosed, has the auditor issued a qualified or adverse opinion (depending on the materiality effect on the financial
statements taken as a whole)?
[AU 317.18]

Note: Consult the Topical Index to AICPA Professional Standards under “Departures From Standard Report” for additional information.
Readers may also wish to refer to TIS section 1400.31, “GAAP Departure
for FASB ASC 810” (AICPA, Technical Practice Aids), for assistance in determining the implications on the auditors report if the reporting entity does
not consolidate a variable interest entity.
Practice Tip
Reporting on financial statements prepared in conformity with an other comprehensive basis of accounting
(OCBOA) is addressed in AU section 623, Special Reports (AICPA, Professional Standards, vol. 1). For purposes
of that section, a comprehensive basis of accounting other than GAAP is one of the following:
a.

A basis of accounting that the reporting entity uses to comply with the requirements or financial
reporting provisions of a governmental regulatory agency to whose jurisdiction the entity is subject.
An example is a basis of accounting insurance companies use pursuant to the rules of a state insurance commission.

b.

A basis of accounting that the reporting entity uses or expects to use to file its income tax return for
the period covered by the financial statements.

c.

The cash receipts and disbursements basis of accounting, and modifications of the cash basis having
substantial support, such as recording depreciation on fixed assets or accruing income taxes.

d.

A definite set of criteria having substantial support that is applied to all material items appearing in
financial statements, such as the price-level basis of accounting.
In considering whether the financial statements (including the accompanying notes) include all informative
disclosures that are appropriate for the basis of accounting used, paragraph .09 of AU section 623 states that
(continued)
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the auditor should apply essentially the same criteria to financial statements prepared on an other comprehensive basis of accounting as he or she does to financial statements prepared in conformity with GAAP.
41.

When reporting on financial statements prepared in conformity
with a comprehensive basis of accounting other than GAAP, as defined in paragraph .04 of AU section 623, does the independent auditor’s report include the following elements (for audits prepared
in conformity with GAAS):
a.

A title that includes the word independent?
[AU 623.05a]

b.

A paragraph that states that

c.

d.

e.
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i.

the financial statements identified in the report were
audited?

ii.

the financial statements are the responsibility of the entity’s management and that the auditor is responsible
for expressing an opinion on the financial statements
based on the audit?
[AU 623.05b]

A paragraph that states that
i.

the audit was conducted in accordance with GAAS
with specific identification of the United States of
America as the country of origin of those standards?

ii.

those standards require that the auditor plan and perform the audit to obtain reasonable assurance about
whether the financial statements are free of material
misstatement?

iii.

an audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial
statements; assessing the accounting principles used
and significant estimates made by management; and
evaluating the overall financial statement presentation?

iv.

the auditor believes that his or her audit provides a reasonable basis for the opinion?
[AU 623.05c]

A paragraph that states
i.

the basis of presentation and refers to the note to the
financial statements that describes the basis?

ii.

that the basis of presentation is a comprehensive basis
of accounting other than GAAP?
[AU 623.05d]

A paragraph that expresses the auditor’s opinion (or disclaims an opinion) on whether the financial statements are
presented fairly, in all material respects, in conformity with
the basis of accounting described?
[AU 623.05e]
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f.

If the financial statements are prepared in conformity with
the requirements or financial reporting provisions of a governmental regulatory agency, a separate paragraph at the end
of the report stating that the report is intended solely for the
information and use of those within the entity and the regulatory agencies to whose jurisdiction the entity is subject, and
is not intended to be and should not be used by anyone other
than these specified parties?
[AU 623.05f]

g.

The manual or printed signature of the auditor’s firm?
[AU 623.05g]

h.

The date of the audit report?
[AU 623.05h]

42.

When the financial statements are prepared in conformity with the
requirements or financial reporting provisions of a governmental
regulatory agency and the financial statements and reports will be
used by parties or distributed by the entity to parties other than the
regulatory agencies to whose jurisdiction the entity is subject, has
the standard form of report been modified as appropriate because
of the departures from GAAP and has an additional paragraph
been added to express an opinion on whether the financial statements are presented in conformity with the regulatory basis of accounting? (Note: Interpretation 15, “Auditor Reports on Regulatory
Accounting or Presentation When the Regulated Entity Distributes
the Financial Statements to Parties Other Than the Regulatory
Agency Either Voluntarily or Upon Specific Request,” of AU section
623 [AICPA, Professional Standards, vol. 1, AU sec. 9623 par. .96–.98]
provides an example report.)
[AU 544.04; AU 9623.96–.98]

43.

If certain other information, including supplementary information
required by GAAP, contained in annual reports and other clientprepared documents described in paragraph .02 of AU section 550,
Other Information in Documents Containing Audited Financial Statements (AICPA, Professional Standards, vol. 1), that contain audited
financial statements has been subjected to auditing procedures applied in the audit of the basic financial statements, does the auditor
express an opinion on whether the information is fairly stated in all
material respects in relation to those financial statements taken as a
whole in the auditor’s report and does the report describe clearly
the character of the auditor’s work and the degree of responsibility
the auditor is taking?
[AU 550.07; AU 558.09]

44.

If other information contained in annual reports and other clientprepared documents described in AU section 550 paragraph .02
that contain audited financial statements is materially inconsistent
with information appearing in the financial statements, has it been
determined whether the financial statements, the auditor’s report,
or both require revision?
[AU 508.11h; AU 550.04]

No

N/A
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45.

46.

47.

48.

If other information contained in annual reports and other clientprepared documents described in AU section 550 paragraph .02
that contain audited financial statements is materially inconsistent
with information appearing in the financial statements, and the auditor has determined that neither the financial statements nor the
auditor’s report require revision, has the auditor either
a.

requested that the client revise the other information to eliminate the material consistency?

b.

considered other actions such as revising the audit report to
include an explanatory paragraph describing the material inconsistency, withholding the use of the audit report in the
document, and withdrawing from the engagement?
[AU 550.04]

If information accompanies the basic financial statements and auditor’s report in an auditor-submitted document, is it accompanied
by a report that
a.

states that the audit was performed for the purpose of forming an opinion on the basic financial statements taken as a
whole?

b.

specifically identifies the accompanying information?

c.

states that the accompanying information is presented for
purposes of additional analysis and is not a required part of
the basic financial statements?

d.

includes either an opinion on whether the accompanying information is fairly stated in all material respects in relation to
the basic financial statements taken as a whole or a disclaimer
of opinion (depending on whether the information was subjected to the auditing procedures applied in the audit of the
basic financial statements)?
[AU 551.05–.06]

If information accompanying the basic financial statements and auditor’s report in an auditor-submitted document is materially misstated in relation to the basic financial statements taken as a whole,
has the auditor either
a.

requested that the client revise the accompanying information to eliminate the material misstatement?

b.

considered other actions such as modifying the audit report
to describe the misstatement or refusing to include the accompanying information in the auditor-submitted document?
[AU 551.09]

When the basic financial statements are accompanied by supplementary information required by GAAP and such supplementary
information has not been audited as part of the basic financial statements, does the auditor’s report exclude any language that refers to
the supplementary information or the limited procedures applied
(except in the circumstances described in AU section 558 paragraph
.08)?
[AU 558.08]
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49.

When the basic financial statements are accompanied by supplementary information required by GAAP and such supplementary
information has been audited as part of the basic financial statements, has the audit report been expanded in accordance with AU
section 550 paragraph .07?
[AU 558.09]

50.

If supplementary information required by GAAP has been omitted,
the presentation of such information departs materially from prescribed guidelines, the auditor is unable to complete prescribed
procedures with respect to such information, or the auditor is unable to remove substantial doubt about whether the supplementary
information conforms to prescribed guidelines, does the report include an additional paragraph stating that fact?
[AU 558.08]

No

N/A
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FSP Section 20,300
Supplemental Information for Life
Insurance Entities That are Securities and
Exchange Commission Registrants
.01 Regulation S-X is the primary source of requirements for financial statements and related footnotes
required to be included in documents filed with the SEC. In addition to Regulation S-X, preparers and
auditors of financial statements should be familiar with the Securities and Exchange Commission’s (SEC’s)
Financial Reporting Releases (FRRs) and Staff Accounting Bulletins (SABs). FRRs communicate the SEC’s
position on accounting and auditing principles and practices. SABs represent interpretations and practices
followed by the Division of Corporation Finance and the Office of the Chief Accountant of the SEC. Insurance companies are subject to the requirements of Articles 1–4, 7, 10, and 12 of Regulation S-X.
.02 When determining compliance with SEC requirements, preparers and auditors should refer to the
appropriate SEC pronouncements to ensure compliance with SEC disclosure rules. In particular, the following documents should be consulted:
●

Regulation S-X, Article 1, Application of Regulation S-X

●

Regulation S-X, Article 2, Qualifications and Reports of Accountants

●

Regulation S-X, Article 3, General Instructions as to Financial Statements

●

Regulation S-X, Article 3A, Consolidated and Combined Financial Statements

●

Regulation S-X, Article 4, Rules of General Application

●

Regulation S-X, Article 7, Insurance Companies

●

Regulation S-X, Article 10, Interim Financial Statements

●

Regulation S-X, Article 12, Form and Content of Schedules

●

SABs reflect the SEC staff’s views regarding accounting-related disclosure practices. They represent
interpretations and policies followed by the Division of Corporation Finance and the Office of the
Chief Accountant in administering the disclosure requirements of the federal securities laws.

●

FRRs adopt, change, or interpret requirements relating to accounting, auditing, and disclosure issues.

●

The Sarbanes-Oxley Act of 2002

●

Rules and standards of the Public Company Accounting Oversight Board

FSP §20,300.02

Illustrative Financial Statements

251

FSP Section 20,400
Illustrative Financial Statements
.01 This section contains illustrative financial statements prepared in conformity with generally accepted
accounting principles (GAAP). The financial statements are for illustrative purposes only, are not intended
to be comprehensive and are not intended to establish preference among alternative principles acceptable
under GAAP. Decisions about the application of the GAAP discussed in the accounting and financial reporting sections of the AICPA Audit and Accounting Guide Life and Health Insurance Entities (2009) should
not be made by reference to the illustrative financial statements but by a careful reading to the specified
authoritative literature. The illustrative financial statements reflect many of the minimum disclosure requirements for a life and health insurance entity but do not include all of the amounts or transactions discussed
in other chapters of the guide or that might be found in practice. For example, the illustrative notes indicate
the subject matter generally required to be disclosed, but they should be expanded, reduced, or otherwise
modified to suit individual circumstances based on a careful reading of the specified authoritative literature.
.02 The illustrative financial statements do not include other transactions not unique to life and health
insurance entities, such as disclosures about segments, employee benefit plans, certain risks and uncertainties, or postemployment benefits other than pensions. Preparers and auditors should consult authoritative
guidance on presenting such other information.
.03 The illustrative financial statements do not reflect rules and releases of the Securities and Exchange
Commission (SEC) that, for SEC registrants, have an authority similar to other officially established accounting principles. SEC Regulation S-X, Article 7, Insurance Companies, should be referred to.
.04 The illustrative financial statements also do not reflect the impact of laws and regulations of the
insurance entity’s state of domicile. The impact on the financial statements of such laws and regulations
vary by state. Many states require conformity with the codification of statutory accounting practices in the
National Association of Insurance Commissioners (NAIC) Accounting Practices and Procedures Manual to the
extent it does not conflict with its own state laws and regulations. Refer to the NAIC Accounting Practices
and Procedures Manual, NAIC Annual Statement Instructions, and specific state laws and regulations to determine the impact of codification and individual state laws and regulations.
.05 Life and health insurance entities generally present unclassified balance sheets.
Note: The illustrative financial statements and notes included in this checklist have been updated to
reflect Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC). However, in FASB’s Notice to Constituents, it suggests the use of plain English in financial statement footnotes to describe broad FASB ASC Topic references. They suggest a reference similar to “as required
by the Derivatives and Hedging Topic of FASB Accounting Standards Codification.” Entities might consider revising their financial statement references to reflect this plain English referencing, rather than
the use of specific FASB ASC references. We have provided these detailed references in the 2009 editions as a learning tool to familiarize constituents with FASB ASC.
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ABC LIFE INSURANCE COMPANY
Balance Sheet*
December 31, 20X1 and 20X0
(Amounts in thousands)
20X1
Assets
Investments:
Debt and equity securities:
Fixed maturities, held to maturity, at amortized cost (estimated
fair value: $47,830 in 20X1 and $45,255 in 20X0)
Fixed maturities, available for sale, at estimated fair value
(amortized cost: $247,525 in 20X1 and $219,565 in 20X0)
Trading account securities, at estimated fair value (cost: $4,220
in 20X1 and $4,419 in 20X0)
Mortgage loans
Real estate
Policy loans
Short-term investments
Total investments
Cash and cash equivalents
Accrued investment income
Premiums due and other receivables,1 net of allowance of $4,500 and
$2,100 for doubtful accounts
Reinsurance receivable on paid and unpaid losses
Reinsurance receivable related to contract holder liabilities
Deferred policy acquisition costs
Property and equipment, net of accumulated depreciation
Other assets
Separate account assets
Total assets
Liabilities
Future policy benefits
Guaranteed interest contracts
Policyholders funds on deposit
Unpaid claims

20X0

$ 44,864

$ 46,310

255,893

214,563

3,950
79,258
6,410
43,549
7,515

4,190
106,692
6,147
51,013
6,321

441,439

435,236

5,285
6,660

3,343
8,026

1,647
596
5,714
38,936
501
152
732

1,092
407
3,048
36,429
420
158
525

$501,662

$488,684

$345,887
21,342
49,408
5,418

$341,207
23,555
46,202
4,737
(continued)

*
Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 820, Fair Value Measurements and Disclosures,
establishes a framework for measuring fair value that applies broadly to financial and nonfinancial assets and liabilities and improves
the consistency, comparability, and reliability of the measurements. FASB ASC 820 codifies and simplifies existing guidance for developing measurements and improves disclosures about the measurements. Additionally, FASB ASC 825, Financial Instruments, improves
financial reporting by providing entities with the opportunity to mitigate volatility in reported earnings caused by measuring related
assets and liabilities differently without having to apply complex hedge accounting provisions. For additional information, see the FASB
Web site at www.fasb.org.
1
FASB ASC 310-10-50 requires, among other things, that the summary of significant accounting policies include the basis for accounting for trade receivables, and the classification and method of accounting for other receivables. It also requires that a description of the
accounting policies and methodology the entity used to estimate its allowance for doubtful accounts be included in the notes to the
financial statements. Such a description should identify the factors that influenced management’s judgment and may also include
discussion of risk elements relevant to particular categories of financial instruments. In addition, FASB ASC 310-10-50-6 requires that the
summary of significant accounting policies include the policy for charging off uncollectible trade receivables.

FASB ASC 310-10-45 contains other presentation and disclosure requirements that may apply to the financial statements of insurance
entities.
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20X1
Policyholders dividends
Amounts held in escrow and accrued expenses
Deferred federal income taxes
Other liabilities
Separate account liabilities
Total liabilities
Commitments and contingencies (Note 12)
Shareholders’ Equity
Capital stock: authorized—5,000,000 shares of $2 par value; 3,341,624
shares issued and outstanding
Retained earnings
Accumulated other comprehensive income
Total shareholders’ equity
Total liabilities and shareholders’ equity

20X0

2,335
4,977
1,412
253
732

3,450
4,562
1,027
4,465
525

431,764

429,730

6,683
57,776
5,439

6,683
55,522
(3,251)

69,898

58,954

$501,662

$488,684

See accompanying notes to financial statements.
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.07
ABC LIFE INSURANCE COMPANY
Statement of Income
Years Ended December 31, 20X1 and 20X0
(Amounts in thousands)
20X0

20X1
Premiums and Other Revenues
Premiums:
Life and annuity premiums
Accident and health premiums
Other premiums
Contract holder fees
Net investment income
Net realized gains (losses) on investments and other
Total premiums and other revenues
Benefits and Other Expenses
Policyholder benefits
Interest credited to policyholder accounts
General expenses
Amortization of deferred policy acquisition costs
Underwriting, acquisition, and insurance expenses
Policyholders’ dividends
Total benefits and expenses
Income before income taxes
Income taxes:
Current
Deferred
Total income taxes

$24,833
10,141
20
1,961
32,998
4,222

$24,783
9,153
43
1,844
35,141
(2,670)

74,175

68,294

39,158
4,363
4,288
1,276
18,029
4,665

30,815
4,156
4,984
1,305
17,266
6,898

71,779

65,424

2,396

2,870

1,547
(1,405)

601
540

142

1,141

2,254

1,729

Net income per common share

.67

.52

Dividends per common share

—

.98

Net income

See accompanying notes to financial statements.
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.08
ABC LIFE INSURANCE COMPANY
Statement of Comprehensive Income (Loss)
Years Ended December 31, 20X1 and 20X0
(Amounts in thousands)
20X1
Net income
Other comprehensive income (loss)

$ 2,254
8,690

Total comprehensive income (loss)

$10,944

20X0
$ 1,729
(1,730)
$

(1)

See Note 5 to the financial statements for information about other
comprehensive income (loss).
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ABC LIFE INSURANCE COMPANY
Statement of Changes in Shareholders’ Equity
Years Ended December 31, 20X1 and 20X0
(Amounts in thousands)

Capital Stock
Balance at January 1, 20X0
Net income for 20X0
Shareholders’ dividends
Other comprehensive income
(loss)

$6,683
—
—
—

Balance at December 31, 20X0
Net income for 20X1
Other comprehensive income
Balance at December 31, 20X1

Retained
Earnings
$57,068
1,729
(3,275)

Total
Shareholders’
Equity

$(1,521)
—
—

$62,230
1,729
(3,275)

—

(1,730)

(1,730)

6,683
—
—

55,522
2,254
—

(3,251)
—
8,690

58,954
2,254
8,690

$6,683

$57,776

See accompanying notes to financial statements.
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$ 5,439

$69,898
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.10
ABC LIFE INSURANCE COMPANY
Statements of Cash Flows
Years Ended December 31, 20X1 and 20X0
(Amounts in thousands)
20X0

20X1
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by
operating activities:
Interest credited to universal life policies
Accrual of discount on investments, net
Net realized (gains) losses on investments
Depreciation and amortization
Amortization of deferred policy acquisition costs
Deferred federal income taxes
Change in operating assets and liabilities: Accrued investment
income
Capitalization of deferred policy acquisition costs
Policy liabilities
Other items, net
Net cash provided by operating activities
Cash flows from investing activities:
Cost of investments purchased:
Fixed maturities and equity securities
Mortgage loans and real estate
Proceeds from investments sold, redeemed, or matured:
Fixed maturities and equity securities
Mortgage loans and real estate
Policy loans, net
Short-term investments, net
Net cash provided by investing activities
Cash flows from financing activities:
Dividends to shareholders
Receipts from universal life policies credited to contract holder
account balances
Return of contract holder account balances on universal life
policies
Withdrawals from interest-sensitive contracts

$ 2,254

$ 1,729

7,927
(976)
(4,222)
3,041
1,276
(2,538)

10,445
(1,328)
2,670
3,534
1,305
540

1,366
(3,783)
(3,440)
(644)

880
(6,645)
(16,234)
3,269

261

165

(228,053)
(921)

(122,495)
—

206,051
27,970
2,320
409

95,177
18,621
6,468
15,446

7,776

13,217

—

(3,275)

7,918

8,365

(4,165)
(9,848)

(3,718)
(13,046)

(6,095)

(11,674)

1,942
3,343

1,708
1,635

Cash and cash equivalents, end of year

$ 5,285

$ 3,343

Supplemental cash flow information:
Income taxes paid

$ 1,205

$ 785

Cash used in financing activities
Net increase in cash and cash equivalents
Cash and cash equivalents, beginning of year

See accompanying notes to financial statements.
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.11
ABC LIFE INSURANCE COMPANY
Notes to Financial Statements
Years Ended December 31, 20X1 and 20X0

1.

Organization and Significant Accounting Policies

Organization. ABC Life Insurance Company (ABC or the company) is a stock life insurance company
incorporated in the state of ABC that offers individual life, disability income, long-term care, annuity,
and investment products. ABC does business in the continental United States, with a concentration in
New York, New Jersey, and Connecticut.
Basis of presentation. The significant accounting policies followed by ABC that materially affect financial
reporting are summarized as follows. The accompanying financial statements have been prepared in
accordance with GAAP that differ from statutory accounting practices (SAP) used for regulatory authorities. The preparation of the financial statements in conformity with GAAP requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Investments. Fixed maturity securities available for sale consist of bonds, notes, and redeemable and
nonredeemable preferred stock not classified as either trading or held to maturity, and are reported at
estimated fair value. Unrealized holding gains and losses, net of tax, on available-for-sale securities are
reported as a net amount in other comprehensive income. Deferred policy acquisition cost offsets for
universal life type contracts and amounts attributable to certain participating contracts are recorded as
a separate component of accumulated other comprehensive income. Fixed maturity securities held to
maturity consist of bonds, notes, redeemable and nonredeemable preferred stock which the insurance
company has the intent and ability to hold to maturity, and are reported at amortized cost and adjusted
for amortization of premium or discount. Declines in fair value of individual held-to-maturity and
available-for-sale securities below their cost that are other then temporary have resulted in writedowns of the individual securities to their fair value. The related write-downs have been included in
earnings as realized losses. Trading account securities consist of bonds, notes, and redeemable and
nonredeemable preferred stock, and common stock held principally for resale in the near term, and are
recorded at their estimated fair values. Realized and unrealized gains and losses on trading account
securities are included in other income.
Mortgage loans on real estate are carried at unpaid balances and are adjusted for amortization of premium or discount, less allowance for losses. Real estate held for sale is carried at the lower of depreciated cost or fair value less estimated selling costs. Real estate classified as held-for-sale is no longer
depreciated. Real estate, including real estate acquired in satisfaction of debt, is carried at depreciated
cost. Impaired real estate is written down to fair value with the impairment loss being included in net
realized gains (losses) on investments and other. Upon foreclosure (including in-substance foreclosure),
the carrying value of the property is recorded at the lower of cost or fair value (less selling costs if to
be sold), which becomes its new cost basis. The estimated fair value for real estate is determined based
upon independent appraisals and other available information about the property, which may take into
consideration a number of factors, including (i) discounted cash flows, (ii) sales of comparable properties, (iii) geographic location of property and related market conditions, and (iv) disposition costs.
Foreclosed properties are actively managed by the company in order to maximize their value. Subsequent to foreclosure, the carrying value of the property is periodically evaluated and a valuation allowance is established, if necessary, to reflect any additional amounts considered unrecoverable upon sale.
At the time of the sale, the difference between the sales price and the carrying value is recorded as a
realized gain or loss. Policy loans are carried at unpaid balances. Short-term investments are stated at
amortized cost, which approximates fair value.
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Provisions for impairments of securities classified as held to maturity are included in net realized gains
(losses) on investments and other. Realized gains and losses are determined by specific identification.
Cash and cash equivalents. Cash equivalents are carried at cost, which approximates fair value. Cash
equivalents are highly liquid financial instruments with an original maturity of three months or less.
Deferred policy acquisition costs. Commissions and other costs of acquiring traditional life insurance,
universal life insurance and investment products, and accident and health insurance, that vary with
and are primarily related to the production of new and renewal business, have been deferred. Traditional life insurance and accident and health insurance acquisition costs are being amortized over the
premium-paying period of the related policies using assumptions consistent with those used in computing future policy benefit liabilities. For universal life-type contracts and investment contracts that
include significant surrender charges or that yield significant revenues from sources other than the
investment of contract holders’ funds, the deferred contract acquisition cost amortization is matched
to the recognition of gross profit.
Otherwise, deferred policy acquisition costs on investment contracts are amortized using an accounting
method that recognizes acquisition costs as expenses at a constant rate applied to net policy liabilities.
The effect on the deferred acquisition costs (DAC) asset that would result from realization of unrealized gains (losses) is recognized with an offset to accumulated other comprehensive income in consolidated shareholders’ equity as of the balance sheet date.
FASB ASC 944-30 provides guidance on accounting by insurance enterprises for DAC on internal replacements of insurance and investment contracts. The FASB ASC glossary defines internal replacement
as a modification in product benefits, features, rights, or coverages that occurs by a contract exchange;
by amendment, endorsement, or rider to a contract; or by the election of a benefit, feature, right, or
coverage within the contract.
If an internal replacement modification substantially changes a contract, then the DAC is written off
immediately through income and any new deferrable costs associated with the new replacement are
deferred. If a contract modification does not substantially change the contract, the DAC amortization
on the original contract will continue and any acquisition costs associated with the related modification
are immediately expensed.
Adoption of FASB ASC 944-30 resulted in a reduction to DAC and value of business acquired on
January 1, 2007, and an acceleration of the amortization period relating primarily to the company’s
group life and health insurance contracts that contain certain rate reset provisions. Prior to the adoption of FASB ASC 944-30, DAC on such contracts was amortized over the expected renewable life of
the contract. Upon adoption of FASB ASC 944-30, DAC on such contracts is to be amortized over the
rate reset period. The impact as of January 1, 2007, was a cumulative effect adjustment of $XXX,XXX
net of income tax of $XXX,XXX, which was recorded as a reduction to retained earnings.
Deferred sales inducements. Costs related to sales inducements offered on sales to new customers, principally on investment contracts and primarily in the form of additional credits to the customer’s account value or enhancements to interest credited for a specified period, which are beyond amounts
currently being credited to existing contracts, are deferred and recorded as other assets. All other sales
inducements are expensed as incurred and included in interest credited to contract holders’ funds.
Deferred sales inducements are amortized to income using the same methodology and assumptions as
DAC, and are included in interest credited to contract holders’ funds. Deferred sales inducements are
periodically reviewed for recoverability and written down when necessary.
Property and equipment. Property and equipment are reported at cost, net of accumulated depreciation
of $501,000 and $420,000 in 20X1 and 20X0, respectively. Property and equipment are depreciated using the straight line method over their estimated useful lives.
Future policy benefits and expenses. The liabilities for traditional life insurance and accident and health
insurance contract benefits and expenses are computed using a net level premium method including
assumptions about investment yields, mortality, withdrawals, and other assumptions based on ABC’s
experience modified as necessary to reflect anticipated trends and to include provisions for possible
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unfavorable deviations. Liability interest assumptions are graded and range from 3 percent to 10 percent. Benefit liabilities for traditional life insurance contracts include certain deferred profits on limitedpayment policies that are being recognized in income over the contract term. Contract benefit claims
are charged to expense in the period that the claims are incurred.
The accrued account balance for nontraditional life insurance and investment contracts is computed as
deposits net of withdrawals made by the contract holder, plus amounts credited based on contract
specifications, less contract fees and charges assessed, plus any additional interest. Interest crediting
rates for universal life and investment products range from 5.50 percent to 9.25 percent.
Included in contract holders’ account balances is a provision for contract holder dividends. Benefit
liabilities for contract holders’ account balances are computed under a retrospective deposit method
and represent contract account balances before applicable surrender charges. Contract benefits and
claims that are charged to expense include benefit claims incurred in the period in excess of related
contract account balances. Interest crediting rates for universal life and investment products range
from 5.50 percent to 9.25 percent. Benefits and expenses are charged against the account balance to
recognize costs as incurred over the estimated lives of the contracts. Expenses include interest credited
to contract account balances and benefits paid in excess of contract account balances.
Minimum guarantees. The company issues variable annuity contracts through separate accounts where
the company contractually guarantees to the contract holder total deposits made to the contract less
any partial withdrawals plus a minimum return. This guarantee includes benefits that are payable in
the event of death, annuitization, or at specified dates during the accumulation period.
Accounting policy for health liabilities. Unpaid claims on accident and health policies represent the estimated liability for benefit expenses both reported but not paid and incurred but not reported to ABC
through December 31. ABC does not discount its liabilities for unpaid claims. Liabilities for unpaid
claims are estimated using individual case-basis valuations and statistical analyses. Those estimates are
subject to the effects of trends in claim severity and frequency. Although considerable variability is
inherent in such estimates, management believes that the liabilities for unpaid claims are adequate.
The estimates are continually reviewed and adjusted as necessary as experience develops or new information becomes known; such adjustments are included in current operations.
Income taxes. Federal income taxes are charged or credited to operations based upon amounts estimated
to be payable or recoverable as a result of taxable operations for the current year. Deferred income
taxes have been provided for temporary differences between the tax basis of assets and liabilities calculated using the criteria of FASB ASC 740, Income Taxes, and their reported amounts in the financial
statements using enacted income tax rates and laws. The Company recognizes interest and penalties
accrued on any unrecognized tax benefits as a component of income tax expense. The Company did
not have any accrued and recognized interest or penalties associated with unrecognized tax benefits
for the years ending December 31, 20X1 and 20X0.2
Reinsurance. In the normal course of business, the company seeks to limit its exposure to loss on any
single insured and to recover a portion of benefits paid by ceding reinsurance to other insurance entities or reinsurers under excess coverage and coinsurance contracts. The company retains a maximum
of $400,000 of coverage per individual life. Amounts paid or deemed to have been paid for reinsurance
contracts are recorded as reinsurance receivable.
Insurance premium revenues. Traditional life premiums, which include those products with fixed and
guaranteed premiums and benefits and consist principally of whole life insurance contracts, limitedpayment life insurance contracts, and certain annuities with life contingencies, are generally recognized
as revenue when due. Revenues on universal life and investment-type contracts consist of contract
charges against contract holders’ funds for the cost of insurance, administration, surrender charges,
actuarial margin, and other fees. Accident and health insurance premiums are recognized as revenue
pro rata over the terms of the contracts.
2

Because these standards are not insurance industry specific, transition and adoption specifics are excluded.
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Separate accounts. Separate account assets and liabilities generally represent funds maintained in accounts to meet specific investment objectives of contract holders who bear the investment risk. Investment income and investment gains and losses accrue directly to such contract holders. The assets supporting the variable portion of both traditional variable annuities and variable contracts with
guarantees are carried at fair value and reported as summary total separate account assets with an
equivalent summary total reported for liabilities. Amounts assessed against the contract holders for
mortality, administrative, and other services are included in revenue and changes in liabilities for minimum guarantees are included in policyholder benefits in the statement of operations. Separate account
net investment income, net investment gains and losses, and the related liability changes are offset
within the same line item in the statement of operations.
Business risks and uncertainties. The development of liabilities for future policy benefits for the company’s products requires management to make estimates and assumptions regarding mortality, morbidity, lapse, expense, and investment experience. Such estimates are primarily based on historical
experience and future expectations of mortality, morbidity, expense, persistency, and investment assumptions. Actual results could differ materially from those estimates. Management monitors actual
experience and, if circumstances warrant, revises its assumptions and the related future policy benefit
estimates.
The company’s investments are primarily comprised of fixed maturity securities, equity securities, real
estate, and mortgage loans. Significant changes in prevailing interest rates and geographic conditions
may adversely affect the timing and amount of cash flows on such investments and their related values. In addition, the value of these investments is often derived from an appraisal, an estimate or
opinion of value. A significant decline in the fair value of these investments could have an adverse
effect on the company’s balance sheet.
The company regularly invests in mortgaged backed securities (MBS) and other securities subject to
prepayment and call risk. Significant changes in prevailing interest rates may adversely affect the timing and amount of cash flows on such securities. In addition, the amortization of market premium and
accretion of market discount for MBS is based on historical experience and estimates of future payment
speeds on the underlying mortgage loans. Actual prepayment speeds will differ from original estimates and may result in material adjustments to amortization or accretion recorded in future periods.
Codification. The NAIC revised the Accounting Practices and Procedures Manual in a process referred to
as codification. Codification became effective on January 1, 2001. The company’s state of domicile has
adopted the provisions of the revised manual effective January 1, 2001. The revised manual has
changed to some extent, prescribed SAP, and has resulted in changes to the company’s statutory-basis
financial statements. The cumulative effect of changes in accounting principles adopted to conform to
the revised Accounting Practices and Procedures Manual of $XXX,XXX has been reported as an adjustment
to increase (decrease) surplus in the company’s statutory-basis financial statements as of January 1,
2001.
Guaranty funds. Guaranty fund (and other) assessments are accrued at the time the events occur on
which assessments are expected to be based.

2.

Earnings Per Common Share

Basic and diluted earnings per common share are as follows.
(Thousands, except per common share data)
20X1
Net income

Income
(Numerator)

Shares
(Denominator)

Per Common
Share Amount

3,342

.67

3,342

.52

2,254

Income applicable to common ownership
20X0
Net income

2,254
1,729

Income applicable to common ownership

1,729
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Investments

In reporting disclosures about investments in securities, entities should comply with the requirements
of FASB ASC 320, Investments—Debt and Equity Securities.

4.

Fair Value of Financial Instruments

The following methods and assumptions were used to estimate the fair value of each class of financial
instruments for which it is practicable to estimate that value.
Short-term investments. For those short-term instruments amortized cost is a reasonable estimate of fair
value.
Investment securities and trading account assets. For securities held for trading purposes and marketable
equity securities held for investment purposes, fair values are based on quoted market prices or dealer
quotes. For other securities held as investments, fair value equals quoted market price, if available. If
a quoted market price is not available, fair value is estimated using quoted market prices for similar
securities.
Mortgage loans on real estate and policy loans. The fair value of mortgage loans on real estate is estimated
using discounted cash flows. The fair value of policy loans is estimated by discounting the future cash
flows using reasonable assumptions for mortality and repayments and using the current rates at which
similar loans would be made to contract holders with similar credit ratings and the same remaining
maturities.
The estimated fair values of ABC’s mortgage loans on real estate and policy loans are as follows.
20X0

20X1
Carrying
Amount
Mortgage loans on real estate
Policy loans

5.

$79,258
43,549

(Amounts in thousands)
Carrying
Amount
Fair Value
$83,506
60,000

$106,692
51,013

Fair Value
$112,027
59,000

Accumulated Other Comprehensive Income

Accumulated other comprehensive income (loss) represents cumulative gains and losses on items that
are not reflected in earnings. The balances and activity for the years 20X1 and 20X0 are as follows.
20X0

20X1

(Amounts in thousands)
Changes in net unrealized gains (losses) on investment securities:
Net unrealized gains (losses) arising during the period
Reclassification adjustment for gains (losses) included in net
earnings
Changes in net unrealized gains (losses) on investment securities
Adjustments for:
Policyholder liabilities, deferred acquisition costs and deferred
federal income taxes
Total other comprehensive income (loss)
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$13,324

$(1,873)

46

(300)

13,370

(2,173)

(4,680)
$ 8,690

443
$(1,730)

263

Illustrative Financial Statements

6.

Income Taxes

Significant components for income tax expense attributable to continuing operations are as follows.
20X1
Current income tax expense
Deferred income tax (benefit) expense
Total income tax expense

20X0

(Amounts in thousands)
$1,547
$601
(1,405)
540
$142

$1,141

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts
of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.
Significant components of the company’s deferred tax liabilities and assets are as follows.
December 31,
20X1

December 31,
20X0

(Amounts in thousands)
Deferred tax liabilities:
Deferred policy acquisition costs
Future policy benefits
Accrual of discount on bonds
Other
Total deferred tax liabilities
Deferred tax assets:
Policyholder dividends
Future policy benefits
Deferred policy acquisition costs
Investment valuation allowance
Retirement plan accruals
Tax credits and loss carryforwards
Investment income differences
Other
Total deferred tax assets

$13,131
—
924
3,641

$12,297
512
1,982
1,024

17,696

15,815

8,067
851
2,078
1,087
1,917
1,820
574
406

8,224
—
1,561
1,651
497
1,945
556
354

16,800

14,788

Valuation allowance for deferred tax
assets

—

(516)

Net deferred tax assets

16,284

14,788

Net deferred tax liabilities

$ 1,412

$ 1,027

A valuation allowance has been established due to the uncertainty of realized certain tax credits and
loss carryforwards, and a portion of other deferred tax assets.
A reconciliation of federal income tax expense as presented in the financial statements and income
taxes calculated using the statutory corporate tax rate follows.
20X0

20X1
Income from operations
Application of income tax rate
Small company deduction for life insurance
companies

(Amounts in thousands)
$2,870
$2,396
838
(556)

1,005
(496)
(continued)
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20X1

20X0

(Amounts in thousands)
Policyholders’ share of income (loss) in excess
of (less than) dividends paid
Dividend received deduction
Other

(264)
(3)
127

Total tax expense

$ 142

752
(50)
(70)
$1,141

Reconciliation of Unrecognized Tax Benefits
20X1
Beginning Balance
Prior period position increases
Prior period position decreases
Current period position increases
Current period position decreases
Decreases relating to settlements with
taxing authorities
Reductions due to a lapse of applicable
statue of limitations
Ending balance

20X0

(Amounts in thousands)
$XXX
$XXX
XXX
XXX
(XXX)
(XXX)
XXX
XXX
(XXX)
(XXX)
(XXX)

(XXX)

(XXX)
XXX

(XXX)
XXX

None of the aforementioned unrecognized tax benefits, if recognized, would affect the effective tax
rate. Additionally, no tax positions exist for which it is reasonably possible that the total amounts of
unrecognized tax benefits will significantly increase or decrease within 12 months of December 31,
20X1. No interest or penalties were recognized in the statement of operations or the statement of financial position for the years ending December 31, 20X1 and 20X0. Tax years that remain subject to examination by major tax jurisdictions include the years ending December 31, 19X8–20X1.

7.
Financial Instruments With Off-Balance Sheet Risk and Concentration of Credit
Risk
At December 31, 20X1, ABC held unrated or less-than-investment grade corporate debt securities of
$8,000,000, net of allowance for losses, with an aggregate market value of $7,500,000. Those holdings
amounted to 4 percent of ABC’s corporate debt securities investments and less than 2 percent of total
assets. The holdings of less-than-investment grade securities are widely diversified and of satisfactory
quality based on ABC’s investment policies and credit standards. ABC also invests in mortgage loans
principally involving commercial real estate. At December 31, 20X1, 3 percent of such mortgages
($2,000,000) involved properties located in California and Arizona. Such investments consist of first
mortgage liens on completed income-producing properties, and mortgages on individual properties do
not exceed $300,000.

8.

Liability for Unpaid Claims

The liability for unpaid claims and claim adjustment expenses is based on the estimated amount payable on claims reported prior to the balance sheet date that have not yet been settled, claims reported
subsequent to the balance sheet date that have been incurred during the period then ended, and an
estimate (based on prior experience) of incurred but unreported claims relating to such period.
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Activity in the liability for unpaid claims and claim adjustment expenses for the company’s health and
disability coverages is summarized as follows.
20X0

20X1
Balance, beginning of year
Less: reinsurance recoverables

(Amounts in thousands)
$ 4,737
$ 7,669
296
1,018

Net balance, beginning of year

4,441

6,651

Amount incurred, related to prior years
Current year

$ (297)
26,197

$ 313
25,671

Total
Amount paid, related to prior years
Current year

25,900
6,923
18,303

25,984
8,937
19,257

25,226

28,194

5,115
303

4,441
296

$ 5,418

$ 4,737

Total
Net balance, end of year
Plus: reinsurance recoverables
Balance, end of year

As a result of changes in estimates of insured events in prior years, the provision of claims and claim
adjustment expenses (net of reinsurance recoveries of $(7,000) and $722,000 in 20X1 and 20X0, respectively) decreased by $297,000 in 20X1 reflecting lower-than-anticipated losses on pppppppppppppppp, and increased by $313,000 in 20X0 reflecting higher-than-anticipated losses and related expenses for claims
for ppppppppppppppp.

9.

Minimum Guarantees

The following summarizes the liabilities for guarantees on variable contracts reflected in the general
account.

Balance at January 1
Incurred guarantee benefits3
Paid guarantee benefits
Balance at December 31,
20XX4

Minimum
Guaranteed
Death Benefit
(MGDB)

Guaranteed
Minimum
Accumulation
Benefit
(GMAB)

Guaranteed
Minimum
Income
Benefit
(GMIB)

$X,XXX,XXX
X,XXX,XXX
X,XXX,XXX

$X,XXX,XXX
X,XXX,XXX
X,XXX,XXX

$X,XXX,XXX
X,XXX,XXX
X,XXX,XXX

$X,XXX,XXX
X,XXX,XXX
X,XXX,XXX

$X,XXX,XX

$X,XXX,XX

$X,XXX,XX

$X,XXX,XX

Totals

The minimum guaranteed death benefit (MGDB) liability is established equal to a benefit ratio multiplied by the cumulative contract charges earned, plus accrued interest less contract benefit payments.
The benefit ratio is calculated as the estimated present value of all expected contract benefits divided
by the present value of all expected contract charges. The company regularly evaluates estimates used
and adjusts the additional liability balance, with a related charge or credit to benefit expense, if actual
experience or other evidence suggests that earlier assumptions should be revised.

3
For guaranteed minimum accumulation benefits, incurred guarantee benefits incorporates all changes in fair value other than
amounts resulting from paid guarantee benefits.
4
Included in the total reserve balance are reserves for variable annuity death benefits of $XXX,XXX, variable annuity income benefits
of $XXX,XXX and other guarantees of $XXX,XXX.
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The following assumptions and methodology were used to determine the MGDB liability at December
31, 20XX:
●

Data used was 1,000 stochastically generated investment performance scenarios.

●

Mean investment performance assumption was XX.

●

Volatility assumption was XX.

●

Mortality was assumed to be 90 percent of the Annuity 2000 table.

●

Lapse rates vary by contract type and duration and range from 1 percent to 20 percent,
with an average of 3 percent.

●

Discount rate was XX percent.

Guaranteed minimum accumulation benefits are considered to be derivatives under FASB ASC 815,
Derivatives and Hedging, and are recognized at fair value through earnings.
The guaranteed minimum income benefit (GMIB) liability is established equal to a benefit ratio multiplied by the cumulative contract charges earned, plus accrued interest less contract benefit payments.
The benefit ratio is calculated as the estimated present value of all expected contract benefits divided
by the present value of all expected contract charges. The company regularly evaluates estimates used
and adjusts the additional liability balance, with a related charge or credit to benefit expense, if actual
experience or other evidence suggests that earlier assumptions should be revised. The assumptions
used for calculating the GMIB liability at December 31, 20XX, are consistent with those used for calculating the MGDB liability. Underlying assumptions for the liability related to income benefits include
assumed future annuitization elections based on factors such as the extent of benefit to the potential
annuitant, eligibility conditions and the annuitant’s attained age. In addition, the calculation of the
GMIB liability assumes X percent of the potential annuitizations that would be beneficial to the contract holder will be elected.

10.

Reinsurance

The company utilizes indemnity reinsurance agreements to reduce its exposure to large losses in all
aspects of its insurance business. Such reinsurance permits recovery of a portion of losses from reinsurers, although it does not discharge the primary liability of the company as direct insurer of the risks
reinsured. The company evaluates the financial strength of potential reinsurers and continually monitors the financial condition of reinsurers. The following tables include premium amounts ceded or
assumed to or from other companies.

Direct Amount

Ceded to Other
Companies

Assumed from
Other
Companies

Net Amount

(Amounts in thousands)
20X1
Premiums:
Life insurance
Accident and health
Annuities
Total earned premiums
20X0
Premiums:
Life insurance
Accident and health
Annuities
Total earned premiums
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$2,090
1,440
3,130

$560
1,290
—

$3,330
—
70

$4,860
150
3,200

$6,660

$1,850

$3,400

$8,210

$2,080
1,510
1,840

$520
1,370
—

$3,680
—
30

$5,240
140
1,870

$5,430

$1,890

$3,710

$7,250
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11.

Separate Accounts

At December 31, 20X0 and 20X1, the company had the following variable contracts with guarantees.
The company’s variable annuity contracts may offer more than one type of guarantee in each contract;
therefore, the sum of amounts listed exceeds the total account balances of variable annuity contracts’
separate accounts with guarantees.
Return of net deposits plus a minimum return:
In the event of death
Account value
Net amount at risk5
Average attained age of contract
holders
Range of guaranteed minimum
return rates
At annuitization
Account value
Net amount at risk6
Weighted average period
remaining until expected
annuitization
Range of guaranteed minimum
return rates
Accumulation at specified date
Account value
Net amount at risk7
Range of guaranteed minimum
return rates

$XXX
$XXX

$XXX
$XXX

XX

XX

X–X%

X–X%

$XXX
$XXX

$XXX
$XXX

XX

XX

X–X%

X–X%

$XXX
$XXX

$XXX
$XXX

X–X%

X–X%

Account balances of contracts with guarantees were invested in variable separate accounts as follows:
December 31,
20X0

Asset Type
U.S. Treasury securities and
obligations of U.S. government
corporations and agencies
Obligations of states of the United
States and political subdivisions of
the states

$

December 31,
20X1

$

Corporate debt securities:
—Investment grade
—Noninvestment grade
Foreign debt securities
Mortgage-backed securities
(continued)

5

Defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date.

6

Defined as the present value of the minimum guaranteed annuity payments determined in accordance with the terms of the contract
in excess of the current account balance.
7

Defined as the present value of the guaranteed minimum accumulation balance in excess of the current account balance.
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Equity securities (including mutual
funds)8
Real estate
Mortgage loans
Derivative financial instruments
Cash and cash equivalents
Total

$X,XXX,XXX

$X,XXX,XXX

Assets transferred from the general account to the separate accounts are recognized at fair value to the
extent of third party contract holders’ proportionate interest in separate accounts when the arrangement meets applicable criteria (FASB ASC 944-80-35-3). The gains recognized assets transferred to the
separate accounts during 20X1 and 20X0 were XX,XXX and XX,XXX, respectively.

12.

Guaranty Fund Assessments

At December 31, 20X1 and 20X0, ABC has recorded $45,000 and $67,000, respectively, in liabilities
related to guaranty fund (and other) assessments which are included in other liabilities in the balance
sheet. At December 31, 20X1 and 20X0, the carried liability was reduced by recoverables for related
premium tax offsets and policy surcharges in the amount of $25,000 and $35,000, respectively. The
period over which the assessments are expected to be paid and the recorded premium tax offsets and
policy surcharges are expected to be realized is up to five and four years, respectively.

13.

Statutory Financial Information

Under the law of ABC state, the state of incorporation, the maximum dividend that may be paid (without prior approval of the ABC state insurance department), in any 12 month period is the greater of
(a) net investment income for the preceding calendar year or (b) 10 percent of contract holders’ surplus
at the end of the preceding calendar year. In general, net investment income for dividend purposes is
interpreted by the insurance department to be the statutory pretax net investment income including
net realized capital losses but excluding net realized capital gains. The maximum permissible amount
of dividends for 20X3, based on statutory net investment income for 20X1, is $20,000.
The company, which is domiciled in ABC state, prepares its statutory financial statements in accordance with accounting principles and practices prescribed or permitted by the ABC state insurance
department, which (state of domicile) recognizes for determining solvency under the (state of domicile)
insurance law. The commissioner of the state of domicile insurance department has the right to permit
other practices that may deviate from prescribed practices. Prescribed SAP are those practices that are
incorporated directly or by reference in state laws, regulations, and general administrative rules applicable to all insurance enterprises domiciled in (state of domicile). Permitted SAP encompass all accounting practices that are not prescribed; such practices differ from state to state, may differ from
company to company within a state, and may change in the future.
Note: Although the following reconciliation to statutory financial information is not required to be
disclosed in financial statements prepared in conformity with GAAP, insurance entities sometimes
include such disclosures to facilitate use of those financial statements for purposes of filing with state

8
The insurance enterprise may want to consider disclosing mutual funds by investment objective or other meaningful groupings that
are useful in understanding the nature of the guarantee risk.
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regulatory authorities. The second disclosure on variances from NAIC SAP (defined as follows) and
permitted accounting practices is required under FASB ASC 944-505-50.
The following reconciles ABC’s statutory net income and statutory surplus and capital stock determined in accordance with accounting practices prescribed or permitted by the insurance department
of Connecticut with net earnings (loss) and equity on a GAAP basis.
20X1
Statutory net income
Adjustments:
Future policy benefits and policyholders’
account balances
Deferred policy acquisition costs
Deferred federal income tax (expense) benefit
Valuation of investments
Postretirement benefits
Other, net

20X0

(Amounts in thousands)
$ 3,572
$ 2,719

572
60
(1,405)
115
272
(932)

894
40
540
270
354
(3,088)

GAAP net income

$ 2,254

$ 1,729

Statutory surplus and capital stock
Adjustments:
Asset valuation reserves
Statutory surplus, capital stock and asset
valuation reserves
Fixed income securities
Future policy benefits and policyholders’
account balances
Deferred federal income taxes
Valuation of investments
Deferred policy acquisition costs
Postretirement benefits
Other, net

$65,388

$54,505

GAAP equity

$69,898

(1,054)

(1,972)

(875)
(29,472)

(967)
(27,905)

115
(1,412)
772
38,936
(2,272)
(228)

270
(1,027)
891
36,429
(2,354)
1,084
$58,954

The company’s statutory financial statements are presented on the basis of accounting practices prescribed or permitted by the [state of domicile] insurance department. [State of domicile] has adopted the
NAIC Accounting Practices and Procedures Manual as the basis of its SAP, except that it has retained the
prescribed practice of writing off goodwill immediately to statutory surplus in the year of acquisition.
In addition, the commissioner of [state of domicile] insurance department has the right to permit other
specific practices that may deviate from prescribed practices. The commissioner has permitted the company to record its home office property at estimated fair value instead of at depreciated cost, as required by NAIC SAP. This accounting practice increased statutory capital and surplus by $X million
and $X million at December 31, 20X1 and 20X0, respectively, over what it would have been had the
permitted practice not been allowed. The company’s statutory capital and surplus, including the effects
of the permitted practice, was $X million and $X million at December 31, 20X1 and 20X0, respectively.
Had the company amortized its goodwill over ten years and recorded its home office property at
depreciated cost, in accordance with NAIC SAP, the company’s capital and surplus would have been
$X million and $X million at December 31, 20X1 and 20X0, respectively.
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Commitments and Contingencies

Future minimum rental payments, principally for administrative offices, under noncancellable operating leases at December 31, 20X1, are as follows: 20X2, $1,113,000; 20X3, $1,064,000; 20X4, $1,011,000;
20X5, $976,000; 20X6, $976,000; and $3,906,000 thereafter. Rental expense was $1,164,000 in 20X1 and
$1,184,000 in 20X0.
ABC is named as defendant in a number of legal actions arising primarily from claims made under
insurance contracts or in connection with previous reinsurance agreements. These actions have been
considered in establishing its contract benefit liability. Management and its legal counsel are of the
opinion that the settlement of these actions will not have a material effect on ABC’s financial position
or results of operations.
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Your Opinion Matters
Thank you for selecting this publication for your accounting or auditing needs.
At the AICPA, we strive to provide the most useful publications available to the profession, which have been
produced with the highest quality. Responsiveness to our members and the profession as a whole is our
hallmark. We rely on feedback from our users to continually hone and improve our products.
Please take a few moments to let us know what you think of this edition. Does it meet your needs? Is it written
clearly? Is it comprehensive in its coverage? Is it easy to use? If not, how can we improve it?
Send your feedback by e-mail to A&APublications@aicpa.org.
Please note the name and edition of the publication, answers to the preceding questions, and anything else
you would like to share with us. Your feedback will help us improve subsequent editions and better serve
you.
Do you want to help even more?
Consider participating in a focus or advisory group related to this subject matter. If you are interested in, and
available for, participating in such a group, please be sure to include that information in your e-mail.
Thank you in advance for taking the time to write. We appreciate your feedback!

Additional Publications for Your Financial Reporting Library
Checklists and Illustrative Financial Statements

AICPA publishes a full range of Checklists to help you prepare financial statements and assist you
in determining the adequacy of disclosures in the financial statements you’re auditing.

AICPA Checklists include:

Corporations
Defined Benefit Pension Plans
Defined Contribution Pension Plans
Depository and Lending Institutions
Health and Welfare Benefit Plans
Health Care Entities
Life and Health Insurance
Not-for-Profit Entities
Property & Liability Insurance Entities
State and Local Governments
Supplements to Corporations Checklist
Real Estate and Construction Contractors
Investment Companies

*****
Audit and Accounting Guides

The content and guidance you trust in the AICPA Audit and Accounting Guides
are being updated for FASB Accounting Standards Codification™(ASC).
To help you during this transition, all non-governmental accounting guidance
in the 2009 editions, as applicable, contains FASB ASC references and content.

AICPA Audit and Accounting Industry Guides include:

Airlines
Brokers and Dealers in Securities
Casinos
Construction Contractors
Depository and Lending Institutions: Banks and Savings Institutions, Credit
Unions, Finance Companies, and Mortgage Companies
Employee Benefit Plans
Entities With Oil and Gas Producing Activities
Government Auditing Standards and Circular A-133 Audits
Health Care Entities
Investment Companies
Life & Health Insurance Entities
Not-for-Profit Entities
Property and Liability Insurance Entities
State and Local Governments

Audit and Accounting Guides – General Guides

Analytical Procedures
Audit Sampling
Auditing Derivative Instruments, Hedging Activities, and Investments in Securities
Auditing Revenue in Certain Industries
Assessing and Responding to Audit Risk In a Financial Statement Audit
Prospective Financial Information
Service Organizations: Applying SAS No. 70, as Amended

For complete details on any of the titles listed above
including Table of Contents, Excerpts, and availability
– and to order – visit the AICPA Store
at www.cpa2biz.com/publications. Or call 1-888-777-7077.

AICPA RESOURCE:
Accounting & Auditing Literature
AICPA RESOURCE is a powerful online research tool that gives you access to the most
comprehensive, up-to-date accounting and auditing information available anywhere —
all linked and cross-referenced for easy information retrieval. AICPA RESOURCE includes
the AICPA, FASB Codification and GASB libraries.You’ll find subscriptions to the following:
• AICPA Professional Standards
• AICPA Technical Practice Aids
• AICPA Accounting Trends & Techniques
• AICPA Audit and Accounting Guides
• AICPA Audit Risk Alerts
• AICPA Checklists and Illustrative Financial Statements
• AICPA Audit & Accounting Manual
• FASB Accounting Standards Codification™
• GASB Original Pronouncements
• Codification of Governmental Accounting and Financial Reporting Standards
• GASB Implementation Guides
• GASB’s Comprehensive Topical Index
Search for pertinent information from both databases by keyword and get the
results ranked by relevancy. Print out important AICPA RESOURCE segments
and integrate the literature into your engagements and financial statements.
Available from anywhere you have Internet access, this comprehensive reference
library is packed with the A & A guidance you need — and use — the most. All
libraries are updated with the latest standards and guidance.
AICPA Complete Library with FASB Codification and GASB Library, No. WGLBY12
AICPA Complete Library with FASB Codification, No. WFLBY12
AICPA Complete Library, No. WALBY12
AICPA Accounting Guidance Library featuring the FASB Accounting
Standards Codification™ and AICPA Audit and Accounting Guides, No. WGCXX12
Log onto www.cpa2biz.com/AICPAresource for subscription details.

